id	sid	tid	token	lemma	pos
ijassa-759	1	1	2017	2017	NUM
ijassa-759	1	2	г	г	PROPN
ijassa-759	1	3	adv	adv	PROPN
ijassa-759	1	4	syst	syst	PROPN
ijassa-759	1	5	sci	sci	PROPN
ijassa-759	1	6	appl	appl	PROPN
ijassa-759	1	7	2020	2020	NUM
ijassa-759	1	8	;	;	PUNCT
ijassa-759	1	9	03	03	NUM
ijassa-759	1	10	;	;	PUNCT
ijassa-759	1	11	1	1	NUM
ijassa-759	1	12	-	-	SYM
ijassa-759	1	13	23	23	NUM
ijassa-759	1	14	published	publish	VERB
ijassa-759	1	15	online	online	ADV
ijassa-759	1	16	at	at	ADP
ijassa-759	1	17	https://ijassa.ipu.ru	https://ijassa.ipu.ru	ADV
ijassa-759	1	18	.	.	PUNCT
ijassa-759	2	1	mathematical	mathematical	ADJ
ijassa-759	2	2	modeling	modeling	NOUN
ijassa-759	2	3	of	of	ADP
ijassa-759	2	4	antitumor	antitumor	PROPN
ijassa-759	2	5	viral	viral	ADJ
ijassa-759	2	6	vaccine	vaccine	NOUN
ijassa-759	2	7	therapy	therapy	NOUN
ijassa-759	2	8	:	:	PUNCT
ijassa-759	2	9	from	from	ADP
ijassa-759	2	10	the	the	DET
ijassa-759	2	11	experiment	experiment	NOUN
ijassa-759	2	12	to	to	ADP
ijassa-759	2	13	the	the	DET
ijassa-759	2	14	clinic	clinic	NOUN
ijassa-759	2	15	nina	nina	PROPN
ijassa-759	2	16	a.	a.	PROPN
ijassa-759	2	17	babushkina1	babushkina1	PROPN
ijassa-759	2	18	*	*	PROPN
ijassa-759	2	19	,	,	PUNCT
ijassa-759	2	20	ekaterina	ekaterina	PROPN
ijassa-759	2	21	a.	a.	PROPN
ijassa-759	2	22	kuzina1	kuzina1	PROPN
ijassa-759	2	23	1	1	X
ijassa-759	2	24	)	)	PUNCT
ijassa-759	2	25	v.a	v.a	PROPN
ijassa-759	2	26	.	.	PROPN
ijassa-759	2	27	trapeznikov	trapeznikov	PROPN
ijassa-759	2	28	institute	institute	PROPN
ijassa-759	2	29	of	of	ADP
ijassa-759	2	30	control	control	PROPN
ijassa-759	2	31	sciences	sciences	PROPN
ijassa-759	2	32	of	of	ADP
ijassa-759	2	33	russian	russian	ADJ
ijassa-759	2	34	academy	academy	PROPN
ijassa-759	2	35	of	of	ADP
ijassa-759	2	36	sciences	sciences	PROPN
ijassa-759	2	37	,	,	PUNCT
ijassa-759	2	38	117997	117997	NUM
ijassa-759	2	39	,	,	PUNCT
ijassa-759	2	40	profsoyuznaya	profsoyuznaya	NOUN
ijassa-759	2	41	street	street	PROPN
ijassa-759	2	42	,	,	PUNCT
ijassa-759	2	43	65	65	NUM
ijassa-759	2	44	,	,	PUNCT
ijassa-759	2	45	moscow	moscow	PROPN
ijassa-759	2	46	,	,	PUNCT
ijassa-759	2	47	russia	russia	PROPN
ijassa-759	2	48	e	e	NOUN
ijassa-759	2	49	-	-	NOUN
ijassa-759	2	50	mail	mail	NOUN
ijassa-759	2	51	:	:	PUNCT
ijassa-759	2	52	babushkina_na@mail.ru	babushkina_na@mail.ru	PROPN
ijassa-759	2	53	,	,	PUNCT
ijassa-759	2	54	kate_k93@mail.ru	kate_k93@mail.ru	ADV
ijassa-759	2	55	abstract	abstract	ADJ
ijassa-759	2	56	:	:	PUNCT
ijassa-759	2	57	the	the	DET
ijassa-759	2	58	paper	paper	NOUN
ijassa-759	2	59	presents	present	VERB
ijassa-759	2	60	the	the	DET
ijassa-759	2	61	model	model	NOUN
ijassa-759	2	62	developed	develop	VERB
ijassa-759	2	63	to	to	PART
ijassa-759	2	64	identify	identify	VERB
ijassa-759	2	65	efficient	efficient	ADJ
ijassa-759	2	66	strategies	strategy	NOUN
ijassa-759	2	67	of	of	ADP
ijassa-759	2	68	antitumor	antitumor	PROPN
ijassa-759	2	69	viral	viral	ADJ
ijassa-759	2	70	vaccine	vaccine	NOUN
ijassa-759	2	71	introduction	introduction	NOUN
ijassa-759	2	72	.	.	PUNCT
ijassa-759	3	1	these	these	DET
ijassa-759	3	2	strategies	strategy	NOUN
ijassa-759	3	3	are	be	AUX
ijassa-759	3	4	able	able	ADJ
ijassa-759	3	5	to	to	PART
ijassa-759	3	6	produce	produce	VERB
ijassa-759	3	7	complete	complete	ADJ
ijassa-759	3	8	suppression	suppression	NOUN
ijassa-759	3	9	of	of	ADP
ijassa-759	3	10	the	the	DET
ijassa-759	3	11	tumor	tumor	NOUN
ijassa-759	3	12	growth	growth	NOUN
ijassa-759	3	13	.	.	PUNCT
ijassa-759	4	1	the	the	DET
ijassa-759	4	2	model	model	NOUN
ijassa-759	4	3	was	be	AUX
ijassa-759	4	4	developed	develop	VERB
ijassa-759	4	5	in	in	ADP
ijassa-759	4	6	matlab	matlab	PROPN
ijassa-759	4	7	-	-	PUNCT
ijassa-759	4	8	simulink	simulink	NOUN
ijassa-759	4	9	.	.	PUNCT
ijassa-759	5	1	three	three	NUM
ijassa-759	5	2	efficient	efficient	ADJ
ijassa-759	5	3	strategies	strategy	NOUN
ijassa-759	5	4	of	of	ADP
ijassa-759	5	5	viral	viral	ADJ
ijassa-759	5	6	vaccine	vaccine	NOUN
ijassa-759	5	7	introduction	introduction	NOUN
ijassa-759	5	8	were	be	AUX
ijassa-759	5	9	produced	produce	VERB
ijassa-759	5	10	.	.	PUNCT
ijassa-759	6	1	it	it	PRON
ijassa-759	6	2	was	be	AUX
ijassa-759	6	3	found	find	VERB
ijassa-759	6	4	that	that	SCONJ
ijassa-759	6	5	the	the	DET
ijassa-759	6	6	choice	choice	NOUN
ijassa-759	6	7	of	of	ADP
ijassa-759	6	8	the	the	DET
ijassa-759	6	9	strategy	strategy	NOUN
ijassa-759	6	10	depends	depend	VERB
ijassa-759	6	11	on	on	ADP
ijassa-759	6	12	the	the	DET
ijassa-759	6	13	tumor	tumor	NOUN
ijassa-759	6	14	size	size	NOUN
ijassa-759	6	15	at	at	ADP
ijassa-759	6	16	the	the	DET
ijassa-759	6	17	start	start	NOUN
ijassa-759	6	18	of	of	ADP
ijassa-759	6	19	the	the	DET
ijassa-759	6	20	treatment	treatment	NOUN
ijassa-759	6	21	,	,	PUNCT
ijassa-759	6	22	and	and	CCONJ
ijassa-759	6	23	the	the	DET
ijassa-759	6	24	range	range	NOUN
ijassa-759	6	25	of	of	ADP
ijassa-759	6	26	the	the	DET
ijassa-759	6	27	tumor	tumor	NOUN
ijassa-759	6	28	sizes	size	NOUN
ijassa-759	6	29	for	for	ADP
ijassa-759	6	30	each	each	PRON
ijassa-759	6	31	of	of	ADP
ijassa-759	6	32	the	the	DET
ijassa-759	6	33	strategies	strategy	NOUN
ijassa-759	6	34	was	be	AUX
ijassa-759	6	35	identified	identify	VERB
ijassa-759	6	36	.	.	PUNCT
ijassa-759	7	1	for	for	ADP
ijassa-759	7	2	the	the	DET
ijassa-759	7	3	small	small	ADJ
ijassa-759	7	4	tumors	tumor	NOUN
ijassa-759	7	5	,	,	PUNCT
ijassa-759	7	6	elimination	elimination	NOUN
ijassa-759	7	7	of	of	ADP
ijassa-759	7	8	the	the	DET
ijassa-759	7	9	tumor	tumor	NOUN
ijassa-759	7	10	can	can	AUX
ijassa-759	7	11	be	be	AUX
ijassa-759	7	12	achieved	achieve	VERB
ijassa-759	7	13	through	through	ADP
ijassa-759	7	14	single	single	ADJ
ijassa-759	7	15	-	-	PUNCT
ijassa-759	7	16	shot	shoot	VERB
ijassa-759	7	17	vaccine	vaccine	NOUN
ijassa-759	7	18	administration	administration	NOUN
ijassa-759	7	19	in	in	ADP
ijassa-759	7	20	dosages	dosage	NOUN
ijassa-759	7	21	that	that	PRON
ijassa-759	7	22	lead	lead	VERB
ijassa-759	7	23	to	to	ADP
ijassa-759	7	24	the	the	DET
ijassa-759	7	25	death	death	NOUN
ijassa-759	7	26	of	of	ADP
ijassa-759	7	27	tumor	tumor	NOUN
ijassa-759	7	28	cells	cell	NOUN
ijassa-759	7	29	caused	cause	VERB
ijassa-759	7	30	directly	directly	ADV
ijassa-759	7	31	by	by	ADP
ijassa-759	7	32	the	the	DET
ijassa-759	7	33	virus	virus	NOUN
ijassa-759	7	34	.	.	PUNCT
ijassa-759	8	1	for	for	ADP
ijassa-759	8	2	the	the	DET
ijassa-759	8	3	big	big	ADJ
ijassa-759	8	4	tumors	tumor	NOUN
ijassa-759	8	5	that	that	PRON
ijassa-759	8	6	are	be	AUX
ijassa-759	8	7	within	within	ADP
ijassa-759	8	8	the	the	DET
ijassa-759	8	9	threshold	threshold	NOUN
ijassa-759	8	10	size	size	NOUN
ijassa-759	8	11	,	,	PUNCT
ijassa-759	8	12	elimination	elimination	NOUN
ijassa-759	8	13	of	of	ADP
ijassa-759	8	14	the	the	DET
ijassa-759	8	15	tumor	tumor	NOUN
ijassa-759	8	16	can	can	AUX
ijassa-759	8	17	be	be	AUX
ijassa-759	8	18	achieved	achieve	VERB
ijassa-759	8	19	through	through	ADP
ijassa-759	8	20	repeated	repeat	VERB
ijassa-759	8	21	vaccine	vaccine	NOUN
ijassa-759	8	22	administrations	administration	NOUN
ijassa-759	8	23	with	with	ADP
ijassa-759	8	24	stepwise	stepwise	ADJ
ijassa-759	8	25	reduction	reduction	NOUN
ijassa-759	8	26	of	of	ADP
ijassa-759	8	27	time	time	NOUN
ijassa-759	8	28	periods	period	NOUN
ijassa-759	8	29	between	between	ADP
ijassa-759	8	30	them	they	PRON
ijassa-759	8	31	.	.	PUNCT
ijassa-759	9	1	for	for	ADP
ijassa-759	9	2	the	the	DET
ijassa-759	9	3	tumors	tumor	NOUN
ijassa-759	9	4	of	of	ADP
ijassa-759	9	5	any	any	DET
ijassa-759	9	6	size	size	NOUN
ijassa-759	9	7	,	,	PUNCT
ijassa-759	9	8	the	the	DET
ijassa-759	9	9	strategy	strategy	NOUN
ijassa-759	9	10	of	of	ADP
ijassa-759	9	11	repeated	repeat	VERB
ijassa-759	9	12	administration	administration	NOUN
ijassa-759	9	13	of	of	ADP
ijassa-759	9	14	the	the	DET
ijassa-759	9	15	virusbased	virusbase	VERB
ijassa-759	9	16	vaccine	vaccine	NOUN
ijassa-759	9	17	that	that	PRON
ijassa-759	9	18	allows	allow	VERB
ijassa-759	9	19	stabilizing	stabilize	VERB
ijassa-759	9	20	the	the	DET
ijassa-759	9	21	tumor	tumor	NOUN
ijassa-759	9	22	size	size	NOUN
ijassa-759	9	23	as	as	ADP
ijassa-759	9	24	per	per	ADP
ijassa-759	9	25	the	the	DET
ijassa-759	9	26	start	start	NOUN
ijassa-759	9	27	of	of	ADP
ijassa-759	9	28	the	the	DET
ijassa-759	9	29	treatment	treatment	NOUN
ijassa-759	9	30	was	be	AUX
ijassa-759	9	31	defined	define	VERB
ijassa-759	9	32	.	.	PUNCT
ijassa-759	10	1	keywords	keyword	NOUN
ijassa-759	10	2	:	:	PUNCT
ijassa-759	10	3	mathematical	mathematical	ADJ
ijassa-759	10	4	model	model	NOUN
ijassa-759	10	5	,	,	PUNCT
ijassa-759	10	6	experimental	experimental	ADJ
ijassa-759	10	7	oncology	oncology	NOUN
ijassa-759	10	8	,	,	PUNCT
ijassa-759	10	9	tumor	tumor	NOUN
ijassa-759	10	10	cells	cell	NOUN
ijassa-759	10	11	,	,	PUNCT
ijassa-759	10	12	kinetic	kinetic	ADJ
ijassa-759	10	13	growth	growth	NOUN
ijassa-759	10	14	curves	curve	NOUN
ijassa-759	10	15	,	,	PUNCT
ijassa-759	10	16	vaccine	vaccine	NOUN
ijassa-759	10	17	therapy	therapy	NOUN
ijassa-759	10	18	,	,	PUNCT
ijassa-759	10	19	virus	virus	NOUN
ijassa-759	10	20	,	,	PUNCT
ijassa-759	10	21	immune	immune	ADJ
ijassa-759	10	22	response	response	NOUN
ijassa-759	10	23	,	,	PUNCT
ijassa-759	10	24	antibodies	antibodie	VERB
ijassa-759	10	25	,	,	PUNCT
ijassa-759	10	26	allometric	allometric	ADJ
ijassa-759	10	27	proportions	proportion	NOUN
ijassa-759	10	28	1	1	NUM
ijassa-759	10	29	.	.	PUNCT
ijassa-759	11	1	introduction	introduction	NOUN
ijassa-759	11	2	effective	effective	ADJ
ijassa-759	11	3	treatment	treatment	NOUN
ijassa-759	11	4	of	of	ADP
ijassa-759	11	5	cancer	cancer	NOUN
ijassa-759	11	6	remains	remain	VERB
ijassa-759	11	7	one	one	NUM
ijassa-759	11	8	of	of	ADP
ijassa-759	11	9	the	the	DET
ijassa-759	11	10	key	key	ADJ
ijassa-759	11	11	challenges	challenge	NOUN
ijassa-759	11	12	of	of	ADP
ijassa-759	11	13	contemporary	contemporary	ADJ
ijassa-759	11	14	healthcare	healthcare	PROPN
ijassa-759	11	15	.	.	PUNCT
ijassa-759	12	1	addressing	address	VERB
ijassa-759	12	2	this	this	DET
ijassa-759	12	3	challenge	challenge	NOUN
ijassa-759	12	4	requires	require	VERB
ijassa-759	12	5	extensive	extensive	ADJ
ijassa-759	12	6	research	research	NOUN
ijassa-759	12	7	based	base	VERB
ijassa-759	12	8	on	on	ADP
ijassa-759	12	9	experimental	experimental	ADJ
ijassa-759	12	10	studies	study	NOUN
ijassa-759	12	11	that	that	PRON
ijassa-759	12	12	are	be	AUX
ijassa-759	12	13	further	far	ADV
ijassa-759	12	14	translated	translate	VERB
ijassa-759	12	15	into	into	ADP
ijassa-759	12	16	clinic	clinic	NOUN
ijassa-759	12	17	.	.	PUNCT
ijassa-759	13	1	one	one	NUM
ijassa-759	13	2	of	of	ADP
ijassa-759	13	3	the	the	DET
ijassa-759	13	4	promising	promising	ADJ
ijassa-759	13	5	directions	direction	NOUN
ijassa-759	13	6	for	for	ADP
ijassa-759	13	7	combating	combat	VERB
ijassa-759	13	8	oncological	oncological	ADJ
ijassa-759	13	9	diseases	disease	NOUN
ijassa-759	13	10	is	be	AUX
ijassa-759	13	11	the	the	DET
ijassa-759	13	12	development	development	NOUN
ijassa-759	13	13	of	of	ADP
ijassa-759	13	14	different	different	ADJ
ijassa-759	13	15	treatment	treatment	NOUN
ijassa-759	13	16	methods	method	NOUN
ijassa-759	13	17	within	within	ADP
ijassa-759	13	18	the	the	DET
ijassa-759	13	19	domain	domain	NOUN
ijassa-759	13	20	of	of	ADP
ijassa-759	13	21	immunotherapy	immunotherapy	NOUN
ijassa-759	13	22	.	.	PUNCT
ijassa-759	14	1	cancer	cancer	NOUN
ijassa-759	14	2	immunotherapy	immunotherapy	NOUN
ijassa-759	14	3	research	research	NOUN
ijassa-759	14	4	by	by	ADP
ijassa-759	14	5	j.	j.	PROPN
ijassa-759	14	6	allison	allison	PROPN
ijassa-759	14	7	and	and	CCONJ
ijassa-759	14	8	t.	t.	PROPN
ijassa-759	14	9	honjo	honjo	PROPN
ijassa-759	14	10	was	be	AUX
ijassa-759	14	11	awarded	award	VERB
ijassa-759	14	12	2018	2018	NUM
ijassa-759	14	13	nobel	nobel	PROPN
ijassa-759	14	14	prize	prize	PROPN
ijassa-759	14	15	in	in	ADP
ijassa-759	14	16	medicine	medicine	NOUN
ijassa-759	14	17	.	.	PUNCT
ijassa-759	15	1	significant	significant	ADJ
ijassa-759	15	2	progress	progress	NOUN
ijassa-759	15	3	in	in	ADP
ijassa-759	15	4	cancer	cancer	NOUN
ijassa-759	15	5	treatment	treatment	NOUN
ijassa-759	15	6	was	be	AUX
ijassa-759	15	7	produced	produce	VERB
ijassa-759	15	8	by	by	ADP
ijassa-759	15	9	breakthroughs	breakthrough	NOUN
ijassa-759	15	10	in	in	ADP
ijassa-759	15	11	molecular	molecular	ADJ
ijassa-759	15	12	biology	biology	NOUN
ijassa-759	15	13	and	and	CCONJ
ijassa-759	15	14	immunology	immunology	NOUN
ijassa-759	15	15	that	that	PRON
ijassa-759	15	16	made	make	VERB
ijassa-759	15	17	it	it	PRON
ijassa-759	15	18	possible	possible	ADJ
ijassa-759	15	19	to	to	PART
ijassa-759	15	20	understand	understand	VERB
ijassa-759	15	21	the	the	DET
ijassa-759	15	22	reasons	reason	NOUN
ijassa-759	15	23	behind	behind	ADP
ijassa-759	15	24	tumor	tumor	NOUN
ijassa-759	15	25	degeneration	degeneration	NOUN
ijassa-759	15	26	and	and	CCONJ
ijassa-759	15	27	the	the	DET
ijassa-759	15	28	development	development	NOUN
ijassa-759	15	29	of	of	ADP
ijassa-759	15	30	tumor	tumor	NOUN
ijassa-759	15	31	process	process	NOUN
ijassa-759	15	32	[	[	X
ijassa-759	15	33	1	1	NUM
ijassa-759	15	34	-	-	SYM
ijassa-759	15	35	3	3	NUM
ijassa-759	15	36	]	]	PUNCT
ijassa-759	15	37	.	.	PUNCT
ijassa-759	16	1	immune	immune	ADJ
ijassa-759	16	2	system	system	NOUN
ijassa-759	16	3	can	can	AUX
ijassa-759	16	4	resist	resist	VERB
ijassa-759	16	5	the	the	DET
ijassa-759	16	6	emergence	emergence	NOUN
ijassa-759	16	7	and	and	CCONJ
ijassa-759	16	8	development	development	NOUN
ijassa-759	16	9	of	of	ADP
ijassa-759	16	10	the	the	DET
ijassa-759	16	11	tumor	tumor	NOUN
ijassa-759	16	12	process	process	NOUN
ijassa-759	16	13	,	,	PUNCT
ijassa-759	16	14	and	and	CCONJ
ijassa-759	16	15	the	the	DET
ijassa-759	16	16	aim	aim	NOUN
ijassa-759	16	17	of	of	ADP
ijassa-759	16	18	immunotherapy	immunotherapy	NOUN
ijassa-759	16	19	is	be	AUX
ijassa-759	16	20	to	to	PART
ijassa-759	16	21	stimulate	stimulate	VERB
ijassa-759	16	22	the	the	DET
ijassa-759	16	23	immune	immune	ADJ
ijassa-759	16	24	system	system	NOUN
ijassa-759	16	25	to	to	PART
ijassa-759	16	26	fight	fight	VERB
ijassa-759	16	27	against	against	ADP
ijassa-759	16	28	the	the	DET
ijassa-759	16	29	tumor	tumor	NOUN
ijassa-759	16	30	cells	cell	NOUN
ijassa-759	16	31	.	.	PUNCT
ijassa-759	17	1	there	there	PRON
ijassa-759	17	2	are	be	VERB
ijassa-759	17	3	two	two	NUM
ijassa-759	17	4	ways	way	NOUN
ijassa-759	17	5	to	to	PART
ijassa-759	17	6	stimulate	stimulate	VERB
ijassa-759	17	7	the	the	DET
ijassa-759	17	8	immune	immune	ADJ
ijassa-759	17	9	system	system	NOUN
ijassa-759	17	10	:	:	PUNCT
ijassa-759	17	11	specific	specific	ADJ
ijassa-759	17	12	and	and	CCONJ
ijassa-759	17	13	non	non	ADJ
ijassa-759	17	14	-	-	ADJ
ijassa-759	17	15	specific	specific	ADJ
ijassa-759	17	16	.	.	PUNCT
ijassa-759	18	1	specific	specific	ADJ
ijassa-759	18	2	antitumor	antitumor	PROPN
ijassa-759	18	3	vaccines	vaccine	NOUN
ijassa-759	18	4	are	be	AUX
ijassa-759	18	5	based	base	VERB
ijassa-759	18	6	on	on	ADP
ijassa-759	18	7	dendritic	dendritic	ADJ
ijassa-759	18	8	cells	cell	NOUN
ijassa-759	18	9	that	that	PRON
ijassa-759	18	10	carry	carry	VERB
ijassa-759	18	11	the	the	DET
ijassa-759	18	12	information	information	NOUN
ijassa-759	18	13	on	on	ADP
ijassa-759	18	14	the	the	DET
ijassa-759	18	15	antigens	antigen	NOUN
ijassa-759	18	16	specific	specific	ADJ
ijassa-759	18	17	for	for	ADP
ijassa-759	18	18	each	each	DET
ijassa-759	18	19	type	type	NOUN
ijassa-759	18	20	of	of	ADP
ijassa-759	18	21	tumor	tumor	NOUN
ijassa-759	18	22	[	[	X
ijassa-759	18	23	4	4	NUM
ijassa-759	18	24	-	-	SYM
ijassa-759	18	25	8	8	NUM
ijassa-759	18	26	]	]	PUNCT
ijassa-759	18	27	.	.	PUNCT
ijassa-759	19	1	non	non	ADJ
ijassa-759	19	2	-	-	ADJ
ijassa-759	19	3	specific	specific	ADJ
ijassa-759	19	4	virus	virus	NOUN
ijassa-759	19	5	-	-	PUNCT
ijassa-759	19	6	based	base	VERB
ijassa-759	19	7	antitumor	antitumor	PROPN
ijassa-759	19	8	vaccines	vaccine	NOUN
ijassa-759	19	9	can	can	AUX
ijassa-759	19	10	induce	induce	VERB
ijassa-759	19	11	the	the	DET
ijassa-759	19	12	immune	immune	ADJ
ijassa-759	19	13	response	response	NOUN
ijassa-759	19	14	against	against	ADP
ijassa-759	19	15	the	the	DET
ijassa-759	19	16	tumor	tumor	NOUN
ijassa-759	19	17	by	by	ADP
ijassa-759	19	18	producing	produce	VERB
ijassa-759	19	19	new	new	ADJ
ijassa-759	19	20	protein	protein	NOUN
ijassa-759	19	21	formations	formation	NOUN
ijassa-759	19	22	on	on	ADP
ijassa-759	19	23	the	the	DET
ijassa-759	19	24	surface	surface	NOUN
ijassa-759	19	25	of	of	ADP
ijassa-759	19	26	the	the	DET
ijassa-759	19	27	tumor	tumor	NOUN
ijassa-759	19	28	cells	cell	NOUN
ijassa-759	19	29	[	[	X
ijassa-759	19	30	913	913	NUM
ijassa-759	19	31	]	]	X
ijassa-759	19	32	.	.	PUNCT
ijassa-759	20	1	such	such	ADJ
ijassa-759	20	2	vaccines	vaccine	NOUN
ijassa-759	20	3	are	be	AUX
ijassa-759	20	4	based	base	VERB
ijassa-759	20	5	on	on	ADP
ijassa-759	20	6	the	the	DET
ijassa-759	20	7	viruses	virus	NOUN
ijassa-759	20	8	that	that	PRON
ijassa-759	20	9	are	be	AUX
ijassa-759	20	10	not	not	PART
ijassa-759	20	11	dangerous	dangerous	ADJ
ijassa-759	20	12	for	for	ADP
ijassa-759	20	13	the	the	DET
ijassa-759	20	14	humans	human	NOUN
ijassa-759	20	15	but	but	CCONJ
ijassa-759	20	16	are	be	AUX
ijassa-759	20	17	able	able	ADJ
ijassa-759	20	18	to	to	PART
ijassa-759	20	19	identify	identify	VERB
ijassa-759	20	20	and	and	CCONJ
ijassa-759	20	21	destroy	destroy	VERB
ijassa-759	20	22	the	the	DET
ijassa-759	20	23	tumor	tumor	NOUN
ijassa-759	20	24	cells	cell	NOUN
ijassa-759	20	25	[	[	X
ijassa-759	20	26	14	14	NUM
ijassa-759	20	27	-	-	SYM
ijassa-759	20	28	17	17	NUM
ijassa-759	20	29	]	]	PUNCT
ijassa-759	20	30	.	.	PUNCT
ijassa-759	21	1	the	the	DET
ijassa-759	21	2	virus	virus	NOUN
ijassa-759	21	3	is	be	AUX
ijassa-759	21	4	able	able	ADJ
ijassa-759	21	5	to	to	PART
ijassa-759	21	6	induce	induce	VERB
ijassa-759	21	7	the	the	DET
ijassa-759	21	8	process	process	NOUN
ijassa-759	21	9	of	of	ADP
ijassa-759	21	10	tumor	tumor	NOUN
ijassa-759	21	11	cells	cell	NOUN
ijassa-759	21	12	’	'	PUNCT
ijassa-759	21	13	death	death	NOUN
ijassa-759	21	14	that	that	PRON
ijassa-759	21	15	has	have	VERB
ijassa-759	21	16	two	two	NUM
ijassa-759	21	17	stages	stage	NOUN
ijassa-759	21	18	.	.	PUNCT
ijassa-759	22	1	the	the	DET
ijassa-759	22	2	first	first	ADJ
ijassa-759	22	3	stage	stage	NOUN
ijassa-759	22	4	is	be	AUX
ijassa-759	22	5	produced	produce	VERB
ijassa-759	22	6	by	by	ADP
ijassa-759	22	7	the	the	DET
ijassa-759	22	8	virus	virus	NOUN
ijassa-759	22	9	itself	itself	PRON
ijassa-759	22	10	.	.	PUNCT
ijassa-759	23	1	settling	settle	VERB
ijassa-759	23	2	down	down	ADP
ijassa-759	23	3	on	on	ADP
ijassa-759	23	4	the	the	DET
ijassa-759	23	5	tumor	tumor	NOUN
ijassa-759	23	6	cell	cell	NOUN
ijassa-759	23	7	,	,	PUNCT
ijassa-759	23	8	the	the	DET
ijassa-759	23	9	virus	virus	NOUN
ijassa-759	23	10	penetrates	penetrate	VERB
ijassa-759	23	11	*	*	PUNCT
ijassa-759	23	12	corresponding	correspond	VERB
ijassa-759	23	13	author	author	NOUN
ijassa-759	23	14	:	:	PUNCT
ijassa-759	23	15	babushkina_na@mail.ru	babushkina_na@mail.ru	PROPN
ijassa-759	23	16	mailto:babushkina_na@mail.ru	mailto:babushkina_na@mail.ru	PROPN
ijassa-759	23	17	mailto:kate_k93@mail.ru	mailto:kate_k93@mail.ru	PROPN
ijassa-759	23	18	n.a	n.a	PROPN
ijassa-759	23	19	.	.	PROPN
ijassa-759	23	20	babushkina	babushkina	PROPN
ijassa-759	23	21	,	,	PUNCT
ijassa-759	24	1	e.a	e.a	PROPN
ijassa-759	24	2	.	.	PROPN
ijassa-759	24	3	kuzina	kuzina	PROPN
ijassa-759	24	4	copyright	copyright	PROPN
ijassa-759	24	5	©	©	PROPN
ijassa-759	24	6	2020	2020	NUM
ijassa-759	24	7	assa	assa	NOUN
ijassa-759	24	8	.	.	PUNCT
ijassa-759	25	1	adv	adv	PROPN
ijassa-759	25	2	.	.	PUNCT
ijassa-759	26	1	in	in	ADP
ijassa-759	26	2	systems	system	NOUN
ijassa-759	26	3	science	science	NOUN
ijassa-759	26	4	and	and	CCONJ
ijassa-759	26	5	appl	appl	NOUN
ijassa-759	26	6	.	.	PUNCT
ijassa-759	27	1	(	(	PUNCT
ijassa-759	27	2	2020	2020	NUM
ijassa-759	27	3	)	)	PUNCT
ijassa-759	27	4	2	2	NUM
ijassa-759	27	5	inside	inside	ADV
ijassa-759	27	6	,	,	PUNCT
ijassa-759	27	7	multiplies	multiply	VERB
ijassa-759	27	8	itself	itself	PRON
ijassa-759	27	9	and	and	CCONJ
ijassa-759	27	10	destroys	destroy	VERB
ijassa-759	27	11	the	the	DET
ijassa-759	27	12	cell	cell	NOUN
ijassa-759	27	13	.	.	PUNCT
ijassa-759	28	1	meanwhile	meanwhile	ADV
ijassa-759	28	2	the	the	DET
ijassa-759	28	3	immune	immune	ADJ
ijassa-759	28	4	system	system	NOUN
ijassa-759	28	5	reacts	react	VERB
ijassa-759	28	6	at	at	ADP
ijassa-759	28	7	the	the	DET
ijassa-759	28	8	virus	virus	NOUN
ijassa-759	28	9	intrusion	intrusion	NOUN
ijassa-759	28	10	and	and	CCONJ
ijassa-759	28	11	destroys	destroy	VERB
ijassa-759	28	12	it	it	PRON
ijassa-759	28	13	together	together	ADV
ijassa-759	28	14	with	with	ADP
ijassa-759	28	15	the	the	DET
ijassa-759	28	16	tumor	tumor	NOUN
ijassa-759	28	17	cell	cell	NOUN
ijassa-759	28	18	.	.	PUNCT
ijassa-759	29	1	the	the	DET
ijassa-759	29	2	second	second	ADJ
ijassa-759	29	3	stage	stage	NOUN
ijassa-759	29	4	of	of	ADP
ijassa-759	29	5	the	the	DET
ijassa-759	29	6	tumor	tumor	NOUN
ijassa-759	29	7	cells	cell	NOUN
ijassa-759	29	8	’	'	PUNCT
ijassa-759	29	9	death	death	NOUN
ijassa-759	29	10	evolves	evolve	VERB
ijassa-759	29	11	later	later	ADV
ijassa-759	29	12	,	,	PUNCT
ijassa-759	29	13	due	due	ADP
ijassa-759	29	14	to	to	ADP
ijassa-759	29	15	the	the	DET
ijassa-759	29	16	immune	immune	ADJ
ijassa-759	29	17	system	system	NOUN
ijassa-759	29	18	’s	’s	PART
ijassa-759	29	19	reaction	reaction	NOUN
ijassa-759	29	20	to	to	ADP
ijassa-759	29	21	the	the	DET
ijassa-759	29	22	population	population	NOUN
ijassa-759	29	23	of	of	ADP
ijassa-759	29	24	infected	infected	ADJ
ijassa-759	29	25	tumor	tumor	NOUN
ijassa-759	29	26	cells	cell	NOUN
ijassa-759	29	27	.	.	PUNCT
ijassa-759	30	1	when	when	SCONJ
ijassa-759	30	2	settling	settle	VERB
ijassa-759	30	3	down	down	ADP
ijassa-759	30	4	on	on	ADP
ijassa-759	30	5	the	the	DET
ijassa-759	30	6	surface	surface	NOUN
ijassa-759	30	7	of	of	ADP
ijassa-759	30	8	the	the	DET
ijassa-759	30	9	cells	cell	NOUN
ijassa-759	30	10	,	,	PUNCT
ijassa-759	30	11	the	the	DET
ijassa-759	30	12	virus	virus	NOUN
ijassa-759	30	13	leaves	leave	VERB
ijassa-759	30	14	specific	specific	ADJ
ijassa-759	30	15	protein	protein	NOUN
ijassa-759	30	16	formations	formation	NOUN
ijassa-759	30	17	on	on	ADP
ijassa-759	30	18	the	the	DET
ijassa-759	30	19	membrane	membrane	NOUN
ijassa-759	30	20	surface	surface	NOUN
ijassa-759	30	21	.	.	PUNCT
ijassa-759	31	1	this	this	PRON
ijassa-759	31	2	produces	produce	VERB
ijassa-759	31	3	a	a	DET
ijassa-759	31	4	population	population	NOUN
ijassa-759	31	5	of	of	ADP
ijassa-759	31	6	infected	infected	ADJ
ijassa-759	31	7	tumor	tumor	NOUN
ijassa-759	31	8	cells	cell	NOUN
ijassa-759	31	9	that	that	PRON
ijassa-759	31	10	are	be	AUX
ijassa-759	31	11	detected	detect	VERB
ijassa-759	31	12	by	by	ADP
ijassa-759	31	13	immune	immune	ADJ
ijassa-759	31	14	system	system	NOUN
ijassa-759	31	15	as	as	ADP
ijassa-759	31	16	foreign	foreign	ADJ
ijassa-759	31	17	.	.	PUNCT
ijassa-759	32	1	in	in	ADP
ijassa-759	32	2	response	response	NOUN
ijassa-759	32	3	,	,	PUNCT
ijassa-759	32	4	immune	immune	ADJ
ijassa-759	32	5	system	system	NOUN
ijassa-759	32	6	produces	produce	VERB
ijassa-759	32	7	antibodies	antibody	NOUN
ijassa-759	32	8	that	that	PRON
ijassa-759	32	9	destroy	destroy	VERB
ijassa-759	32	10	the	the	DET
ijassa-759	32	11	infected	infected	ADJ
ijassa-759	32	12	tumor	tumor	NOUN
ijassa-759	32	13	cells	cell	NOUN
ijassa-759	32	14	[	[	X
ijassa-759	32	15	17	17	NUM
ijassa-759	32	16	-	-	SYM
ijassa-759	32	17	19	19	NUM
ijassa-759	32	18	]	]	PUNCT
ijassa-759	32	19	.	.	PUNCT
ijassa-759	33	1	thus	thus	ADV
ijassa-759	33	2	the	the	DET
ijassa-759	33	3	virus	virus	NOUN
ijassa-759	33	4	acts	act	VERB
ijassa-759	33	5	as	as	ADP
ijassa-759	33	6	a	a	DET
ijassa-759	33	7	specific	specific	ADJ
ijassa-759	33	8	marker	marker	NOUN
ijassa-759	33	9	of	of	ADP
ijassa-759	33	10	the	the	DET
ijassa-759	33	11	tumor	tumor	NOUN
ijassa-759	33	12	cells	cell	NOUN
ijassa-759	33	13	and	and	CCONJ
ijassa-759	33	14	helps	help	VERB
ijassa-759	33	15	to	to	PART
ijassa-759	33	16	overcome	overcome	VERB
ijassa-759	33	17	the	the	DET
ijassa-759	33	18	irresponsiveness	irresponsiveness	ADJ
ijassa-759	33	19	of	of	ADP
ijassa-759	33	20	the	the	DET
ijassa-759	33	21	immune	immune	ADJ
ijassa-759	33	22	system	system	NOUN
ijassa-759	33	23	against	against	ADP
ijassa-759	33	24	uninfected	uninfected	ADJ
ijassa-759	33	25	tumor	tumor	NOUN
ijassa-759	33	26	cells	cell	NOUN
ijassa-759	33	27	.	.	PUNCT
ijassa-759	34	1	one	one	NUM
ijassa-759	34	2	of	of	ADP
ijassa-759	34	3	the	the	DET
ijassa-759	34	4	key	key	ADJ
ijassa-759	34	5	advantages	advantage	NOUN
ijassa-759	34	6	of	of	ADP
ijassa-759	34	7	immunotherapy	immunotherapy	NOUN
ijassa-759	34	8	is	be	AUX
ijassa-759	34	9	the	the	DET
ijassa-759	34	10	absence	absence	NOUN
ijassa-759	34	11	of	of	ADP
ijassa-759	34	12	toxic	toxic	ADJ
ijassa-759	34	13	effects	effect	NOUN
ijassa-759	34	14	associated	associate	VERB
ijassa-759	34	15	with	with	ADP
ijassa-759	34	16	chemotherapy	chemotherapy	NOUN
ijassa-759	34	17	and	and	CCONJ
ijassa-759	34	18	radiation	radiation	NOUN
ijassa-759	34	19	therapy	therapy	NOUN
ijassa-759	34	20	.	.	PUNCT
ijassa-759	35	1	since	since	SCONJ
ijassa-759	35	2	there	there	PRON
ijassa-759	35	3	is	be	VERB
ijassa-759	35	4	no	no	DET
ijassa-759	35	5	need	need	NOUN
ijassa-759	35	6	for	for	ADP
ijassa-759	35	7	additional	additional	ADJ
ijassa-759	35	8	treatment	treatment	NOUN
ijassa-759	35	9	to	to	PART
ijassa-759	35	10	mitigate	mitigate	VERB
ijassa-759	35	11	the	the	DET
ijassa-759	35	12	negative	negative	ADJ
ijassa-759	35	13	side	side	NOUN
ijassa-759	35	14	effects	effect	NOUN
ijassa-759	35	15	,	,	PUNCT
ijassa-759	35	16	this	this	PRON
ijassa-759	35	17	makes	make	VERB
ijassa-759	35	18	immunotherapy	immunotherapy	NOUN
ijassa-759	35	19	a	a	DET
ijassa-759	35	20	more	more	ADV
ijassa-759	35	21	harmless	harmless	ADJ
ijassa-759	35	22	and	and	CCONJ
ijassa-759	35	23	costeffective	costeffective	ADJ
ijassa-759	35	24	method	method	NOUN
ijassa-759	35	25	as	as	SCONJ
ijassa-759	35	26	compared	compare	VERB
ijassa-759	35	27	to	to	ADP
ijassa-759	35	28	other	other	ADJ
ijassa-759	35	29	approaches	approach	NOUN
ijassa-759	35	30	to	to	ADP
ijassa-759	35	31	cancer	cancer	NOUN
ijassa-759	35	32	treatment	treatment	NOUN
ijassa-759	35	33	.	.	PUNCT
ijassa-759	36	1	low	low	ADJ
ijassa-759	36	2	toxicity	toxicity	NOUN
ijassa-759	36	3	makes	make	VERB
ijassa-759	36	4	it	it	PRON
ijassa-759	36	5	possible	possible	ADJ
ijassa-759	36	6	to	to	PART
ijassa-759	36	7	expand	expand	VERB
ijassa-759	36	8	the	the	DET
ijassa-759	36	9	range	range	NOUN
ijassa-759	36	10	of	of	ADP
ijassa-759	36	11	dosages	dosage	NOUN
ijassa-759	36	12	–	–	PUNCT
ijassa-759	36	13	however	however	ADV
ijassa-759	36	14	,	,	PUNCT
ijassa-759	36	15	this	this	PRON
ijassa-759	36	16	requires	require	VERB
ijassa-759	36	17	additional	additional	ADJ
ijassa-759	36	18	experimental	experimental	ADJ
ijassa-759	36	19	studies	study	NOUN
ijassa-759	36	20	and	and	CCONJ
ijassa-759	36	21	therefore	therefore	ADV
ijassa-759	36	22	implies	imply	VERB
ijassa-759	36	23	higher	high	ADJ
ijassa-759	36	24	research	research	NOUN
ijassa-759	36	25	costs	cost	NOUN
ijassa-759	36	26	.	.	PUNCT
ijassa-759	37	1	computational	computational	ADJ
ijassa-759	37	2	experiments	experiment	NOUN
ijassa-759	37	3	based	base	VERB
ijassa-759	37	4	on	on	ADP
ijassa-759	37	5	the	the	DET
ijassa-759	37	6	mathematical	mathematical	ADJ
ijassa-759	37	7	model	model	NOUN
ijassa-759	37	8	of	of	ADP
ijassa-759	37	9	vaccine	vaccine	NOUN
ijassa-759	37	10	therapy	therapy	NOUN
ijassa-759	37	11	make	make	VERB
ijassa-759	37	12	it	it	PRON
ijassa-759	37	13	possible	possible	ADJ
ijassa-759	37	14	to	to	PART
ijassa-759	37	15	define	define	VERB
ijassa-759	37	16	the	the	DET
ijassa-759	37	17	optimal	optimal	ADJ
ijassa-759	37	18	dosages	dosage	NOUN
ijassa-759	37	19	,	,	PUNCT
ijassa-759	37	20	assess	assess	VERB
ijassa-759	37	21	the	the	DET
ijassa-759	37	22	effectiveness	effectiveness	NOUN
ijassa-759	37	23	of	of	ADP
ijassa-759	37	24	immune	immune	ADJ
ijassa-759	37	25	response	response	NOUN
ijassa-759	37	26	depending	depend	VERB
ijassa-759	37	27	on	on	ADP
ijassa-759	37	28	the	the	DET
ijassa-759	37	29	vaccine	vaccine	NOUN
ijassa-759	37	30	dosage	dosage	NOUN
ijassa-759	37	31	,	,	PUNCT
ijassa-759	37	32	and	and	CCONJ
ijassa-759	37	33	describe	describe	VERB
ijassa-759	37	34	the	the	DET
ijassa-759	37	35	dynamics	dynamic	NOUN
ijassa-759	37	36	of	of	ADP
ijassa-759	37	37	the	the	DET
ijassa-759	37	38	tumor	tumor	NOUN
ijassa-759	37	39	process	process	NOUN
ijassa-759	37	40	for	for	ADP
ijassa-759	37	41	different	different	ADJ
ijassa-759	37	42	treatment	treatment	NOUN
ijassa-759	37	43	strategies	strategy	NOUN
ijassa-759	37	44	.	.	PUNCT
ijassa-759	38	1	data	datum	NOUN
ijassa-759	38	2	obtained	obtain	VERB
ijassa-759	38	3	through	through	ADP
ijassa-759	38	4	computational	computational	ADJ
ijassa-759	38	5	experiments	experiment	NOUN
ijassa-759	38	6	may	may	AUX
ijassa-759	38	7	be	be	AUX
ijassa-759	38	8	used	use	VERB
ijassa-759	38	9	to	to	PART
ijassa-759	38	10	define	define	VERB
ijassa-759	38	11	optimal	optimal	ADJ
ijassa-759	38	12	treatment	treatment	NOUN
ijassa-759	38	13	strategies	strategy	NOUN
ijassa-759	38	14	that	that	PRON
ijassa-759	38	15	produce	produce	VERB
ijassa-759	38	16	complete	complete	ADJ
ijassa-759	38	17	tumor	tumor	NOUN
ijassa-759	38	18	regression	regression	NOUN
ijassa-759	38	19	.	.	PUNCT
ijassa-759	39	1	given	give	VERB
ijassa-759	39	2	the	the	DET
ijassa-759	39	3	high	high	ADJ
ijassa-759	39	4	costs	cost	NOUN
ijassa-759	39	5	of	of	ADP
ijassa-759	39	6	experimental	experimental	ADJ
ijassa-759	39	7	and	and	CCONJ
ijassa-759	39	8	clinical	clinical	ADJ
ijassa-759	39	9	studies	study	NOUN
ijassa-759	39	10	,	,	PUNCT
ijassa-759	39	11	computational	computational	ADJ
ijassa-759	39	12	experiments	experiment	NOUN
ijassa-759	39	13	based	base	VERB
ijassa-759	39	14	on	on	ADP
ijassa-759	39	15	mathematical	mathematical	ADJ
ijassa-759	39	16	models	model	NOUN
ijassa-759	39	17	can	can	AUX
ijassa-759	39	18	produce	produce	VERB
ijassa-759	39	19	a	a	DET
ijassa-759	39	20	lot	lot	NOUN
ijassa-759	39	21	of	of	ADP
ijassa-759	39	22	useful	useful	ADJ
ijassa-759	39	23	information	information	NOUN
ijassa-759	39	24	based	base	VERB
ijassa-759	39	25	on	on	ADP
ijassa-759	39	26	the	the	DET
ijassa-759	39	27	limited	limit	VERB
ijassa-759	39	28	amount	amount	NOUN
ijassa-759	39	29	of	of	ADP
ijassa-759	39	30	experimental	experimental	ADJ
ijassa-759	39	31	data	datum	NOUN
ijassa-759	39	32	.	.	PUNCT
ijassa-759	40	1	modelling	model	VERB
ijassa-759	40	2	makes	make	VERB
ijassa-759	40	3	it	it	PRON
ijassa-759	40	4	possible	possible	ADJ
ijassa-759	40	5	to	to	PART
ijassa-759	40	6	expand	expand	VERB
ijassa-759	40	7	the	the	DET
ijassa-759	40	8	study	study	NOUN
ijassa-759	40	9	of	of	ADP
ijassa-759	40	10	the	the	DET
ijassa-759	40	11	range	range	NOUN
ijassa-759	40	12	of	of	ADP
ijassa-759	40	13	applicable	applicable	ADJ
ijassa-759	40	14	dosages	dosage	NOUN
ijassa-759	40	15	and	and	CCONJ
ijassa-759	40	16	treatment	treatment	NOUN
ijassa-759	40	17	strategies	strategy	NOUN
ijassa-759	40	18	when	when	SCONJ
ijassa-759	40	19	exploring	explore	VERB
ijassa-759	40	20	the	the	DET
ijassa-759	40	21	new	new	ADJ
ijassa-759	40	22	methods	method	NOUN
ijassa-759	40	23	of	of	ADP
ijassa-759	40	24	antitumor	antitumor	PROPN
ijassa-759	40	25	therapy	therapy	NOUN
ijassa-759	40	26	,	,	PUNCT
ijassa-759	40	27	thus	thus	ADV
ijassa-759	40	28	reducing	reduce	VERB
ijassa-759	40	29	time	time	NOUN
ijassa-759	40	30	and	and	CCONJ
ijassa-759	40	31	labor	labor	NOUN
ijassa-759	40	32	costs	cost	NOUN
ijassa-759	40	33	and	and	CCONJ
ijassa-759	40	34	the	the	DET
ijassa-759	40	35	number	number	NOUN
ijassa-759	40	36	of	of	ADP
ijassa-759	40	37	animals	animal	NOUN
ijassa-759	40	38	required	require	VERB
ijassa-759	40	39	for	for	ADP
ijassa-759	40	40	conducting	conduct	VERB
ijassa-759	40	41	an	an	DET
ijassa-759	40	42	experiment	experiment	NOUN
ijassa-759	40	43	in	in	ADP
ijassa-759	40	44	vivo	vivo	NOUN
ijassa-759	40	45	.	.	PUNCT
ijassa-759	41	1	moreover	moreover	ADV
ijassa-759	41	2	,	,	PUNCT
ijassa-759	41	3	research	research	NOUN
ijassa-759	41	4	in	in	ADP
ijassa-759	41	5	molecular	molecular	ADJ
ijassa-759	41	6	biology	biology	NOUN
ijassa-759	41	7	,	,	PUNCT
ijassa-759	41	8	cell	cell	NOUN
ijassa-759	41	9	biology	biology	NOUN
ijassa-759	41	10	,	,	PUNCT
ijassa-759	41	11	biophysics	biophysic	NOUN
ijassa-759	41	12	and	and	CCONJ
ijassa-759	41	13	immunology	immunology	NOUN
ijassa-759	41	14	has	have	AUX
ijassa-759	41	15	produced	produce	VERB
ijassa-759	41	16	a	a	DET
ijassa-759	41	17	large	large	ADJ
ijassa-759	41	18	amount	amount	NOUN
ijassa-759	41	19	of	of	ADP
ijassa-759	41	20	data	datum	NOUN
ijassa-759	41	21	that	that	PRON
ijassa-759	41	22	also	also	ADV
ijassa-759	41	23	require	require	VERB
ijassa-759	41	24	processing	processing	NOUN
ijassa-759	41	25	and	and	CCONJ
ijassa-759	41	26	analysis	analysis	NOUN
ijassa-759	41	27	with	with	ADP
ijassa-759	41	28	the	the	DET
ijassa-759	41	29	use	use	NOUN
ijassa-759	41	30	of	of	ADP
ijassa-759	41	31	specialized	specialized	ADJ
ijassa-759	41	32	computer	computer	NOUN
ijassa-759	41	33	technologies	technology	NOUN
ijassa-759	41	34	based	base	VERB
ijassa-759	41	35	on	on	ADP
ijassa-759	41	36	mathematical	mathematical	ADJ
ijassa-759	41	37	modelling	modelling	NOUN
ijassa-759	41	38	[	[	X
ijassa-759	41	39	8	8	NUM
ijassa-759	41	40	-	-	SYM
ijassa-759	41	41	11	11	NUM
ijassa-759	41	42	]	]	PUNCT
ijassa-759	41	43	.	.	PUNCT
ijassa-759	42	1	however	however	ADV
ijassa-759	42	2	,	,	PUNCT
ijassa-759	42	3	despite	despite	SCONJ
ijassa-759	42	4	its	its	PRON
ijassa-759	42	5	advantages	advantage	NOUN
ijassa-759	42	6	,	,	PUNCT
ijassa-759	42	7	modelling	modelling	NOUN
ijassa-759	42	8	is	be	AUX
ijassa-759	42	9	still	still	ADV
ijassa-759	42	10	not	not	PART
ijassa-759	42	11	widely	widely	ADV
ijassa-759	42	12	used	use	VERB
ijassa-759	42	13	in	in	ADP
ijassa-759	42	14	experimental	experimental	ADJ
ijassa-759	42	15	and	and	CCONJ
ijassa-759	42	16	clinical	clinical	ADJ
ijassa-759	42	17	oncology	oncology	NOUN
ijassa-759	42	18	.	.	PUNCT
ijassa-759	43	1	this	this	DET
ijassa-759	43	2	paper	paper	NOUN
ijassa-759	43	3	aims	aim	VERB
ijassa-759	43	4	to	to	PART
ijassa-759	43	5	demonstrate	demonstrate	VERB
ijassa-759	43	6	that	that	SCONJ
ijassa-759	43	7	computational	computational	ADJ
ijassa-759	43	8	experiments	experiment	NOUN
ijassa-759	43	9	based	base	VERB
ijassa-759	43	10	on	on	ADP
ijassa-759	43	11	mathematical	mathematical	ADJ
ijassa-759	43	12	modelling	modelling	NOUN
ijassa-759	43	13	may	may	AUX
ijassa-759	43	14	produce	produce	VERB
ijassa-759	43	15	meaningful	meaningful	ADJ
ijassa-759	43	16	results	result	NOUN
ijassa-759	43	17	for	for	ADP
ijassa-759	43	18	defining	define	VERB
ijassa-759	43	19	cancer	cancer	NOUN
ijassa-759	43	20	treatment	treatment	NOUN
ijassa-759	43	21	strategies	strategy	NOUN
ijassa-759	43	22	,	,	PUNCT
ijassa-759	43	23	complementing	complement	VERB
ijassa-759	43	24	in	in	ADP
ijassa-759	43	25	vivo	vivo	ADJ
ijassa-759	43	26	experimental	experimental	ADJ
ijassa-759	43	27	approaches	approach	NOUN
ijassa-759	43	28	and	and	CCONJ
ijassa-759	43	29	enabling	enable	VERB
ijassa-759	43	30	more	more	ADV
ijassa-759	43	31	efficient	efficient	ADJ
ijassa-759	43	32	translation	translation	NOUN
ijassa-759	43	33	of	of	ADP
ijassa-759	43	34	experimental	experimental	ADJ
ijassa-759	43	35	results	result	NOUN
ijassa-759	43	36	to	to	ADP
ijassa-759	43	37	the	the	DET
ijassa-759	43	38	clinic	clinic	NOUN
ijassa-759	43	39	,	,	PUNCT
ijassa-759	43	40	building	build	VERB
ijassa-759	43	41	on	on	ADP
ijassa-759	43	42	the	the	DET
ijassa-759	43	43	study	study	NOUN
ijassa-759	43	44	published	publish	VERB
ijassa-759	43	45	in	in	ADP
ijassa-759	43	46	mathematical	mathematical	ADJ
ijassa-759	43	47	biology	biology	NOUN
ijassa-759	43	48	&	&	CCONJ
ijassa-759	43	49	bioinformatics	bioinformatic	NOUN
ijassa-759	43	50	earlier	early	ADV
ijassa-759	43	51	in	in	ADP
ijassa-759	43	52	2019	2019	NUM
ijassa-759	43	53	[	[	SYM
ijassa-759	43	54	19	19	NUM
ijassa-759	43	55	]	]	PUNCT
ijassa-759	43	56	.	.	PUNCT
ijassa-759	44	1	2	2	X
ijassa-759	44	2	.	.	X
ijassa-759	44	3	problem	problem	NOUN
ijassa-759	44	4	statement	statement	NOUN
ijassa-759	44	5	this	this	DET
ijassa-759	44	6	study	study	NOUN
ijassa-759	44	7	aims	aim	VERB
ijassa-759	44	8	to	to	PART
ijassa-759	44	9	develop	develop	VERB
ijassa-759	44	10	an	an	DET
ijassa-759	44	11	algorithm	algorithm	NOUN
ijassa-759	44	12	for	for	ADP
ijassa-759	44	13	finding	find	VERB
ijassa-759	44	14	strategies	strategy	NOUN
ijassa-759	44	15	for	for	ADP
ijassa-759	44	16	the	the	DET
ijassa-759	44	17	use	use	NOUN
ijassa-759	44	18	of	of	ADP
ijassa-759	44	19	antitumor	antitumor	PROPN
ijassa-759	44	20	viral	viral	ADJ
ijassa-759	44	21	vaccine	vaccine	NOUN
ijassa-759	44	22	to	to	PART
ijassa-759	44	23	completely	completely	ADV
ijassa-759	44	24	suppress	suppress	VERB
ijassa-759	44	25	tumor	tumor	NOUN
ijassa-759	44	26	growth	growth	NOUN
ijassa-759	44	27	.	.	PUNCT
ijassa-759	45	1	to	to	PART
ijassa-759	45	2	achieve	achieve	VERB
ijassa-759	45	3	this	this	DET
ijassa-759	45	4	aim	aim	NOUN
ijassa-759	45	5	,	,	PUNCT
ijassa-759	45	6	a	a	DET
ijassa-759	45	7	software	software	NOUN
ijassa-759	45	8	package	package	NOUN
ijassa-759	45	9	was	be	AUX
ijassa-759	45	10	developed	develop	VERB
ijassa-759	45	11	in	in	ADP
ijassa-759	45	12	the	the	DET
ijassa-759	45	13	matlab	matlab	PROPN
ijassa-759	45	14	-	-	PUNCT
ijassa-759	45	15	simulink	simulink	NOUN
ijassa-759	45	16	system	system	NOUN
ijassa-759	45	17	,	,	PUNCT
ijassa-759	45	18	which	which	PRON
ijassa-759	45	19	includes	include	VERB
ijassa-759	45	20	several	several	ADJ
ijassa-759	45	21	mathematical	mathematical	ADJ
ijassa-759	45	22	models	model	NOUN
ijassa-759	45	23	:	:	PUNCT
ijassa-759	45	24	mathematical	mathematical	ADJ
ijassa-759	45	25	model	model	NOUN
ijassa-759	45	26	of	of	ADP
ijassa-759	45	27	vaccine	vaccine	NOUN
ijassa-759	45	28	therapy	therapy	NOUN
ijassa-759	45	29	,	,	PUNCT
ijassa-759	45	30	describing	describe	VERB
ijassa-759	45	31	the	the	DET
ijassa-759	45	32	mechanism	mechanism	NOUN
ijassa-759	45	33	of	of	ADP
ijassa-759	45	34	tumor	tumor	NOUN
ijassa-759	45	35	cell	cell	NOUN
ijassa-759	45	36	death	death	NOUN
ijassa-759	45	37	as	as	ADP
ijassa-759	45	38	a	a	DET
ijassa-759	45	39	result	result	NOUN
ijassa-759	45	40	of	of	ADP
ijassa-759	45	41	the	the	DET
ijassa-759	45	42	immune	immune	ADJ
ijassa-759	45	43	response	response	NOUN
ijassa-759	45	44	to	to	ADP
ijassa-759	45	45	the	the	DET
ijassa-759	45	46	injection	injection	NOUN
ijassa-759	45	47	of	of	ADP
ijassa-759	45	48	the	the	DET
ijassa-759	45	49	virus	virus	NOUN
ijassa-759	46	1	[	[	X
ijassa-759	46	2	10,18,19	10,18,19	NUM
ijassa-759	46	3	]	]	X
ijassa-759	46	4	,	,	PUNCT
ijassa-759	46	5	mathematical	mathematical	ADJ
ijassa-759	46	6	model	model	NOUN
ijassa-759	46	7	of	of	ADP
ijassa-759	46	8	infectious	infectious	ADJ
ijassa-759	46	9	disease	disease	NOUN
ijassa-759	46	10	by	by	ADP
ijassa-759	46	11	g.	g.	PROPN
ijassa-759	46	12	i.	i.	PROPN
ijassa-759	46	13	marchuk	marchuk	PROPN
ijassa-759	46	14	,	,	PUNCT
ijassa-759	46	15	describing	describe	VERB
ijassa-759	46	16	the	the	DET
ijassa-759	46	17	dynamics	dynamic	NOUN
ijassa-759	46	18	of	of	ADP
ijassa-759	46	19	the	the	DET
ijassa-759	46	20	formation	formation	NOUN
ijassa-759	46	21	of	of	ADP
ijassa-759	46	22	antibodies	antibody	NOUN
ijassa-759	46	23	against	against	ADP
ijassa-759	46	24	the	the	DET
ijassa-759	46	25	virus	virus	NOUN
ijassa-759	46	26	by	by	ADP
ijassa-759	46	27	the	the	DET
ijassa-759	46	28	immune	immune	ADJ
ijassa-759	46	29	system	system	NOUN
ijassa-759	46	30	[	[	X
ijassa-759	46	31	20	20	NUM
ijassa-759	46	32	-	-	SYM
ijassa-759	46	33	22	22	NUM
ijassa-759	46	34	]	]	PUNCT
ijassa-759	46	35	,	,	PUNCT
ijassa-759	46	36	mathematical	mathematical	ADJ
ijassa-759	46	37	model	model	NOUN
ijassa-759	46	38	by	by	ADP
ijassa-759	46	39	h.	h.	PROPN
ijassa-759	46	40	f.	f.	PROPN
ijassa-759	46	41	skipper	skipper	PROPN
ijassa-759	46	42	,	,	PUNCT
ijassa-759	46	43	describing	describe	VERB
ijassa-759	46	44	how	how	SCONJ
ijassa-759	46	45	the	the	DET
ijassa-759	46	46	proportion	proportion	NOUN
ijassa-759	46	47	of	of	ADP
ijassa-759	46	48	the	the	DET
ijassa-759	46	49	fast	fast	ADJ
ijassa-759	46	50	proliferating	proliferate	VERB
ijassa-759	46	51	tumor	tumor	NOUN
ijassa-759	46	52	cells	cell	NOUN
ijassa-759	46	53	decreases	decrease	VERB
ijassa-759	46	54	in	in	ADP
ijassa-759	46	55	the	the	DET
ijassa-759	46	56	growing	grow	VERB
ijassa-759	46	57	tumor	tumor	NOUN
ijassa-759	47	1	[	[	X
ijassa-759	47	2	10,23	10,23	NOUN
ijassa-759	47	3	]	]	PUNCT
ijassa-759	47	4	,	,	PUNCT
ijassa-759	47	5	mathematical	mathematical	ADJ
ijassa-759	47	6	model	model	NOUN
ijassa-759	47	7	of	of	ADP
ijassa-759	47	8	antitumor	antitumor	PROPN
ijassa-759	47	9	therapy	therapy	NOUN
ijassa-759	47	10	with	with	ADP
ijassa-759	47	11	discontinuous	discontinuous	ADJ
ijassa-759	47	12	trajectories	trajectory	NOUN
ijassa-759	47	13	,	,	PUNCT
ijassa-759	47	14	evaluating	evaluate	VERB
ijassa-759	47	15	the	the	DET
ijassa-759	47	16	effectiveness	effectiveness	NOUN
ijassa-759	47	17	of	of	ADP
ijassa-759	47	18	therapeutic	therapeutic	ADJ
ijassa-759	47	19	effects	effect	NOUN
ijassa-759	47	20	on	on	ADP
ijassa-759	47	21	the	the	DET
ijassa-759	47	22	experimental	experimental	ADJ
ijassa-759	47	23	trajectories	trajectory	NOUN
ijassa-759	47	24	of	of	ADP
ijassa-759	47	25	tumor	tumor	NOUN
ijassa-759	47	26	growth	growth	NOUN
ijassa-759	47	27	after	after	ADP
ijassa-759	47	28	the	the	DET
ijassa-759	47	29	injection	injection	NOUN
ijassa-759	47	30	of	of	ADP
ijassa-759	47	31	a	a	DET
ijassa-759	47	32	viral	viral	ADJ
ijassa-759	47	33	vaccine	vaccine	NOUN
ijassa-759	47	34	[	[	X
ijassa-759	47	35	10,18,19	10,18,19	NUM
ijassa-759	47	36	]	]	X
ijassa-759	47	37	.	.	PUNCT
ijassa-759	48	1	the	the	DET
ijassa-759	48	2	values	value	NOUN
ijassa-759	48	3	of	of	ADP
ijassa-759	48	4	the	the	DET
ijassa-759	48	5	parameters	parameter	NOUN
ijassa-759	48	6	of	of	ADP
ijassa-759	48	7	the	the	DET
ijassa-759	48	8	complex	complex	ADJ
ijassa-759	48	9	mathematical	mathematical	ADJ
ijassa-759	48	10	models	model	NOUN
ijassa-759	48	11	are	be	AUX
ijassa-759	48	12	given	give	VERB
ijassa-759	48	13	in	in	ADP
ijassa-759	48	14	the	the	DET
ijassa-759	48	15	table	table	NOUN
ijassa-759	48	16	1	1	NUM
ijassa-759	49	1	[	[	SYM
ijassa-759	49	2	19	19	NUM
ijassa-759	49	3	,	,	PUNCT
ijassa-759	49	4	p.	p.	NOUN
ijassa-759	49	5	44	44	NUM
ijassa-759	49	6	]	]	PUNCT
ijassa-759	49	7	.	.	PUNCT
ijassa-759	50	1	the	the	DET
ijassa-759	50	2	complexity	complexity	NOUN
ijassa-759	50	3	and	and	CCONJ
ijassa-759	50	4	nonlinearity	nonlinearity	NOUN
ijassa-759	50	5	of	of	ADP
ijassa-759	50	6	differential	differential	ADJ
ijassa-759	50	7	equations	equation	NOUN
ijassa-759	50	8	of	of	ADP
ijassa-759	50	9	mathematical	mathematical	ADJ
ijassa-759	50	10	models	model	NOUN
ijassa-759	50	11	does	do	AUX
ijassa-759	50	12	mathematical	mathematical	VERB
ijassa-759	50	13	modeling	modeling	NOUN
ijassa-759	50	14	of	of	ADP
ijassa-759	50	15	antitumor	antitumor	PROPN
ijassa-759	50	16	viral	viral	ADJ
ijassa-759	50	17	vaccine	vaccine	NOUN
ijassa-759	50	18	therapy	therapy	NOUN
ijassa-759	50	19	…	…	PUNCT
ijassa-759	50	20	copyright	copyright	NOUN
ijassa-759	50	21	©	©	PROPN
ijassa-759	50	22	2020	2020	NUM
ijassa-759	50	23	assa	assa	NOUN
ijassa-759	50	24	.	.	PUNCT
ijassa-759	51	1	adv	adv	PROPN
ijassa-759	51	2	.	.	PUNCT
ijassa-759	52	1	in	in	ADP
ijassa-759	52	2	systems	system	NOUN
ijassa-759	52	3	science	science	NOUN
ijassa-759	52	4	and	and	CCONJ
ijassa-759	52	5	appl	appl	NOUN
ijassa-759	52	6	.	.	PUNCT
ijassa-759	53	1	(	(	PUNCT
ijassa-759	53	2	2020	2020	NUM
ijassa-759	53	3	)	)	PUNCT
ijassa-759	53	4	3	3	NUM
ijassa-759	53	5	not	not	PART
ijassa-759	53	6	allow	allow	VERB
ijassa-759	53	7	to	to	PART
ijassa-759	53	8	obtain	obtain	VERB
ijassa-759	53	9	the	the	DET
ijassa-759	53	10	solution	solution	NOUN
ijassa-759	53	11	analytically	analytically	ADV
ijassa-759	53	12	without	without	ADP
ijassa-759	53	13	the	the	DET
ijassa-759	53	14	use	use	NOUN
ijassa-759	53	15	of	of	ADP
ijassa-759	53	16	computational	computational	ADJ
ijassa-759	53	17	software	software	NOUN
ijassa-759	53	18	.	.	PUNCT
ijassa-759	54	1	on	on	ADP
ijassa-759	54	2	the	the	DET
ijassa-759	54	3	basis	basis	NOUN
ijassa-759	54	4	of	of	ADP
ijassa-759	54	5	the	the	DET
ijassa-759	54	6	developed	develop	VERB
ijassa-759	54	7	software	software	NOUN
ijassa-759	54	8	package	package	NOUN
ijassa-759	54	9	,	,	PUNCT
ijassa-759	54	10	a	a	DET
ijassa-759	54	11	computational	computational	ADJ
ijassa-759	54	12	experiment	experiment	NOUN
ijassa-759	54	13	was	be	AUX
ijassa-759	54	14	conducted	conduct	VERB
ijassa-759	54	15	,	,	PUNCT
ijassa-759	54	16	which	which	PRON
ijassa-759	54	17	allowed	allow	VERB
ijassa-759	54	18	to	to	PART
ijassa-759	54	19	investigate	investigate	VERB
ijassa-759	54	20	the	the	DET
ijassa-759	54	21	effectiveness	effectiveness	NOUN
ijassa-759	54	22	of	of	ADP
ijassa-759	54	23	various	various	ADJ
ijassa-759	54	24	strategies	strategy	NOUN
ijassa-759	54	25	for	for	ADP
ijassa-759	54	26	the	the	DET
ijassa-759	54	27	injection	injection	NOUN
ijassa-759	54	28	of	of	ADP
ijassa-759	54	29	viral	viral	ADJ
ijassa-759	54	30	vaccines	vaccine	NOUN
ijassa-759	54	31	depending	depend	VERB
ijassa-759	54	32	on	on	ADP
ijassa-759	54	33	the	the	DET
ijassa-759	54	34	dose	dose	NOUN
ijassa-759	54	35	and	and	CCONJ
ijassa-759	54	36	size	size	NOUN
ijassa-759	54	37	of	of	ADP
ijassa-759	54	38	the	the	DET
ijassa-759	54	39	tumor	tumor	NOUN
ijassa-759	54	40	at	at	ADP
ijassa-759	54	41	the	the	DET
ijassa-759	54	42	time	time	NOUN
ijassa-759	54	43	of	of	ADP
ijassa-759	54	44	its	its	PRON
ijassa-759	54	45	injection	injection	NOUN
ijassa-759	54	46	.	.	PUNCT
ijassa-759	55	1	3	3	X
ijassa-759	55	2	.	.	X
ijassa-759	55	3	mathematical	mathematical	ADJ
ijassa-759	55	4	model	model	NOUN
ijassa-759	55	5	of	of	ADP
ijassa-759	55	6	vaccine	vaccine	NOUN
ijassa-759	55	7	therapy	therapy	NOUN
ijassa-759	55	8	with	with	ADP
ijassa-759	55	9	virus	virus	NOUN
ijassa-759	55	10	val	val	NOUN
ijassa-759	55	11	the	the	DET
ijassa-759	55	12	mathematical	mathematical	ADJ
ijassa-759	55	13	model	model	NOUN
ijassa-759	55	14	of	of	ADP
ijassa-759	55	15	vaccine	vaccine	NOUN
ijassa-759	55	16	therapy	therapy	NOUN
ijassa-759	55	17	describes	describe	VERB
ijassa-759	55	18	the	the	DET
ijassa-759	55	19	mechanism	mechanism	NOUN
ijassa-759	55	20	of	of	ADP
ijassa-759	55	21	tumor	tumor	NOUN
ijassa-759	55	22	cells	cell	NOUN
ijassa-759	55	23	’	'	PUNCT
ijassa-759	55	24	death	death	NOUN
ijassa-759	55	25	under	under	ADP
ijassa-759	55	26	the	the	DET
ijassa-759	55	27	influence	influence	NOUN
ijassa-759	55	28	of	of	ADP
ijassa-759	55	29	two	two	NUM
ijassa-759	55	30	factors	factor	NOUN
ijassa-759	55	31	–	–	PUNCT
ijassa-759	55	32	the	the	DET
ijassa-759	55	33	virus	virus	NOUN
ijassa-759	55	34	itself	itself	PRON
ijassa-759	55	35	and	and	CCONJ
ijassa-759	55	36	antibodies	antibodie	VERB
ijassa-759	55	37	against	against	ADP
ijassa-759	55	38	infected	infected	ADJ
ijassa-759	55	39	tumor	tumor	NOUN
ijassa-759	55	40	cells	cell	NOUN
ijassa-759	55	41	,	,	PUNCT
ijassa-759	55	42	on	on	ADP
ijassa-759	55	43	the	the	DET
ijassa-759	55	44	basis	basis	NOUN
ijassa-759	55	45	of	of	ADP
ijassa-759	55	46	experimental	experimental	ADJ
ijassa-759	55	47	data	datum	NOUN
ijassa-759	55	48	on	on	ADP
ijassa-759	55	49	the	the	DET
ijassa-759	55	50	growth	growth	NOUN
ijassa-759	55	51	of	of	ADP
ijassa-759	55	52	erlich	erlich	NOUN
ijassa-759	55	53	tumor	tumor	NOUN
ijassa-759	55	54	in	in	ADP
ijassa-759	55	55	experimental	experimental	ADJ
ijassa-759	55	56	animals	animal	NOUN
ijassa-759	55	57	after	after	ADP
ijassa-759	55	58	a	a	DET
ijassa-759	55	59	single	single	ADJ
ijassa-759	55	60	administration	administration	NOUN
ijassa-759	55	61	of	of	ADP
ijassa-759	55	62	the	the	DET
ijassa-759	55	63	vaccine	vaccine	NOUN
ijassa-759	55	64	with	with	ADP
ijassa-759	55	65	venezuelan	venezuelan	ADJ
ijassa-759	55	66	equine	equine	NOUN
ijassa-759	55	67	encephalitis	encephalitis	NOUN
ijassa-759	55	68	(	(	PUNCT
ijassa-759	55	69	vee	vee	PROPN
ijassa-759	55	70	)	)	PUNCT
ijassa-759	55	71	virus	virus	NOUN
ijassa-759	55	72	[	[	X
ijassa-759	55	73	17	17	NUM
ijassa-759	55	74	]	]	PUNCT
ijassa-759	55	75	.	.	PUNCT
ijassa-759	56	1	the	the	DET
ijassa-759	56	2	experiments	experiment	NOUN
ijassa-759	56	3	were	be	AUX
ijassa-759	56	4	carried	carry	VERB
ijassa-759	56	5	out	out	ADP
ijassa-759	56	6	on	on	ADP
ijassa-759	56	7	2	2	NUM
ijassa-759	56	8	-	-	PUNCT
ijassa-759	56	9	month	month	NOUN
ijassa-759	56	10	-	-	PUNCT
ijassa-759	56	11	old	old	ADJ
ijassa-759	56	12	female	female	ADJ
ijassa-759	56	13	mice	mouse	NOUN
ijassa-759	56	14	of	of	ADP
ijassa-759	56	15	the	the	DET
ijassa-759	56	16	line	line	NOUN
ijassa-759	56	17	balb	balb	VERB
ijassa-759	56	18	/	/	SYM
ijassa-759	56	19	c	c	NOUN
ijassa-759	56	20	,	,	PUNCT
ijassa-759	56	21	с57в1/6	с57в1/6	PROPN
ijassa-759	56	22	and	and	CCONJ
ijassa-759	56	23	dba/2	dba/2	PROPN
ijassa-759	56	24	.	.	PUNCT
ijassa-759	57	1	in	in	ADP
ijassa-759	57	2	total	total	ADJ
ijassa-759	57	3	,	,	PUNCT
ijassa-759	57	4	690	690	NUM
ijassa-759	57	5	animals	animal	NOUN
ijassa-759	57	6	were	be	AUX
ijassa-759	57	7	used	use	VERB
ijassa-759	57	8	in	in	ADP
ijassa-759	57	9	the	the	DET
ijassa-759	57	10	experiments	experiment	NOUN
ijassa-759	57	11	[	[	X
ijassa-759	57	12	17	17	NUM
ijassa-759	57	13	]	]	PUNCT
ijassa-759	57	14	.	.	PUNCT
ijassa-759	58	1	the	the	DET
ijassa-759	58	2	process	process	NOUN
ijassa-759	58	3	of	of	ADP
ijassa-759	58	4	tumor	tumor	NOUN
ijassa-759	58	5	cell	cell	NOUN
ijassa-759	58	6	growth	growth	NOUN
ijassa-759	58	7	without	without	ADP
ijassa-759	58	8	treatment	treatment	NOUN
ijassa-759	58	9	(	(	PUNCT
ijassa-759	58	10	control	control	NOUN
ijassa-759	58	11	)	)	PUNCT
ijassa-759	58	12	is	be	AUX
ijassa-759	58	13	described	describe	VERB
ijassa-759	58	14	by	by	ADP
ijassa-759	58	15	a	a	DET
ijassa-759	58	16	simple	simple	ADJ
ijassa-759	58	17	differential	differential	NOUN
ijassa-759	58	18	equation	equation	NOUN
ijassa-759	58	19	[	[	X
ijassa-759	58	20	19	19	NUM
ijassa-759	58	21	,	,	PUNCT
ijassa-759	58	22	p.	p.	NOUN
ijassa-759	58	23	38	38	NUM
ijassa-759	58	24	]	]	PUNCT
ijassa-759	58	25	:	:	PUNCT
ijassa-759	58	26	(	(	PUNCT
ijassa-759	58	27	)	)	PUNCT
ijassa-759	58	28	(	(	PUNCT
ijassa-759	58	29	)	)	PUNCT
ijassa-759	58	30	(	(	PUNCT
ijassa-759	58	31	)	)	PUNCT
ijassa-759	58	32	dn	dn	PROPN
ijassa-759	58	33	t	t	PROPN
ijassa-759	58	34	t	t	PROPN
ijassa-759	58	35	n	n	ADP
ijassa-759	58	36	t	t	NOUN
ijassa-759	58	37	dt	dt	NOUN
ijassa-759	58	38	=	=	SYM
ijassa-759	58	39			ADJ
ijassa-759	58	40			PROPN
ijassa-759	58	41	,	,	PUNCT
ijassa-759	58	42	with	with	ADP
ijassa-759	58	43	0	0	NUM
ijassa-759	58	44	0	0	NUM
ijassa-759	58	45	(	(	PUNCT
ijassa-759	58	46	)	)	PUNCT
ijassa-759	58	47	n	n	PRON
ijassa-759	58	48	t	t	PROPN
ijassa-759	58	49	n=	n=	ADJ
ijassa-759	58	50	,	,	PUNCT
ijassa-759	58	51	(	(	PUNCT
ijassa-759	58	52	1	1	X
ijassa-759	58	53	)	)	PUNCT
ijassa-759	58	54	where	where	SCONJ
ijassa-759	58	55	n(t	n(t	PROPN
ijassa-759	58	56	)	)	PUNCT
ijassa-759	58	57	is	be	AUX
ijassa-759	58	58	the	the	DET
ijassa-759	58	59	number	number	NOUN
ijassa-759	58	60	of	of	ADP
ijassa-759	58	61	tumor	tumor	NOUN
ijassa-759	58	62	cells	cell	NOUN
ijassa-759	58	63	,	,	PUNCT
ijassa-759	58	64	t	t	PROPN
ijassa-759	58	65	denotes	denote	NOUN
ijassa-759	58	66	time	time	NOUN
ijassa-759	58	67	,	,	PUNCT
ijassa-759	58	68			X
ijassa-759	58	69	(	(	PUNCT
ijassa-759	58	70	t	t	NOUN
ijassa-759	58	71	)	)	PUNCT
ijassa-759	58	72	is	be	AUX
ijassa-759	58	73	the	the	DET
ijassa-759	58	74	parameter	parameter	NOUN
ijassa-759	58	75	characterizing	characterize	VERB
ijassa-759	58	76	the	the	DET
ijassa-759	58	77	growth	growth	NOUN
ijassa-759	58	78	rate	rate	NOUN
ijassa-759	58	79	of	of	ADP
ijassa-759	58	80	tumor	tumor	NOUN
ijassa-759	58	81	cells	cell	NOUN
ijassa-759	58	82	,	,	PUNCT
ijassa-759	58	83	n0	n0	NUM
ijassa-759	58	84	is	be	AUX
ijassa-759	58	85	the	the	DET
ijassa-759	58	86	initial	initial	ADJ
ijassa-759	58	87	number	number	NOUN
ijassa-759	58	88	of	of	ADP
ijassa-759	58	89	tumor	tumor	NOUN
ijassa-759	58	90	cells	cell	NOUN
ijassa-759	58	91	at	at	ADP
ijassa-759	58	92	time	time	NOUN
ijassa-759	58	93	t	t	PROPN
ijassa-759	58	94	=	=	SYM
ijassa-759	58	95	0	0	X
ijassa-759	58	96	.	.	PUNCT
ijassa-759	59	1	the	the	DET
ijassa-759	59	2	type	type	NOUN
ijassa-759	59	3	of	of	ADP
ijassa-759	59	4	function	function	NOUN
ijassa-759	59	5	describing	describe	VERB
ijassa-759	59	6	tumor	tumor	NOUN
ijassa-759	59	7	growth	growth	NOUN
ijassa-759	59	8	without	without	ADP
ijassa-759	59	9	treatment	treatment	NOUN
ijassa-759	59	10	was	be	AUX
ijassa-759	59	11	determined	determine	VERB
ijassa-759	59	12	by	by	ADP
ijassa-759	59	13	experimental	experimental	ADJ
ijassa-759	59	14	curves	curve	NOUN
ijassa-759	59	15	of	of	ADP
ijassa-759	59	16	erlich	erlich	NOUN
ijassa-759	59	17	adenocarcinoma	adenocarcinoma	NOUN
ijassa-759	59	18	growth	growth	NOUN
ijassa-759	59	19	by	by	ADP
ijassa-759	59	20	regression	regression	NOUN
ijassa-759	59	21	analysis	analysis	NOUN
ijassa-759	59	22	in	in	ADP
ijassa-759	59	23	matlab	matlab	PROPN
ijassa-759	59	24	(	(	PUNCT
ijassa-759	59	25	fig	fig	NOUN
ijassa-759	59	26	.	.	PUNCT
ijassa-759	60	1	1	1	NUM
ijassa-759	60	2	)	)	PUNCT
ijassa-759	60	3	.	.	PUNCT
ijassa-759	61	1	the	the	DET
ijassa-759	61	2	experimental	experimental	ADJ
ijassa-759	61	3	curve	curve	NOUN
ijassa-759	61	4	of	of	ADP
ijassa-759	61	5	tumor	tumor	NOUN
ijassa-759	61	6	growth	growth	NOUN
ijassa-759	61	7	without	without	ADP
ijassa-759	61	8	treatment	treatment	NOUN
ijassa-759	61	9	is	be	AUX
ijassa-759	61	10	most	most	ADV
ijassa-759	61	11	accurately	accurately	ADV
ijassa-759	61	12	described	describe	VERB
ijassa-759	61	13	by	by	ADP
ijassa-759	61	14	the	the	DET
ijassa-759	61	15	gompertz	gompertz	NOUN
ijassa-759	61	16	function	function	NOUN
ijassa-759	61	17	,	,	PUNCT
ijassa-759	61	18	which	which	PRON
ijassa-759	61	19	is	be	AUX
ijassa-759	61	20	the	the	DET
ijassa-759	61	21	solution	solution	NOUN
ijassa-759	61	22	of	of	ADP
ijassa-759	61	23	the	the	DET
ijassa-759	61	24	differential	differential	ADJ
ijassa-759	61	25	equation	equation	NOUN
ijassa-759	61	26	(	(	PUNCT
ijassa-759	61	27	1	1	NUM
ijassa-759	61	28	)	)	PUNCT
ijassa-759	61	29	for	for	ADP
ijassa-759	61	30			X
ijassa-759	61	31	(	(	PUNCT
ijassa-759	61	32	t	t	NOUN
ijassa-759	61	33	)	)	PUNCT
ijassa-759	61	34	=	=	PUNCT
ijassa-759	62	1	n	n	ADV
ijassa-759	62	2	n	n	NUM
ijassa-759	62	3	exp	exp	NOUN
ijassa-759	62	4	(	(	PUNCT
ijassa-759	62	5	–	–	PUNCT
ijassa-759	62	6	n	n	NUM
ijassa-759	62	7	t	t	PROPN
ijassa-759	62	8	)	)	PUNCT
ijassa-759	62	9	.	.	PUNCT
ijassa-759	63	1	fig	fig	NOUN
ijassa-759	63	2	.	.	PUNCT
ijassa-759	64	1	1	1	X
ijassa-759	64	2	.	.	X
ijassa-759	64	3	approximation	approximation	NOUN
ijassa-759	64	4	of	of	ADP
ijassa-759	64	5	experimental	experimental	ADJ
ijassa-759	64	6	data	datum	NOUN
ijassa-759	64	7	on	on	ADP
ijassa-759	64	8	the	the	DET
ijassa-759	64	9	growth	growth	NOUN
ijassa-759	64	10	of	of	ADP
ijassa-759	64	11	ehrlich	ehrlich	PROPN
ijassa-759	64	12	adenocarcinoma	adenocarcinoma	NOUN
ijassa-759	64	13	in	in	ADP
ijassa-759	64	14	control	control	NOUN
ijassa-759	64	15	by	by	ADP
ijassa-759	64	16	the	the	DET
ijassa-759	64	17	gompertz	gompertz	NOUN
ijassa-759	64	18	function	function	NOUN
ijassa-759	64	19	the	the	DET
ijassa-759	64	20	gompertz	gompertz	NOUN
ijassa-759	64	21	function	function	NOUN
ijassa-759	64	22	is	be	AUX
ijassa-759	64	23	:	:	PUNCT
ijassa-759	64	24	0	0	NUM
ijassa-759	64	25	(	(	PUNCT
ijassa-759	64	26	)	)	PUNCT
ijassa-759	64	27	exp	exp	NOUN
ijassa-759	64	28	(	(	PUNCT
ijassa-759	64	29	exp	exp	NOUN
ijassa-759	64	30	(	(	PUNCT
ijassa-759	64	31	)	)	PUNCT
ijassa-759	64	32	)	)	PUNCT
ijassa-759	64	33	exp	exp	NOUN
ijassa-759	64	34	(	(	PUNCT
ijassa-759	64	35	(	(	PUNCT
ijassa-759	64	36	1	1	NUM
ijassa-759	64	37	exp	exp	NOUN
ijassa-759	64	38	(	(	PUNCT
ijassa-759	64	39	)	)	PUNCT
ijassa-759	64	40	)	)	PUNCT
ijassa-759	64	41	n	n	CCONJ
ijassa-759	64	42	n	n	CCONJ
ijassa-759	64	43	n	n	CCONJ
ijassa-759	64	44	n	n	CCONJ
ijassa-759	64	45	nn	nn	PROPN
ijassa-759	64	46	t	t	PROPN
ijassa-759	64	47	n	n	PROPN
ijassa-759	64	48	t	t	PROPN
ijassa-759	64	49	n	n	CCONJ
ijassa-759	64	50	t=	t=	PROPN
ijassa-759	65	1	−	−	ADJ
ijassa-759	65	2			NUM
ijassa-759	65	3	−	−	NOUN
ijassa-759	65	4	=	=	SYM
ijassa-759	65	5			X
ijassa-759	65	6	−	−	NOUN
ijassa-759	65	7	−	−	NOUN
ijassa-759	65	8	,	,	PUNCT
ijassa-759	65	9	(	(	PUNCT
ijassa-759	65	10	2	2	X
ijassa-759	65	11	)	)	PUNCT
ijassa-759	66	1	where	where	SCONJ
ijassa-759	66	2	0	0	NUM
ijassa-759	66	3	exp	exp	NOUN
ijassa-759	66	4	(	(	PUNCT
ijassa-759	66	5	)	)	PUNCT
ijassa-759	66	6	nn	nn	PROPN
ijassa-759	66	7	n	n	PROPN
ijassa-759	66	8	=	=	NOUN
ijassa-759	66	9			NOUN
ijassa-759	66	10	is	be	AUX
ijassa-759	66	11	the	the	DET
ijassa-759	66	12	maximum	maximum	ADJ
ijassa-759	66	13	tumor	tumor	NOUN
ijassa-759	66	14	size	size	NOUN
ijassa-759	66	15	for	for	ADP
ijassa-759	66	16	t	t	PROPN
ijassa-759	66	17	→	→	SYM
ijassa-759	66	18			PROPN
ijassa-759	66	19	.	.	PUNCT
ijassa-759	67	1	calculated	calculate	VERB
ijassa-759	67	2	values	value	NOUN
ijassa-759	67	3	of	of	ADP
ijassa-759	67	4	the	the	DET
ijassa-759	67	5	parameters	parameter	NOUN
ijassa-759	67	6	of	of	ADP
ijassa-759	67	7	the	the	DET
ijassa-759	67	8	gompertz	gompertz	NOUN
ijassa-759	67	9	function	function	NOUN
ijassa-759	67	10	and	and	CCONJ
ijassa-759	67	11	the	the	DET
ijassa-759	67	12	sum	sum	NOUN
ijassa-759	67	13	of	of	ADP
ijassa-759	67	14	squared	square	VERB
ijassa-759	67	15	deviations	deviation	NOUN
ijassa-759	67	16	(	(	PUNCT
ijassa-759	67	17	sко	sко	NOUN
ijassa-759	67	18	=	=	SYM
ijassa-759	67	19	0.21	0.21	NUM
ijassa-759	67	20	)	)	PUNCT
ijassa-759	67	21	are	be	AUX
ijassa-759	67	22	shown	show	VERB
ijassa-759	67	23	in	in	ADP
ijassa-759	67	24	table	table	NOUN
ijassa-759	67	25	1	1	NUM
ijassa-759	67	26	[	[	SYM
ijassa-759	67	27	19	19	NUM
ijassa-759	67	28	,	,	PUNCT
ijassa-759	67	29	p.	p.	NOUN
ijassa-759	67	30	44	44	NUM
ijassa-759	67	31	]	]	PUNCT
ijassa-759	67	32	.	.	PUNCT
ijassa-759	68	1	analysis	analysis	NOUN
ijassa-759	68	2	of	of	ADP
ijassa-759	68	3	experimental	experimental	ADJ
ijassa-759	68	4	data	datum	NOUN
ijassa-759	68	5	on	on	ADP
ijassa-759	68	6	tumor	tumor	NOUN
ijassa-759	68	7	growth	growth	NOUN
ijassa-759	68	8	after	after	ADP
ijassa-759	68	9	the	the	DET
ijassa-759	68	10	introduction	introduction	NOUN
ijassa-759	68	11	of	of	ADP
ijassa-759	68	12	a	a	DET
ijassa-759	68	13	viral	viral	ADJ
ijassa-759	68	14	vaccine	vaccine	NOUN
ijassa-759	68	15	(	(	PUNCT
ijassa-759	68	16	fig	fig	NOUN
ijassa-759	68	17	.	.	PUNCT
ijassa-759	69	1	2	2	NUM
ijassa-759	69	2	,	,	PUNCT
ijassa-759	69	3	lower	low	ADJ
ijassa-759	69	4	curve	curve	NOUN
ijassa-759	69	5	)	)	PUNCT
ijassa-759	69	6	allows	allow	VERB
ijassa-759	69	7	us	we	PRON
ijassa-759	69	8	to	to	PART
ijassa-759	69	9	distinguish	distinguish	VERB
ijassa-759	69	10	two	two	NUM
ijassa-759	69	11	periods	period	NOUN
ijassa-759	69	12	of	of	ADP
ijassa-759	69	13	intensive	intensive	ADJ
ijassa-759	69	14	death	death	NOUN
ijassa-759	69	15	of	of	ADP
ijassa-759	69	16	tumor	tumor	NOUN
ijassa-759	69	17	cells	cell	NOUN
ijassa-759	69	18	.	.	PUNCT
ijassa-759	70	1	n.a	n.a	PROPN
ijassa-759	70	2	.	.	PROPN
ijassa-759	70	3	babushkina	babushkina	PROPN
ijassa-759	70	4	,	,	PUNCT
ijassa-759	70	5	e.a	e.a	PROPN
ijassa-759	70	6	.	.	PROPN
ijassa-759	70	7	kuzina	kuzina	PROPN
ijassa-759	70	8	copyright	copyright	PROPN
ijassa-759	71	1	©	©	PROPN
ijassa-759	71	2	2020	2020	NUM
ijassa-759	71	3	assa	assa	NOUN
ijassa-759	71	4	.	.	PUNCT
ijassa-759	72	1	adv	adv	PROPN
ijassa-759	72	2	.	.	PUNCT
ijassa-759	73	1	in	in	ADP
ijassa-759	73	2	systems	system	NOUN
ijassa-759	73	3	science	science	NOUN
ijassa-759	73	4	and	and	CCONJ
ijassa-759	73	5	appl	appl	NOUN
ijassa-759	73	6	.	.	PUNCT
ijassa-759	74	1	(	(	PUNCT
ijassa-759	74	2	2020	2020	NUM
ijassa-759	74	3	)	)	PUNCT
ijassa-759	74	4	4	4	NUM
ijassa-759	74	5	the	the	DET
ijassa-759	74	6	first	first	ADJ
ijassa-759	74	7	period	period	NOUN
ijassa-759	74	8	lasts	last	VERB
ijassa-759	74	9	from	from	ADP
ijassa-759	74	10	6	6	NUM
ijassa-759	74	11	to	to	PART
ijassa-759	74	12	8	8	NUM
ijassa-759	74	13	days	day	NOUN
ijassa-759	74	14	,	,	PUNCT
ijassa-759	74	15	and	and	CCONJ
ijassa-759	74	16	the	the	DET
ijassa-759	74	17	second	second	ADJ
ijassa-759	74	18	from	from	ADP
ijassa-759	74	19	13	13	NUM
ijassa-759	74	20	to	to	PART
ijassa-759	74	21	16	16	NUM
ijassa-759	74	22	days	day	NOUN
ijassa-759	74	23	.	.	PUNCT
ijassa-759	75	1	we	we	PRON
ijassa-759	75	2	can	can	AUX
ijassa-759	75	3	assume	assume	VERB
ijassa-759	75	4	that	that	SCONJ
ijassa-759	75	5	the	the	DET
ijassa-759	75	6	first	first	ADJ
ijassa-759	75	7	stage	stage	NOUN
ijassa-759	75	8	is	be	AUX
ijassa-759	75	9	associated	associate	VERB
ijassa-759	75	10	with	with	ADP
ijassa-759	75	11	the	the	DET
ijassa-759	75	12	reaction	reaction	NOUN
ijassa-759	75	13	of	of	ADP
ijassa-759	75	14	the	the	DET
ijassa-759	75	15	immune	immune	ADJ
ijassa-759	75	16	system	system	NOUN
ijassa-759	75	17	to	to	ADP
ijassa-759	75	18	the	the	DET
ijassa-759	75	19	virus	virus	NOUN
ijassa-759	75	20	and	and	CCONJ
ijassa-759	75	21	the	the	DET
ijassa-759	75	22	formation	formation	NOUN
ijassa-759	75	23	of	of	ADP
ijassa-759	75	24	antibodies	antibody	NOUN
ijassa-759	75	25	specific	specific	ADJ
ijassa-759	75	26	to	to	ADP
ijassa-759	75	27	this	this	DET
ijassa-759	75	28	virus	virus	NOUN
ijassa-759	75	29	.	.	PUNCT
ijassa-759	76	1	and	and	CCONJ
ijassa-759	76	2	the	the	DET
ijassa-759	76	3	second	second	ADJ
ijassa-759	76	4	stage	stage	NOUN
ijassa-759	76	5	is	be	AUX
ijassa-759	76	6	associated	associate	VERB
ijassa-759	76	7	with	with	ADP
ijassa-759	76	8	the	the	DET
ijassa-759	76	9	appearance	appearance	NOUN
ijassa-759	76	10	of	of	ADP
ijassa-759	76	11	dead	dead	ADJ
ijassa-759	76	12	tumor	tumor	NOUN
ijassa-759	76	13	cells	cell	NOUN
ijassa-759	76	14	infected	infect	VERB
ijassa-759	76	15	with	with	ADP
ijassa-759	76	16	a	a	DET
ijassa-759	76	17	virus	virus	NOUN
ijassa-759	76	18	,	,	PUNCT
ijassa-759	76	19	and	and	CCONJ
ijassa-759	76	20	the	the	DET
ijassa-759	76	21	formation	formation	NOUN
ijassa-759	76	22	of	of	ADP
ijassa-759	76	23	antibodies	antibody	NOUN
ijassa-759	76	24	specific	specific	ADJ
ijassa-759	76	25	to	to	ADP
ijassa-759	76	26	these	these	DET
ijassa-759	76	27	tumor	tumor	NOUN
ijassa-759	76	28	cells	cell	NOUN
ijassa-759	76	29	[	[	X
ijassa-759	76	30	15	15	NUM
ijassa-759	76	31	-	-	SYM
ijassa-759	76	32	17	17	NUM
ijassa-759	76	33	]	]	PUNCT
ijassa-759	76	34	.	.	PUNCT
ijassa-759	77	1	fig	fig	NOUN
ijassa-759	77	2	.	.	PUNCT
ijassa-759	78	1	2	2	X
ijassa-759	78	2	.	.	X
ijassa-759	78	3	experimental	experimental	ADJ
ijassa-759	78	4	data	datum	NOUN
ijassa-759	78	5	on	on	ADP
ijassa-759	78	6	the	the	DET
ijassa-759	78	7	growth	growth	NOUN
ijassa-759	78	8	of	of	ADP
ijassa-759	78	9	ehrlich	ehrlich	PROPN
ijassa-759	78	10	adenocarcinoma	adenocarcinoma	NOUN
ijassa-759	78	11	without	without	ADP
ijassa-759	78	12	treatment	treatment	NOUN
ijassa-759	78	13	and	and	CCONJ
ijassa-759	78	14	after	after	ADP
ijassa-759	78	15	a	a	DET
ijassa-759	78	16	single	single	ADJ
ijassa-759	78	17	injection	injection	NOUN
ijassa-759	78	18	of	of	ADP
ijassa-759	78	19	the	the	DET
ijassa-759	78	20	vaccine	vaccine	NOUN
ijassa-759	78	21	[	[	X
ijassa-759	78	22	17	17	NUM
ijassa-759	78	23	-	-	SYM
ijassa-759	78	24	19	19	NUM
ijassa-759	78	25	]	]	PUNCT
ijassa-759	78	26	as	as	ADP
ijassa-759	78	27	a	a	DET
ijassa-759	78	28	result	result	NOUN
ijassa-759	78	29	of	of	ADP
ijassa-759	78	30	the	the	DET
ijassa-759	78	31	interaction	interaction	NOUN
ijassa-759	78	32	of	of	ADP
ijassa-759	78	33	the	the	DET
ijassa-759	78	34	virus	virus	NOUN
ijassa-759	78	35	with	with	ADP
ijassa-759	78	36	tumor	tumor	NOUN
ijassa-759	78	37	cells	cell	NOUN
ijassa-759	78	38	,	,	PUNCT
ijassa-759	78	39	three	three	NUM
ijassa-759	78	40	populations	population	NOUN
ijassa-759	78	41	of	of	ADP
ijassa-759	78	42	tumor	tumor	NOUN
ijassa-759	78	43	cells	cell	NOUN
ijassa-759	78	44	emerge	emerge	VERB
ijassa-759	78	45	(	(	PUNCT
ijassa-759	78	46	fig	fig	NOUN
ijassa-759	78	47	.	.	PUNCT
ijassa-759	79	1	3	3	NUM
ijassa-759	79	2	)	)	PUNCT
ijassa-759	79	3	.	.	PUNCT
ijassa-759	80	1	fig	fig	NOUN
ijassa-759	80	2	.	.	PUNCT
ijassa-759	81	1	3	3	X
ijassa-759	81	2	.	.	X
ijassa-759	81	3	interaction	interaction	NOUN
ijassa-759	81	4	of	of	ADP
ijassa-759	81	5	the	the	DET
ijassa-759	81	6	virus	virus	NOUN
ijassa-759	81	7	with	with	ADP
ijassa-759	81	8	tumor	tumor	NOUN
ijassa-759	81	9	cells	cell	NOUN
ijassa-759	81	10	and	and	CCONJ
ijassa-759	81	11	immune	immune	ADJ
ijassa-759	81	12	system	system	NOUN
ijassa-759	81	13	the	the	DET
ijassa-759	81	14	population	population	NOUN
ijassa-759	81	15	of	of	ADP
ijassa-759	81	16	tumor	tumor	NOUN
ijassa-759	81	17	cells	cell	NOUN
ijassa-759	81	18	carrying	carry	VERB
ijassa-759	81	19	the	the	DET
ijassa-759	81	20	virus	virus	NOUN
ijassa-759	81	21	is	be	AUX
ijassa-759	81	22	part	part	NOUN
ijassa-759	81	23	of	of	ADP
ijassa-759	81	24	the	the	DET
ijassa-759	81	25	tumor	tumor	NOUN
ijassa-759	81	26	cells	cell	NOUN
ijassa-759	81	27	on	on	ADP
ijassa-759	81	28	which	which	PRON
ijassa-759	81	29	the	the	DET
ijassa-759	81	30	virus	virus	NOUN
ijassa-759	81	31	is	be	AUX
ijassa-759	81	32	absorbed	absorb	VERB
ijassa-759	81	33	.	.	PUNCT
ijassa-759	82	1	penetrating	penetrate	VERB
ijassa-759	82	2	inside	inside	ADP
ijassa-759	82	3	the	the	DET
ijassa-759	82	4	cell	cell	NOUN
ijassa-759	82	5	and	and	CCONJ
ijassa-759	82	6	multiplying	multiply	VERB
ijassa-759	82	7	there	there	ADV
ijassa-759	82	8	,	,	PUNCT
ijassa-759	82	9	the	the	DET
ijassa-759	82	10	virus	virus	NOUN
ijassa-759	82	11	makes	make	VERB
ijassa-759	82	12	the	the	DET
ijassa-759	82	13	tumor	tumor	NOUN
ijassa-759	82	14	cell	cell	NOUN
ijassa-759	82	15	die	die	VERB
ijassa-759	82	16	.	.	PUNCT
ijassa-759	83	1	mathematical	mathematical	ADJ
ijassa-759	83	2	modeling	modeling	NOUN
ijassa-759	83	3	of	of	ADP
ijassa-759	83	4	antitumor	antitumor	PROPN
ijassa-759	83	5	viral	viral	ADJ
ijassa-759	83	6	vaccine	vaccine	NOUN
ijassa-759	83	7	therapy	therapy	NOUN
ijassa-759	83	8	…	…	PUNCT
ijassa-759	83	9	copyright	copyright	NOUN
ijassa-759	83	10	©	©	PROPN
ijassa-759	83	11	2020	2020	NUM
ijassa-759	83	12	assa	assa	NOUN
ijassa-759	83	13	.	.	PUNCT
ijassa-759	84	1	adv	adv	PROPN
ijassa-759	84	2	.	.	PUNCT
ijassa-759	85	1	in	in	ADP
ijassa-759	85	2	systems	system	NOUN
ijassa-759	85	3	science	science	NOUN
ijassa-759	85	4	and	and	CCONJ
ijassa-759	85	5	appl	appl	NOUN
ijassa-759	85	6	.	.	PUNCT
ijassa-759	86	1	(	(	PUNCT
ijassa-759	86	2	2020	2020	NUM
ijassa-759	86	3	)	)	PUNCT
ijassa-759	86	4	5	5	NUM
ijassa-759	86	5	the	the	DET
ijassa-759	86	6	population	population	NOUN
ijassa-759	86	7	of	of	ADP
ijassa-759	86	8	infected	infected	ADJ
ijassa-759	86	9	tumor	tumor	NOUN
ijassa-759	86	10	cells	cell	NOUN
ijassa-759	86	11	has	have	VERB
ijassa-759	86	12	specific	specific	ADJ
ijassa-759	86	13	protein	protein	NOUN
ijassa-759	86	14	formations	formation	NOUN
ijassa-759	86	15	on	on	ADP
ijassa-759	86	16	the	the	DET
ijassa-759	86	17	cell	cell	NOUN
ijassa-759	86	18	membrane	membrane	NOUN
ijassa-759	86	19	which	which	PRON
ijassa-759	86	20	are	be	AUX
ijassa-759	86	21	perceived	perceive	VERB
ijassa-759	86	22	as	as	ADP
ijassa-759	86	23	alien	alien	ADJ
ijassa-759	86	24	by	by	ADP
ijassa-759	86	25	the	the	DET
ijassa-759	86	26	immune	immune	ADJ
ijassa-759	86	27	system	system	NOUN
ijassa-759	86	28	.	.	PUNCT
ijassa-759	87	1	thus	thus	ADV
ijassa-759	87	2	this	this	DET
ijassa-759	87	3	population	population	NOUN
ijassa-759	87	4	dies	die	VERB
ijassa-759	87	5	under	under	ADP
ijassa-759	87	6	the	the	DET
ijassa-759	87	7	action	action	NOUN
ijassa-759	87	8	of	of	ADP
ijassa-759	87	9	the	the	DET
ijassa-759	87	10	antibodies	antibody	NOUN
ijassa-759	87	11	produced	produce	VERB
ijassa-759	87	12	by	by	ADP
ijassa-759	87	13	the	the	DET
ijassa-759	87	14	immune	immune	ADJ
ijassa-759	87	15	system	system	NOUN
ijassa-759	87	16	.	.	PUNCT
ijassa-759	88	1	the	the	DET
ijassa-759	88	2	population	population	NOUN
ijassa-759	88	3	of	of	ADP
ijassa-759	88	4	uninfected	uninfected	ADJ
ijassa-759	88	5	tumor	tumor	NOUN
ijassa-759	88	6	cells	cell	NOUN
ijassa-759	88	7	remains	remain	VERB
ijassa-759	88	8	alive	alive	ADJ
ijassa-759	88	9	and	and	CCONJ
ijassa-759	88	10	is	be	AUX
ijassa-759	88	11	capable	capable	ADJ
ijassa-759	88	12	of	of	ADP
ijassa-759	88	13	multiplying	multiply	VERB
ijassa-759	88	14	and	and	CCONJ
ijassa-759	88	15	resuming	resume	VERB
ijassa-759	88	16	tumor	tumor	NOUN
ijassa-759	88	17	growth	growth	NOUN
ijassa-759	88	18	.	.	PUNCT
ijassa-759	89	1	a	a	DET
ijassa-759	89	2	mathematical	mathematical	ADJ
ijassa-759	89	3	model	model	NOUN
ijassa-759	89	4	of	of	ADP
ijassa-759	89	5	vaccine	vaccine	NOUN
ijassa-759	89	6	therapy	therapy	NOUN
ijassa-759	89	7	describing	describe	VERB
ijassa-759	89	8	the	the	DET
ijassa-759	89	9	dynamics	dynamic	NOUN
ijassa-759	89	10	of	of	ADP
ijassa-759	89	11	two	two	NUM
ijassa-759	89	12	-	-	PUNCT
ijassa-759	89	13	stage	stage	NOUN
ijassa-759	89	14	tumor	tumor	NOUN
ijassa-759	89	15	cell	cell	NOUN
ijassa-759	89	16	death	death	NOUN
ijassa-759	89	17	is	be	AUX
ijassa-759	89	18	presented	present	VERB
ijassa-759	89	19	in	in	ADP
ijassa-759	89	20	the	the	DET
ijassa-759	89	21	form	form	NOUN
ijassa-759	89	22	of	of	ADP
ijassa-759	89	23	a	a	DET
ijassa-759	89	24	system	system	NOUN
ijassa-759	89	25	of	of	ADP
ijassa-759	89	26	differential	differential	ADJ
ijassa-759	89	27	equations	equation	NOUN
ijassa-759	89	28	(	(	PUNCT
ijassa-759	89	29	1–10	1–10	NOUN
ijassa-759	89	30	)	)	PUNCT
ijassa-759	90	1	[	[	X
ijassa-759	90	2	18–20	18–20	NUM
ijassa-759	90	3	]	]	PUNCT
ijassa-759	90	4	.	.	PUNCT
ijassa-759	91	1	the	the	DET
ijassa-759	91	2	dynamics	dynamic	NOUN
ijassa-759	91	3	of	of	ADP
ijassa-759	91	4	tumor	tumor	NOUN
ijassa-759	91	5	growth	growth	NOUN
ijassa-759	91	6	before	before	ADP
ijassa-759	91	7	the	the	DET
ijassa-759	91	8	introduction	introduction	NOUN
ijassa-759	91	9	of	of	ADP
ijassa-759	91	10	the	the	DET
ijassa-759	91	11	vaccine	vaccine	NOUN
ijassa-759	91	12	is	be	AUX
ijassa-759	91	13	described	describe	VERB
ijassa-759	91	14	by	by	ADP
ijassa-759	91	15	a	a	DET
ijassa-759	91	16	differential	differential	ADJ
ijassa-759	91	17	equation	equation	NOUN
ijassa-759	91	18	of	of	ADP
ijassa-759	91	19	the	the	DET
ijassa-759	91	20	form	form	NOUN
ijassa-759	91	21	:	:	PUNCT
ijassa-759	91	22			ADJ
ijassa-759	91	23	0	0	NOUN
ijassa-759	91	24	,	,	PUNCT
ijassa-759	91	25	,	,	PUNCT
ijassa-759	91	26	(	(	PUNCT
ijassa-759	91	27	)	)	PUNCT
ijassa-759	91	28	(	(	PUNCT
ijassa-759	91	29	)	)	PUNCT
ijassa-759	91	30	(	(	PUNCT
ijassa-759	91	31	)	)	PUNCT
ijassa-759	91	32	,	,	PUNCT
ijassa-759	91	33	vt	vt	PROPN
ijassa-759	91	34	dn	dn	PROPN
ijassa-759	91	35	t	t	PROPN
ijassa-759	91	36	t	t	PROPN
ijassa-759	91	37	n	n	ADP
ijassa-759	91	38	t	t	X
ijassa-759	91	39	t	t	X
ijassa-759	91	40	dt	dt	X
ijassa-759	91	41	=	=	SYM
ijassa-759	91	42			ADJ
ijassa-759	91	43			NOUN
ijassa-759	91	44	with	with	ADP
ijassa-759	91	45	0	0	NUM
ijassa-759	91	46	0	0	NUM
ijassa-759	91	47	(	(	PUNCT
ijassa-759	91	48	)	)	PUNCT
ijassa-759	91	49	n	n	CCONJ
ijassa-759	91	50	n	n	PRON
ijassa-759	91	51	t=	t=	NOUN
ijassa-759	91	52	,	,	PUNCT
ijassa-759	91	53	(	(	PUNCT
ijassa-759	91	54	3	3	X
ijassa-759	91	55	)	)	PUNCT
ijassa-759	91	56	where	where	SCONJ
ijassa-759	91	57	(	(	PUNCT
ijassa-759	91	58	)	)	PUNCT
ijassa-759	91	59	n	n	PRON
ijassa-759	91	60	t	t	PROPN
ijassa-759	91	61	is	be	AUX
ijassa-759	91	62	the	the	DET
ijassa-759	91	63	population	population	NOUN
ijassa-759	91	64	of	of	ADP
ijassa-759	91	65	tumor	tumor	NOUN
ijassa-759	91	66	cells	cell	NOUN
ijassa-759	91	67	before	before	ADP
ijassa-759	91	68	administration	administration	NOUN
ijassa-759	91	69	of	of	ADP
ijassa-759	91	70	the	the	DET
ijassa-759	91	71	vaccine	vaccine	NOUN
ijassa-759	91	72	,	,	PUNCT
ijassa-759	91	73	1v	1v	NUM
ijassa-759	91	74	cvt	cvt	PROPN
ijassa-759	91	75	z=	z=	PUNCT
ijassa-759	91	76			PROPN
ijassa-759	91	77	+	+	CCONJ
ijassa-759	91	78	is	be	AUX
ijassa-759	91	79	the	the	DET
ijassa-759	91	80	beginning	beginning	NOUN
ijassa-759	91	81	of	of	ADP
ijassa-759	91	82	the	the	DET
ijassa-759	91	83	immune	immune	ADJ
ijassa-759	91	84	response	response	NOUN
ijassa-759	91	85	against	against	ADP
ijassa-759	91	86	viruses	virus	NOUN
ijassa-759	91	87	.	.	PUNCT
ijassa-759	92	1	1	1	NUM
ijassa-759	92	2	is	be	AUX
ijassa-759	92	3	the	the	DET
ijassa-759	92	4	moment	moment	NOUN
ijassa-759	92	5	of	of	ADP
ijassa-759	92	6	injection	injection	NOUN
ijassa-759	92	7	of	of	ADP
ijassa-759	92	8	the	the	DET
ijassa-759	92	9	vaccine	vaccine	NOUN
ijassa-759	92	10	,	,	PUNCT
ijassa-759	92	11	cvz	cvz	PROPN
ijassa-759	92	12	is	be	AUX
ijassa-759	92	13	the	the	DET
ijassa-759	92	14	period	period	NOUN
ijassa-759	92	15	of	of	ADP
ijassa-759	92	16	the	the	DET
ijassa-759	92	17	delay	delay	NOUN
ijassa-759	92	18	of	of	ADP
ijassa-759	92	19	immune	immune	ADJ
ijassa-759	92	20	response	response	NOUN
ijassa-759	92	21	against	against	ADP
ijassa-759	92	22	the	the	DET
ijassa-759	92	23	virus	virus	NOUN
ijassa-759	92	24	.	.	PUNCT
ijassa-759	93	1	the	the	DET
ijassa-759	93	2	dynamics	dynamic	NOUN
ijassa-759	93	3	of	of	ADP
ijassa-759	93	4	growth	growth	NOUN
ijassa-759	93	5	and	and	CCONJ
ijassa-759	93	6	death	death	NOUN
ijassa-759	93	7	of	of	ADP
ijassa-759	93	8	infected	infected	ADJ
ijassa-759	93	9	tumor	tumor	NOUN
ijassa-759	93	10	cells	cell	NOUN
ijassa-759	93	11	after	after	ADP
ijassa-759	93	12	the	the	DET
ijassa-759	93	13	introduction	introduction	NOUN
ijassa-759	93	14	of	of	ADP
ijassa-759	93	15	the	the	DET
ijassa-759	93	16	virus	virus	NOUN
ijassa-759	93	17	is	be	AUX
ijassa-759	93	18	described	describe	VERB
ijassa-759	93	19	by	by	ADP
ijassa-759	93	20	the	the	DET
ijassa-759	93	21	differential	differential	ADJ
ijassa-759	93	22	equation	equation	NOUN
ijassa-759	93	23	of	of	ADP
ijassa-759	93	24	the	the	DET
ijassa-759	93	25	form	form	NOUN
ijassa-759	93	26	:	:	PUNCT
ijassa-759	93	27	(	(	PUNCT
ijassa-759	93	28			NOUN
ijassa-759	93	29	,	,	PUNCT
ijassa-759	93	30	,	,	PUNCT
ijassa-759	93	31	(	(	PUNCT
ijassa-759	93	32	)	)	PUNCT
ijassa-759	93	33	[	[	PUNCT
ijassa-759	93	34	(	(	PUNCT
ijassa-759	93	35	)	)	PUNCT
ijassa-759	93	36	(	(	PUNCT
ijassa-759	93	37	)	)	PUNCT
ijassa-759	93	38	(	(	PUNCT
ijassa-759	93	39	)	)	PUNCT
ijassa-759	93	40	]	]	PUNCT
ijassa-759	94	1	(	(	PUNCT
ijassa-759	94	2	)	)	PUNCT
ijassa-759	94	3	,	,	PUNCT
ijassa-759	94	4	v	v	X
ijassa-759	94	5	v	v	ADP
ijassa-759	94	6	av	av	PROPN
ijassa-759	94	7	v	v	ADP
ijassa-759	94	8	v	v	NUM
ijassa-759	94	9	v	v	NOUN
ijassa-759	94	10	n	n	ADV
ijassa-759	94	11	dn	dn	NOUN
ijassa-759	94	12	t	t	PROPN
ijassa-759	95	1	t	t	PROPN
ijassa-759	96	1	k	k	PROPN
ijassa-759	97	1	v	v	ADP
ijassa-759	97	2	t	t	X
ijassa-759	97	3	k	k	PROPN
ijassa-759	98	1	a	a	PROPN
ijassa-759	98	2	t	t	PROPN
ijassa-759	98	3	n	n	ADP
ijassa-759	98	4	t	t	PROPN
ijassa-759	98	5	t	t	PROPN
ijassa-759	98	6	t	t	PROPN
ijassa-759	98	7	t	t	PROPN
ijassa-759	98	8	dt	dt	X
ijassa-759	98	9	=	=	SYM
ijassa-759	98	10			ADJ
ijassa-759	98	11	−	−	PROPN
ijassa-759	98	12	−	−	PROPN
ijassa-759	98	13			PROPN
ijassa-759	98	14			NOUN
ijassa-759	98	15	with	with	ADP
ijassa-759	98	16	0	0	NUM
ijassa-759	98	17	(	(	PUNCT
ijassa-759	98	18	)	)	PUNCT
ijassa-759	98	19	v	v	NOUN
ijassa-759	98	20	vn	vn	PROPN
ijassa-759	98	21	n	n	CCONJ
ijassa-759	98	22	t=	t=	PRON
ijassa-759	98	23	(	(	PUNCT
ijassa-759	98	24	4	4	NUM
ijassa-759	98	25	)	)	PUNCT
ijassa-759	98	26	where	where	SCONJ
ijassa-759	98	27	(	(	PUNCT
ijassa-759	98	28	)	)	PUNCT
ijassa-759	98	29	vn	vn	PROPN
ijassa-759	98	30	t	t	PROPN
ijassa-759	98	31	is	be	AUX
ijassa-759	98	32	the	the	DET
ijassa-759	98	33	population	population	NOUN
ijassa-759	98	34	of	of	ADP
ijassa-759	98	35	infected	infected	ADJ
ijassa-759	98	36	tumor	tumor	NOUN
ijassa-759	98	37	cells	cell	NOUN
ijassa-759	98	38	following	follow	VERB
ijassa-759	98	39	injection	injection	NOUN
ijassa-759	98	40	of	of	ADP
ijassa-759	98	41	the	the	DET
ijassa-759	98	42	vaccine	vaccine	NOUN
ijassa-759	98	43	,	,	PUNCT
ijassa-759	98	44	(	(	PUNCT
ijassa-759	98	45	)	)	PUNCT
ijassa-759	98	46	v	v	NOUN
ijassa-759	98	47	t	t	PROPN
ijassa-759	98	48	is	be	AUX
ijassa-759	98	49	the	the	DET
ijassa-759	98	50	number	number	NOUN
ijassa-759	98	51	of	of	ADP
ijassa-759	98	52	viruses	virus	NOUN
ijassa-759	98	53	,	,	PUNCT
ijassa-759	98	54	(	(	PUNCT
ijassa-759	98	55	)	)	PUNCT
ijassa-759	98	56	va	va	PROPN
ijassa-759	98	57	t	t	PROPN
ijassa-759	98	58	is	be	AUX
ijassa-759	98	59	the	the	DET
ijassa-759	98	60	number	number	NOUN
ijassa-759	98	61	of	of	ADP
ijassa-759	98	62	antibodies	antibody	NOUN
ijassa-759	98	63	against	against	ADP
ijassa-759	98	64	the	the	DET
ijassa-759	98	65	virus	virus	NOUN
ijassa-759	98	66	,	,	PUNCT
ijassa-759	98	67	vk	vk	PROPN
ijassa-759	98	68	is	be	AUX
ijassa-759	98	69	the	the	DET
ijassa-759	98	70	coefficient	coefficient	NOUN
ijassa-759	98	71	of	of	ADP
ijassa-759	98	72	the	the	DET
ijassa-759	98	73	rate	rate	NOUN
ijassa-759	98	74	of	of	ADP
ijassa-759	98	75	reproduction	reproduction	NOUN
ijassa-759	98	76	of	of	ADP
ijassa-759	98	77	the	the	DET
ijassa-759	98	78	virus	virus	NOUN
ijassa-759	98	79	in	in	ADP
ijassa-759	98	80	a	a	DET
ijassa-759	98	81	tumor	tumor	NOUN
ijassa-759	98	82	cell	cell	NOUN
ijassa-759	98	83	,	,	PUNCT
ijassa-759	98	84	avk	avk	PROPN
ijassa-759	98	85	is	be	AUX
ijassa-759	98	86	the	the	DET
ijassa-759	98	87	coefficient	coefficient	NOUN
ijassa-759	98	88	of	of	ADP
ijassa-759	98	89	the	the	DET
ijassa-759	98	90	rate	rate	NOUN
ijassa-759	98	91	of	of	ADP
ijassa-759	98	92	death	death	NOUN
ijassa-759	98	93	of	of	ADP
ijassa-759	98	94	viruses	virus	NOUN
ijassa-759	98	95	as	as	ADP
ijassa-759	98	96	a	a	DET
ijassa-759	98	97	result	result	NOUN
ijassa-759	98	98	of	of	ADP
ijassa-759	98	99	interaction	interaction	NOUN
ijassa-759	98	100	with	with	ADP
ijassa-759	98	101	antibodies	antibody	NOUN
ijassa-759	98	102	(	(	PUNCT
ijassa-759	98	103	)	)	PUNCT
ijassa-759	98	104	va	va	PROPN
ijassa-759	98	105	t	t	PROPN
ijassa-759	98	106	.	.	PUNCT
ijassa-759	99	1	the	the	DET
ijassa-759	99	2	dynamics	dynamic	NOUN
ijassa-759	99	3	of	of	ADP
ijassa-759	99	4	growth	growth	NOUN
ijassa-759	99	5	and	and	CCONJ
ijassa-759	99	6	death	death	NOUN
ijassa-759	99	7	of	of	ADP
ijassa-759	99	8	infected	infected	ADJ
ijassa-759	99	9	tumor	tumor	NOUN
ijassa-759	99	10	cells	cell	NOUN
ijassa-759	99	11	under	under	ADP
ijassa-759	99	12	the	the	DET
ijassa-759	99	13	action	action	NOUN
ijassa-759	99	14	of	of	ADP
ijassa-759	99	15	antibodies	antibody	NOUN
ijassa-759	99	16	at	at	ADP
ijassa-759	99	17	the	the	DET
ijassa-759	99	18	second	second	ADJ
ijassa-759	99	19	stage	stage	NOUN
ijassa-759	99	20	is	be	AUX
ijassa-759	99	21	described	describe	VERB
ijassa-759	99	22	by	by	ADP
ijassa-759	99	23	the	the	DET
ijassa-759	99	24	differential	differential	ADJ
ijassa-759	99	25	equation	equation	NOUN
ijassa-759	99	26	of	of	ADP
ijassa-759	99	27	the	the	DET
ijassa-759	99	28	form	form	NOUN
ijassa-759	99	29	:	:	PUNCT
ijassa-759	99	30			ADJ
ijassa-759	99	31			PROPN
ijassa-759	99	32	,	,	PUNCT
ijassa-759	99	33	,	,	PUNCT
ijassa-759	99	34	(	(	PUNCT
ijassa-759	99	35	)	)	PUNCT
ijassa-759	99	36	[	[	PUNCT
ijassa-759	99	37	(	(	PUNCT
ijassa-759	99	38	)	)	PUNCT
ijassa-759	99	39	(	(	PUNCT
ijassa-759	99	40	)	)	PUNCT
ijassa-759	99	41	]	]	PUNCT
ijassa-759	99	42	(	(	PUNCT
ijassa-759	99	43	)	)	PUNCT
ijassa-759	99	44	,	,	PUNCT
ijassa-759	99	45	v	v	ADP
ijassa-759	99	46	an	an	DET
ijassa-759	99	47	n	n	NUM
ijassa-759	99	48	v	v	NOUN
ijassa-759	99	49	n	n	PRON
ijassa-759	99	50	l	l	NOUN
ijassa-759	99	51	dn	dn	NOUN
ijassa-759	99	52	t	t	PROPN
ijassa-759	99	53	t	t	PROPN
ijassa-759	99	54	k	k	PROPN
ijassa-759	99	55	a	a	PROPN
ijassa-759	99	56	t	t	PROPN
ijassa-759	99	57	n	n	ADP
ijassa-759	99	58	t	t	PROPN
ijassa-759	99	59	t	t	PROPN
ijassa-759	99	60	t	t	PROPN
ijassa-759	99	61	t	t	PROPN
ijassa-759	99	62	dt	dt	X
ijassa-759	99	63	=	=	SYM
ijassa-759	99	64			ADJ
ijassa-759	99	65	−	−	PROPN
ijassa-759	99	66			PROPN
ijassa-759	99	67			NOUN
ijassa-759	99	68	with	with	ADP
ijassa-759	99	69	0	0	NUM
ijassa-759	99	70	(	(	PUNCT
ijassa-759	99	71	)	)	PUNCT
ijassa-759	99	72	v	v	NOUN
ijassa-759	99	73	nn	nn	PROPN
ijassa-759	99	74	n	n	CCONJ
ijassa-759	99	75	t=	t=	PRON
ijassa-759	99	76	,	,	PUNCT
ijassa-759	99	77	(	(	PUNCT
ijassa-759	99	78	5	5	X
ijassa-759	99	79	)	)	PUNCT
ijassa-759	99	80	where	where	SCONJ
ijassa-759	99	81	1n	1n	PROPN
ijassa-759	99	82	cnt	cnt	PROPN
ijassa-759	99	83	z=	z=	VERB
ijassa-759	99	84			PROPN
ijassa-759	99	85	+	+	CCONJ
ijassa-759	99	86	is	be	AUX
ijassa-759	99	87	the	the	DET
ijassa-759	99	88	moment	moment	NOUN
ijassa-759	99	89	of	of	ADP
ijassa-759	99	90	the	the	DET
ijassa-759	99	91	immune	immune	ADJ
ijassa-759	99	92	response	response	NOUN
ijassa-759	99	93	against	against	ADP
ijassa-759	99	94	infected	infected	ADJ
ijassa-759	99	95	tumor	tumor	NOUN
ijassa-759	99	96	cells	cell	NOUN
ijassa-759	99	97	,	,	PUNCT
ijassa-759	99	98	cnz	cnz	NOUN
ijassa-759	99	99	is	be	AUX
ijassa-759	99	100	the	the	DET
ijassa-759	99	101	delay	delay	NOUN
ijassa-759	99	102	time	time	NOUN
ijassa-759	99	103	of	of	ADP
ijassa-759	99	104	the	the	DET
ijassa-759	99	105	immune	immune	ADJ
ijassa-759	99	106	response	response	NOUN
ijassa-759	99	107	against	against	ADP
ijassa-759	99	108	infected	infected	ADJ
ijassa-759	99	109	tumor	tumor	NOUN
ijassa-759	99	110	cells	cell	NOUN
ijassa-759	99	111	,	,	PUNCT
ijassa-759	99	112	(	(	PUNCT
ijassa-759	99	113	)	)	PUNCT
ijassa-759	99	114	na	na	NOUN
ijassa-759	99	115	t	t	PROPN
ijassa-759	99	116	is	be	AUX
ijassa-759	99	117	the	the	DET
ijassa-759	99	118	number	number	NOUN
ijassa-759	99	119	of	of	ADP
ijassa-759	99	120	antibodies	antibody	NOUN
ijassa-759	99	121	against	against	ADP
ijassa-759	99	122	infected	infected	ADJ
ijassa-759	99	123	tumor	tumor	NOUN
ijassa-759	99	124	cells	cell	NOUN
ijassa-759	99	125	,	,	PUNCT
ijassa-759	99	126	ank	ank	PROPN
ijassa-759	99	127	is	be	AUX
ijassa-759	99	128	the	the	DET
ijassa-759	99	129	dimensional	dimensional	ADJ
ijassa-759	99	130	coefficient	coefficient	NOUN
ijassa-759	99	131	.	.	PUNCT
ijassa-759	100	1	the	the	DET
ijassa-759	100	2	death	death	NOUN
ijassa-759	100	3	of	of	ADP
ijassa-759	100	4	tumor	tumor	NOUN
ijassa-759	100	5	cells	cell	NOUN
ijassa-759	100	6	at	at	ADP
ijassa-759	100	7	each	each	PRON
ijassa-759	100	8	of	of	ADP
ijassa-759	100	9	the	the	DET
ijassa-759	100	10	two	two	NUM
ijassa-759	100	11	stages	stage	NOUN
ijassa-759	100	12	occurs	occur	VERB
ijassa-759	100	13	as	as	ADP
ijassa-759	100	14	a	a	DET
ijassa-759	100	15	result	result	NOUN
ijassa-759	100	16	of	of	ADP
ijassa-759	100	17	the	the	DET
ijassa-759	100	18	development	development	NOUN
ijassa-759	100	19	of	of	ADP
ijassa-759	100	20	the	the	DET
ijassa-759	100	21	body	body	NOUN
ijassa-759	100	22	's	's	PART
ijassa-759	100	23	immune	immune	ADJ
ijassa-759	100	24	response	response	NOUN
ijassa-759	100	25	to	to	ADP
ijassa-759	100	26	the	the	DET
ijassa-759	100	27	introduction	introduction	NOUN
ijassa-759	100	28	of	of	ADP
ijassa-759	100	29	a	a	DET
ijassa-759	100	30	viral	viral	ADJ
ijassa-759	100	31	vaccine	vaccine	NOUN
ijassa-759	100	32	.	.	PUNCT
ijassa-759	101	1	the	the	DET
ijassa-759	101	2	first	first	ADJ
ijassa-759	101	3	stage	stage	NOUN
ijassa-759	101	4	is	be	AUX
ijassa-759	101	5	associated	associate	VERB
ijassa-759	101	6	with	with	ADP
ijassa-759	101	7	the	the	DET
ijassa-759	101	8	formation	formation	NOUN
ijassa-759	101	9	of	of	ADP
ijassa-759	101	10	antibodies	antibody	NOUN
ijassa-759	101	11	against	against	ADP
ijassa-759	101	12	the	the	DET
ijassa-759	101	13	virus	virus	NOUN
ijassa-759	101	14	(	(	PUNCT
ijassa-759	101	15	)	)	PUNCT
ijassa-759	101	16	va	va	PROPN
ijassa-759	101	17	t	t	PROPN
ijassa-759	101	18	,	,	PUNCT
ijassa-759	101	19	and	and	CCONJ
ijassa-759	101	20	the	the	DET
ijassa-759	101	21	second	second	ADJ
ijassa-759	101	22	stage	stage	NOUN
ijassa-759	101	23	is	be	AUX
ijassa-759	101	24	associated	associate	VERB
ijassa-759	101	25	with	with	ADP
ijassa-759	101	26	the	the	DET
ijassa-759	101	27	formation	formation	NOUN
ijassa-759	101	28	of	of	ADP
ijassa-759	101	29	antibodies	antibody	NOUN
ijassa-759	101	30	against	against	ADP
ijassa-759	101	31	infected	infected	ADJ
ijassa-759	101	32	tumor	tumor	NOUN
ijassa-759	101	33	cells	cell	NOUN
ijassa-759	101	34	(	(	PUNCT
ijassa-759	101	35	)	)	PUNCT
ijassa-759	101	36	na	na	NOUN
ijassa-759	101	37	t	t	PROPN
ijassa-759	101	38	.	.	PUNCT
ijassa-759	102	1	graphs	graph	NOUN
ijassa-759	102	2	of	of	ADP
ijassa-759	102	3	antibody	antibody	NOUN
ijassa-759	102	4	formation	formation	NOUN
ijassa-759	102	5	dynamics	dynamic	NOUN
ijassa-759	102	6	(	(	PUNCT
ijassa-759	102	7	)	)	PUNCT
ijassa-759	102	8	va	va	PROPN
ijassa-759	102	9	t	t	PROPN
ijassa-759	102	10	against	against	ADP
ijassa-759	102	11	the	the	DET
ijassa-759	102	12	virus	virus	NOUN
ijassa-759	102	13	and	and	CCONJ
ijassa-759	102	14	against	against	ADP
ijassa-759	102	15	infected	infect	VERB
ijassa-759	102	16	tumor	tumor	NOUN
ijassa-759	102	17	cells	cell	NOUN
ijassa-759	102	18	(	(	PUNCT
ijassa-759	102	19	)	)	PUNCT
ijassa-759	102	20	na	na	NOUN
ijassa-759	102	21	t	t	PROPN
ijassa-759	102	22	are	be	AUX
ijassa-759	102	23	shown	show	VERB
ijassa-759	102	24	in	in	ADP
ijassa-759	102	25	fig	fig	NOUN
ijassa-759	102	26	.	.	PUNCT
ijassa-759	103	1	4	4	NUM
ijassa-759	104	1	[	[	SYM
ijassa-759	104	2	19	19	NUM
ijassa-759	104	3	,	,	PUNCT
ijassa-759	104	4	p.	p.	NOUN
ijassa-759	104	5	39	39	NUM
ijassa-759	104	6	]	]	PUNCT
ijassa-759	104	7	.	.	PUNCT
ijassa-759	105	1	n.a	n.a	PROPN
ijassa-759	105	2	.	.	PROPN
ijassa-759	105	3	babushkina	babushkina	PROPN
ijassa-759	105	4	,	,	PUNCT
ijassa-759	105	5	e.a	e.a	PROPN
ijassa-759	105	6	.	.	PROPN
ijassa-759	105	7	kuzina	kuzina	PROPN
ijassa-759	105	8	copyright	copyright	PROPN
ijassa-759	106	1	©	©	PROPN
ijassa-759	106	2	2020	2020	NUM
ijassa-759	106	3	assa	assa	NOUN
ijassa-759	106	4	.	.	PUNCT
ijassa-759	107	1	adv	adv	PROPN
ijassa-759	107	2	.	.	PUNCT
ijassa-759	108	1	in	in	ADP
ijassa-759	108	2	systems	system	NOUN
ijassa-759	108	3	science	science	NOUN
ijassa-759	108	4	and	and	CCONJ
ijassa-759	108	5	appl	appl	NOUN
ijassa-759	108	6	.	.	PUNCT
ijassa-759	109	1	(	(	PUNCT
ijassa-759	109	2	2020	2020	NUM
ijassa-759	109	3	)	)	PUNCT
ijassa-759	109	4	6	6	NUM
ijassa-759	109	5	fig	fig	NOUN
ijassa-759	109	6	.	.	PUNCT
ijassa-759	110	1	4	4	X
ijassa-759	110	2	.	.	X
ijassa-759	110	3	graph	graph	NOUN
ijassa-759	110	4	of	of	ADP
ijassa-759	110	5	the	the	DET
ijassa-759	110	6	dynamics	dynamic	NOUN
ijassa-759	110	7	of	of	ADP
ijassa-759	110	8	the	the	DET
ijassa-759	110	9	number	number	NOUN
ijassa-759	110	10	of	of	ADP
ijassa-759	110	11	antibodies	antibody	NOUN
ijassa-759	110	12	against	against	ADP
ijassa-759	110	13	the	the	DET
ijassa-759	110	14	virus	virus	NOUN
ijassa-759	110	15	(	(	PUNCT
ijassa-759	110	16	)	)	PUNCT
ijassa-759	110	17	va	va	PROPN
ijassa-759	110	18	t	t	PROPN
ijassa-759	110	19	(	(	PUNCT
ijassa-759	110	20	the	the	DET
ijassa-759	110	21	first	first	ADJ
ijassa-759	110	22	stage	stage	NOUN
ijassa-759	110	23	of	of	ADP
ijassa-759	110	24	the	the	DET
ijassa-759	110	25	immune	immune	ADJ
ijassa-759	110	26	response	response	NOUN
ijassa-759	110	27	)	)	PUNCT
ijassa-759	110	28	and	and	CCONJ
ijassa-759	110	29	against	against	ADP
ijassa-759	110	30	infected	infect	VERB
ijassa-759	110	31	tumor	tumor	NOUN
ijassa-759	110	32	cells	cell	NOUN
ijassa-759	110	33	(	(	PUNCT
ijassa-759	110	34	)	)	PUNCT
ijassa-759	110	35	na	na	PART
ijassa-759	110	36	t	t	PROPN
ijassa-759	110	37	(	(	PUNCT
ijassa-759	110	38	the	the	DET
ijassa-759	110	39	second	second	ADJ
ijassa-759	110	40	stage	stage	NOUN
ijassa-759	110	41	of	of	ADP
ijassa-759	110	42	the	the	DET
ijassa-759	110	43	immune	immune	ADJ
ijassa-759	110	44	response	response	NOUN
ijassa-759	110	45	)	)	PUNCT
ijassa-759	110	46	)	)	PUNCT
ijassa-759	110	47	for	for	ADP
ijassa-759	110	48	the	the	DET
ijassa-759	110	49	experimental	experimental	ADJ
ijassa-759	110	50	dose	dose	NOUN
ijassa-759	110	51	0	0	NUM
ijassa-759	110	52	0.015v	0.015v	PROPN
ijassa-759	110	53	=	=	PUNCT
ijassa-759	110	54	on	on	ADP
ijassa-759	110	55	τ1	τ1	NOUN
ijassa-759	110	56	=	=	PUNCT
ijassa-759	110	57	1day	1day	PROPN
ijassa-759	110	58	the	the	DET
ijassa-759	110	59	mechanism	mechanism	NOUN
ijassa-759	110	60	of	of	ADP
ijassa-759	110	61	their	their	PRON
ijassa-759	110	62	formation	formation	NOUN
ijassa-759	110	63	is	be	AUX
ijassa-759	110	64	calculated	calculate	VERB
ijassa-759	110	65	on	on	ADP
ijassa-759	110	66	the	the	DET
ijassa-759	110	67	basis	basis	NOUN
ijassa-759	110	68	of	of	ADP
ijassa-759	110	69	the	the	DET
ijassa-759	110	70	model	model	NOUN
ijassa-759	110	71	of	of	ADP
ijassa-759	110	72	infectious	infectious	ADJ
ijassa-759	110	73	disease	disease	NOUN
ijassa-759	110	74	by	by	ADP
ijassa-759	110	75	g.	g.	PROPN
ijassa-759	110	76	i.	i.	PROPN
ijassa-759	110	77	marchuk	marchuk	PROPN
ijassa-759	111	1	[	[	X
ijassa-759	111	2	20	20	NUM
ijassa-759	111	3	-	-	SYM
ijassa-759	111	4	22	22	NUM
ijassa-759	111	5	]	]	PUNCT
ijassa-759	111	6	.	.	PUNCT
ijassa-759	112	1	the	the	DET
ijassa-759	112	2	parameters	parameter	NOUN
ijassa-759	112	3	of	of	ADP
ijassa-759	112	4	this	this	DET
ijassa-759	112	5	model	model	NOUN
ijassa-759	112	6	are	be	AUX
ijassa-759	112	7	adapted	adapt	VERB
ijassa-759	112	8	for	for	ADP
ijassa-759	112	9	experimental	experimental	ADJ
ijassa-759	112	10	curves	curve	NOUN
ijassa-759	112	11	of	of	ADP
ijassa-759	112	12	tumor	tumor	NOUN
ijassa-759	112	13	growth	growth	NOUN
ijassa-759	112	14	after	after	ADP
ijassa-759	112	15	the	the	DET
ijassa-759	112	16	introduction	introduction	NOUN
ijassa-759	112	17	of	of	ADP
ijassa-759	112	18	viral	viral	ADJ
ijassa-759	112	19	vaccines	vaccine	NOUN
ijassa-759	112	20	.	.	PUNCT
ijassa-759	113	1	the	the	DET
ijassa-759	113	2	dynamics	dynamic	NOUN
ijassa-759	113	3	of	of	ADP
ijassa-759	113	4	the	the	DET
ijassa-759	113	5	number	number	NOUN
ijassa-759	113	6	of	of	ADP
ijassa-759	113	7	viruses	virus	NOUN
ijassa-759	113	8	according	accord	VERB
ijassa-759	113	9	to	to	ADP
ijassa-759	113	10	the	the	DET
ijassa-759	113	11	mathematical	mathematical	ADJ
ijassa-759	113	12	model	model	NOUN
ijassa-759	113	13	of	of	ADP
ijassa-759	113	14	an	an	DET
ijassa-759	113	15	infectious	infectious	ADJ
ijassa-759	113	16	disease	disease	NOUN
ijassa-759	113	17	[	[	X
ijassa-759	113	18	20	20	NUM
ijassa-759	113	19	,	,	PUNCT
ijassa-759	113	20	22	22	NUM
ijassa-759	113	21	]	]	PUNCT
ijassa-759	113	22	is	be	AUX
ijassa-759	113	23	described	describe	VERB
ijassa-759	113	24	by	by	ADP
ijassa-759	113	25	the	the	DET
ijassa-759	113	26	equation	equation	NOUN
ijassa-759	113	27	of	of	ADP
ijassa-759	113	28	the	the	DET
ijassa-759	113	29	form	form	NOUN
ijassa-759	113	30	:	:	PUNCT
ijassa-759	113	31	(	(	PUNCT
ijassa-759	113	32	)	)	PUNCT
ijassa-759	113	33	(	(	PUNCT
ijassa-759	113	34	)	)	PUNCT
ijassa-759	113	35	(	(	PUNCT
ijassa-759	113	36	)	)	PUNCT
ijassa-759	113	37	(	(	PUNCT
ijassa-759	113	38	)	)	PUNCT
ijassa-759	113	39	,	,	PUNCT
ijassa-759	113	40	v	v	X
ijassa-759	113	41	v	v	NUM
ijassa-759	113	42	v	v	ADP
ijassa-759	113	43	dv	dv	PROPN
ijassa-759	113	44	t	t	PROPN
ijassa-759	113	45	v	v	PROPN
ijassa-759	113	46	t	t	PROPN
ijassa-759	113	47	a	a	DET
ijassa-759	113	48	t	t	NOUN
ijassa-759	113	49	v	v	ADP
ijassa-759	113	50	t	t	NOUN
ijassa-759	113	51	dt	dt	NOUN
ijassa-759	113	52	=	=	SYM
ijassa-759	113	53			X
ijassa-759	113	54	−	−	X
ijassa-759	113	55	(	(	PUNCT
ijassa-759	113	56	6	6	NUM
ijassa-759	113	57	)	)	PUNCT
ijassa-759	113	58	where	where	SCONJ
ijassa-759	113	59	0	0	NUM
ijassa-759	113	60	1	1	NUM
ijassa-759	113	61	(	(	PUNCT
ijassa-759	113	62	)	)	PUNCT
ijassa-759	113	63	v	v	NOUN
ijassa-759	113	64	v=	v=	NOUN
ijassa-759	113	65			NOUN
ijassa-759	113	66	is	be	AUX
ijassa-759	113	67	the	the	DET
ijassa-759	113	68	initial	initial	ADJ
ijassa-759	113	69	dose	dose	NOUN
ijassa-759	113	70	of	of	ADP
ijassa-759	113	71	virus	virus	NOUN
ijassa-759	113	72	vaccine	vaccine	NOUN
ijassa-759	113	73	,	,	PUNCT
ijassa-759	113	74	1	1	NUM
ijassa-759	113	75	is	be	AUX
ijassa-759	113	76	the	the	DET
ijassa-759	113	77	moment	moment	NOUN
ijassa-759	113	78	of	of	ADP
ijassa-759	113	79	the	the	DET
ijassa-759	113	80	first	first	ADJ
ijassa-759	113	81	introduction	introduction	NOUN
ijassa-759	113	82	of	of	ADP
ijassa-759	113	83	a	a	DET
ijassa-759	113	84	viral	viral	ADJ
ijassa-759	113	85	vaccine	vaccine	NOUN
ijassa-759	113	86	,	,	PUNCT
ijassa-759	113	87	v	v	PROPN
ijassa-759	113	88	is	be	AUX
ijassa-759	113	89	the	the	DET
ijassa-759	113	90	rate	rate	NOUN
ijassa-759	113	91	of	of	ADP
ijassa-759	113	92	reproduction	reproduction	NOUN
ijassa-759	113	93	of	of	ADP
ijassa-759	113	94	the	the	DET
ijassa-759	113	95	virus	virus	NOUN
ijassa-759	113	96	inside	inside	ADP
ijassa-759	113	97	the	the	DET
ijassa-759	113	98	cell	cell	NOUN
ijassa-759	113	99	,	,	PUNCT
ijassa-759	113	100	v	v	X
ijassa-759	113	101	is	be	AUX
ijassa-759	113	102	the	the	DET
ijassa-759	113	103	rate	rate	NOUN
ijassa-759	113	104	of	of	ADP
ijassa-759	113	105	death	death	NOUN
ijassa-759	113	106	of	of	ADP
ijassa-759	113	107	viruses	virus	NOUN
ijassa-759	113	108	in	in	ADP
ijassa-759	113	109	their	their	PRON
ijassa-759	113	110	interaction	interaction	NOUN
ijassa-759	113	111	with	with	ADP
ijassa-759	113	112	antibodies	antibody	NOUN
ijassa-759	113	113	(	(	PUNCT
ijassa-759	113	114	)	)	PUNCT
ijassa-759	113	115	va	va	PROPN
ijassa-759	113	116	t	t	PROPN
ijassa-759	114	1	[	[	X
ijassa-759	114	2	19	19	NUM
ijassa-759	114	3	,	,	PUNCT
ijassa-759	114	4	p.	p.	NOUN
ijassa-759	114	5	39	39	NUM
ijassa-759	114	6	]	]	PUNCT
ijassa-759	114	7	.	.	PUNCT
ijassa-759	115	1	the	the	DET
ijassa-759	115	2	initial	initial	ADJ
ijassa-759	115	3	condition	condition	NOUN
ijassa-759	115	4	for	for	ADP
ijassa-759	115	5	the	the	DET
ijassa-759	115	6	solution	solution	NOUN
ijassa-759	115	7	of	of	ADP
ijassa-759	115	8	equation	equation	NOUN
ijassa-759	115	9	(	(	PUNCT
ijassa-759	115	10	4	4	X
ijassa-759	115	11	)	)	PUNCT
ijassa-759	115	12	is	be	AUX
ijassa-759	115	13	taken	take	VERB
ijassa-759	115	14	as	as	ADP
ijassa-759	115	15	a	a	DET
ijassa-759	115	16	control	control	NOUN
ijassa-759	115	17	parameter	parameter	NOUN
ijassa-759	115	18	characterizing	characterize	VERB
ijassa-759	115	19	the	the	DET
ijassa-759	115	20	introduced	introduce	VERB
ijassa-759	115	21	dose	dose	NOUN
ijassa-759	115	22	of	of	ADP
ijassa-759	115	23	the	the	DET
ijassa-759	115	24	viral	viral	ADJ
ijassa-759	115	25	vaccine	vaccine	NOUN
ijassa-759	115	26	0	0	NUM
ijassa-759	115	27	1	1	NUM
ijassa-759	115	28	(	(	PUNCT
ijassa-759	115	29	)	)	PUNCT
ijassa-759	115	30	v	v	NOUN
ijassa-759	115	31	v=	v=	NOUN
ijassa-759	115	32			PROPN
ijassa-759	115	33	.	.	PUNCT
ijassa-759	116	1	the	the	DET
ijassa-759	116	2	first	first	ADJ
ijassa-759	116	3	stage	stage	NOUN
ijassa-759	116	4	of	of	ADP
ijassa-759	116	5	the	the	DET
ijassa-759	116	6	body	body	NOUN
ijassa-759	116	7	's	's	PART
ijassa-759	116	8	immune	immune	ADJ
ijassa-759	116	9	response	response	NOUN
ijassa-759	116	10	to	to	ADP
ijassa-759	116	11	the	the	DET
ijassa-759	116	12	introduction	introduction	NOUN
ijassa-759	116	13	of	of	ADP
ijassa-759	116	14	the	the	DET
ijassa-759	116	15	virus	virus	NOUN
ijassa-759	116	16	is	be	AUX
ijassa-759	116	17	determined	determine	VERB
ijassa-759	116	18	by	by	ADP
ijassa-759	116	19	the	the	DET
ijassa-759	116	20	number	number	NOUN
ijassa-759	116	21	of	of	ADP
ijassa-759	116	22	antibodies	antibody	NOUN
ijassa-759	116	23	(	(	PUNCT
ijassa-759	116	24	)	)	PUNCT
ijassa-759	116	25	va	va	PROPN
ijassa-759	116	26	t	t	PROPN
ijassa-759	116	27	,	,	PUNCT
ijassa-759	116	28	which	which	PRON
ijassa-759	116	29	is	be	AUX
ijassa-759	116	30	calculated	calculate	VERB
ijassa-759	116	31	from	from	ADP
ijassa-759	116	32	the	the	DET
ijassa-759	116	33	following	following	ADJ
ijassa-759	116	34	equations	equation	NOUN
ijassa-759	116	35	:	:	PUNCT
ijassa-759	116	36	(	(	PUNCT
ijassa-759	116	37	)	)	PUNCT
ijassa-759	116	38	(	(	PUNCT
ijassa-759	116	39	)	)	PUNCT
ijassa-759	116	40	(	(	PUNCT
ijassa-759	116	41	)	)	PUNCT
ijassa-759	116	42	(	(	PUNCT
ijassa-759	116	43	)	)	PUNCT
ijassa-759	116	44	(	(	PUNCT
ijassa-759	116	45	)	)	PUNCT
ijassa-759	116	46	,	,	PUNCT
ijassa-759	116	47	v	v	ADP
ijassa-759	116	48	a	a	DET
ijassa-759	116	49	v	v	NOUN
ijassa-759	116	50	v	v	ADP
ijassa-759	116	51	av	av	PROPN
ijassa-759	116	52	v	v	NUM
ijassa-759	116	53	v	v	NUM
ijassa-759	116	54	v	v	NOUN
ijassa-759	116	55	da	da	PROPN
ijassa-759	116	56	t	t	PROPN
ijassa-759	116	57	c	c	PROPN
ijassa-759	116	58	t	t	PROPN
ijassa-759	116	59	t	t	PROPN
ijassa-759	116	60	a	a	DET
ijassa-759	116	61	t	t	NOUN
ijassa-759	116	62	v	v	ADP
ijassa-759	116	63	t	t	PROPN
ijassa-759	116	64	a	a	DET
ijassa-759	116	65	t	t	NOUN
ijassa-759	116	66	dt	dt	NOUN
ijassa-759	116	67	=	=	SYM
ijassa-759	116	68			X
ijassa-759	116	69	−	−	NOUN
ijassa-759	116	70	−	−	NOUN
ijassa-759	116	71	−	−	PROPN
ijassa-759	116	72	(	(	PUNCT
ijassa-759	116	73	7	7	X
ijassa-759	116	74	)	)	PUNCT
ijassa-759	116	75	where	where	SCONJ
ijassa-759	116	76	a	a	ADV
ijassa-759	116	77	is	be	AUX
ijassa-759	116	78	the	the	DET
ijassa-759	116	79	rate	rate	NOUN
ijassa-759	116	80	of	of	ADP
ijassa-759	116	81	formation	formation	NOUN
ijassa-759	116	82	of	of	ADP
ijassa-759	116	83	antibodies	antibody	NOUN
ijassa-759	116	84	from	from	ADP
ijassa-759	116	85	one	one	NUM
ijassa-759	116	86	plasma	plasma	NOUN
ijassa-759	116	87	cell	cell	NOUN
ijassa-759	116	88	,	,	PUNCT
ijassa-759	116	89	av	av	NOUN
ijassa-759	116	90	is	be	AUX
ijassa-759	116	91	the	the	DET
ijassa-759	116	92	rate	rate	NOUN
ijassa-759	116	93	of	of	ADP
ijassa-759	116	94	loss	loss	NOUN
ijassa-759	116	95	of	of	ADP
ijassa-759	116	96	antibodies	antibody	NOUN
ijassa-759	116	97	due	due	ADP
ijassa-759	116	98	to	to	ADP
ijassa-759	116	99	the	the	DET
ijassa-759	116	100	interaction	interaction	NOUN
ijassa-759	116	101	with	with	ADP
ijassa-759	116	102	viruses	virus	NOUN
ijassa-759	116	103	(	(	PUNCT
ijassa-759	116	104	)	)	PUNCT
ijassa-759	116	105	va	va	PROPN
ijassa-759	116	106	t	t	PROPN
ijassa-759	116	107	,	,	PUNCT
ijassa-759	116	108	v	v	X
ijassa-759	116	109	is	be	AUX
ijassa-759	116	110	the	the	DET
ijassa-759	116	111	rate	rate	NOUN
ijassa-759	116	112	of	of	ADP
ijassa-759	116	113	reduction	reduction	NOUN
ijassa-759	116	114	of	of	ADP
ijassa-759	116	115	the	the	DET
ijassa-759	116	116	number	number	NOUN
ijassa-759	116	117	of	of	ADP
ijassa-759	116	118	antibodies	antibody	NOUN
ijassa-759	116	119	due	due	ADP
ijassa-759	116	120	to	to	ADP
ijassa-759	116	121	natural	natural	ADJ
ijassa-759	116	122	destruction	destruction	NOUN
ijassa-759	116	123	,	,	PUNCT
ijassa-759	116	124	1v	1v	NUM
ijassa-759	116	125	cvt	cvt	PROPN
ijassa-759	116	126	z=	z=	PUNCT
ijassa-759	116	127			PROPN
ijassa-759	116	128	+	+	CCONJ
ijassa-759	116	129	is	be	AUX
ijassa-759	116	130	the	the	DET
ijassa-759	116	131	moment	moment	NOUN
ijassa-759	116	132	of	of	ADP
ijassa-759	116	133	the	the	DET
ijassa-759	116	134	beginning	beginning	NOUN
ijassa-759	116	135	of	of	ADP
ijassa-759	116	136	immune	immune	ADJ
ijassa-759	116	137	response	response	NOUN
ijassa-759	116	138	against	against	ADP
ijassa-759	116	139	viruses	virus	NOUN
ijassa-759	116	140	[	[	X
ijassa-759	116	141	19	19	NUM
ijassa-759	116	142	,	,	PUNCT
ijassa-759	116	143	p.	p.	NOUN
ijassa-759	116	144	40	40	NUM
ijassa-759	116	145	]	]	PUNCT
ijassa-759	116	146	.	.	PUNCT
ijassa-759	117	1	due	due	ADP
ijassa-759	117	2	to	to	ADP
ijassa-759	117	3	the	the	DET
ijassa-759	117	4	fact	fact	NOUN
ijassa-759	117	5	that	that	SCONJ
ijassa-759	117	6	the	the	DET
ijassa-759	117	7	time	time	NOUN
ijassa-759	117	8	of	of	ADP
ijassa-759	117	9	virus	virus	NOUN
ijassa-759	117	10	reproduction	reproduction	NOUN
ijassa-759	117	11	in	in	ADP
ijassa-759	117	12	the	the	DET
ijassa-759	117	13	experimental	experimental	ADJ
ijassa-759	117	14	tumor	tumor	NOUN
ijassa-759	117	15	was	be	AUX
ijassa-759	117	16	not	not	PART
ijassa-759	117	17	recorded	record	VERB
ijassa-759	117	18	in	in	ADP
ijassa-759	117	19	the	the	DET
ijassa-759	117	20	available	available	ADJ
ijassa-759	117	21	experimental	experimental	ADJ
ijassa-759	117	22	data	datum	NOUN
ijassa-759	117	23	[	[	X
ijassa-759	117	24	15	15	NUM
ijassa-759	117	25	-	-	SYM
ijassa-759	117	26	17	17	NUM
ijassa-759	117	27	]	]	PUNCT
ijassa-759	117	28	,	,	PUNCT
ijassa-759	117	29	when	when	SCONJ
ijassa-759	117	30	constructing	construct	VERB
ijassa-759	117	31	the	the	DET
ijassa-759	117	32	model	model	NOUN
ijassa-759	117	33	,	,	PUNCT
ijassa-759	117	34	it	it	PRON
ijassa-759	117	35	was	be	AUX
ijassa-759	117	36	assumed	assume	VERB
ijassa-759	117	37	that	that	SCONJ
ijassa-759	117	38	the	the	DET
ijassa-759	117	39	period	period	NOUN
ijassa-759	117	40	of	of	ADP
ijassa-759	117	41	virus	virus	NOUN
ijassa-759	117	42	reproduction	reproduction	NOUN
ijassa-759	117	43	inside	inside	ADP
ijassa-759	117	44	the	the	DET
ijassa-759	117	45	tumor	tumor	NOUN
ijassa-759	117	46	cell	cell	NOUN
ijassa-759	117	47	,	,	PUNCT
ijassa-759	117	48	leading	lead	VERB
ijassa-759	117	49	to	to	ADP
ijassa-759	117	50	its	its	PRON
ijassa-759	117	51	death	death	NOUN
ijassa-759	117	52	,	,	PUNCT
ijassa-759	117	53	can	can	AUX
ijassa-759	117	54	be	be	AUX
ijassa-759	117	55	considered	consider	VERB
ijassa-759	117	56	with	with	ADP
ijassa-759	117	57	sufficient	sufficient	ADJ
ijassa-759	117	58	accuracy	accuracy	NOUN
ijassa-759	117	59	equal	equal	ADJ
ijassa-759	117	60	to	to	ADP
ijassa-759	117	61	the	the	DET
ijassa-759	117	62	time	time	NOUN
ijassa-759	117	63	of	of	ADP
ijassa-759	117	64	delay	delay	NOUN
ijassa-759	117	65	of	of	ADP
ijassa-759	117	66	the	the	DET
ijassa-759	117	67	immune	immune	ADJ
ijassa-759	117	68	response	response	NOUN
ijassa-759	117	69	against	against	ADP
ijassa-759	117	70	the	the	DET
ijassa-759	117	71	virus	virus	NOUN
ijassa-759	117	72	cvz	cvz	ADV
ijassa-759	117	73	.	.	PUNCT
ijassa-759	118	1	then	then	ADV
ijassa-759	118	2	in	in	ADP
ijassa-759	118	3	equations	equation	NOUN
ijassa-759	118	4	(	(	PUNCT
ijassa-759	118	5	7	7	NUM
ijassa-759	118	6	)	)	PUNCT
ijassa-759	118	7	and	and	CCONJ
ijassa-759	118	8	(	(	PUNCT
ijassa-759	118	9	8)	8)	NUM
ijassa-759	118	10	the	the	DET
ijassa-759	118	11	time	time	NOUN
ijassa-759	118	12	of	of	ADP
ijassa-759	118	13	introduction	introduction	NOUN
ijassa-759	118	14	of	of	ADP
ijassa-759	118	15	the	the	DET
ijassa-759	118	16	virus	virus	NOUN
ijassa-759	118	17	was	be	AUX
ijassa-759	118	18	taken	take	VERB
ijassa-759	118	19	into	into	ADP
ijassa-759	118	20	account	account	NOUN
ijassa-759	118	21	as	as	ADP
ijassa-759	118	22	a	a	DET
ijassa-759	118	23	parameter	parameter	NOUN
ijassa-759	118	24	tv	tv	NOUN
ijassa-759	118	25	=	=	PUNCT
ijassa-759	118	26	1	1	NUM
ijassa-759	118	27	+	+	NOUN
ijassa-759	118	28	zcv	zcv	PROPN
ijassa-759	118	29	,	,	PUNCT
ijassa-759	118	30	which	which	PRON
ijassa-759	118	31	records	record	VERB
ijassa-759	118	32	the	the	DET
ijassa-759	118	33	moment	moment	NOUN
ijassa-759	118	34	of	of	ADP
ijassa-759	118	35	the	the	DET
ijassa-759	118	36	beginning	beginning	NOUN
ijassa-759	118	37	of	of	ADP
ijassa-759	118	38	the	the	DET
ijassa-759	118	39	immune	immune	ADJ
ijassa-759	118	40	response	response	NOUN
ijassa-759	118	41	against	against	ADP
ijassa-759	118	42	viruses	virus	NOUN
ijassa-759	118	43	.	.	PUNCT
ijassa-759	119	1	mathematical	mathematical	ADJ
ijassa-759	119	2	modeling	modeling	NOUN
ijassa-759	119	3	of	of	ADP
ijassa-759	119	4	antitumor	antitumor	PROPN
ijassa-759	119	5	viral	viral	ADJ
ijassa-759	119	6	vaccine	vaccine	NOUN
ijassa-759	119	7	therapy	therapy	NOUN
ijassa-759	119	8	…	…	PUNCT
ijassa-759	119	9	copyright	copyright	NOUN
ijassa-759	119	10	©	©	PROPN
ijassa-759	119	11	2020	2020	NUM
ijassa-759	119	12	assa	assa	NOUN
ijassa-759	119	13	.	.	PUNCT
ijassa-759	120	1	adv	adv	PROPN
ijassa-759	120	2	.	.	PUNCT
ijassa-759	121	1	in	in	ADP
ijassa-759	121	2	systems	system	NOUN
ijassa-759	121	3	science	science	NOUN
ijassa-759	121	4	and	and	CCONJ
ijassa-759	121	5	appl	appl	NOUN
ijassa-759	121	6	.	.	PUNCT
ijassa-759	122	1	(	(	PUNCT
ijassa-759	122	2	2020	2020	NUM
ijassa-759	122	3	)	)	PUNCT
ijassa-759	122	4	7	7	NUM
ijassa-759	122	5	number	number	NOUN
ijassa-759	122	6	of	of	ADP
ijassa-759	122	7	plasma	plasma	NOUN
ijassa-759	122	8	cells	cell	NOUN
ijassa-759	122	9	(	(	PUNCT
ijassa-759	122	10	)	)	PUNCT
ijassa-759	122	11	vc	vc	PROPN
ijassa-759	122	12	t	t	PROPN
ijassa-759	122	13	is	be	AUX
ijassa-759	122	14	determined	determine	VERB
ijassa-759	122	15	from	from	ADP
ijassa-759	122	16	the	the	DET
ijassa-759	122	17	equation	equation	NOUN
ijassa-759	122	18	:	:	PUNCT
ijassa-759	122	19	(	(	PUNCT
ijassa-759	122	20	)	)	PUNCT
ijassa-759	122	21	(	(	PUNCT
ijassa-759	122	22	)	)	PUNCT
ijassa-759	122	23	(	(	PUNCT
ijassa-759	122	24	)	)	PUNCT
ijassa-759	122	25	(	(	PUNCT
ijassa-759	122	26	)	)	PUNCT
ijassa-759	122	27	v	v	NOUN
ijassa-759	122	28	vc	vc	PROPN
ijassa-759	122	29	v	v	NUM
ijassa-759	122	30	v	v	PROPN
ijassa-759	122	31	cv	cv	PROPN
ijassa-759	122	32	v	v	X
ijassa-759	122	33	vn	vn	PROPN
ijassa-759	122	34	dc	dc	PROPN
ijassa-759	122	35	t	t	PROPN
ijassa-759	122	36	v	v	PROPN
ijassa-759	122	37	t	t	PROPN
ijassa-759	122	38	t	t	PROPN
ijassa-759	122	39	a	a	DET
ijassa-759	122	40	t	t	NOUN
ijassa-759	122	41	t	t	NOUN
ijassa-759	122	42	c	c	NOUN
ijassa-759	122	43	t	t	PROPN
ijassa-759	122	44	c	c	NOUN
ijassa-759	123	1	dt	dt	INTJ
ijassa-759	123	2			PROPN
ijassa-759	123	3			NOUN
ijassa-759	123	4			NOUN
ijassa-759	123	5			PROPN
ijassa-759	123	6			PROPN
ijassa-759	123	7	=	=	SYM
ijassa-759	123	8			NUM
ijassa-759	123	9	−	−	PROPN
ijassa-759	123	10	−	−	PROPN
ijassa-759	123	11	−	−	NOUN
ijassa-759	123	12	−	−	PROPN
ijassa-759	123	13	,	,	PUNCT
ijassa-759	123	14	with	with	ADP
ijassa-759	123	15	,	,	PUNCT
ijassa-759	123	16	(	(	PUNCT
ijassa-759	123	17	)	)	PUNCT
ijassa-759	123	18	v	v	NOUN
ijassa-759	123	19	v	v	ADP
ijassa-759	123	20	vnc	vnc	PROPN
ijassa-759	123	21	t	t	NOUN
ijassa-759	123	22	c=	c=	NOUN
ijassa-759	123	23	(	(	PUNCT
ijassa-759	123	24	8)	8)	NUM
ijassa-759	123	25	where	where	SCONJ
ijassa-759	123	26	с	с	PROPN
ijassa-759	123	27	is	be	AUX
ijassa-759	123	28	the	the	DET
ijassa-759	123	29	rate	rate	NOUN
ijassa-759	123	30	of	of	ADP
ijassa-759	123	31	formation	formation	NOUN
ijassa-759	123	32	of	of	ADP
ijassa-759	123	33	plasma	plasma	NOUN
ijassa-759	123	34	cells	cell	NOUN
ijassa-759	123	35	,	,	PUNCT
ijassa-759	123	36	cv	cv	ADV
ijassa-759	123	37	is	be	AUX
ijassa-759	123	38	the	the	DET
ijassa-759	123	39	constant	constant	ADJ
ijassa-759	123	40	coefficient	coefficient	NOUN
ijassa-759	123	41	,	,	PUNCT
ijassa-759	123	42	cvz	cvz	PROPN
ijassa-759	123	43	is	be	AUX
ijassa-759	123	44	the	the	DET
ijassa-759	123	45	period	period	NOUN
ijassa-759	123	46	of	of	ADP
ijassa-759	123	47	delay	delay	NOUN
ijassa-759	123	48	in	in	ADP
ijassa-759	123	49	the	the	DET
ijassa-759	123	50	development	development	NOUN
ijassa-759	123	51	of	of	ADP
ijassa-759	123	52	antibodies	antibody	NOUN
ijassa-759	123	53	against	against	ADP
ijassa-759	123	54	the	the	DET
ijassa-759	123	55	virus	virus	NOUN
ijassa-759	123	56	(	(	PUNCT
ijassa-759	123	57	first	first	ADJ
ijassa-759	123	58	stage	stage	NOUN
ijassa-759	123	59	of	of	ADP
ijassa-759	123	60	immune	immune	ADJ
ijassa-759	123	61	response	response	NOUN
ijassa-759	123	62	)	)	PUNCT
ijassa-759	123	63	.	.	PUNCT
ijassa-759	124	1	the	the	DET
ijassa-759	124	2	second	second	ADJ
ijassa-759	124	3	term	term	NOUN
ijassa-759	124	4	of	of	ADP
ijassa-759	124	5	this	this	DET
ijassa-759	124	6	equation	equation	NOUN
ijassa-759	124	7	reflects	reflect	VERB
ijassa-759	124	8	the	the	DET
ijassa-759	124	9	maintenance	maintenance	NOUN
ijassa-759	124	10	of	of	ADP
ijassa-759	124	11	the	the	DET
ijassa-759	124	12	initial	initial	ADJ
ijassa-759	124	13	number	number	NOUN
ijassa-759	124	14	of	of	ADP
ijassa-759	124	15	plasma	plasma	NOUN
ijassa-759	124	16	cells	cell	NOUN
ijassa-759	124	17	in	in	ADP
ijassa-759	124	18	the	the	DET
ijassa-759	124	19	norm	norm	NOUN
ijassa-759	124	20	vnc	vnc	NOUN
ijassa-759	125	1	[	[	X
ijassa-759	125	2	19	19	NUM
ijassa-759	125	3	,	,	PUNCT
ijassa-759	125	4	p.	p.	NOUN
ijassa-759	125	5	40	40	NUM
ijassa-759	125	6	]	]	PUNCT
ijassa-759	125	7	.	.	PUNCT
ijassa-759	126	1	the	the	DET
ijassa-759	126	2	second	second	ADJ
ijassa-759	126	3	stage	stage	NOUN
ijassa-759	126	4	of	of	ADP
ijassa-759	126	5	the	the	DET
ijassa-759	126	6	immune	immune	ADJ
ijassa-759	126	7	response	response	NOUN
ijassa-759	126	8	of	of	ADP
ijassa-759	126	9	the	the	DET
ijassa-759	126	10	body	body	NOUN
ijassa-759	126	11	to	to	ADP
ijassa-759	126	12	the	the	DET
ijassa-759	126	13	formed	form	VERB
ijassa-759	126	14	infected	infect	VERB
ijassa-759	126	15	tumor	tumor	NOUN
ijassa-759	126	16	cells	cell	NOUN
ijassa-759	126	17	was	be	AUX
ijassa-759	126	18	determined	determine	VERB
ijassa-759	126	19	by	by	ADP
ijassa-759	126	20	the	the	DET
ijassa-759	126	21	number	number	NOUN
ijassa-759	126	22	of	of	ADP
ijassa-759	126	23	antibodies	antibody	NOUN
ijassa-759	126	24	,	,	PUNCT
ijassa-759	126	25	which	which	PRON
ijassa-759	126	26	was	be	AUX
ijassa-759	126	27	calculated	calculate	VERB
ijassa-759	126	28	from	from	ADP
ijassa-759	126	29	the	the	DET
ijassa-759	126	30	following	following	ADJ
ijassa-759	126	31	equations	equation	NOUN
ijassa-759	126	32	:	:	PUNCT
ijassa-759	126	33	(	(	PUNCT
ijassa-759	126	34	)	)	PUNCT
ijassa-759	126	35	(	(	PUNCT
ijassa-759	126	36	)	)	PUNCT
ijassa-759	126	37	(	(	PUNCT
ijassa-759	126	38	)	)	PUNCT
ijassa-759	126	39	(	(	PUNCT
ijassa-759	126	40	)	)	PUNCT
ijassa-759	126	41	(	(	PUNCT
ijassa-759	126	42	)	)	PUNCT
ijassa-759	126	43	,	,	PUNCT
ijassa-759	126	44	n	n	PROPN
ijassa-759	126	45	an	an	DET
ijassa-759	126	46	n	n	CCONJ
ijassa-759	126	47	n	n	ADV
ijassa-759	126	48	an	an	DET
ijassa-759	126	49	n	n	ADV
ijassa-759	126	50	v	v	NOUN
ijassa-759	126	51	nn	nn	PROPN
ijassa-759	126	52	n	n	CCONJ
ijassa-759	126	53	da	da	PROPN
ijassa-759	126	54	t	t	PROPN
ijassa-759	126	55	c	c	PROPN
ijassa-759	126	56	t	t	PROPN
ijassa-759	126	57	t	t	PROPN
ijassa-759	126	58	a	a	DET
ijassa-759	126	59	t	t	PROPN
ijassa-759	126	60	n	n	ADP
ijassa-759	126	61	t	t	PROPN
ijassa-759	126	62	a	a	DET
ijassa-759	126	63	t	t	NOUN
ijassa-759	126	64	dt	dt	NOUN
ijassa-759	126	65	=	=	SYM
ijassa-759	126	66			X
ijassa-759	126	67	−	−	NOUN
ijassa-759	126	68	−	−	NOUN
ijassa-759	126	69	−	−	PROPN
ijassa-759	126	70	(	(	PUNCT
ijassa-759	126	71	9	9	X
ijassa-759	126	72	)	)	PUNCT
ijassa-759	126	73	where	where	SCONJ
ijassa-759	126	74	an	an	NOUN
ijassa-759	126	75	is	be	AUX
ijassa-759	126	76	the	the	DET
ijassa-759	126	77	rate	rate	NOUN
ijassa-759	126	78	of	of	ADP
ijassa-759	126	79	formation	formation	NOUN
ijassa-759	126	80	of	of	ADP
ijassa-759	126	81	antibodies	antibody	NOUN
ijassa-759	126	82	,	,	PUNCT
ijassa-759	126	83	an	an	PROPN
ijassa-759	126	84	is	be	AUX
ijassa-759	126	85	the	the	DET
ijassa-759	126	86	coefficient	coefficient	NOUN
ijassa-759	126	87	that	that	PRON
ijassa-759	126	88	describes	describe	VERB
ijassa-759	126	89	the	the	DET
ijassa-759	126	90	rate	rate	NOUN
ijassa-759	126	91	of	of	ADP
ijassa-759	126	92	reduction	reduction	NOUN
ijassa-759	126	93	of	of	ADP
ijassa-759	126	94	the	the	DET
ijassa-759	126	95	number	number	NOUN
ijassa-759	126	96	of	of	ADP
ijassa-759	126	97	antibodies	antibody	NOUN
ijassa-759	126	98	(	(	PUNCT
ijassa-759	126	99	)	)	PUNCT
ijassa-759	126	100	na	na	NOUN
ijassa-759	126	101	t	t	NOUN
ijassa-759	126	102	due	due	ADP
ijassa-759	126	103	to	to	ADP
ijassa-759	126	104	their	their	PRON
ijassa-759	126	105	interaction	interaction	NOUN
ijassa-759	126	106	with	with	ADP
ijassa-759	126	107	infected	infected	ADJ
ijassa-759	126	108	tumor	tumor	NOUN
ijassa-759	126	109	cells	cell	NOUN
ijassa-759	126	110	(	(	PUNCT
ijassa-759	126	111	)	)	PUNCT
ijassa-759	126	112	vn	vn	PROPN
ijassa-759	126	113	t	t	PROPN
ijassa-759	126	114	,	,	PUNCT
ijassa-759	126	115	nn	nn	PROPN
ijassa-759	126	116	is	be	AUX
ijassa-759	126	117	the	the	DET
ijassa-759	126	118	rate	rate	NOUN
ijassa-759	126	119	of	of	ADP
ijassa-759	126	120	reduction	reduction	NOUN
ijassa-759	126	121	of	of	ADP
ijassa-759	126	122	the	the	DET
ijassa-759	126	123	number	number	NOUN
ijassa-759	126	124	of	of	ADP
ijassa-759	126	125	antibodies	antibody	NOUN
ijassa-759	126	126	due	due	ADP
ijassa-759	126	127	to	to	ADP
ijassa-759	126	128	natural	natural	ADJ
ijassa-759	126	129	destruction	destruction	NOUN
ijassa-759	126	130	[	[	X
ijassa-759	126	131	19	19	NUM
ijassa-759	126	132	,	,	PUNCT
ijassa-759	126	133	p.	p.	NOUN
ijassa-759	126	134	40	40	NUM
ijassa-759	126	135	]	]	PUNCT
ijassa-759	126	136	.	.	PUNCT
ijassa-759	127	1	number	number	NOUN
ijassa-759	127	2	of	of	ADP
ijassa-759	127	3	plasma	plasma	NOUN
ijassa-759	127	4	cells	cell	NOUN
ijassa-759	127	5	(	(	PUNCT
ijassa-759	127	6	)	)	PUNCT
ijassa-759	127	7	nc	nc	PROPN
ijassa-759	127	8	t	t	PROPN
ijassa-759	127	9	is	be	AUX
ijassa-759	127	10	determined	determine	VERB
ijassa-759	127	11	from	from	ADP
ijassa-759	127	12	the	the	DET
ijassa-759	127	13	equation	equation	NOUN
ijassa-759	127	14	:	:	PUNCT
ijassa-759	127	15	,	,	PUNCT
ijassa-759	127	16	(	(	PUNCT
ijassa-759	127	17	)	)	PUNCT
ijassa-759	127	18	(	(	PUNCT
ijassa-759	127	19	)	)	PUNCT
ijassa-759	127	20	(	(	PUNCT
ijassa-759	127	21	)	)	PUNCT
ijassa-759	127	22	(	(	PUNCT
ijassa-759	127	23	)	)	PUNCT
ijassa-759	128	1	n	n	X
ijassa-759	128	2	cn	cn	PROPN
ijassa-759	128	3	v	v	PROPN
ijassa-759	128	4	n	n	CCONJ
ijassa-759	128	5	n	n	CCONJ
ijassa-759	128	6	n	n	ADV
ijassa-759	128	7	cn	cn	PROPN
ijassa-759	128	8	n	n	CCONJ
ijassa-759	128	9	nn	nn	PROPN
ijassa-759	128	10	dc	dc	PROPN
ijassa-759	128	11	t	t	PROPN
ijassa-759	128	12	n	n	ADP
ijassa-759	128	13	t	t	PROPN
ijassa-759	128	14	t	t	PROPN
ijassa-759	128	15	a	a	DET
ijassa-759	128	16	t	t	NOUN
ijassa-759	128	17	t	t	NOUN
ijassa-759	128	18	c	c	NOUN
ijassa-759	128	19	t	t	PROPN
ijassa-759	128	20	c	c	NOUN
ijassa-759	128	21	dt	dt	INTJ
ijassa-759	128	22			PROPN
ijassa-759	128	23			NOUN
ijassa-759	128	24			NOUN
ijassa-759	129	1			PROPN
ijassa-759	129	2			PROPN
ijassa-759	129	3	=	=	SYM
ijassa-759	129	4			NUM
ijassa-759	129	5	−	−	PROPN
ijassa-759	129	6	−	−	NOUN
ijassa-759	129	7	−	−	NOUN
ijassa-759	129	8	−	−	PROPN
ijassa-759	129	9	with	with	ADP
ijassa-759	129	10	,	,	PUNCT
ijassa-759	129	11	(	(	PUNCT
ijassa-759	129	12	)	)	PUNCT
ijassa-759	129	13	n	n	CCONJ
ijassa-759	129	14	n	n	PROPN
ijassa-759	129	15	nnc	nnc	PROPN
ijassa-759	129	16	t	t	PROPN
ijassa-759	129	17	c=	c=	NOUN
ijassa-759	129	18	(	(	PUNCT
ijassa-759	129	19	10	10	NUM
ijassa-759	129	20	)	)	PUNCT
ijassa-759	129	21	where	where	SCONJ
ijassa-759	129	22	cn	cn	NOUN
ijassa-759	129	23	is	be	AUX
ijassa-759	129	24	the	the	DET
ijassa-759	129	25	rate	rate	NOUN
ijassa-759	129	26	of	of	ADP
ijassa-759	129	27	formation	formation	NOUN
ijassa-759	129	28	of	of	ADP
ijassa-759	129	29	plasma	plasma	NOUN
ijassa-759	129	30	cells	cell	NOUN
ijassa-759	129	31	,	,	PUNCT
ijassa-759	129	32	cn	cn	PROPN
ijassa-759	129	33	is	be	AUX
ijassa-759	129	34	the	the	DET
ijassa-759	129	35	constant	constant	ADJ
ijassa-759	129	36	coefficient	coefficient	NOUN
ijassa-759	129	37	,	,	PUNCT
ijassa-759	129	38	сnz	сnz	X
ijassa-759	129	39	is	be	AUX
ijassa-759	129	40	the	the	DET
ijassa-759	129	41	period	period	NOUN
ijassa-759	129	42	of	of	ADP
ijassa-759	129	43	delay	delay	NOUN
ijassa-759	129	44	in	in	ADP
ijassa-759	129	45	the	the	DET
ijassa-759	129	46	development	development	NOUN
ijassa-759	129	47	of	of	ADP
ijassa-759	129	48	antibodies	antibody	NOUN
ijassa-759	129	49	against	against	ADP
ijassa-759	129	50	the	the	DET
ijassa-759	129	51	infected	infected	ADJ
ijassa-759	129	52	tumor	tumor	NOUN
ijassa-759	129	53	cells	cell	NOUN
ijassa-759	129	54	(	(	PUNCT
ijassa-759	129	55	second	second	ADJ
ijassa-759	129	56	stage	stage	NOUN
ijassa-759	129	57	of	of	ADP
ijassa-759	129	58	immune	immune	ADJ
ijassa-759	129	59	response	response	NOUN
ijassa-759	129	60	)	)	PUNCT
ijassa-759	129	61	,	,	PUNCT
ijassa-759	129	62	nnc	nnc	PROPN
ijassa-759	129	63	is	be	AUX
ijassa-759	129	64	the	the	DET
ijassa-759	129	65	initial	initial	ADJ
ijassa-759	129	66	number	number	NOUN
ijassa-759	129	67	of	of	ADP
ijassa-759	129	68	plasma	plasma	NOUN
ijassa-759	129	69	cells	cell	NOUN
ijassa-759	129	70	in	in	ADP
ijassa-759	129	71	the	the	DET
ijassa-759	129	72	norm	norm	NOUN
ijassa-759	129	73	[	[	X
ijassa-759	129	74	19	19	NUM
ijassa-759	129	75	,	,	PUNCT
ijassa-759	129	76	p.	p.	NOUN
ijassa-759	129	77	40	40	NUM
ijassa-759	129	78	]	]	PUNCT
ijassa-759	129	79	.	.	PUNCT
ijassa-759	130	1	to	to	PART
ijassa-759	130	2	adequately	adequately	ADV
ijassa-759	130	3	describe	describe	VERB
ijassa-759	130	4	the	the	DET
ijassa-759	130	5	effectiveness	effectiveness	NOUN
ijassa-759	130	6	of	of	ADP
ijassa-759	130	7	viral	viral	ADJ
ijassa-759	130	8	vaccines	vaccine	NOUN
ijassa-759	130	9	,	,	PUNCT
ijassa-759	130	10	it	it	PRON
ijassa-759	130	11	is	be	AUX
ijassa-759	130	12	necessary	necessary	ADJ
ijassa-759	130	13	to	to	PART
ijassa-759	130	14	take	take	VERB
ijassa-759	130	15	into	into	ADP
ijassa-759	130	16	account	account	NOUN
ijassa-759	130	17	that	that	SCONJ
ijassa-759	130	18	one	one	NUM
ijassa-759	130	19	of	of	ADP
ijassa-759	130	20	the	the	DET
ijassa-759	130	21	factors	factor	NOUN
ijassa-759	130	22	of	of	ADP
ijassa-759	130	23	high	high	ADJ
ijassa-759	130	24	selectivity	selectivity	NOUN
ijassa-759	130	25	of	of	ADP
ijassa-759	130	26	viruses	virus	NOUN
ijassa-759	130	27	in	in	ADP
ijassa-759	130	28	relation	relation	NOUN
ijassa-759	130	29	to	to	ADP
ijassa-759	130	30	tumor	tumor	NOUN
ijassa-759	130	31	cells	cell	NOUN
ijassa-759	130	32	is	be	AUX
ijassa-759	130	33	the	the	DET
ijassa-759	130	34	high	high	ADJ
ijassa-759	130	35	rate	rate	NOUN
ijassa-759	130	36	of	of	ADP
ijassa-759	130	37	their	their	PRON
ijassa-759	130	38	division	division	NOUN
ijassa-759	130	39	in	in	ADP
ijassa-759	130	40	comparison	comparison	NOUN
ijassa-759	130	41	with	with	ADP
ijassa-759	130	42	normal	normal	ADJ
ijassa-759	130	43	body	body	NOUN
ijassa-759	130	44	tissues	tissue	NOUN
ijassa-759	131	1	[	[	X
ijassa-759	131	2	4	4	NUM
ijassa-759	131	3	-	-	SYM
ijassa-759	131	4	7	7	NUM
ijassa-759	131	5	]	]	PUNCT
ijassa-759	131	6	.	.	PUNCT
ijassa-759	132	1	the	the	DET
ijassa-759	132	2	measured	measure	VERB
ijassa-759	132	3	tumor	tumor	NOUN
ijassa-759	132	4	volume	volume	NOUN
ijassa-759	132	5	contains	contain	VERB
ijassa-759	132	6	fractions	fraction	NOUN
ijassa-759	132	7	of	of	ADP
ijassa-759	132	8	rapidly	rapidly	ADV
ijassa-759	132	9	and	and	CCONJ
ijassa-759	132	10	slowly	slowly	ADV
ijassa-759	132	11	proliferating	proliferate	VERB
ijassa-759	132	12	tumor	tumor	NOUN
ijassa-759	132	13	cells	cell	NOUN
ijassa-759	132	14	,	,	PUNCT
ijassa-759	132	15	which	which	PRON
ijassa-759	132	16	is	be	AUX
ijassa-759	132	17	described	describe	VERB
ijassa-759	132	18	in	in	ADP
ijassa-759	132	19	detail	detail	NOUN
ijassa-759	132	20	in	in	ADP
ijassa-759	132	21	the	the	DET
ijassa-759	132	22	mathematical	mathematical	ADJ
ijassa-759	132	23	model	model	NOUN
ijassa-759	132	24	of	of	ADP
ijassa-759	132	25	tumor	tumor	NOUN
ijassa-759	132	26	growth	growth	NOUN
ijassa-759	132	27	by	by	ADP
ijassa-759	132	28	skipper	skipper	NOUN
ijassa-759	132	29	[	[	X
ijassa-759	132	30	23	23	NUM
ijassa-759	132	31	]	]	PUNCT
ijassa-759	132	32	.	.	PUNCT
ijassa-759	133	1	as	as	ADP
ijassa-759	133	2	the	the	DET
ijassa-759	133	3	size	size	NOUN
ijassa-759	133	4	of	of	ADP
ijassa-759	133	5	the	the	DET
ijassa-759	133	6	tumor	tumor	NOUN
ijassa-759	133	7	increases	increase	NOUN
ijassa-759	133	8	,	,	PUNCT
ijassa-759	133	9	the	the	DET
ijassa-759	133	10	fraction	fraction	NOUN
ijassa-759	133	11	of	of	ADP
ijassa-759	133	12	rapidly	rapidly	ADV
ijassa-759	133	13	dividing	divide	VERB
ijassa-759	133	14	tumor	tumor	NOUN
ijassa-759	133	15	cells	cell	NOUN
ijassa-759	133	16	decreases	decrease	VERB
ijassa-759	133	17	,	,	PUNCT
ijassa-759	133	18	while	while	SCONJ
ijassa-759	133	19	the	the	DET
ijassa-759	133	20	fraction	fraction	NOUN
ijassa-759	133	21	of	of	ADP
ijassa-759	133	22	slowly	slowly	ADV
ijassa-759	133	23	dividing	divide	VERB
ijassa-759	133	24	cells	cell	NOUN
ijassa-759	133	25	and	and	CCONJ
ijassa-759	133	26	temporarily	temporarily	ADV
ijassa-759	133	27	non	non	ADJ
ijassa-759	133	28	-	-	ADJ
ijassa-759	133	29	dividing	dividing	ADJ
ijassa-759	133	30	cells	cell	NOUN
ijassa-759	133	31	increases	increase	NOUN
ijassa-759	133	32	.	.	PUNCT
ijassa-759	134	1	to	to	PART
ijassa-759	134	2	describe	describe	VERB
ijassa-759	134	3	how	how	SCONJ
ijassa-759	134	4	the	the	DET
ijassa-759	134	5	tumor	tumor	NOUN
ijassa-759	134	6	size	size	NOUN
ijassa-759	134	7	is	be	AUX
ijassa-759	134	8	related	relate	VERB
ijassa-759	134	9	to	to	ADP
ijassa-759	134	10	the	the	DET
ijassa-759	134	11	efficiency	efficiency	NOUN
ijassa-759	134	12	of	of	ADP
ijassa-759	134	13	the	the	DET
ijassa-759	134	14	vaccine	vaccine	NOUN
ijassa-759	134	15	,	,	PUNCT
ijassa-759	134	16	(	(	PUNCT
ijassa-759	134	17	)	)	PUNCT
ijassa-759	134	18	np	np	NOUN
ijassa-759	134	19	t	t	PROPN
ijassa-759	134	20	function	function	NOUN
ijassa-759	134	21	is	be	AUX
ijassa-759	134	22	included	include	VERB
ijassa-759	134	23	in	in	ADP
ijassa-759	134	24	the	the	DET
ijassa-759	134	25	model	model	NOUN
ijassa-759	134	26	.	.	PUNCT
ijassa-759	135	1	this	this	DET
ijassa-759	135	2	function	function	NOUN
ijassa-759	135	3	describes	describe	VERB
ijassa-759	135	4	the	the	DET
ijassa-759	135	5	dynamics	dynamic	NOUN
ijassa-759	135	6	of	of	ADP
ijassa-759	135	7	the	the	DET
ijassa-759	135	8	decline	decline	NOUN
ijassa-759	135	9	in	in	ADP
ijassa-759	135	10	the	the	DET
ijassa-759	135	11	share	share	NOUN
ijassa-759	135	12	of	of	ADP
ijassa-759	135	13	rapidly	rapidly	ADV
ijassa-759	135	14	proliferating	proliferate	VERB
ijassa-759	135	15	cells	cell	NOUN
ijassa-759	135	16	with	with	ADP
ijassa-759	135	17	increasing	increase	VERB
ijassa-759	135	18	size	size	NOUN
ijassa-759	135	19	of	of	ADP
ijassa-759	135	20	the	the	DET
ijassa-759	135	21	tumor	tumor	NOUN
ijassa-759	135	22	[	[	X
ijassa-759	135	23	19	19	NUM
ijassa-759	135	24	]	]	SYM
ijassa-759	135	25	:	:	PUNCT
ijassa-759	135	26	2	2	NUM
ijassa-759	135	27	2	2	NUM
ijassa-759	135	28	21	21	NUM
ijassa-759	135	29	(	(	PUNCT
ijassa-759	135	30	)	)	PUNCT
ijassa-759	135	31	1	1	NUM
ijassa-759	135	32	(	(	PUNCT
ijassa-759	135	33	)	)	PUNCT
ijassa-759	135	34	,	,	PUNCT
ijassa-759	136	1	1	1	NUM
ijassa-759	136	2	p	p	NOUN
ijassa-759	136	3	p	p	X
ijassa-759	136	4	p	p	X
ijassa-759	136	5	p	p	PROPN
ijassa-759	136	6	t	t	PROPN
ijassa-759	136	7	p	p	PROPN
ijassa-759	136	8	t	t	PROPN
ijassa-759	136	9	arctg	arctg	VERB
ijassa-759	137	1	k	k	PROPN
ijassa-759	137	2	t	t	PROPN
ijassa-759	137	3			PROPN
ijassa-759	137	4			PUNCT
ijassa-759	137	5			PROPN
ijassa-759	137	6			PROPN
ijassa-759	137	7	=	=	SYM
ijassa-759	137	8	−	−	PROPN
ijassa-759	137	9			NOUN
ijassa-759	137	10			NOUN
ijassa-759	137	11			NOUN
ijassa-759	137	12	−	−	NOUN
ijassa-759	137	13			PUNCT
ijassa-759	137	14			PROPN
ijassa-759	137	15			PROPN
ijassa-759	137	16	(	(	PUNCT
ijassa-759	137	17	11	11	NUM
ijassa-759	137	18	)	)	PUNCT
ijassa-759	137	19	where	where	SCONJ
ijassa-759	137	20	p	p	NOUN
ijassa-759	137	21	and	and	CCONJ
ijassa-759	137	22	pk	pk	NOUN
ijassa-759	137	23	are	be	AUX
ijassa-759	137	24	constant	constant	ADJ
ijassa-759	137	25	parameters	parameter	NOUN
ijassa-759	137	26	,	,	PUNCT
ijassa-759	137	27	t	t	PROPN
ijassa-759	137	28	denotes	denote	VERB
ijassa-759	137	29	time	time	NOUN
ijassa-759	137	30	(	(	PUNCT
ijassa-759	137	31	in	in	ADP
ijassa-759	137	32	days	day	NOUN
ijassa-759	137	33	)	)	PUNCT
ijassa-759	137	34	,	,	PUNCT
ijassa-759	137	35	*	*	PUNCT
ijassa-759	137	36	1	1	NUM
ijassa-759	137	37	/	/	SYM
ijassa-759	137	38	p	p	NOUN
ijassa-759	138	1	t	t	X
ijassa-759	138	2	=	=	NOUN
ijassa-759	138	3	,	,	PUNCT
ijassa-759	138	4	where	where	SCONJ
ijassa-759	138	5	*	*	PUNCT
ijassa-759	138	6	t	t	PROPN
ijassa-759	138	7	is	be	AUX
ijassa-759	138	8	the	the	DET
ijassa-759	138	9	moment	moment	NOUN
ijassa-759	138	10	when	when	SCONJ
ijassa-759	138	11	numbers	number	NOUN
ijassa-759	138	12	of	of	ADP
ijassa-759	138	13	the	the	DET
ijassa-759	138	14	rapidly	rapidly	ADV
ijassa-759	138	15	and	and	CCONJ
ijassa-759	138	16	slowly	slowly	ADV
ijassa-759	138	17	proliferating	proliferate	VERB
ijassa-759	138	18	cells	cell	NOUN
ijassa-759	138	19	are	be	AUX
ijassa-759	138	20	equal	equal	ADJ
ijassa-759	138	21	[	[	X
ijassa-759	138	22	19	19	NUM
ijassa-759	138	23	,	,	PUNCT
ijassa-759	138	24	p.	p.	NOUN
ijassa-759	138	25	41	41	NUM
ijassa-759	138	26	]	]	PUNCT
ijassa-759	138	27	.	.	PUNCT
ijassa-759	139	1	then	then	ADV
ijassa-759	139	2	the	the	DET
ijassa-759	139	3	number	number	NOUN
ijassa-759	139	4	of	of	ADP
ijassa-759	139	5	infected	infected	ADJ
ijassa-759	139	6	cells	cell	NOUN
ijassa-759	139	7	in	in	ADP
ijassa-759	139	8	the	the	DET
ijassa-759	139	9	measured	measured	ADJ
ijassa-759	139	10	tumor	tumor	NOUN
ijassa-759	139	11	volume	volume	NOUN
ijassa-759	139	12	is	be	AUX
ijassa-759	139	13	calculated	calculate	VERB
ijassa-759	139	14	as	as	ADP
ijassa-759	139	15	(	(	PUNCT
ijassa-759	139	16	)	)	PUNCT
ijassa-759	139	17	(	(	PUNCT
ijassa-759	139	18	)	)	PUNCT
ijassa-759	139	19	(	(	PUNCT
ijassa-759	139	20	)	)	PUNCT
ijassa-759	139	21	v	v	NOUN
ijassa-759	139	22	n	n	CCONJ
ijassa-759	139	23	n	n	CCONJ
ijassa-759	139	24	nn	nn	PROPN
ijassa-759	139	25	t	t	PROPN
ijassa-759	139	26	n	n	PROPN
ijassa-759	139	27	t	t	PROPN
ijassa-759	139	28	p	p	PROPN
ijassa-759	139	29	t=	t=	PROPN
ijassa-759	139	30	,	,	PUNCT
ijassa-759	139	31	where	where	SCONJ
ijassa-759	139	32	1n	1n	PROPN
ijassa-759	139	33	cnt	cnt	PROPN
ijassa-759	139	34	z=	z=	VERB
ijassa-759	139	35			PROPN
ijassa-759	139	36	+	+	CCONJ
ijassa-759	139	37	is	be	AUX
ijassa-759	139	38	the	the	DET
ijassa-759	139	39	moment	moment	NOUN
ijassa-759	139	40	when	when	SCONJ
ijassa-759	139	41	the	the	DET
ijassa-759	139	42	immune	immune	ADJ
ijassa-759	139	43	response	response	NOUN
ijassa-759	139	44	against	against	ADP
ijassa-759	139	45	infected	infected	ADJ
ijassa-759	139	46	tumor	tumor	NOUN
ijassa-759	139	47	cells	cell	NOUN
ijassa-759	139	48	begins	begin	VERB
ijassa-759	139	49	.	.	PUNCT
ijassa-759	140	1	as	as	ADP
ijassa-759	140	2	a	a	DET
ijassa-759	140	3	result	result	NOUN
ijassa-759	140	4	of	of	ADP
ijassa-759	140	5	the	the	DET
ijassa-759	140	6	interaction	interaction	NOUN
ijassa-759	140	7	of	of	ADP
ijassa-759	140	8	the	the	DET
ijassa-759	140	9	virus	virus	NOUN
ijassa-759	140	10	with	with	ADP
ijassa-759	140	11	tumor	tumor	NOUN
ijassa-759	140	12	cells	cell	NOUN
ijassa-759	140	13	,	,	PUNCT
ijassa-759	140	14	three	three	NUM
ijassa-759	140	15	populations	population	NOUN
ijassa-759	140	16	of	of	ADP
ijassa-759	140	17	tumor	tumor	NOUN
ijassa-759	140	18	n.a	n.a	PROPN
ijassa-759	140	19	.	.	PROPN
ijassa-759	140	20	babushkina	babushkina	PROPN
ijassa-759	140	21	,	,	PUNCT
ijassa-759	140	22	e.a	e.a	PROPN
ijassa-759	140	23	.	.	PROPN
ijassa-759	140	24	kuzina	kuzina	PROPN
ijassa-759	140	25	copyright	copyright	PROPN
ijassa-759	140	26	©	©	PROPN
ijassa-759	140	27	2020	2020	NUM
ijassa-759	140	28	assa	assa	NOUN
ijassa-759	140	29	.	.	PUNCT
ijassa-759	141	1	adv	adv	PROPN
ijassa-759	141	2	.	.	PUNCT
ijassa-759	142	1	in	in	ADP
ijassa-759	142	2	systems	system	NOUN
ijassa-759	142	3	science	science	NOUN
ijassa-759	142	4	and	and	CCONJ
ijassa-759	142	5	appl	appl	NOUN
ijassa-759	142	6	.	.	PUNCT
ijassa-759	143	1	(	(	PUNCT
ijassa-759	143	2	2020	2020	NUM
ijassa-759	143	3	)	)	PUNCT
ijassa-759	143	4	8	8	NUM
ijassa-759	143	5	cells	cell	NOUN
ijassa-759	143	6	develop	develop	VERB
ijassa-759	143	7	in	in	ADP
ijassa-759	143	8	the	the	DET
ijassa-759	143	9	tumor	tumor	NOUN
ijassa-759	143	10	volume	volume	NOUN
ijassa-759	143	11	(	(	PUNCT
ijassa-759	143	12	)	)	PUNCT
ijassa-759	143	13	vn	vn	PROPN
ijassa-759	143	14	t	t	PROPN
ijassa-759	143	15	(	(	PUNCT
ijassa-759	143	16	fig	fig	NOUN
ijassa-759	143	17	.	.	PUNCT
ijassa-759	144	1	5	5	NUM
ijassa-759	144	2	)	)	PUNCT
ijassa-759	145	1	[	[	X
ijassa-759	145	2	19	19	NUM
ijassa-759	145	3	,	,	PUNCT
ijassa-759	145	4	p.	p.	NOUN
ijassa-759	145	5	41	41	NUM
ijassa-759	145	6	]	]	PUNCT
ijassa-759	145	7	.	.	PUNCT
ijassa-759	146	1	the	the	DET
ijassa-759	146	2	structure	structure	NOUN
ijassa-759	146	3	of	of	ADP
ijassa-759	146	4	the	the	DET
ijassa-759	146	5	equations	equation	NOUN
ijassa-759	146	6	of	of	ADP
ijassa-759	146	7	the	the	DET
ijassa-759	146	8	model	model	NOUN
ijassa-759	146	9	is	be	AUX
ijassa-759	146	10	such	such	ADJ
ijassa-759	146	11	that	that	SCONJ
ijassa-759	146	12	the	the	DET
ijassa-759	146	13	existence	existence	NOUN
ijassa-759	146	14	,	,	PUNCT
ijassa-759	146	15	uniqueness	uniqueness	NOUN
ijassa-759	146	16	and	and	CCONJ
ijassa-759	146	17	nonnegativity	nonnegativity	NOUN
ijassa-759	146	18	of	of	ADP
ijassa-759	146	19	solutions	solution	NOUN
ijassa-759	146	20	in	in	ADP
ijassa-759	146	21	this	this	DET
ijassa-759	146	22	work	work	NOUN
ijassa-759	146	23	under	under	ADP
ijassa-759	146	24	nonnegative	nonnegative	ADJ
ijassa-759	146	25	initial	initial	ADJ
ijassa-759	146	26	conditions	condition	NOUN
ijassa-759	146	27	are	be	AUX
ijassa-759	146	28	satisfied	satisfied	ADJ
ijassa-759	146	29	,	,	PUNCT
ijassa-759	146	30	which	which	PRON
ijassa-759	146	31	was	be	AUX
ijassa-759	146	32	proved	prove	VERB
ijassa-759	146	33	and	and	CCONJ
ijassa-759	146	34	stated	state	VERB
ijassa-759	146	35	in	in	ADP
ijassa-759	146	36	the	the	DET
ijassa-759	146	37	work	work	NOUN
ijassa-759	146	38	of	of	ADP
ijassa-759	146	39	n.	n.	PROPN
ijassa-759	147	1	v.	v.	ADP
ijassa-759	147	2	pertsev	pertsev	VERB
ijassa-759	148	1	[	[	X
ijassa-759	148	2	21	21	NUM
ijassa-759	148	3	,	,	PUNCT
ijassa-759	148	4	p.	p.	NOUN
ijassa-759	148	5	156	156	NUM
ijassa-759	148	6	-	-	SYM
ijassa-759	148	7	157	157	NUM
ijassa-759	148	8	]	]	PUNCT
ijassa-759	148	9	.	.	PUNCT
ijassa-759	149	1	fig	fig	NOUN
ijassa-759	149	2	.	.	PUNCT
ijassa-759	150	1	5	5	X
ijassa-759	150	2	.	.	X
ijassa-759	150	3	calculation	calculation	NOUN
ijassa-759	150	4	curves	curve	NOUN
ijassa-759	150	5	of	of	ADP
ijassa-759	150	6	the	the	DET
ijassa-759	150	7	dynamics	dynamic	NOUN
ijassa-759	150	8	of	of	ADP
ijassa-759	150	9	infected	infected	ADJ
ijassa-759	150	10	cells	cell	NOUN
ijassa-759	150	11	(	(	PUNCT
ijassa-759	150	12	)	)	PUNCT
ijassa-759	150	13	vn	vn	PROPN
ijassa-759	150	14	t	t	PROPN
ijassa-759	150	15	(	(	PUNCT
ijassa-759	150	16	dotted	dotted	ADJ
ijassa-759	150	17	line	line	NOUN
ijassa-759	150	18	)	)	PUNCT
ijassa-759	150	19	and	and	CCONJ
ijassa-759	150	20	the	the	DET
ijassa-759	150	21	kinetic	kinetic	ADJ
ijassa-759	150	22	trajectory	trajectory	NOUN
ijassa-759	150	23	of	of	ADP
ijassa-759	150	24	tumor	tumor	NOUN
ijassa-759	150	25	growth	growth	NOUN
ijassa-759	150	26	(	(	PUNCT
ijassa-759	150	27	)	)	PUNCT
ijassa-759	150	28	n	n	ADP
ijassa-759	150	29	t	t	PROPN
ijassa-759	150	30	after	after	SCONJ
ijassa-759	150	31	dose	dose	NOUN
ijassa-759	150	32	injection	injection	NOUN
ijassa-759	150	33	0	0	NUM
ijassa-759	150	34	0.015v	0.015v	NUM
ijassa-759	150	35	=	=	PUNCT
ijassa-759	151	1	at	at	ADP
ijassa-759	151	2	τ1	τ1	NOUN
ijassa-759	151	3	=	=	SYM
ijassa-759	151	4	1	1	NUM
ijassa-759	151	5	day	day	NOUN
ijassa-759	151	6	,	,	PUNCT
ijassa-759	151	7	v	v	PROPN
ijassa-759	151	8	and	and	CCONJ
ijassa-759	151	9	n	n	PROPN
ijassa-759	151	10	are	be	AUX
ijassa-759	151	11	duration	duration	NOUN
ijassa-759	151	12	of	of	ADP
ijassa-759	151	13	the	the	DET
ijassa-759	151	14	delay	delay	NOUN
ijassa-759	151	15	tumor	tumor	NOUN
ijassa-759	151	16	growth	growth	NOUN
ijassa-759	151	17	after	after	ADP
ijassa-759	151	18	each	each	DET
ijassa-759	151	19	stage	stage	NOUN
ijassa-759	151	20	of	of	ADP
ijassa-759	151	21	tumor	tumor	NOUN
ijassa-759	151	22	cells	cell	NOUN
ijassa-759	151	23	’	'	PUNCT
ijassa-759	151	24	death	death	NOUN
ijassa-759	151	25	.	.	PUNCT
ijassa-759	152	1	experimental	experimental	ADJ
ijassa-759	152	2	data	datum	NOUN
ijassa-759	152	3	is	be	AUX
ijassa-759	152	4	denoted	denote	VERB
ijassa-759	152	5	by	by	ADP
ijassa-759	152	6	+	+	CCONJ
ijassa-759	152	7	figure	figure	NOUN
ijassa-759	152	8	5	5	NUM
ijassa-759	152	9	shows	show	VERB
ijassa-759	152	10	two	two	NUM
ijassa-759	152	11	calculated	calculated	ADJ
ijassa-759	152	12	curves	curve	NOUN
ijassa-759	152	13	.	.	PUNCT
ijassa-759	153	1	the	the	DET
ijassa-759	153	2	dotted	dotted	ADJ
ijassa-759	153	3	line	line	NOUN
ijassa-759	153	4	describes	describe	VERB
ijassa-759	153	5	the	the	DET
ijassa-759	153	6	dynamics	dynamic	NOUN
ijassa-759	153	7	of	of	ADP
ijassa-759	153	8	growth	growth	NOUN
ijassa-759	153	9	and	and	CCONJ
ijassa-759	153	10	death	death	NOUN
ijassa-759	153	11	of	of	ADP
ijassa-759	153	12	infected	infected	ADJ
ijassa-759	153	13	tumor	tumor	NOUN
ijassa-759	153	14	cells	cell	NOUN
ijassa-759	153	15	in	in	ADP
ijassa-759	153	16	accordance	accordance	NOUN
ijassa-759	153	17	with	with	ADP
ijassa-759	153	18	the	the	DET
ijassa-759	153	19	model	model	NOUN
ijassa-759	153	20	of	of	ADP
ijassa-759	153	21	vaccine	vaccine	NOUN
ijassa-759	153	22	therapy	therapy	NOUN
ijassa-759	153	23	(	(	PUNCT
ijassa-759	153	24	1	1	NUM
ijassa-759	153	25	)	)	PUNCT
ijassa-759	153	26	–	–	PUNCT
ijassa-759	153	27	(	(	PUNCT
ijassa-759	153	28	11	11	NUM
ijassa-759	153	29	)	)	PUNCT
ijassa-759	153	30	.	.	PUNCT
ijassa-759	154	1	the	the	DET
ijassa-759	154	2	solid	solid	ADJ
ijassa-759	154	3	line	line	NOUN
ijassa-759	154	4	shows	show	VERB
ijassa-759	154	5	the	the	DET
ijassa-759	154	6	dynamics	dynamic	NOUN
ijassa-759	154	7	of	of	ADP
ijassa-759	154	8	the	the	DET
ijassa-759	154	9	number	number	NOUN
ijassa-759	154	10	of	of	ADP
ijassa-759	154	11	surviving	survive	VERB
ijassa-759	154	12	tumor	tumor	NOUN
ijassa-759	154	13	cells	cell	NOUN
ijassa-759	154	14	after	after	ADP
ijassa-759	154	15	the	the	DET
ijassa-759	154	16	first	first	ADJ
ijassa-759	154	17	stage	stage	NOUN
ijassa-759	154	18	and	and	CCONJ
ijassa-759	154	19	the	the	DET
ijassa-759	154	20	second	second	ADJ
ijassa-759	154	21	stage	stage	NOUN
ijassa-759	154	22	of	of	ADP
ijassa-759	154	23	immune	immune	ADJ
ijassa-759	154	24	response	response	NOUN
ijassa-759	154	25	in	in	ADP
ijassa-759	154	26	accordance	accordance	NOUN
ijassa-759	154	27	with	with	ADP
ijassa-759	154	28	the	the	DET
ijassa-759	154	29	mathematical	mathematical	ADJ
ijassa-759	154	30	model	model	NOUN
ijassa-759	154	31	of	of	ADP
ijassa-759	154	32	anticancer	anticancer	NOUN
ijassa-759	154	33	therapy	therapy	NOUN
ijassa-759	154	34	with	with	ADP
ijassa-759	154	35	discontinuous	discontinuous	ADJ
ijassa-759	154	36	trajectories	trajectory	NOUN
ijassa-759	154	37	[	[	X
ijassa-759	154	38	19	19	NUM
ijassa-759	154	39	]	]	PUNCT
ijassa-759	154	40	.	.	PUNCT
ijassa-759	155	1	4	4	X
ijassa-759	155	2	.	.	X
ijassa-759	155	3	a	a	DET
ijassa-759	155	4	mathematical	mathematical	ADJ
ijassa-759	155	5	model	model	NOUN
ijassa-759	155	6	of	of	ADP
ijassa-759	155	7	anticancer	anticancer	NOUN
ijassa-759	155	8	therapy	therapy	NOUN
ijassa-759	155	9	with	with	ADP
ijassa-759	155	10	discontinuous	discontinuous	ADJ
ijassa-759	155	11	trajectories	trajectory	NOUN
ijassa-759	155	12	to	to	PART
ijassa-759	155	13	predict	predict	VERB
ijassa-759	155	14	the	the	DET
ijassa-759	155	15	dynamics	dynamic	NOUN
ijassa-759	155	16	of	of	ADP
ijassa-759	155	17	tumor	tumor	NOUN
ijassa-759	155	18	growth	growth	NOUN
ijassa-759	155	19	when	when	SCONJ
ijassa-759	155	20	constructing	construct	VERB
ijassa-759	155	21	a	a	DET
ijassa-759	155	22	mathematical	mathematical	ADJ
ijassa-759	155	23	model	model	NOUN
ijassa-759	155	24	of	of	ADP
ijassa-759	155	25	antitumor	antitumor	PROPN
ijassa-759	155	26	therapy	therapy	NOUN
ijassa-759	155	27	with	with	ADP
ijassa-759	155	28	discontinuous	discontinuous	ADJ
ijassa-759	155	29	trajectories	trajectory	NOUN
ijassa-759	155	30	,	,	PUNCT
ijassa-759	155	31	several	several	ADJ
ijassa-759	155	32	assumptions	assumption	NOUN
ijassa-759	155	33	were	be	AUX
ijassa-759	155	34	made	make	VERB
ijassa-759	155	35	to	to	PART
ijassa-759	155	36	describe	describe	VERB
ijassa-759	155	37	the	the	DET
ijassa-759	155	38	death	death	NOUN
ijassa-759	155	39	and	and	CCONJ
ijassa-759	155	40	subsequent	subsequent	ADJ
ijassa-759	155	41	growth	growth	NOUN
ijassa-759	155	42	of	of	ADP
ijassa-759	155	43	the	the	DET
ijassa-759	155	44	experimental	experimental	ADJ
ijassa-759	155	45	tumor	tumor	NOUN
ijassa-759	156	1	[	[	X
ijassa-759	156	2	10	10	NUM
ijassa-759	156	3	,	,	PUNCT
ijassa-759	156	4	18	18	NUM
ijassa-759	156	5	]	]	PUNCT
ijassa-759	156	6	.	.	PUNCT
ijassa-759	157	1	1	1	X
ijassa-759	157	2	.	.	X
ijassa-759	157	3	tumor	tumor	NOUN
ijassa-759	157	4	growth	growth	NOUN
ijassa-759	157	5	without	without	ADP
ijassa-759	157	6	the	the	DET
ijassa-759	157	7	introduction	introduction	NOUN
ijassa-759	157	8	of	of	ADP
ijassa-759	157	9	a	a	DET
ijassa-759	157	10	viral	viral	ADJ
ijassa-759	157	11	vaccine	vaccine	NOUN
ijassa-759	157	12	(	(	PUNCT
ijassa-759	157	13	control	control	NOUN
ijassa-759	157	14	)	)	PUNCT
ijassa-759	157	15	and	and	CCONJ
ijassa-759	157	16	after	after	SCONJ
ijassa-759	157	17	its	its	PRON
ijassa-759	157	18	introduction	introduction	NOUN
ijassa-759	157	19	is	be	AUX
ijassa-759	157	20	described	describe	VERB
ijassa-759	157	21	by	by	ADP
ijassa-759	157	22	the	the	DET
ijassa-759	157	23	gompertz	gompertz	NOUN
ijassa-759	157	24	function	function	NOUN
ijassa-759	157	25	with	with	ADP
ijassa-759	157	26	the	the	DET
ijassa-759	157	27	preservation	preservation	NOUN
ijassa-759	157	28	of	of	ADP
ijassa-759	157	29	the	the	DET
ijassa-759	157	30	values	value	NOUN
ijassa-759	157	31	of	of	ADP
ijassa-759	157	32	the	the	DET
ijassa-759	157	33	parameters	parameter	NOUN
ijassa-759	157	34	of	of	ADP
ijassa-759	157	35	the	the	DET
ijassa-759	157	36	function	function	NOUN
ijassa-759	157	37	.	.	PUNCT
ijassa-759	158	1	2	2	X
ijassa-759	158	2	.	.	X
ijassa-759	158	3	the	the	DET
ijassa-759	158	4	death	death	NOUN
ijassa-759	158	5	of	of	ADP
ijassa-759	158	6	tumor	tumor	NOUN
ijassa-759	158	7	cells	cell	NOUN
ijassa-759	158	8	occurs	occur	VERB
ijassa-759	158	9	instantly	instantly	ADV
ijassa-759	158	10	,	,	PUNCT
ijassa-759	158	11	causing	cause	VERB
ijassa-759	158	12	a	a	DET
ijassa-759	158	13	sudden	sudden	ADJ
ijassa-759	158	14	decrease	decrease	NOUN
ijassa-759	158	15	in	in	ADP
ijassa-759	158	16	the	the	DET
ijassa-759	158	17	size	size	NOUN
ijassa-759	158	18	of	of	ADP
ijassa-759	158	19	the	the	DET
ijassa-759	158	20	tumor	tumor	NOUN
ijassa-759	158	21	at	at	ADP
ijassa-759	158	22	the	the	DET
ijassa-759	158	23	beginning	beginning	NOUN
ijassa-759	158	24	of	of	ADP
ijassa-759	158	25	the	the	DET
ijassa-759	158	26	immune	immune	ADJ
ijassa-759	158	27	response	response	NOUN
ijassa-759	158	28	at	at	ADP
ijassa-759	158	29	each	each	DET
ijassa-759	158	30	stage	stage	NOUN
ijassa-759	158	31	of	of	ADP
ijassa-759	158	32	cell	cell	NOUN
ijassa-759	158	33	death	death	NOUN
ijassa-759	158	34	.	.	PUNCT
ijassa-759	159	1	3	3	X
ijassa-759	159	2	.	.	X
ijassa-759	159	3	the	the	DET
ijassa-759	159	4	trajectory	trajectory	NOUN
ijassa-759	159	5	of	of	ADP
ijassa-759	159	6	tumor	tumor	NOUN
ijassa-759	159	7	growth	growth	NOUN
ijassa-759	159	8	after	after	ADP
ijassa-759	159	9	the	the	DET
ijassa-759	159	10	death	death	NOUN
ijassa-759	159	11	of	of	ADP
ijassa-759	159	12	tumor	tumor	NOUN
ijassa-759	159	13	cells	cell	NOUN
ijassa-759	159	14	is	be	AUX
ijassa-759	159	15	shifted	shift	VERB
ijassa-759	159	16	in	in	ADP
ijassa-759	159	17	time	time	NOUN
ijassa-759	159	18	for	for	ADP
ijassa-759	159	19	the	the	DET
ijassa-759	159	20	duration	duration	NOUN
ijassa-759	159	21	of	of	ADP
ijassa-759	159	22	the	the	DET
ijassa-759	159	23	delay	delay	NOUN
ijassa-759	159	24	in	in	ADP
ijassa-759	159	25	tumor	tumor	NOUN
ijassa-759	159	26	growth	growth	NOUN
ijassa-759	159	27	0	0	NUM
ijassa-759	159	28	(	(	PUNCT
ijassa-759	159	29	)	)	PUNCT
ijassa-759	159	30	v	v	VERB
ijassa-759	159	31	after	after	ADP
ijassa-759	159	32	each	each	DET
ijassa-759	159	33	stage	stage	NOUN
ijassa-759	159	34	of	of	ADP
ijassa-759	159	35	their	their	PRON
ijassa-759	159	36	death	death	NOUN
ijassa-759	159	37	.	.	PUNCT
ijassa-759	160	1	4	4	X
ijassa-759	160	2	.	.	X
ijassa-759	160	3	duration	duration	NOUN
ijassa-759	160	4	of	of	ADP
ijassa-759	160	5	tumor	tumor	NOUN
ijassa-759	160	6	growth	growth	NOUN
ijassa-759	160	7	delay	delay	NOUN
ijassa-759	160	8	0	0	NUM
ijassa-759	160	9	(	(	PUNCT
ijassa-759	160	10	)	)	PUNCT
ijassa-759	160	11	v	v	PROPN
ijassa-759	160	12	is	be	AUX
ijassa-759	160	13	the	the	DET
ijassa-759	160	14	time	time	NOUN
ijassa-759	160	15	interval	interval	NOUN
ijassa-759	160	16	between	between	ADP
ijassa-759	160	17	the	the	DET
ijassa-759	160	18	start	start	NOUN
ijassa-759	160	19	of	of	ADP
ijassa-759	160	20	immune	immune	ADJ
ijassa-759	160	21	response	response	NOUN
ijassa-759	160	22	(	(	PUNCT
ijassa-759	160	23	i.e.	i.e.	X
ijassa-759	160	24	when	when	SCONJ
ijassa-759	160	25	the	the	DET
ijassa-759	160	26	number	number	NOUN
ijassa-759	160	27	of	of	ADP
ijassa-759	160	28	tumor	tumor	NOUN
ijassa-759	160	29	cells	cell	NOUN
ijassa-759	160	30	starts	start	VERB
ijassa-759	160	31	to	to	PART
ijassa-759	160	32	decline	decline	VERB
ijassa-759	160	33	affected	affect	VERB
ijassa-759	160	34	first	first	ADV
ijassa-759	160	35	by	by	ADP
ijassa-759	160	36	the	the	DET
ijassa-759	160	37	virus	virus	NOUN
ijassa-759	160	38	at	at	ADP
ijassa-759	160	39	vt	vt	PROPN
ijassa-759	160	40	and	and	CCONJ
ijassa-759	160	41	then	then	ADV
ijassa-759	160	42	by	by	ADP
ijassa-759	160	43	the	the	DET
ijassa-759	160	44	antibodies	antibody	NOUN
ijassa-759	160	45	at	at	ADP
ijassa-759	160	46	nt	not	PART
ijassa-759	160	47	)	)	PUNCT
ijassa-759	160	48	and	and	CCONJ
ijassa-759	160	49	the	the	DET
ijassa-759	160	50	moment	moment	NOUN
ijassa-759	160	51	when	when	SCONJ
ijassa-759	160	52	the	the	DET
ijassa-759	160	53	tumor	tumor	NOUN
ijassa-759	160	54	,	,	PUNCT
ijassa-759	160	55	resuming	resume	VERB
ijassa-759	160	56	its	its	PRON
ijassa-759	160	57	growth	growth	NOUN
ijassa-759	160	58	,	,	PUNCT
ijassa-759	160	59	reaches	reach	VERB
ijassa-759	160	60	the	the	DET
ijassa-759	160	61	same	same	ADJ
ijassa-759	160	62	size	size	NOUN
ijassa-759	160	63	as	as	ADP
ijassa-759	160	64	at	at	ADP
ijassa-759	160	65	vt	vt	NOUN
ijassa-759	160	66	and	and	CCONJ
ijassa-759	160	67	nt	not	PART
ijassa-759	160	68	respectively	respectively	ADV
ijassa-759	160	69	[	[	X
ijassa-759	160	70	10	10	NUM
ijassa-759	160	71	,	,	PUNCT
ijassa-759	160	72	18	18	NUM
ijassa-759	160	73	]	]	PUNCT
ijassa-759	160	74	.	.	PUNCT
ijassa-759	161	1	the	the	DET
ijassa-759	161	2	mathematical	mathematical	ADJ
ijassa-759	161	3	model	model	NOUN
ijassa-759	161	4	of	of	ADP
ijassa-759	161	5	anticancer	anticancer	NOUN
ijassa-759	161	6	therapy	therapy	NOUN
ijassa-759	161	7	with	with	ADP
ijassa-759	161	8	discontinuous	discontinuous	ADJ
ijassa-759	161	9	trajectories	trajectory	NOUN
ijassa-759	161	10	is	be	AUX
ijassa-759	161	11	used	use	VERB
ijassa-759	161	12	to	to	PART
ijassa-759	161	13	construct	construct	VERB
ijassa-759	161	14	dynamic	dynamic	ADJ
ijassa-759	161	15	trajectories	trajectory	NOUN
ijassa-759	161	16	of	of	ADP
ijassa-759	161	17	tumor	tumor	NOUN
ijassa-759	161	18	growth	growth	NOUN
ijassa-759	161	19	after	after	ADP
ijassa-759	161	20	two	two	NUM
ijassa-759	161	21	-	-	PUNCT
ijassa-759	161	22	stage	stage	NOUN
ijassa-759	161	23	death	death	NOUN
ijassa-759	161	24	of	of	ADP
ijassa-759	161	25	tumor	tumor	NOUN
ijassa-759	161	26	cells	cell	NOUN
ijassa-759	161	27	after	after	ADP
ijassa-759	161	28	the	the	DET
ijassa-759	161	29	mathematical	mathematical	ADJ
ijassa-759	161	30	modeling	modeling	NOUN
ijassa-759	161	31	of	of	ADP
ijassa-759	161	32	antitumor	antitumor	PROPN
ijassa-759	161	33	viral	viral	ADJ
ijassa-759	161	34	vaccine	vaccine	NOUN
ijassa-759	161	35	therapy	therapy	NOUN
ijassa-759	161	36	…	…	PUNCT
ijassa-759	161	37	copyright	copyright	NOUN
ijassa-759	161	38	©	©	PROPN
ijassa-759	161	39	2020	2020	NUM
ijassa-759	161	40	assa	assa	NOUN
ijassa-759	161	41	.	.	PUNCT
ijassa-759	162	1	adv	adv	PROPN
ijassa-759	162	2	.	.	PUNCT
ijassa-759	163	1	in	in	ADP
ijassa-759	163	2	systems	system	NOUN
ijassa-759	163	3	science	science	NOUN
ijassa-759	163	4	and	and	CCONJ
ijassa-759	163	5	appl	appl	NOUN
ijassa-759	163	6	.	.	PUNCT
ijassa-759	164	1	(	(	PUNCT
ijassa-759	164	2	2020	2020	NUM
ijassa-759	164	3	)	)	PUNCT
ijassa-759	164	4	9	9	NUM
ijassa-759	164	5	introduction	introduction	NOUN
ijassa-759	164	6	of	of	ADP
ijassa-759	164	7	a	a	DET
ijassa-759	164	8	viral	viral	ADJ
ijassa-759	164	9	vaccine	vaccine	NOUN
ijassa-759	164	10	(	(	PUNCT
ijassa-759	164	11	fig	fig	NOUN
ijassa-759	164	12	.	.	NOUN
ijassa-759	164	13	5	5	NUM
ijassa-759	164	14	–	–	PUNCT
ijassa-759	164	15	(	(	PUNCT
ijassa-759	164	16	)	)	PUNCT
ijassa-759	164	17	n	n	PRON
ijassa-759	164	18	t	t	NOUN
ijassa-759	164	19	)	)	PUNCT
ijassa-759	165	1	[	[	X
ijassa-759	165	2	19	19	NUM
ijassa-759	165	3	,	,	PUNCT
ijassa-759	165	4	p.	p.	NOUN
ijassa-759	165	5	41	41	NUM
ijassa-759	165	6	]	]	PUNCT
ijassa-759	165	7	.	.	PUNCT
ijassa-759	166	1	the	the	DET
ijassa-759	166	2	dynamics	dynamic	NOUN
ijassa-759	166	3	of	of	ADP
ijassa-759	166	4	tumor	tumor	NOUN
ijassa-759	166	5	growth	growth	NOUN
ijassa-759	166	6	before	before	SCONJ
ijassa-759	166	7	the	the	DET
ijassa-759	166	8	injection	injection	NOUN
ijassa-759	166	9	of	of	ADP
ijassa-759	166	10	the	the	DET
ijassa-759	166	11	vaccine	vaccine	NOUN
ijassa-759	166	12	is	be	AUX
ijassa-759	166	13	described	describe	VERB
ijassa-759	166	14	by	by	ADP
ijassa-759	166	15	a	a	DET
ijassa-759	166	16	differential	differential	ADJ
ijassa-759	166	17	equation	equation	NOUN
ijassa-759	166	18	(	(	PUNCT
ijassa-759	166	19	12	12	NUM
ijassa-759	166	20	)	)	PUNCT
ijassa-759	166	21	,	,	PUNCT
ijassa-759	166	22	which	which	PRON
ijassa-759	166	23	is	be	AUX
ijassa-759	166	24	similar	similar	ADJ
ijassa-759	166	25	to	to	ADP
ijassa-759	166	26	the	the	DET
ijassa-759	166	27	equation	equation	NOUN
ijassa-759	166	28	of	of	ADP
ijassa-759	166	29	tumor	tumor	NOUN
ijassa-759	166	30	growth	growth	NOUN
ijassa-759	166	31	in	in	ADP
ijassa-759	166	32	the	the	DET
ijassa-759	166	33	control	control	NOUN
ijassa-759	166	34	(	(	PUNCT
ijassa-759	166	35	1	1	NUM
ijassa-759	166	36	):	):	PUNCT
ijassa-759	166	37			ADJ
ijassa-759	166	38	0	0	NOUN
ijassa-759	166	39	,	,	PUNCT
ijassa-759	166	40	,	,	PUNCT
ijassa-759	166	41	(	(	PUNCT
ijassa-759	166	42	)	)	PUNCT
ijassa-759	166	43	(	(	PUNCT
ijassa-759	166	44	)	)	PUNCT
ijassa-759	166	45	(	(	PUNCT
ijassa-759	166	46	)	)	PUNCT
ijassa-759	166	47	,	,	PUNCT
ijassa-759	166	48	vt	vt	PROPN
ijassa-759	166	49	dn	dn	PROPN
ijassa-759	166	50	t	t	PROPN
ijassa-759	166	51	t	t	PROPN
ijassa-759	166	52	n	n	ADP
ijassa-759	166	53	t	t	X
ijassa-759	166	54	t	t	X
ijassa-759	166	55	dt	dt	X
ijassa-759	166	56	=	=	SYM
ijassa-759	166	57			ADJ
ijassa-759	166	58			NOUN
ijassa-759	166	59	with	with	ADP
ijassa-759	166	60	0	0	NUM
ijassa-759	166	61	0	0	NUM
ijassa-759	166	62	(	(	PUNCT
ijassa-759	166	63	)	)	PUNCT
ijassa-759	166	64	n	n	CCONJ
ijassa-759	166	65	n	n	PRON
ijassa-759	166	66	t=	t=	NOUN
ijassa-759	166	67	,	,	PUNCT
ijassa-759	166	68	(	(	PUNCT
ijassa-759	166	69	12	12	NUM
ijassa-759	166	70	)	)	PUNCT
ijassa-759	166	71	where	where	SCONJ
ijassa-759	166	72	(	(	PUNCT
ijassa-759	166	73	)	)	PUNCT
ijassa-759	166	74	n	n	PRON
ijassa-759	166	75	t	t	PROPN
ijassa-759	166	76	is	be	AUX
ijassa-759	166	77	the	the	DET
ijassa-759	166	78	size	size	NOUN
ijassa-759	166	79	of	of	ADP
ijassa-759	166	80	the	the	DET
ijassa-759	166	81	tumor	tumor	NOUN
ijassa-759	166	82	before	before	ADP
ijassa-759	166	83	vaccine	vaccine	NOUN
ijassa-759	166	84	injection	injection	NOUN
ijassa-759	166	85	,	,	PUNCT
ijassa-759	166	86			X
ijassa-759	166	87	(	(	PUNCT
ijassa-759	166	88	t	t	NOUN
ijassa-759	166	89	)	)	PUNCT
ijassa-759	166	90	=	=	PUNCT
ijassa-759	167	1	n	n	ADV
ijassa-759	167	2	n	n	NUM
ijassa-759	167	3	exp	exp	NOUN
ijassa-759	167	4	(	(	PUNCT
ijassa-759	167	5	–	–	PUNCT
ijassa-759	167	6	n	n	NUM
ijassa-759	167	7	t	t	NOUN
ijassa-759	167	8	)	)	PUNCT
ijassa-759	167	9	is	be	AUX
ijassa-759	167	10	tumor	tumor	NOUN
ijassa-759	167	11	growth	growth	NOUN
ijassa-759	167	12	rate	rate	NOUN
ijassa-759	167	13	in	in	ADP
ijassa-759	167	14	control	control	NOUN
ijassa-759	167	15	,	,	PUNCT
ijassa-759	168	1	1v	1v	NUM
ijassa-759	168	2	cvt	cvt	PROPN
ijassa-759	168	3	z=	z=	PUNCT
ijassa-759	168	4			PROPN
ijassa-759	168	5	+	+	CCONJ
ijassa-759	168	6	is	be	AUX
ijassa-759	168	7	the	the	DET
ijassa-759	168	8	moment	moment	NOUN
ijassa-759	168	9	when	when	SCONJ
ijassa-759	168	10	tumor	tumor	NOUN
ijassa-759	168	11	cells	cell	NOUN
ijassa-759	168	12	start	start	VERB
ijassa-759	168	13	to	to	PART
ijassa-759	168	14	die	die	VERB
ijassa-759	168	15	in	in	ADP
ijassa-759	168	16	response	response	NOUN
ijassa-759	168	17	to	to	ADP
ijassa-759	168	18	the	the	DET
ijassa-759	168	19	virus	virus	NOUN
ijassa-759	168	20	(	(	PUNCT
ijassa-759	168	21	1st	1st	ADJ
ijassa-759	168	22	stage	stage	NOUN
ijassa-759	168	23	of	of	ADP
ijassa-759	168	24	immune	immune	ADJ
ijassa-759	168	25	response	response	NOUN
ijassa-759	168	26	)	)	PUNCT
ijassa-759	168	27	,	,	PUNCT
ijassa-759	168	28	1	1	NUM
ijassa-759	168	29	is	be	AUX
ijassa-759	168	30	the	the	DET
ijassa-759	168	31	moment	moment	NOUN
ijassa-759	168	32	of	of	ADP
ijassa-759	168	33	vaccine	vaccine	NOUN
ijassa-759	168	34	injection	injection	NOUN
ijassa-759	168	35	,	,	PUNCT
ijassa-759	168	36	cvz	cvz	PROPN
ijassa-759	168	37	is	be	AUX
ijassa-759	168	38	the	the	DET
ijassa-759	168	39	period	period	NOUN
ijassa-759	168	40	of	of	ADP
ijassa-759	168	41	delay	delay	NOUN
ijassa-759	168	42	of	of	ADP
ijassa-759	168	43	the	the	DET
ijassa-759	168	44	immune	immune	ADJ
ijassa-759	168	45	response	response	NOUN
ijassa-759	168	46	against	against	ADP
ijassa-759	168	47	the	the	DET
ijassa-759	168	48	virus	virus	NOUN
ijassa-759	168	49	.	.	PUNCT
ijassa-759	169	1	the	the	DET
ijassa-759	169	2	dynamics	dynamic	NOUN
ijassa-759	169	3	of	of	ADP
ijassa-759	169	4	tumor	tumor	NOUN
ijassa-759	169	5	growth	growth	NOUN
ijassa-759	169	6	after	after	SCONJ
ijassa-759	169	7	the	the	DET
ijassa-759	169	8	first	first	ADJ
ijassa-759	169	9	stage	stage	NOUN
ijassa-759	169	10	of	of	ADP
ijassa-759	169	11	tumor	tumor	NOUN
ijassa-759	169	12	death	death	NOUN
ijassa-759	169	13	is	be	AUX
ijassa-759	169	14	described	describe	VERB
ijassa-759	169	15	by	by	ADP
ijassa-759	169	16	a	a	DET
ijassa-759	169	17	differential	differential	ADJ
ijassa-759	169	18	equation	equation	NOUN
ijassa-759	169	19	of	of	ADP
ijassa-759	169	20	the	the	DET
ijassa-759	169	21	form	form	NOUN
ijassa-759	169	22	:	:	PUNCT
ijassa-759	169	23			ADJ
ijassa-759	169	24			PROPN
ijassa-759	169	25	,	,	PUNCT
ijassa-759	169	26	,	,	PUNCT
ijassa-759	169	27	(	(	PUNCT
ijassa-759	169	28	)	)	PUNCT
ijassa-759	169	29	(	(	PUNCT
ijassa-759	169	30	)	)	PUNCT
ijassa-759	169	31	(	(	PUNCT
ijassa-759	169	32	)	)	PUNCT
ijassa-759	169	33	,	,	PUNCT
ijassa-759	169	34	v	v	X
ijassa-759	169	35	v	v	PRON
ijassa-759	169	36	v	v	NOUN
ijassa-759	169	37	nt	not	PART
ijassa-759	169	38	t	t	PROPN
ijassa-759	169	39	t	t	PROPN
ijassa-759	169	40	dn	dn	PROPN
ijassa-759	169	41	t	t	PROPN
ijassa-759	169	42	t	t	PROPN
ijassa-759	169	43	n	n	PROPN
ijassa-759	169	44	t	t	X
ijassa-759	169	45	t	t	X
ijassa-759	169	46	dt	dt	X
ijassa-759	170	1	=	=	NOUN
ijassa-759	170	2			X
ijassa-759	170	3	−	−	NOUN
ijassa-759	170	4	−	−	NOUN
ijassa-759	170	5			NOUN
ijassa-759	170	6	with	with	ADP
ijassa-759	170	7	)	)	PUNCT
ijassa-759	170	8	)	)	PUNCT
ijassa-759	171	1	(	(	PUNCT
ijassa-759	171	2	(	(	PUNCT
ijassa-759	171	3	)	)	PUNCT
ijassa-759	171	4	(	(	PUNCT
ijassa-759	171	5	)	)	PUNCT
ijassa-759	171	6	(	(	PUNCT
ijassa-759	171	7	r	r	NOUN
ijassa-759	171	8	v	v	NUM
ijassa-759	171	9	v	v	NUM
ijassa-759	171	10	v	v	NOUN
ijassa-759	171	11	v	v	ADP
ijassa-759	171	12	vtn	vtn	NOUN
ijassa-759	172	1	n	n	PROPN
ijassa-759	172	2	t	t	NOUN
ijassa-759	172	3	s	s	PROPN
ijassa-759	172	4	t	t	PROPN
ijassa-759	172	5	t	t	NOUN
ijassa-759	172	6	t=	t=	PROPN
ijassa-759	173	1			ADJ
ijassa-759	173	2	−	−	PROPN
ijassa-759	173	3	(	(	PUNCT
ijassa-759	173	4	13	13	NUM
ijassa-759	173	5	)	)	PUNCT
ijassa-759	173	6	where	where	SCONJ
ijassa-759	173	7	(	(	PUNCT
ijassa-759	173	8	)	)	PUNCT
ijassa-759	173	9	vt	vt	NOUN
ijassa-759	173	10	t	t	PROPN
ijassa-759	173	11	−	−	PROPN
ijassa-759	173	12	is	be	AUX
ijassa-759	173	13	pulsed	pulse	VERB
ijassa-759	173	14	dirac	dirac	NOUN
ijassa-759	173	15	function	function	NOUN
ijassa-759	173	16	,	,	PUNCT
ijassa-759	173	17	describing	describe	VERB
ijassa-759	173	18	the	the	DET
ijassa-759	173	19	instantaneous	instantaneous	ADJ
ijassa-759	173	20	death	death	NOUN
ijassa-759	173	21	of	of	ADP
ijassa-759	173	22	tumor	tumor	NOUN
ijassa-759	173	23	cells	cell	NOUN
ijassa-759	173	24	in	in	ADP
ijassa-759	173	25	the	the	DET
ijassa-759	173	26	first	first	ADJ
ijassa-759	173	27	stage	stage	NOUN
ijassa-759	173	28	of	of	ADP
ijassa-759	173	29	the	the	DET
ijassa-759	173	30	immune	immune	ADJ
ijassa-759	173	31	response	response	NOUN
ijassa-759	173	32	,	,	PUNCT
ijassa-759	173	33	(	(	PUNCT
ijassa-759	173	34	)	)	PUNCT
ijassa-759	173	35	v	v	NOUN
ijassa-759	173	36	vs	vs	ADP
ijassa-759	173	37	t	t	PROPN
ijassa-759	173	38	denotes	denote	VERB
ijassa-759	173	39	the	the	DET
ijassa-759	173	40	proportion	proportion	NOUN
ijassa-759	173	41	of	of	ADP
ijassa-759	173	42	dying	die	VERB
ijassa-759	173	43	tumor	tumor	NOUN
ijassa-759	173	44	cells	cell	NOUN
ijassa-759	173	45	infected	infect	VERB
ijassa-759	173	46	with	with	ADP
ijassa-759	173	47	the	the	DET
ijassa-759	173	48	virus	virus	NOUN
ijassa-759	173	49	at	at	ADP
ijassa-759	173	50	the	the	DET
ijassa-759	173	51	first	first	ADJ
ijassa-759	173	52	stage	stage	NOUN
ijassa-759	173	53	of	of	ADP
ijassa-759	173	54	the	the	DET
ijassa-759	173	55	immune	immune	ADJ
ijassa-759	173	56	response	response	NOUN
ijassa-759	173	57	,	,	PUNCT
ijassa-759	173	58	which	which	PRON
ijassa-759	173	59	is	be	AUX
ijassa-759	173	60	determined	determine	VERB
ijassa-759	173	61	from	from	ADP
ijassa-759	173	62	the	the	DET
ijassa-759	173	63	equation	equation	NOUN
ijassa-759	173	64	:	:	PUNCT
ijassa-759	173	65	(	(	PUNCT
ijassa-759	173	66	)	)	PUNCT
ijassa-759	173	67	(	(	PUNCT
ijassa-759	173	68	)	)	PUNCT
ijassa-759	173	69	(	(	PUNCT
ijassa-759	173	70	)	)	PUNCT
ijassa-759	173	71	v	v	NOUN
ijassa-759	173	72	v	v	NUM
ijassa-759	173	73	v	v	NUM
ijassa-759	173	74	v	v	NUM
ijassa-759	173	75	v	v	NOUN
ijassa-759	173	76	v	v	NOUN
ijassa-759	173	77	n	n	ADP
ijassa-759	173	78	t	t	PROPN
ijassa-759	173	79	s	s	PROPN
ijassa-759	173	80	t	t	PROPN
ijassa-759	173	81	n	n	PROPN
ijassa-759	173	82	t	t	NOUN
ijassa-759	173	83			PUNCT
ijassa-759	174	1	=	=	PUNCT
ijassa-759	174	2	(	(	PUNCT
ijassa-759	174	3	14	14	NUM
ijassa-759	174	4	)	)	PUNCT
ijassa-759	174	5	where	where	SCONJ
ijassa-759	174	6	(	(	PUNCT
ijassa-759	174	7	)	)	PUNCT
ijassa-759	174	8	v	v	NOUN
ijassa-759	174	9	vn	vn	PROPN
ijassa-759	174	10	t	t	PROPN
ijassa-759	174	11	denotes	denote	VERB
ijassa-759	174	12	the	the	DET
ijassa-759	174	13	population	population	NOUN
ijassa-759	174	14	of	of	ADP
ijassa-759	174	15	infected	infected	ADJ
ijassa-759	174	16	tumor	tumor	NOUN
ijassa-759	174	17	cells	cell	NOUN
ijassa-759	174	18	at	at	ADP
ijassa-759	174	19	the	the	DET
ijassa-759	174	20	start	start	NOUN
ijassa-759	174	21	of	of	ADP
ijassa-759	174	22	the	the	DET
ijassa-759	174	23	immune	immune	ADJ
ijassa-759	174	24	response	response	NOUN
ijassa-759	174	25	,	,	PUNCT
ijassa-759	174	26	(	(	PUNCT
ijassa-759	174	27	)	)	PUNCT
ijassa-759	174	28	v	v	NOUN
ijassa-759	174	29	vn	vn	PROPN
ijassa-759	174	30	t	t	NOUN
ijassa-759	174	31	is	be	AUX
ijassa-759	174	32	the	the	DET
ijassa-759	174	33	number	number	NOUN
ijassa-759	174	34	of	of	ADP
ijassa-759	174	35	dying	die	VERB
ijassa-759	174	36	tumor	tumor	NOUN
ijassa-759	174	37	cells	cell	NOUN
ijassa-759	174	38	in	in	ADP
ijassa-759	174	39	the	the	DET
ijassa-759	174	40	first	first	ADJ
ijassa-759	174	41	stage	stage	NOUN
ijassa-759	174	42	of	of	ADP
ijassa-759	174	43	the	the	DET
ijassa-759	174	44	immune	immune	ADJ
ijassa-759	174	45	response	response	NOUN
ijassa-759	174	46	,	,	PUNCT
ijassa-759	174	47	which	which	PRON
ijassa-759	174	48	is	be	AUX
ijassa-759	174	49	calculated	calculate	VERB
ijassa-759	174	50	as	as	ADP
ijassa-759	174	51	the	the	DET
ijassa-759	174	52	difference	difference	NOUN
ijassa-759	174	53	between	between	ADP
ijassa-759	174	54	the	the	DET
ijassa-759	174	55	maximum	maximum	ADJ
ijassa-759	174	56	and	and	CCONJ
ijassa-759	174	57	minimum	minimum	ADJ
ijassa-759	174	58	number	number	NOUN
ijassa-759	174	59	of	of	ADP
ijassa-759	174	60	infected	infected	ADJ
ijassa-759	174	61	cells	cell	NOUN
ijassa-759	174	62	in	in	ADP
ijassa-759	174	63	the	the	DET
ijassa-759	174	64	period	period	NOUN
ijassa-759	174	65	from	from	ADP
ijassa-759	174	66	the	the	DET
ijassa-759	174	67	beginning	beginning	NOUN
ijassa-759	174	68	to	to	ADP
ijassa-759	174	69	the	the	DET
ijassa-759	174	70	end	end	NOUN
ijassa-759	174	71	of	of	ADP
ijassa-759	174	72	the	the	DET
ijassa-759	174	73	1st	1st	ADJ
ijassa-759	174	74	stage	stage	NOUN
ijassa-759	174	75	of	of	ADP
ijassa-759	174	76	immune	immune	ADJ
ijassa-759	174	77	response	response	NOUN
ijassa-759	174	78	according	accord	VERB
ijassa-759	174	79	to	to	ADP
ijassa-759	174	80	the	the	DET
ijassa-759	174	81	equation	equation	NOUN
ijassa-759	174	82	:	:	PUNCT
ijassa-759	174	83	1	1	NUM
ijassa-759	174	84	2	2	NUM
ijassa-759	174	85	(	(	PUNCT
ijassa-759	174	86	)	)	PUNCT
ijassa-759	174	87	(	(	PUNCT
ijassa-759	174	88	)	)	PUNCT
ijassa-759	174	89	(	(	PUNCT
ijassa-759	174	90	)	)	PUNCT
ijassa-759	174	91	v	v	NOUN
ijassa-759	174	92	v	v	NUM
ijassa-759	174	93	v	v	NOUN
ijassa-759	174	94	vv	vv	INTJ
ijassa-759	174	95	vn	vn	PROPN
ijassa-759	174	96	t	t	PROPN
ijassa-759	174	97	n	n	PROPN
ijassa-759	174	98	t	t	PROPN
ijassa-759	174	99	n	n	CCONJ
ijassa-759	174	100	t	t	NOUN
ijassa-759	174	101	=	=	SYM
ijassa-759	174	102	−	−	PROPN
ijassa-759	174	103	(	(	PUNCT
ijassa-759	174	104	15	15	NUM
ijassa-759	174	105	)	)	PUNCT
ijassa-759	174	106	where	where	SCONJ
ijassa-759	174	107	1	1	NUM
ijassa-759	174	108	vt	vt	NOUN
ijassa-759	174	109	and	and	CCONJ
ijassa-759	174	110	2	2	NUM
ijassa-759	174	111	vt	vt	NOUN
ijassa-759	174	112	are	be	AUX
ijassa-759	174	113	the	the	DET
ijassa-759	174	114	moments	moment	NOUN
ijassa-759	174	115	when	when	SCONJ
ijassa-759	174	116	the	the	DET
ijassa-759	174	117	number	number	NOUN
ijassa-759	174	118	of	of	ADP
ijassa-759	174	119	infected	infected	ADJ
ijassa-759	174	120	cells	cell	NOUN
ijassa-759	174	121	during	during	ADP
ijassa-759	174	122	the	the	DET
ijassa-759	174	123	1st	1st	ADJ
ijassa-759	174	124	stage	stage	NOUN
ijassa-759	174	125	of	of	ADP
ijassa-759	174	126	the	the	DET
ijassa-759	174	127	immune	immune	ADJ
ijassa-759	174	128	response	response	NOUN
ijassa-759	174	129	against	against	ADP
ijassa-759	174	130	the	the	DET
ijassa-759	174	131	virus	virus	NOUN
ijassa-759	174	132	reaches	reach	VERB
ijassa-759	174	133	maximal	maximal	ADJ
ijassa-759	174	134	and	and	CCONJ
ijassa-759	174	135	minimal	minimal	ADJ
ijassa-759	174	136	level	level	NOUN
ijassa-759	174	137	(	(	PUNCT
ijassa-759	174	138	fig	fig	NOUN
ijassa-759	174	139	.	.	PUNCT
ijassa-759	175	1	5	5	NUM
ijassa-759	175	2	,	,	PUNCT
ijassa-759	175	3	dotted	dotted	ADJ
ijassa-759	175	4	line	line	NOUN
ijassa-759	175	5	)	)	PUNCT
ijassa-759	175	6	,	,	PUNCT
ijassa-759	175	7	(	(	PUNCT
ijassa-759	175	8	)	)	PUNCT
ijassa-759	175	9	r	r	NOUN
ijassa-759	175	10	vn	vn	PROPN
ijassa-759	175	11	t	t	PROPN
ijassa-759	175	12	is	be	AUX
ijassa-759	175	13	the	the	DET
ijassa-759	175	14	number	number	NOUN
ijassa-759	175	15	of	of	ADP
ijassa-759	175	16	remaining	remain	VERB
ijassa-759	175	17	tumor	tumor	NOUN
ijassa-759	175	18	cells	cell	NOUN
ijassa-759	175	19	that	that	PRON
ijassa-759	175	20	continue	continue	VERB
ijassa-759	175	21	to	to	PART
ijassa-759	175	22	produce	produce	VERB
ijassa-759	175	23	tumor	tumor	NOUN
ijassa-759	175	24	growth	growth	NOUN
ijassa-759	175	25	,	,	PUNCT
ijassa-759	175	26	which	which	PRON
ijassa-759	175	27	is	be	AUX
ijassa-759	175	28	calculated	calculate	VERB
ijassa-759	175	29	from	from	ADP
ijassa-759	175	30	the	the	DET
ijassa-759	175	31	equation	equation	NOUN
ijassa-759	175	32	:	:	PUNCT
ijassa-759	175	33	)	)	PUNCT
ijassa-759	175	34	(	(	PUNCT
ijassa-759	175	35	)	)	PUNCT
ijassa-759	175	36	(	(	PUNCT
ijassa-759	175	37	)	)	PUNCT
ijassa-759	175	38	(	(	PUNCT
ijassa-759	175	39	r	r	NOUN
ijassa-759	175	40	v	v	NUM
ijassa-759	175	41	v	v	NOUN
ijassa-759	175	42	v	v	ADP
ijassa-759	175	43	vn	vn	PROPN
ijassa-759	175	44	tn	tn	PROPN
ijassa-759	175	45	t	t	PROPN
ijassa-759	175	46	n	n	PROPN
ijassa-759	175	47	t	t	PROPN
ijassa-759	175	48	−=	−=	PROPN
ijassa-759	175	49	(	(	PUNCT
ijassa-759	175	50	16	16	NUM
ijassa-759	175	51	)	)	PUNCT
ijassa-759	175	52	the	the	DET
ijassa-759	175	53	trajectory	trajectory	NOUN
ijassa-759	175	54	of	of	ADP
ijassa-759	175	55	tumor	tumor	NOUN
ijassa-759	175	56	growth	growth	NOUN
ijassa-759	175	57	after	after	SCONJ
ijassa-759	175	58	the	the	DET
ijassa-759	175	59	first	first	ADJ
ijassa-759	175	60	stage	stage	NOUN
ijassa-759	175	61	of	of	ADP
ijassa-759	175	62	tumor	tumor	NOUN
ijassa-759	175	63	cell	cell	NOUN
ijassa-759	175	64	death	death	NOUN
ijassa-759	175	65	is	be	AUX
ijassa-759	175	66	described	describe	VERB
ijassa-759	175	67	by	by	ADP
ijassa-759	175	68	the	the	DET
ijassa-759	175	69	gompertz	gompertz	NOUN
ijassa-759	175	70	equations	equation	NOUN
ijassa-759	175	71	with	with	ADP
ijassa-759	175	72	a	a	DET
ijassa-759	175	73	time	time	NOUN
ijassa-759	175	74	shift	shift	NOUN
ijassa-759	175	75	for	for	ADP
ijassa-759	175	76	the	the	DET
ijassa-759	175	77	duration	duration	NOUN
ijassa-759	175	78	of	of	ADP
ijassa-759	175	79	tumor	tumor	NOUN
ijassa-759	175	80	growth	growth	NOUN
ijassa-759	175	81	delay	delay	NOUN
ijassa-759	175	82	(	(	PUNCT
ijassa-759	175	83	fig	fig	NOUN
ijassa-759	175	84	.	.	PUNCT
ijassa-759	176	1	5	5	NUM
ijassa-759	176	2	):	):	PUNCT
ijassa-759	176	3	0	0	NUM
ijassa-759	176	4	0	0	NUM
ijassa-759	176	5	(	(	PUNCT
ijassa-759	176	6	)	)	PUNCT
ijassa-759	176	7	exp	exp	NOUN
ijassa-759	176	8	(	(	PUNCT
ijassa-759	176	9	(	(	PUNCT
ijassa-759	176	10	1	1	NUM
ijassa-759	176	11	exp	exp	NOUN
ijassa-759	176	12	(	(	PUNCT
ijassa-759	176	13	(	(	PUNCT
ijassa-759	176	14	(	(	PUNCT
ijassa-759	176	15	)	)	PUNCT
ijassa-759	176	16	)	)	PUNCT
ijassa-759	176	17	)	)	PUNCT
ijassa-759	176	18	)	)	PUNCT
ijassa-759	176	19	)	)	PUNCT
ijassa-759	176	20	,	,	PUNCT
ijassa-759	177	1	v	v	NOUN
ijassa-759	177	2	n	n	CCONJ
ijassa-759	177	3	n	n	ADV
ijassa-759	177	4	v	v	NOUN
ijassa-759	177	5	vn	vn	PROPN
ijassa-759	177	6	t	t	PROPN
ijassa-759	177	7	t	t	PROPN
ijassa-759	177	8	n	n	PROPN
ijassa-759	177	9	t	t	NOUN
ijassa-759	177	10	v−	v−	NOUN
ijassa-759	177	11	=	=	PUNCT
ijassa-759	177	12			X
ijassa-759	177	13	−	−	NOUN
ijassa-759	177	14	−	−	PROPN
ijassa-759	177	15	−	−	NOUN
ijassa-759	177	16	(	(	PUNCT
ijassa-759	177	17	17	17	NUM
ijassa-759	177	18	)	)	PUNCT
ijassa-759	177	19	where	where	SCONJ
ijassa-759	177	20	0	0	NUM
ijassa-759	177	21	(	(	PUNCT
ijassa-759	177	22	,	,	PUNCT
ijassa-759	177	23	)	)	PUNCT
ijassa-759	177	24	v	v	NOUN
ijassa-759	177	25	vv	vv	NOUN
ijassa-759	177	26	t	t	PROPN
ijassa-759	177	27	is	be	AUX
ijassa-759	177	28	the	the	DET
ijassa-759	177	29	delay	delay	NOUN
ijassa-759	177	30	in	in	ADP
ijassa-759	177	31	tumor	tumor	NOUN
ijassa-759	177	32	growth	growth	NOUN
ijassa-759	177	33	after	after	ADP
ijassa-759	177	34	the	the	DET
ijassa-759	177	35	first	first	ADJ
ijassa-759	177	36	stage	stage	NOUN
ijassa-759	177	37	of	of	ADP
ijassa-759	177	38	the	the	DET
ijassa-759	177	39	immune	immune	ADJ
ijassa-759	177	40	response	response	NOUN
ijassa-759	177	41	.	.	PUNCT
ijassa-759	178	1	the	the	DET
ijassa-759	178	2	dynamics	dynamic	NOUN
ijassa-759	178	3	of	of	ADP
ijassa-759	178	4	tumor	tumor	NOUN
ijassa-759	178	5	growth	growth	NOUN
ijassa-759	178	6	after	after	ADP
ijassa-759	178	7	the	the	DET
ijassa-759	178	8	second	second	ADJ
ijassa-759	178	9	stage	stage	NOUN
ijassa-759	178	10	of	of	ADP
ijassa-759	178	11	tumor	tumor	NOUN
ijassa-759	178	12	cells	cell	NOUN
ijassa-759	178	13	’	'	PUNCT
ijassa-759	178	14	death	death	NOUN
ijassa-759	178	15	is	be	AUX
ijassa-759	178	16	described	describe	VERB
ijassa-759	178	17	n.a	n.a	PROPN
ijassa-759	178	18	.	.	PROPN
ijassa-759	178	19	babushkina	babushkina	PROPN
ijassa-759	178	20	,	,	PUNCT
ijassa-759	179	1	e.a	e.a	PROPN
ijassa-759	179	2	.	.	PROPN
ijassa-759	179	3	kuzina	kuzina	PROPN
ijassa-759	179	4	copyright	copyright	PROPN
ijassa-759	179	5	©	©	PROPN
ijassa-759	179	6	2020	2020	NUM
ijassa-759	179	7	assa	assa	NOUN
ijassa-759	179	8	.	.	PUNCT
ijassa-759	180	1	adv	adv	PROPN
ijassa-759	180	2	.	.	PUNCT
ijassa-759	181	1	in	in	ADP
ijassa-759	181	2	systems	system	NOUN
ijassa-759	181	3	science	science	NOUN
ijassa-759	181	4	and	and	CCONJ
ijassa-759	181	5	appl	appl	NOUN
ijassa-759	181	6	.	.	PUNCT
ijassa-759	182	1	(	(	PUNCT
ijassa-759	182	2	2020	2020	NUM
ijassa-759	182	3	)	)	PUNCT
ijassa-759	182	4	10	10	NUM
ijassa-759	182	5	by	by	ADP
ijassa-759	182	6	the	the	DET
ijassa-759	182	7	differential	differential	ADJ
ijassa-759	182	8	equation	equation	NOUN
ijassa-759	182	9	of	of	ADP
ijassa-759	182	10	the	the	DET
ijassa-759	182	11	form	form	NOUN
ijassa-759	182	12	:	:	PUNCT
ijassa-759	182	13			ADJ
ijassa-759	182	14			PROPN
ijassa-759	182	15	,	,	PUNCT
ijassa-759	182	16	,	,	PUNCT
ijassa-759	182	17	(	(	PUNCT
ijassa-759	182	18	)	)	PUNCT
ijassa-759	182	19	(	(	PUNCT
ijassa-759	182	20	)	)	PUNCT
ijassa-759	182	21	(	(	PUNCT
ijassa-759	182	22	)	)	PUNCT
ijassa-759	182	23	,	,	PUNCT
ijassa-759	182	24	n	n	CCONJ
ijassa-759	182	25	n	n	PROPN
ijassa-759	183	1	n	n	ADV
ijassa-759	183	2	lt	lt	VERB
ijassa-759	183	3	dn	dn	PROPN
ijassa-759	183	4	t	t	PROPN
ijassa-759	183	5	t	t	PROPN
ijassa-759	183	6	t	t	PROPN
ijassa-759	184	1	n	n	ADP
ijassa-759	184	2	t	t	PROPN
ijassa-759	184	3	t	t	PROPN
ijassa-759	184	4	t	t	X
ijassa-759	184	5	dt	dt	X
ijassa-759	184	6	=	=	NOUN
ijassa-759	184	7			X
ijassa-759	184	8	−	−	NOUN
ijassa-759	184	9	−	−	NOUN
ijassa-759	184	10			NOUN
ijassa-759	184	11	with	with	ADP
ijassa-759	184	12	)	)	PUNCT
ijassa-759	184	13	)	)	PUNCT
ijassa-759	185	1	(	(	PUNCT
ijassa-759	185	2	(	(	PUNCT
ijassa-759	185	3	)	)	PUNCT
ijassa-759	185	4	(	(	PUNCT
ijassa-759	185	5	)	)	PUNCT
ijassa-759	185	6	(	(	PUNCT
ijassa-759	185	7	r	r	NOUN
ijassa-759	185	8	n	n	PART
ijassa-759	185	9	v	v	NOUN
ijassa-759	185	10	n	n	CCONJ
ijassa-759	185	11	n	n	ADV
ijassa-759	185	12	ntn	ntn	NOUN
ijassa-759	185	13	n	n	PROPN
ijassa-759	185	14	t	t	PROPN
ijassa-759	185	15	s	s	PROPN
ijassa-759	185	16	t	t	PROPN
ijassa-759	185	17	t	t	NOUN
ijassa-759	185	18	t=	t=	PROPN
ijassa-759	185	19			NUM
ijassa-759	185	20	−	−	PROPN
ijassa-759	185	21	(	(	PUNCT
ijassa-759	185	22	18	18	NUM
ijassa-759	185	23	)	)	PUNCT
ijassa-759	186	1	where	where	SCONJ
ijassa-759	186	2	1n	1n	PROPN
ijassa-759	186	3	cnt	cnt	PROPN
ijassa-759	186	4	z=	z=	VERB
ijassa-759	186	5			PROPN
ijassa-759	186	6	+	+	CCONJ
ijassa-759	186	7	is	be	AUX
ijassa-759	186	8	the	the	DET
ijassa-759	186	9	moment	moment	NOUN
ijassa-759	186	10	when	when	SCONJ
ijassa-759	186	11	the	the	DET
ijassa-759	186	12	immune	immune	ADJ
ijassa-759	186	13	response	response	NOUN
ijassa-759	186	14	against	against	ADP
ijassa-759	186	15	virus	virus	NOUN
ijassa-759	186	16	-	-	PUNCT
ijassa-759	186	17	infected	infect	VERB
ijassa-759	186	18	tumor	tumor	NOUN
ijassa-759	186	19	cells	cell	NOUN
ijassa-759	186	20	begins	begin	VERB
ijassa-759	186	21	,	,	PUNCT
ijassa-759	186	22	cnz	cnz	NOUN
ijassa-759	186	23	is	be	AUX
ijassa-759	186	24	the	the	DET
ijassa-759	186	25	period	period	NOUN
ijassa-759	186	26	of	of	ADP
ijassa-759	186	27	delay	delay	NOUN
ijassa-759	186	28	of	of	ADP
ijassa-759	186	29	immune	immune	ADJ
ijassa-759	186	30	response	response	NOUN
ijassa-759	186	31	against	against	ADP
ijassa-759	186	32	virus	virus	NOUN
ijassa-759	186	33	-	-	PUNCT
ijassa-759	186	34	infected	infect	VERB
ijassa-759	186	35	tumor	tumor	NOUN
ijassa-759	186	36	cells	cell	NOUN
ijassa-759	186	37	,	,	PUNCT
ijassa-759	186	38	(	(	PUNCT
ijassa-759	186	39	)	)	PUNCT
ijassa-759	186	40	nt	not	PART
ijassa-759	186	41	t	t	NOUN
ijassa-759	186	42	−	−	NOUN
ijassa-759	186	43	is	be	AUX
ijassa-759	186	44	the	the	DET
ijassa-759	186	45	pulsed	pulse	VERB
ijassa-759	186	46	dirac	dirac	NOUN
ijassa-759	186	47	function	function	NOUN
ijassa-759	186	48	,	,	PUNCT
ijassa-759	186	49	describing	describe	VERB
ijassa-759	186	50	the	the	DET
ijassa-759	186	51	instantaneous	instantaneous	ADJ
ijassa-759	186	52	death	death	NOUN
ijassa-759	186	53	of	of	ADP
ijassa-759	186	54	tumor	tumor	NOUN
ijassa-759	186	55	cells	cell	NOUN
ijassa-759	186	56	in	in	ADP
ijassa-759	186	57	the	the	DET
ijassa-759	186	58	second	second	ADJ
ijassa-759	186	59	stage	stage	NOUN
ijassa-759	186	60	of	of	ADP
ijassa-759	186	61	the	the	DET
ijassa-759	186	62	immune	immune	ADJ
ijassa-759	186	63	response	response	NOUN
ijassa-759	186	64	,	,	PUNCT
ijassa-759	186	65	(	(	PUNCT
ijassa-759	186	66	)	)	PUNCT
ijassa-759	186	67	n	n	X
ijassa-759	186	68	ns	ns	NUM
ijassa-759	186	69	t	t	PROPN
ijassa-759	186	70	is	be	AUX
ijassa-759	186	71	the	the	DET
ijassa-759	186	72	proportion	proportion	NOUN
ijassa-759	186	73	of	of	ADP
ijassa-759	186	74	dying	die	VERB
ijassa-759	186	75	tumor	tumor	NOUN
ijassa-759	186	76	cells	cell	NOUN
ijassa-759	186	77	infected	infect	VERB
ijassa-759	186	78	with	with	ADP
ijassa-759	186	79	the	the	DET
ijassa-759	186	80	virus	virus	NOUN
ijassa-759	186	81	at	at	ADP
ijassa-759	186	82	the	the	DET
ijassa-759	186	83	second	second	ADJ
ijassa-759	186	84	stage	stage	NOUN
ijassa-759	186	85	of	of	ADP
ijassa-759	186	86	the	the	DET
ijassa-759	186	87	immune	immune	ADJ
ijassa-759	186	88	response	response	NOUN
ijassa-759	186	89	,	,	PUNCT
ijassa-759	186	90	which	which	PRON
ijassa-759	186	91	is	be	AUX
ijassa-759	186	92	determined	determine	VERB
ijassa-759	186	93	from	from	ADP
ijassa-759	186	94	the	the	DET
ijassa-759	186	95	equation	equation	NOUN
ijassa-759	186	96	:	:	PUNCT
ijassa-759	186	97	(	(	PUNCT
ijassa-759	186	98	)	)	PUNCT
ijassa-759	186	99	(	(	PUNCT
ijassa-759	186	100	)	)	PUNCT
ijassa-759	186	101	,	,	PUNCT
ijassa-759	186	102	(	(	PUNCT
ijassa-759	186	103	)	)	PUNCT
ijassa-759	186	104	v	v	NOUN
ijassa-759	186	105	n	n	CCONJ
ijassa-759	186	106	n	n	CCONJ
ijassa-759	186	107	n	n	CCONJ
ijassa-759	186	108	n	n	CCONJ
ijassa-759	186	109	n	n	NOUN
ijassa-759	186	110	t	t	PROPN
ijassa-759	186	111	s	s	PROPN
ijassa-759	186	112	t	t	PROPN
ijassa-759	186	113	n	n	PROPN
ijassa-759	186	114	t	t	NOUN
ijassa-759	186	115			PUNCT
ijassa-759	187	1	=	=	PUNCT
ijassa-759	187	2	(	(	PUNCT
ijassa-759	187	3	19	19	NUM
ijassa-759	187	4	)	)	PUNCT
ijassa-759	187	5	(	(	PUNCT
ijassa-759	187	6	)	)	PUNCT
ijassa-759	187	7	v	v	NOUN
ijassa-759	187	8	nn	nn	PROPN
ijassa-759	187	9	t	t	NOUN
ijassa-759	187	10	denotes	denote	NOUN
ijassa-759	187	11	the	the	DET
ijassa-759	187	12	number	number	NOUN
ijassa-759	187	13	of	of	ADP
ijassa-759	187	14	dying	die	VERB
ijassa-759	187	15	tumor	tumor	NOUN
ijassa-759	187	16	cells	cell	NOUN
ijassa-759	187	17	in	in	ADP
ijassa-759	187	18	the	the	DET
ijassa-759	187	19	second	second	ADJ
ijassa-759	187	20	stage	stage	NOUN
ijassa-759	187	21	of	of	ADP
ijassa-759	187	22	the	the	DET
ijassa-759	187	23	immune	immune	ADJ
ijassa-759	187	24	response	response	NOUN
ijassa-759	187	25	.	.	PUNCT
ijassa-759	188	1	it	it	PRON
ijassa-759	188	2	is	be	AUX
ijassa-759	188	3	calculated	calculate	VERB
ijassa-759	188	4	as	as	ADP
ijassa-759	188	5	the	the	DET
ijassa-759	188	6	difference	difference	NOUN
ijassa-759	188	7	between	between	ADP
ijassa-759	188	8	the	the	DET
ijassa-759	188	9	maximum	maximum	ADJ
ijassa-759	188	10	and	and	CCONJ
ijassa-759	188	11	minimum	minimum	ADJ
ijassa-759	188	12	number	number	NOUN
ijassa-759	188	13	of	of	ADP
ijassa-759	188	14	infected	infected	ADJ
ijassa-759	188	15	cells	cell	NOUN
ijassa-759	188	16	in	in	ADP
ijassa-759	188	17	the	the	DET
ijassa-759	188	18	period	period	NOUN
ijassa-759	188	19	from	from	ADP
ijassa-759	188	20	the	the	DET
ijassa-759	188	21	beginning	beginning	NOUN
ijassa-759	188	22	to	to	ADP
ijassa-759	188	23	the	the	DET
ijassa-759	188	24	end	end	NOUN
ijassa-759	188	25	of	of	ADP
ijassa-759	188	26	the	the	DET
ijassa-759	188	27	2nd	2nd	ADJ
ijassa-759	188	28	stage	stage	NOUN
ijassa-759	188	29	of	of	ADP
ijassa-759	188	30	immune	immune	ADJ
ijassa-759	188	31	response	response	NOUN
ijassa-759	188	32	according	accord	VERB
ijassa-759	188	33	to	to	ADP
ijassa-759	188	34	the	the	DET
ijassa-759	188	35	equation	equation	NOUN
ijassa-759	188	36	:	:	PUNCT
ijassa-759	188	37	1	1	NUM
ijassa-759	188	38	2	2	NUM
ijassa-759	188	39	(	(	PUNCT
ijassa-759	188	40	)	)	PUNCT
ijassa-759	188	41	(	(	PUNCT
ijassa-759	188	42	)	)	PUNCT
ijassa-759	188	43	(	(	PUNCT
ijassa-759	188	44	)	)	PUNCT
ijassa-759	188	45	,	,	PUNCT
ijassa-759	188	46	n	n	PROPN
ijassa-759	188	47	n	n	PRON
ijassa-759	188	48	v	v	NOUN
ijassa-759	188	49	vv	vv	INTJ
ijassa-759	188	50	nn	nn	PROPN
ijassa-759	188	51	t	t	PROPN
ijassa-759	188	52	n	n	PROPN
ijassa-759	188	53	t	t	PROPN
ijassa-759	188	54	n	n	CCONJ
ijassa-759	188	55	t	t	NOUN
ijassa-759	188	56	=	=	SYM
ijassa-759	188	57	−	−	PROPN
ijassa-759	188	58	(	(	PUNCT
ijassa-759	188	59	20	20	NUM
ijassa-759	188	60	)	)	PUNCT
ijassa-759	188	61	where	where	SCONJ
ijassa-759	188	62	1	1	NUM
ijassa-759	188	63	nt	not	PART
ijassa-759	188	64	and	and	CCONJ
ijassa-759	188	65	2	2	NUM
ijassa-759	188	66	nt	not	PART
ijassa-759	188	67	are	be	AUX
ijassa-759	188	68	the	the	DET
ijassa-759	188	69	moments	moment	NOUN
ijassa-759	188	70	when	when	SCONJ
ijassa-759	188	71	the	the	DET
ijassa-759	188	72	number	number	NOUN
ijassa-759	188	73	of	of	ADP
ijassa-759	188	74	infected	infected	ADJ
ijassa-759	188	75	cells	cell	NOUN
ijassa-759	188	76	during	during	ADP
ijassa-759	188	77	the	the	DET
ijassa-759	188	78	2nd	2nd	ADJ
ijassa-759	188	79	stage	stage	NOUN
ijassa-759	188	80	of	of	ADP
ijassa-759	188	81	immune	immune	ADJ
ijassa-759	188	82	response	response	NOUN
ijassa-759	188	83	against	against	ADP
ijassa-759	188	84	the	the	DET
ijassa-759	188	85	virus	virus	NOUN
ijassa-759	188	86	reaches	reach	VERB
ijassa-759	188	87	maximal	maximal	ADJ
ijassa-759	188	88	and	and	CCONJ
ijassa-759	188	89	minimal	minimal	ADJ
ijassa-759	188	90	level	level	NOUN
ijassa-759	188	91	(	(	PUNCT
ijassa-759	188	92	fig	fig	NOUN
ijassa-759	188	93	.	.	PUNCT
ijassa-759	189	1	5	5	NUM
ijassa-759	189	2	,	,	PUNCT
ijassa-759	189	3	dotted	dotted	ADJ
ijassa-759	189	4	line	line	NOUN
ijassa-759	189	5	)	)	PUNCT
ijassa-759	189	6	,	,	PUNCT
ijassa-759	189	7	(	(	PUNCT
ijassa-759	189	8	)	)	PUNCT
ijassa-759	189	9	r	r	NOUN
ijassa-759	189	10	nn	nn	PROPN
ijassa-759	189	11	t	t	PROPN
ijassa-759	189	12	is	be	AUX
ijassa-759	189	13	the	the	DET
ijassa-759	189	14	number	number	NOUN
ijassa-759	189	15	of	of	ADP
ijassa-759	189	16	remaining	remain	VERB
ijassa-759	189	17	tumor	tumor	NOUN
ijassa-759	189	18	cells	cell	NOUN
ijassa-759	189	19	that	that	PRON
ijassa-759	189	20	continue	continue	VERB
ijassa-759	189	21	to	to	PART
ijassa-759	189	22	produce	produce	VERB
ijassa-759	189	23	tumor	tumor	NOUN
ijassa-759	189	24	growth	growth	NOUN
ijassa-759	189	25	,	,	PUNCT
ijassa-759	189	26	which	which	PRON
ijassa-759	189	27	is	be	AUX
ijassa-759	189	28	calculated	calculate	VERB
ijassa-759	189	29	from	from	ADP
ijassa-759	189	30	the	the	DET
ijassa-759	189	31	equation	equation	NOUN
ijassa-759	189	32	:	:	PUNCT
ijassa-759	189	33	)	)	PUNCT
ijassa-759	189	34	(	(	PUNCT
ijassa-759	189	35	)	)	PUNCT
ijassa-759	189	36	(	(	PUNCT
ijassa-759	189	37	)	)	PUNCT
ijassa-759	189	38	(	(	PUNCT
ijassa-759	189	39	r	r	NOUN
ijassa-759	189	40	n	n	CCONJ
ijassa-759	189	41	n	n	PROPN
ijassa-759	189	42	v	v	PROPN
ijassa-759	189	43	nn	nn	PROPN
ijassa-759	189	44	tn	tn	PROPN
ijassa-759	189	45	t	t	PROPN
ijassa-759	189	46	n	n	PROPN
ijassa-759	189	47	t	t	PROPN
ijassa-759	189	48	−=	−=	PROPN
ijassa-759	189	49	(	(	PUNCT
ijassa-759	189	50	21	21	NUM
ijassa-759	189	51	)	)	PUNCT
ijassa-759	189	52	then	then	ADV
ijassa-759	189	53	the	the	DET
ijassa-759	189	54	trajectory	trajectory	NOUN
ijassa-759	189	55	of	of	ADP
ijassa-759	189	56	tumor	tumor	NOUN
ijassa-759	189	57	growth	growth	NOUN
ijassa-759	189	58	after	after	SCONJ
ijassa-759	189	59	the	the	DET
ijassa-759	189	60	second	second	ADJ
ijassa-759	189	61	stage	stage	NOUN
ijassa-759	189	62	of	of	ADP
ijassa-759	189	63	tumor	tumor	NOUN
ijassa-759	189	64	cell	cell	NOUN
ijassa-759	189	65	death	death	NOUN
ijassa-759	189	66	is	be	AUX
ijassa-759	189	67	described	describe	VERB
ijassa-759	189	68	by	by	ADP
ijassa-759	189	69	the	the	DET
ijassa-759	189	70	gompertz	gompertz	NOUN
ijassa-759	189	71	equation	equation	NOUN
ijassa-759	189	72	with	with	ADP
ijassa-759	189	73	a	a	DET
ijassa-759	189	74	time	time	NOUN
ijassa-759	189	75	shift	shift	NOUN
ijassa-759	189	76	for	for	ADP
ijassa-759	189	77	the	the	DET
ijassa-759	189	78	duration	duration	NOUN
ijassa-759	189	79	of	of	ADP
ijassa-759	189	80	tumor	tumor	NOUN
ijassa-759	189	81	growth	growth	NOUN
ijassa-759	189	82	delay	delay	NOUN
ijassa-759	189	83	(	(	PUNCT
ijassa-759	189	84	fig	fig	NOUN
ijassa-759	189	85	.	.	PUNCT
ijassa-759	190	1	5	5	NUM
ijassa-759	190	2	):	):	PUNCT
ijassa-759	190	3	0	0	NUM
ijassa-759	190	4	0	0	NUM
ijassa-759	190	5	(	(	PUNCT
ijassa-759	190	6	)	)	PUNCT
ijassa-759	190	7	exp	exp	NOUN
ijassa-759	190	8	(	(	PUNCT
ijassa-759	190	9	(	(	PUNCT
ijassa-759	190	10	1	1	NUM
ijassa-759	190	11	exp	exp	NOUN
ijassa-759	190	12	(	(	PUNCT
ijassa-759	190	13	(	(	PUNCT
ijassa-759	190	14	(	(	PUNCT
ijassa-759	190	15	)	)	PUNCT
ijassa-759	190	16	)	)	PUNCT
ijassa-759	190	17	)	)	PUNCT
ijassa-759	190	18	)	)	PUNCT
ijassa-759	190	19	)	)	PUNCT
ijassa-759	191	1	n	n	CCONJ
ijassa-759	191	2	n	n	CCONJ
ijassa-759	191	3	n	n	CCONJ
ijassa-759	191	4	n	n	CCONJ
ijassa-759	191	5	nn	nn	PROPN
ijassa-759	191	6	t	t	PROPN
ijassa-759	191	7	t	t	PROPN
ijassa-759	191	8	n	n	PROPN
ijassa-759	191	9	t	t	NOUN
ijassa-759	191	10	v−	v−	NOUN
ijassa-759	191	11	=	=	PUNCT
ijassa-759	191	12			X
ijassa-759	191	13	−	−	NOUN
ijassa-759	191	14	−	−	PROPN
ijassa-759	191	15	−	−	NOUN
ijassa-759	191	16	(	(	PUNCT
ijassa-759	191	17	22	22	NUM
ijassa-759	191	18	)	)	PUNCT
ijassa-759	191	19	where	where	SCONJ
ijassa-759	191	20	0	0	NUM
ijassa-759	191	21	(	(	PUNCT
ijassa-759	191	22	)	)	PUNCT
ijassa-759	192	1	n	n	CCONJ
ijassa-759	192	2	v	v	PROPN
ijassa-759	192	3	is	be	AUX
ijassa-759	192	4	the	the	DET
ijassa-759	192	5	delay	delay	NOUN
ijassa-759	192	6	in	in	ADP
ijassa-759	192	7	tumor	tumor	NOUN
ijassa-759	192	8	growth	growth	NOUN
ijassa-759	192	9	after	after	ADP
ijassa-759	192	10	cells	cell	NOUN
ijassa-759	192	11	’	’	PART
ijassa-759	192	12	death	death	NOUN
ijassa-759	192	13	in	in	ADP
ijassa-759	192	14	the	the	DET
ijassa-759	192	15	second	second	ADJ
ijassa-759	192	16	stage	stage	NOUN
ijassa-759	192	17	of	of	ADP
ijassa-759	192	18	the	the	DET
ijassa-759	192	19	immune	immune	ADJ
ijassa-759	192	20	response	response	NOUN
ijassa-759	192	21	.	.	PUNCT
ijassa-759	193	1	the	the	DET
ijassa-759	193	2	duration	duration	NOUN
ijassa-759	193	3	of	of	ADP
ijassa-759	193	4	the	the	DET
ijassa-759	193	5	delay	delay	NOUN
ijassa-759	193	6	of	of	ADP
ijassa-759	193	7	tumor	tumor	NOUN
ijassa-759	193	8	growth	growth	NOUN
ijassa-759	193	9	0	0	NUM
ijassa-759	193	10	(	(	PUNCT
ijassa-759	193	11	)	)	PUNCT
ijassa-759	193	12	v	v	NOUN
ijassa-759	193	13	v	v	PROPN
ijassa-759	193	14	and	and	CCONJ
ijassa-759	193	15	0	0	NUM
ijassa-759	193	16	(	(	PUNCT
ijassa-759	193	17	)	)	PUNCT
ijassa-759	193	18	n	n	CCONJ
ijassa-759	193	19	v	v	PROPN
ijassa-759	193	20	was	be	AUX
ijassa-759	193	21	determined	determine	VERB
ijassa-759	193	22	as	as	ADP
ijassa-759	193	23	the	the	DET
ijassa-759	193	24	time	time	NOUN
ijassa-759	193	25	interval	interval	NOUN
ijassa-759	193	26	between	between	ADP
ijassa-759	193	27	the	the	DET
ijassa-759	193	28	start	start	NOUN
ijassa-759	193	29	of	of	ADP
ijassa-759	193	30	immune	immune	ADJ
ijassa-759	193	31	response	response	NOUN
ijassa-759	193	32	(	(	PUNCT
ijassa-759	193	33	i.e.	i.e.	X
ijassa-759	193	34	when	when	SCONJ
ijassa-759	193	35	the	the	DET
ijassa-759	193	36	number	number	NOUN
ijassa-759	193	37	of	of	ADP
ijassa-759	193	38	tumor	tumor	NOUN
ijassa-759	193	39	cells	cell	NOUN
ijassa-759	193	40	starts	start	VERB
ijassa-759	193	41	to	to	PART
ijassa-759	193	42	decline	decline	VERB
ijassa-759	193	43	affected	affect	VERB
ijassa-759	193	44	first	first	ADV
ijassa-759	193	45	by	by	ADP
ijassa-759	193	46	the	the	DET
ijassa-759	193	47	virus	virus	NOUN
ijassa-759	193	48	at	at	ADP
ijassa-759	193	49	vt	vt	PROPN
ijassa-759	193	50	and	and	CCONJ
ijassa-759	193	51	then	then	ADV
ijassa-759	193	52	by	by	ADP
ijassa-759	193	53	the	the	DET
ijassa-759	193	54	antibodies	antibody	NOUN
ijassa-759	193	55	at	at	ADP
ijassa-759	193	56	nt	not	PART
ijassa-759	193	57	)	)	PUNCT
ijassa-759	193	58	and	and	CCONJ
ijassa-759	193	59	the	the	DET
ijassa-759	193	60	moment	moment	NOUN
ijassa-759	193	61	when	when	SCONJ
ijassa-759	193	62	the	the	DET
ijassa-759	193	63	tumor	tumor	NOUN
ijassa-759	193	64	,	,	PUNCT
ijassa-759	193	65	resuming	resume	VERB
ijassa-759	193	66	its	its	PRON
ijassa-759	193	67	growth	growth	NOUN
ijassa-759	193	68	,	,	PUNCT
ijassa-759	193	69	reaches	reach	VERB
ijassa-759	193	70	the	the	DET
ijassa-759	193	71	same	same	ADJ
ijassa-759	193	72	size	size	NOUN
ijassa-759	193	73	as	as	ADP
ijassa-759	193	74	at	at	ADP
ijassa-759	193	75	vt	vt	NOUN
ijassa-759	193	76	and	and	CCONJ
ijassa-759	193	77	nt	not	PART
ijassa-759	193	78	respectively	respectively	ADV
ijassa-759	193	79	.	.	PUNCT
ijassa-759	194	1	therefore	therefore	ADV
ijassa-759	194	2	:	:	PUNCT
ijassa-759	194	3	0	0	NUM
ijassa-759	194	4	(	(	PUNCT
ijassa-759	194	5	)	)	PUNCT
ijassa-759	194	6	(	(	PUNCT
ijassa-759	194	7	(	(	PUNCT
ijassa-759	194	8	)	)	PUNCT
ijassa-759	194	9	)	)	PUNCT
ijassa-759	195	1	v	v	X
ijassa-759	195	2	v	v	NUM
ijassa-759	195	3	vn	vn	PROPN
ijassa-759	195	4	t	t	PROPN
ijassa-759	195	5	n	n	PROPN
ijassa-759	195	6	t	t	NOUN
ijassa-759	195	7	v=	v=	NOUN
ijassa-759	195	8	+	+	CCONJ
ijassa-759	195	9			PROPN
ijassa-759	195	10	,	,	PUNCT
ijassa-759	195	11	(	(	PUNCT
ijassa-759	195	12	23	23	NUM
ijassa-759	195	13	)	)	PUNCT
ijassa-759	195	14	0	0	NUM
ijassa-759	195	15	(	(	PUNCT
ijassa-759	195	16	)	)	PUNCT
ijassa-759	195	17	(	(	PUNCT
ijassa-759	195	18	(	(	PUNCT
ijassa-759	195	19	)	)	PUNCT
ijassa-759	195	20	)	)	PUNCT
ijassa-759	195	21	n	n	CCONJ
ijassa-759	195	22	n	n	CCONJ
ijassa-759	195	23	nn	nn	PROPN
ijassa-759	195	24	t	t	PROPN
ijassa-759	195	25	n	n	PROPN
ijassa-759	195	26	t	t	NOUN
ijassa-759	195	27	v=	v=	NOUN
ijassa-759	195	28	+	+	CCONJ
ijassa-759	195	29			PROPN
ijassa-759	195	30	.	.	PUNCT
ijassa-759	196	1	(	(	PUNCT
ijassa-759	196	2	24	24	NUM
ijassa-759	196	3	)	)	PUNCT
ijassa-759	196	4	the	the	DET
ijassa-759	196	5	values	value	NOUN
ijassa-759	196	6	of	of	ADP
ijassa-759	196	7	the	the	DET
ijassa-759	196	8	parameters	parameter	NOUN
ijassa-759	196	9	of	of	ADP
ijassa-759	196	10	the	the	DET
ijassa-759	196	11	vaccine	vaccine	NOUN
ijassa-759	196	12	therapy	therapy	NOUN
ijassa-759	196	13	model	model	NOUN
ijassa-759	196	14	and	and	CCONJ
ijassa-759	196	15	the	the	DET
ijassa-759	196	16	model	model	NOUN
ijassa-759	196	17	of	of	ADP
ijassa-759	196	18	anticancer	anticancer	NOUN
ijassa-759	196	19	therapy	therapy	NOUN
ijassa-759	196	20	with	with	ADP
ijassa-759	196	21	discontinuous	discontinuous	ADJ
ijassa-759	196	22	trajectories	trajectory	NOUN
ijassa-759	196	23	are	be	AUX
ijassa-759	196	24	given	give	VERB
ijassa-759	196	25	in	in	ADP
ijassa-759	196	26	appendix	appendix	NOUN
ijassa-759	196	27	1	1	NUM
ijassa-759	196	28	.	.	PUNCT
ijassa-759	196	29	mathematical	mathematical	ADJ
ijassa-759	196	30	modeling	modeling	NOUN
ijassa-759	196	31	of	of	ADP
ijassa-759	196	32	antitumor	antitumor	PROPN
ijassa-759	196	33	viral	viral	ADJ
ijassa-759	196	34	vaccine	vaccine	NOUN
ijassa-759	196	35	therapy	therapy	NOUN
ijassa-759	196	36	…	…	PUNCT
ijassa-759	196	37	copyright	copyright	NOUN
ijassa-759	196	38	©	©	PROPN
ijassa-759	196	39	2020	2020	NUM
ijassa-759	196	40	assa	assa	NOUN
ijassa-759	196	41	.	.	PUNCT
ijassa-759	197	1	adv	adv	PROPN
ijassa-759	197	2	.	.	PUNCT
ijassa-759	198	1	in	in	ADP
ijassa-759	198	2	systems	system	NOUN
ijassa-759	198	3	science	science	NOUN
ijassa-759	198	4	and	and	CCONJ
ijassa-759	198	5	appl	appl	NOUN
ijassa-759	198	6	.	.	PUNCT
ijassa-759	199	1	(	(	PUNCT
ijassa-759	199	2	2020	2020	NUM
ijassa-759	199	3	)	)	PUNCT
ijassa-759	199	4	11	11	NUM
ijassa-759	199	5	5	5	NUM
ijassa-759	199	6	.	.	PUNCT
ijassa-759	199	7	finding	find	VERB
ijassa-759	199	8	effective	effective	ADJ
ijassa-759	199	9	strategies	strategy	NOUN
ijassa-759	199	10	of	of	ADP
ijassa-759	199	11	viral	viral	ADJ
ijassa-759	199	12	vaccine	vaccine	NOUN
ijassa-759	199	13	introduction	introduction	NOUN
ijassa-759	199	14	evaluation	evaluation	NOUN
ijassa-759	199	15	of	of	ADP
ijassa-759	199	16	the	the	DET
ijassa-759	199	17	effectiveness	effectiveness	NOUN
ijassa-759	199	18	of	of	ADP
ijassa-759	199	19	various	various	ADJ
ijassa-759	199	20	strategies	strategy	NOUN
ijassa-759	199	21	of	of	ADP
ijassa-759	199	22	tumor	tumor	NOUN
ijassa-759	199	23	growth	growth	NOUN
ijassa-759	199	24	after	after	SCONJ
ijassa-759	199	25	the	the	DET
ijassa-759	199	26	injection	injection	NOUN
ijassa-759	199	27	of	of	ADP
ijassa-759	199	28	the	the	DET
ijassa-759	199	29	viral	viral	ADJ
ijassa-759	199	30	vaccine	vaccine	NOUN
ijassa-759	199	31	was	be	AUX
ijassa-759	199	32	carried	carry	VERB
ijassa-759	199	33	out	out	ADP
ijassa-759	199	34	on	on	ADP
ijassa-759	199	35	the	the	DET
ijassa-759	199	36	basis	basis	NOUN
ijassa-759	199	37	of	of	ADP
ijassa-759	199	38	a	a	DET
ijassa-759	199	39	mathematical	mathematical	ADJ
ijassa-759	199	40	model	model	NOUN
ijassa-759	199	41	of	of	ADP
ijassa-759	199	42	anticancer	anticancer	NOUN
ijassa-759	199	43	therapy	therapy	NOUN
ijassa-759	199	44	with	with	ADP
ijassa-759	199	45	discontinuous	discontinuous	ADJ
ijassa-759	199	46	trajectories	trajectory	NOUN
ijassa-759	199	47	according	accord	VERB
ijassa-759	199	48	to	to	ADP
ijassa-759	199	49	the	the	DET
ijassa-759	199	50	equations	equation	NOUN
ijassa-759	199	51	(	(	PUNCT
ijassa-759	199	52	12	12	NUM
ijassa-759	199	53	)	)	PUNCT
ijassa-759	199	54	(	(	PUNCT
ijassa-759	199	55	24	24	NUM
ijassa-759	199	56	)	)	PUNCT
ijassa-759	199	57	.	.	PUNCT
ijassa-759	200	1	the	the	DET
ijassa-759	200	2	aim	aim	NOUN
ijassa-759	200	3	of	of	ADP
ijassa-759	200	4	efficient	efficient	ADJ
ijassa-759	200	5	strategy	strategy	NOUN
ijassa-759	200	6	is	be	AUX
ijassa-759	200	7	to	to	PART
ijassa-759	200	8	reduce	reduce	VERB
ijassa-759	200	9	the	the	DET
ijassa-759	200	10	number	number	NOUN
ijassa-759	200	11	of	of	ADP
ijassa-759	200	12	tumor	tumor	NOUN
ijassa-759	200	13	cells	cell	NOUN
ijassa-759	200	14	below	below	ADP
ijassa-759	200	15	the	the	DET
ijassa-759	200	16	lethality	lethality	NOUN
ijassa-759	200	17	threshold	threshold	NOUN
ijassa-759	200	18	.	.	PUNCT
ijassa-759	201	1	in	in	ADP
ijassa-759	201	2	this	this	DET
ijassa-759	201	3	case	case	NOUN
ijassa-759	201	4	tumor	tumor	NOUN
ijassa-759	201	5	will	will	AUX
ijassa-759	201	6	not	not	PART
ijassa-759	201	7	be	be	AUX
ijassa-759	201	8	able	able	ADJ
ijassa-759	201	9	to	to	PART
ijassa-759	201	10	resume	resume	VERB
ijassa-759	201	11	its	its	PRON
ijassa-759	201	12	growth	growth	NOUN
ijassa-759	201	13	.	.	PUNCT
ijassa-759	202	1	this	this	DET
ijassa-759	202	2	threshold	threshold	NOUN
ijassa-759	202	3	is	be	AUX
ijassa-759	202	4	denoted	denote	VERB
ijassa-759	202	5	let	let	VERB
ijassa-759	202	6	0n	0n	NOUN
ijassa-759	202	7	.	.	PUNCT
ijassa-759	203	1	if	if	SCONJ
ijassa-759	203	2	the	the	DET
ijassa-759	203	3	number	number	NOUN
ijassa-759	203	4	of	of	ADP
ijassa-759	203	5	surviving	survive	VERB
ijassa-759	203	6	cells	cell	NOUN
ijassa-759	203	7	is	be	AUX
ijassa-759	203	8	below	below	ADP
ijassa-759	203	9	the	the	DET
ijassa-759	203	10	threshold	threshold	NOUN
ijassa-759	203	11	after	after	ADP
ijassa-759	203	12	the	the	DET
ijassa-759	203	13	first	first	ADJ
ijassa-759	203	14	stage	stage	NOUN
ijassa-759	203	15	of	of	ADP
ijassa-759	203	16	immune	immune	ADJ
ijassa-759	203	17	response	response	NOUN
ijassa-759	203	18	(	(	PUNCT
ijassa-759	203	19	0	0	NUM
ijassa-759	203	20	(	(	PUNCT
ijassa-759	203	21	)	)	PUNCT
ijassa-759	203	22	r	r	NOUN
ijassa-759	203	23	let	let	VERB
ijassa-759	203	24	vn	vn	PROPN
ijassa-759	203	25	t	t	PROPN
ijassa-759	203	26	n	n	PROPN
ijassa-759	203	27	)	)	PUNCT
ijassa-759	203	28	or	or	CCONJ
ijassa-759	203	29	after	after	ADP
ijassa-759	203	30	the	the	DET
ijassa-759	203	31	second	second	ADJ
ijassa-759	203	32	stage	stage	NOUN
ijassa-759	203	33	of	of	ADP
ijassa-759	203	34	the	the	DET
ijassa-759	203	35	immune	immune	ADJ
ijassa-759	203	36	response	response	NOUN
ijassa-759	203	37	(	(	PUNCT
ijassa-759	203	38	0	0	NUM
ijassa-759	203	39	(	(	PUNCT
ijassa-759	203	40	)	)	PUNCT
ijassa-759	203	41	r	r	NOUN
ijassa-759	203	42	let	let	VERB
ijassa-759	203	43	nn	nn	INTJ
ijassa-759	203	44	t	t	PROPN
ijassa-759	203	45	n	n	PROPN
ijassa-759	203	46	)	)	PUNCT
ijassa-759	203	47	,	,	PUNCT
ijassa-759	203	48	this	this	PRON
ijassa-759	203	49	is	be	AUX
ijassa-759	203	50	interpreted	interpret	VERB
ijassa-759	203	51	in	in	ADP
ijassa-759	203	52	the	the	DET
ijassa-759	203	53	model	model	NOUN
ijassa-759	203	54	as	as	ADP
ijassa-759	203	55	the	the	DET
ijassa-759	203	56	complete	complete	ADJ
ijassa-759	203	57	destruction	destruction	NOUN
ijassa-759	203	58	of	of	ADP
ijassa-759	203	59	tumor	tumor	NOUN
ijassa-759	203	60	cells	cell	NOUN
ijassa-759	203	61	.	.	PUNCT
ijassa-759	204	1	in	in	ADP
ijassa-759	204	2	this	this	DET
ijassa-759	204	3	case	case	NOUN
ijassa-759	204	4	,	,	PUNCT
ijassa-759	204	5	the	the	DET
ijassa-759	204	6	life	life	NOUN
ijassa-759	204	7	expectancy	expectancy	NOUN
ijassa-759	204	8	of	of	ADP
ijassa-759	204	9	treated	treat	VERB
ijassa-759	204	10	animals	animal	NOUN
ijassa-759	204	11	will	will	AUX
ijassa-759	204	12	be	be	AUX
ijassa-759	204	13	equal	equal	ADJ
ijassa-759	204	14	to	to	ADP
ijassa-759	204	15	the	the	DET
ijassa-759	204	16	average	average	ADJ
ijassa-759	204	17	life	life	NOUN
ijassa-759	204	18	expectancy	expectancy	NOUN
ijassa-759	204	19	of	of	ADP
ijassa-759	204	20	experimental	experimental	ADJ
ijassa-759	204	21	animals	animal	NOUN
ijassa-759	204	22	without	without	ADP
ijassa-759	204	23	tumors	tumor	NOUN
ijassa-759	204	24	tl	tl	PROPN
ijassa-759	204	25	=	=	SYM
ijassa-759	204	26	3	3	NUM
ijassa-759	204	27	years	year	NOUN
ijassa-759	204	28	.	.	PUNCT
ijassa-759	205	1	5.1	5.1	NUM
ijassa-759	205	2	.	.	PUNCT
ijassa-759	205	3	strategy	strategy	NOUN
ijassa-759	205	4	of	of	ADP
ijassa-759	205	5	stabilization	stabilization	NOUN
ijassa-759	205	6	of	of	ADP
ijassa-759	205	7	tumor	tumor	NOUN
ijassa-759	205	8	growth	growth	NOUN
ijassa-759	205	9	with	with	ADP
ijassa-759	205	10	multiple	multiple	ADJ
ijassa-759	205	11	injection	injection	NOUN
ijassa-759	205	12	of	of	ADP
ijassa-759	205	13	the	the	DET
ijassa-759	205	14	viral	viral	ADJ
ijassa-759	205	15	vaccine	vaccine	NOUN
ijassa-759	205	16	modeling	modeling	NOUN
ijassa-759	205	17	of	of	ADP
ijassa-759	205	18	multiple	multiple	ADJ
ijassa-759	205	19	injections	injection	NOUN
ijassa-759	205	20	of	of	ADP
ijassa-759	205	21	a	a	DET
ijassa-759	205	22	viral	viral	ADJ
ijassa-759	205	23	vaccine	vaccine	NOUN
ijassa-759	205	24	within	within	ADP
ijassa-759	205	25	the	the	DET
ijassa-759	205	26	framework	framework	NOUN
ijassa-759	205	27	of	of	ADP
ijassa-759	205	28	the	the	DET
ijassa-759	205	29	constructed	construct	VERB
ijassa-759	205	30	model	model	NOUN
ijassa-759	205	31	allowed	allow	VERB
ijassa-759	205	32	us	we	PRON
ijassa-759	205	33	to	to	PART
ijassa-759	205	34	determine	determine	VERB
ijassa-759	205	35	the	the	DET
ijassa-759	205	36	algorithm	algorithm	NOUN
ijassa-759	205	37	for	for	ADP
ijassa-759	205	38	finding	find	VERB
ijassa-759	205	39	a	a	DET
ijassa-759	205	40	strategy	strategy	NOUN
ijassa-759	205	41	for	for	ADP
ijassa-759	205	42	stabilizing	stabilize	VERB
ijassa-759	205	43	tumor	tumor	NOUN
ijassa-759	205	44	growth	growth	NOUN
ijassa-759	205	45	with	with	ADP
ijassa-759	205	46	multiple	multiple	ADJ
ijassa-759	205	47	injections	injection	NOUN
ijassa-759	205	48	of	of	ADP
ijassa-759	205	49	a	a	DET
ijassa-759	205	50	constant	constant	ADJ
ijassa-759	205	51	dose	dose	NOUN
ijassa-759	205	52	of	of	ADP
ijassa-759	205	53	a	a	DET
ijassa-759	205	54	viral	viral	ADJ
ijassa-759	205	55	vaccine	vaccine	NOUN
ijassa-759	205	56	v0	v0	NOUN
ijassa-759	205	57	stab	stab	NOUN
ijassa-759	205	58	(	(	PUNCT
ijassa-759	205	59	τ1	τ1	NOUN
ijassa-759	205	60	)	)	PUNCT
ijassa-759	205	61	.	.	PUNCT
ijassa-759	206	1	results	result	NOUN
ijassa-759	206	2	indicate	indicate	VERB
ijassa-759	206	3	that	that	SCONJ
ijassa-759	206	4	the	the	DET
ijassa-759	206	5	strategy	strategy	NOUN
ijassa-759	206	6	of	of	ADP
ijassa-759	206	7	stabilization	stabilization	NOUN
ijassa-759	206	8	is	be	AUX
ijassa-759	206	9	possible	possible	ADJ
ijassa-759	206	10	for	for	ADP
ijassa-759	206	11	a	a	DET
ijassa-759	206	12	narrow	narrow	ADJ
ijassa-759	206	13	range	range	NOUN
ijassa-759	206	14	of	of	ADP
ijassa-759	206	15	dosage	dosage	NOUN
ijassa-759	206	16	.	.	PUNCT
ijassa-759	207	1	this	this	DET
ijassa-759	207	2	dosage	dosage	NOUN
ijassa-759	207	3	should	should	AUX
ijassa-759	207	4	be	be	AUX
ijassa-759	207	5	able	able	ADJ
ijassa-759	207	6	to	to	PART
ijassa-759	207	7	produce	produce	VERB
ijassa-759	207	8	an	an	DET
ijassa-759	207	9	equal	equal	ADJ
ijassa-759	207	10	number	number	NOUN
ijassa-759	207	11	of	of	ADP
ijassa-759	207	12	antibodies	antibody	NOUN
ijassa-759	207	13	at	at	ADP
ijassa-759	207	14	each	each	PRON
ijassa-759	207	15	of	of	ADP
ijassa-759	207	16	the	the	DET
ijassa-759	207	17	two	two	NUM
ijassa-759	207	18	stages	stage	NOUN
ijassa-759	207	19	of	of	ADP
ijassa-759	207	20	the	the	DET
ijassa-759	207	21	immune	immune	ADJ
ijassa-759	207	22	response	response	NOUN
ijassa-759	207	23	stab	stab	NOUN
ijassa-759	207	24	stab	stab	NOUN
ijassa-759	207	25	0	0	NUM
ijassa-759	207	26	1	1	NUM
ijassa-759	207	27	0	0	NUM
ijassa-759	207	28	1	1	NUM
ijassa-759	207	29	(	(	PUNCT
ijassa-759	207	30	,	,	PUNCT
ijassa-759	207	31	)	)	PUNCT
ijassa-759	207	32	(	(	PUNCT
ijassa-759	207	33	,	,	PUNCT
ijassa-759	207	34	)	)	PUNCT
ijassa-759	207	35	v	v	NOUN
ijassa-759	207	36	na	na	NOUN
ijassa-759	207	37	v	v	NOUN
ijassa-759	207	38	a	a	DET
ijassa-759	207	39	v	v	NOUN
ijassa-759	207	40	=	=	PUNCT
ijassa-759	207	41			PROPN
ijassa-759	207	42	(	(	PUNCT
ijassa-759	207	43	fig	fig	NOUN
ijassa-759	207	44	.	.	PUNCT
ijassa-759	208	1	6	6	NUM
ijassa-759	208	2	,	,	PUNCT
ijassa-759	208	3	a	a	DET
ijassa-759	208	4	,	,	PUNCT
ijassa-759	208	5	b	b	NOUN
ijassa-759	208	6	)	)	PUNCT
ijassa-759	208	7	and	and	CCONJ
ijassa-759	208	8	(	(	PUNCT
ijassa-759	208	9	fig	fig	NOUN
ijassa-759	208	10	.	.	PUNCT
ijassa-759	209	1	7	7	NUM
ijassa-759	209	2	,	,	PUNCT
ijassa-759	209	3	a	a	DET
ijassa-759	209	4	,	,	PUNCT
ijassa-759	209	5	b	b	NOUN
ijassa-759	209	6	)	)	PUNCT
ijassa-759	209	7	.	.	PUNCT
ijassa-759	210	1	а	а	PROPN
ijassa-759	210	2	b	b	NOUN
ijassa-759	210	3	fig	fig	NOUN
ijassa-759	210	4	.	.	PUNCT
ijassa-759	211	1	6	6	NUM
ijassa-759	211	2	.	.	X
ijassa-759	211	3	strategy	strategy	NOUN
ijassa-759	211	4	to	to	PART
ijassa-759	211	5	stabilize	stabilize	VERB
ijassa-759	211	6	the	the	DET
ijassa-759	211	7	tumor	tumor	NOUN
ijassa-759	211	8	size	size	NOUN
ijassa-759	211	9	with	with	ADP
ijassa-759	211	10	the	the	DET
ijassa-759	211	11	injection	injection	NOUN
ijassa-759	211	12	of	of	ADP
ijassa-759	211	13	a	a	DET
ijassa-759	211	14	viral	viral	ADJ
ijassa-759	211	15	vaccine	vaccine	NOUN
ijassa-759	211	16	on	on	ADP
ijassa-759	211	17	τ1	τ1	NOUN
ijassa-759	211	18	=	=	SYM
ijassa-759	211	19	3	3	NUM
ijassa-759	211	20	days	day	NOUN
ijassa-759	211	21	with	with	ADP
ijassa-759	211	22	an	an	DET
ijassa-759	211	23	interval	interval	NOUN
ijassa-759	211	24	between	between	ADP
ijassa-759	211	25	injections	injection	NOUN
ijassa-759	211	26	∆t	∆t	PROPN
ijassa-759	211	27	=	=	SYM
ijassa-759	211	28	18.4	18.4	NUM
ijassa-759	211	29	days	day	NOUN
ijassa-759	211	30	:	:	PUNCT
ijassa-759	211	31	а	а	PROPN
ijassa-759	211	32	shows	show	VERB
ijassa-759	211	33	the	the	DET
ijassa-759	211	34	trajectories	trajectory	NOUN
ijassa-759	211	35	of	of	ADP
ijassa-759	211	36	growth	growth	NOUN
ijassa-759	211	37	and	and	CCONJ
ijassa-759	211	38	death	death	NOUN
ijassa-759	211	39	of	of	ADP
ijassa-759	211	40	tumor	tumor	NOUN
ijassa-759	211	41	cells	cell	NOUN
ijassa-759	211	42	;	;	PUNCT
ijassa-759	211	43	b	b	X
ijassa-759	211	44	shows	show	VERB
ijassa-759	211	45	the	the	DET
ijassa-759	211	46	dynamics	dynamic	NOUN
ijassa-759	211	47	of	of	ADP
ijassa-759	211	48	antibody	antibody	NOUN
ijassa-759	211	49	formation	formation	NOUN
ijassa-759	211	50	0	0	NUM
ijassa-759	211	51	1	1	NUM
ijassa-759	211	52	(	(	PUNCT
ijassa-759	211	53	,	,	PUNCT
ijassa-759	211	54	)	)	PUNCT
ijassa-759	211	55	va	va	NOUN
ijassa-759	211	56	v	v	X
ijassa-759	211	57			NOUN
ijassa-759	211	58	at	at	ADP
ijassa-759	211	59	the	the	DET
ijassa-759	211	60	1st	1st	NOUN
ijassa-759	211	61	and	and	CCONJ
ijassa-759	211	62	0	0	NUM
ijassa-759	211	63	1	1	NUM
ijassa-759	211	64	(	(	PUNCT
ijassa-759	211	65	,	,	PUNCT
ijassa-759	211	66	)	)	PUNCT
ijassa-759	211	67	na	na	PART
ijassa-759	211	68	v	v	ADP
ijassa-759	211	69			NOUN
ijassa-759	211	70	at	at	ADP
ijassa-759	211	71	the	the	DET
ijassa-759	211	72	2nd	2nd	ADJ
ijassa-759	211	73	stage	stage	NOUN
ijassa-759	211	74	of	of	ADP
ijassa-759	211	75	immune	immune	ADJ
ijassa-759	211	76	response	response	NOUN
ijassa-759	211	77	n.a	n.a	PROPN
ijassa-759	211	78	.	.	PROPN
ijassa-759	211	79	babushkina	babushkina	PROPN
ijassa-759	211	80	,	,	PUNCT
ijassa-759	211	81	e.a	e.a	PROPN
ijassa-759	211	82	.	.	PROPN
ijassa-759	211	83	kuzina	kuzina	PROPN
ijassa-759	211	84	copyright	copyright	PROPN
ijassa-759	212	1	©	©	PROPN
ijassa-759	212	2	2020	2020	NUM
ijassa-759	212	3	assa	assa	NOUN
ijassa-759	212	4	.	.	PUNCT
ijassa-759	213	1	adv	adv	PROPN
ijassa-759	213	2	.	.	PUNCT
ijassa-759	214	1	in	in	ADP
ijassa-759	214	2	systems	system	NOUN
ijassa-759	214	3	science	science	NOUN
ijassa-759	214	4	and	and	CCONJ
ijassa-759	214	5	appl	appl	NOUN
ijassa-759	214	6	.	.	PUNCT
ijassa-759	215	1	(	(	PUNCT
ijassa-759	215	2	2020	2020	NUM
ijassa-759	215	3	)	)	PUNCT
ijassa-759	215	4	12	12	NUM
ijassa-759	215	5	а	а	PROPN
ijassa-759	215	6	b	b	PROPN
ijassa-759	215	7	fig	fig	NOUN
ijassa-759	215	8	.	.	PUNCT
ijassa-759	216	1	7	7	X
ijassa-759	216	2	.	.	X
ijassa-759	216	3	strategy	strategy	NOUN
ijassa-759	216	4	to	to	PART
ijassa-759	216	5	stabilize	stabilize	VERB
ijassa-759	216	6	the	the	DET
ijassa-759	216	7	tumor	tumor	NOUN
ijassa-759	216	8	size	size	NOUN
ijassa-759	216	9	with	with	ADP
ijassa-759	216	10	the	the	DET
ijassa-759	216	11	injection	injection	NOUN
ijassa-759	216	12	of	of	ADP
ijassa-759	216	13	a	a	DET
ijassa-759	216	14	viral	viral	ADJ
ijassa-759	216	15	vaccine	vaccine	NOUN
ijassa-759	216	16	on	on	ADP
ijassa-759	216	17	τ1	τ1	NOUN
ijassa-759	216	18	=	=	SYM
ijassa-759	216	19	20	20	NUM
ijassa-759	216	20	days	day	NOUN
ijassa-759	216	21	with	with	ADP
ijassa-759	216	22	an	an	DET
ijassa-759	216	23	interval	interval	NOUN
ijassa-759	216	24	between	between	ADP
ijassa-759	216	25	injections	injection	NOUN
ijassa-759	216	26	∆t	∆t	PROPN
ijassa-759	216	27	=	=	SYM
ijassa-759	216	28	25.7	25.7	NUM
ijassa-759	216	29	days	day	NOUN
ijassa-759	216	30	:	:	PUNCT
ijassa-759	216	31	а	а	PROPN
ijassa-759	216	32	shows	show	VERB
ijassa-759	216	33	the	the	DET
ijassa-759	216	34	trajectories	trajectory	NOUN
ijassa-759	216	35	of	of	ADP
ijassa-759	216	36	growth	growth	NOUN
ijassa-759	216	37	and	and	CCONJ
ijassa-759	216	38	death	death	NOUN
ijassa-759	216	39	of	of	ADP
ijassa-759	216	40	tumor	tumor	NOUN
ijassa-759	216	41	cells	cell	NOUN
ijassa-759	216	42	;	;	PUNCT
ijassa-759	216	43	b	b	X
ijassa-759	216	44	shows	show	VERB
ijassa-759	216	45	the	the	DET
ijassa-759	216	46	dynamics	dynamic	NOUN
ijassa-759	216	47	of	of	ADP
ijassa-759	216	48	antibody	antibody	NOUN
ijassa-759	216	49	formation	formation	NOUN
ijassa-759	216	50	0	0	NUM
ijassa-759	216	51	1	1	NUM
ijassa-759	216	52	(	(	PUNCT
ijassa-759	216	53	,	,	PUNCT
ijassa-759	216	54	)	)	PUNCT
ijassa-759	216	55	va	va	NOUN
ijassa-759	216	56	v	v	X
ijassa-759	216	57			NOUN
ijassa-759	216	58	at	at	ADP
ijassa-759	216	59	the	the	DET
ijassa-759	216	60	1st	1st	NOUN
ijassa-759	216	61	and	and	CCONJ
ijassa-759	216	62	0	0	NUM
ijassa-759	216	63	1	1	NUM
ijassa-759	216	64	(	(	PUNCT
ijassa-759	216	65	,	,	PUNCT
ijassa-759	216	66	)	)	PUNCT
ijassa-759	216	67	na	na	PART
ijassa-759	216	68	v	v	ADP
ijassa-759	216	69			NOUN
ijassa-759	216	70	at	at	ADP
ijassa-759	216	71	the	the	DET
ijassa-759	216	72	2nd	2nd	ADJ
ijassa-759	216	73	stage	stage	NOUN
ijassa-759	216	74	of	of	ADP
ijassa-759	216	75	immune	immune	ADJ
ijassa-759	216	76	response	response	NOUN
ijassa-759	216	77	the	the	DET
ijassa-759	216	78	strategy	strategy	NOUN
ijassa-759	216	79	of	of	ADP
ijassa-759	216	80	tumor	tumor	NOUN
ijassa-759	216	81	growth	growth	NOUN
ijassa-759	216	82	stabilization	stabilization	NOUN
ijassa-759	216	83	is	be	AUX
ijassa-759	216	84	performed	perform	VERB
ijassa-759	216	85	in	in	ADP
ijassa-759	216	86	the	the	DET
ijassa-759	216	87	range	range	NOUN
ijassa-759	216	88	of	of	ADP
ijassa-759	216	89	doses	dose	NOUN
ijassa-759	216	90	from	from	ADP
ijassa-759	216	91	stab	stab	ADJ
ijassa-759	216	92	0v	0v	NOUN
ijassa-759	216	93	=	=	NOUN
ijassa-759	216	94	0.04	0.04	NUM
ijassa-759	216	95	to	to	PART
ijassa-759	216	96	stab	stab	VERB
ijassa-759	216	97	0v	0v	NOUN
ijassa-759	216	98	=	=	SYM
ijassa-759	216	99	0.06	0.06	NUM
ijassa-759	216	100	(	(	PUNCT
ijassa-759	216	101	fig	fig	NOUN
ijassa-759	216	102	.	.	PUNCT
ijassa-759	217	1	8,b	8,b	NUM
ijassa-759	217	2	)	)	PUNCT
ijassa-759	217	3	at	at	ADP
ijassa-759	217	4	a	a	DET
ijassa-759	217	5	constant	constant	ADJ
ijassa-759	217	6	value	value	NOUN
ijassa-759	217	7	of	of	ADP
ijassa-759	217	8	the	the	DET
ijassa-759	217	9	duration	duration	NOUN
ijassa-759	217	10	of	of	ADP
ijassa-759	217	11	the	the	DET
ijassa-759	217	12	interval	interval	NOUN
ijassa-759	217	13	between	between	ADP
ijassa-759	217	14	administration	administration	NOUN
ijassa-759	217	15	of	of	ADP
ijassa-759	217	16	the	the	DET
ijassa-759	217	17	vaccine	vaccine	NOUN
ijassa-759	217	18	.	.	PUNCT
ijassa-759	218	1	duration	duration	NOUN
ijassa-759	218	2	of	of	ADP
ijassa-759	218	3	intervals	interval	NOUN
ijassa-759	218	4	between	between	ADP
ijassa-759	218	5	repeated	repeat	VERB
ijassa-759	218	6	introductions	introduction	NOUN
ijassa-759	218	7	of	of	ADP
ijassa-759	218	8	the	the	DET
ijassa-759	218	9	vaccine	vaccine	NOUN
ijassa-759	218	10	∆t	∆t	VERB
ijassa-759	218	11	increases	increase	NOUN
ijassa-759	218	12	with	with	ADP
ijassa-759	218	13	the	the	DET
ijassa-759	218	14	size	size	NOUN
ijassa-759	218	15	of	of	ADP
ijassa-759	218	16	the	the	DET
ijassa-759	218	17	tumor	tumor	NOUN
ijassa-759	218	18	(	(	PUNCT
ijassa-759	218	19	fig	fig	NOUN
ijassa-759	218	20	.	.	PUNCT
ijassa-759	219	1	8,a	8,a	NUM
ijassa-759	219	2	)	)	PUNCT
ijassa-759	219	3	.	.	PUNCT
ijassa-759	220	1	а	а	PROPN
ijassa-759	220	2	b	b	NOUN
ijassa-759	220	3	fig	fig	NOUN
ijassa-759	220	4	.	.	PUNCT
ijassa-759	221	1	8	8	NUM
ijassa-759	221	2	.	.	PUNCT
ijassa-759	222	1	the	the	DET
ijassa-759	222	2	dependence	dependence	NOUN
ijassa-759	222	3	of	of	ADP
ijassa-759	222	4	the	the	DET
ijassa-759	222	5	values	value	NOUN
ijassa-759	222	6	of	of	ADP
ijassa-759	222	7	the	the	DET
ijassa-759	222	8	parameters	parameter	NOUN
ijassa-759	222	9	under	under	ADP
ijassa-759	222	10	the	the	DET
ijassa-759	222	11	strategy	strategy	NOUN
ijassa-759	222	12	of	of	ADP
ijassa-759	222	13	stabilization	stabilization	NOUN
ijassa-759	222	14	of	of	ADP
ijassa-759	222	15	tumor	tumor	NOUN
ijassa-759	222	16	growth	growth	NOUN
ijassa-759	222	17	on	on	ADP
ijassa-759	222	18	the	the	DET
ijassa-759	222	19	size	size	NOUN
ijassa-759	222	20	of	of	ADP
ijassa-759	222	21	the	the	DET
ijassa-759	222	22	tumor	tumor	NOUN
ijassa-759	222	23	at	at	ADP
ijassa-759	222	24	the	the	DET
ijassa-759	222	25	beginning	beginning	NOUN
ijassa-759	222	26	of	of	ADP
ijassa-759	222	27	treatment	treatment	NOUN
ijassa-759	222	28	:	:	PUNCT
ijassa-759	222	29	а	а	PROPN
ijassa-759	222	30	shows	show	VERB
ijassa-759	222	31	the	the	DET
ijassa-759	222	32	intervals	interval	NOUN
ijassa-759	222	33	between	between	ADP
ijassa-759	222	34	vaccine	vaccine	NOUN
ijassa-759	222	35	introductions	introduction	NOUN
ijassa-759	222	36	stab	stab	VERB
ijassa-759	222	37	0	0	NUM
ijassa-759	222	38	1	1	NUM
ijassa-759	222	39	(	(	PUNCT
ijassa-759	222	40	,	,	PUNCT
ijassa-759	222	41	)	)	PUNCT
ijassa-759	222	42	t	t	PROPN
ijassa-759	222	43	v	v	PROPN
ijassa-759	222	44			PROPN
ijassa-759	222	45	,	,	PUNCT
ijassa-759	222	46	b	b	PROPN
ijassa-759	222	47	shows	show	VERB
ijassa-759	222	48	the	the	DET
ijassa-759	222	49	value	value	NOUN
ijassa-759	222	50	of	of	ADP
ijassa-759	222	51	the	the	DET
ijassa-759	222	52	introduced	introduce	VERB
ijassa-759	222	53	dose	dose	NOUN
ijassa-759	222	54	stab	stab	NOUN
ijassa-759	222	55	0	0	NUM
ijassa-759	222	56	1	1	NUM
ijassa-759	222	57	(	(	PUNCT
ijassa-759	222	58	)	)	PUNCT
ijassa-759	222	59	v	v	NOUN
ijassa-759	222	60			NOUN
ijassa-759	222	61	this	this	DET
ijassa-759	222	62	strategy	strategy	NOUN
ijassa-759	222	63	requires	require	VERB
ijassa-759	222	64	sufficiently	sufficiently	ADV
ijassa-759	222	65	large	large	ADJ
ijassa-759	222	66	dosage	dosage	NOUN
ijassa-759	222	67	which	which	PRON
ijassa-759	222	68	will	will	AUX
ijassa-759	222	69	be	be	AUX
ijassa-759	222	70	able	able	ADJ
ijassa-759	222	71	to	to	PART
ijassa-759	222	72	produce	produce	VERB
ijassa-759	222	73	equally	equally	ADV
ijassa-759	222	74	big	big	ADJ
ijassa-759	222	75	number	number	NOUN
ijassa-759	222	76	of	of	ADP
ijassa-759	222	77	antibodies	antibody	NOUN
ijassa-759	222	78	at	at	ADP
ijassa-759	222	79	the	the	DET
ijassa-759	222	80	1st	1st	NOUN
ijassa-759	222	81	and	and	CCONJ
ijassa-759	222	82	the	the	DET
ijassa-759	222	83	2nd	2nd	ADJ
ijassa-759	222	84	stages	stage	NOUN
ijassa-759	222	85	of	of	ADP
ijassa-759	222	86	immune	immune	ADJ
ijassa-759	222	87	response	response	NOUN
ijassa-759	222	88	.	.	PUNCT
ijassa-759	223	1	thus	thus	ADV
ijassa-759	223	2	,	,	PUNCT
ijassa-759	223	3	this	this	DET
ijassa-759	223	4	strategy	strategy	NOUN
ijassa-759	223	5	allows	allow	VERB
ijassa-759	223	6	to	to	PART
ijassa-759	223	7	transfer	transfer	VERB
ijassa-759	223	8	the	the	DET
ijassa-759	223	9	course	course	NOUN
ijassa-759	223	10	of	of	ADP
ijassa-759	223	11	the	the	DET
ijassa-759	223	12	disease	disease	NOUN
ijassa-759	223	13	into	into	ADP
ijassa-759	223	14	a	a	DET
ijassa-759	223	15	chronic	chronic	ADJ
ijassa-759	223	16	state	state	NOUN
ijassa-759	223	17	by	by	ADP
ijassa-759	223	18	restraining	restrain	VERB
ijassa-759	223	19	the	the	DET
ijassa-759	223	20	growth	growth	NOUN
ijassa-759	223	21	of	of	ADP
ijassa-759	223	22	the	the	DET
ijassa-759	223	23	tumor	tumor	NOUN
ijassa-759	223	24	.	.	PUNCT
ijassa-759	224	1	within	within	ADP
ijassa-759	224	2	the	the	DET
ijassa-759	224	3	framework	framework	NOUN
ijassa-759	224	4	of	of	ADP
ijassa-759	224	5	the	the	DET
ijassa-759	224	6	constructed	construct	VERB
ijassa-759	224	7	model	model	NOUN
ijassa-759	224	8	,	,	PUNCT
ijassa-759	224	9	it	it	PRON
ijassa-759	224	10	is	be	AUX
ijassa-759	224	11	shown	show	VERB
ijassa-759	224	12	that	that	SCONJ
ijassa-759	224	13	it	it	PRON
ijassa-759	224	14	is	be	AUX
ijassa-759	224	15	possible	possible	ADJ
ijassa-759	224	16	to	to	PART
ijassa-759	224	17	restrain	restrain	VERB
ijassa-759	224	18	the	the	DET
ijassa-759	224	19	growth	growth	NOUN
ijassa-759	224	20	of	of	ADP
ijassa-759	224	21	a	a	DET
ijassa-759	224	22	tumor	tumor	NOUN
ijassa-759	224	23	of	of	ADP
ijassa-759	224	24	any	any	DET
ijassa-759	224	25	size	size	NOUN
ijassa-759	224	26	for	for	ADP
ijassa-759	224	27	an	an	DET
ijassa-759	224	28	unlimited	unlimited	ADJ
ijassa-759	224	29	time	time	NOUN
ijassa-759	224	30	.	.	PUNCT
ijassa-759	225	1	however	however	ADV
ijassa-759	225	2	,	,	PUNCT
ijassa-759	225	3	if	if	SCONJ
ijassa-759	225	4	vaccine	vaccine	NOUN
ijassa-759	225	5	is	be	AUX
ijassa-759	225	6	not	not	PART
ijassa-759	225	7	introduced	introduce	VERB
ijassa-759	225	8	any	any	ADV
ijassa-759	225	9	longer	long	ADV
ijassa-759	225	10	,	,	PUNCT
ijassa-759	225	11	the	the	DET
ijassa-759	225	12	tumor	tumor	NOUN
ijassa-759	225	13	growth	growth	NOUN
ijassa-759	225	14	could	could	AUX
ijassa-759	225	15	resume	resume	VERB
ijassa-759	225	16	.	.	PUNCT
ijassa-759	226	1	the	the	DET
ijassa-759	226	2	strategy	strategy	NOUN
ijassa-759	226	3	of	of	ADP
ijassa-759	226	4	tumor	tumor	NOUN
ijassa-759	226	5	growth	growth	NOUN
ijassa-759	226	6	stabilization	stabilization	NOUN
ijassa-759	226	7	is	be	AUX
ijassa-759	226	8	similar	similar	ADJ
ijassa-759	226	9	to	to	ADP
ijassa-759	226	10	the	the	DET
ijassa-759	226	11	effect	effect	NOUN
ijassa-759	226	12	of	of	ADP
ijassa-759	226	13	inoculation	inoculation	NOUN
ijassa-759	226	14	from	from	ADP
ijassa-759	226	15	own	own	ADJ
ijassa-759	226	16	tumor	tumor	NOUN
ijassa-759	226	17	cells	cell	NOUN
ijassa-759	226	18	in	in	ADP
ijassa-759	226	19	the	the	DET
ijassa-759	226	20	period	period	NOUN
ijassa-759	226	21	between	between	ADP
ijassa-759	226	22	two	two	NUM
ijassa-759	226	23	successive	successive	ADJ
ijassa-759	226	24	injections	injection	NOUN
ijassa-759	226	25	of	of	ADP
ijassa-759	226	26	the	the	DET
ijassa-759	226	27	vaccine	vaccine	NOUN
ijassa-759	226	28	.	.	PUNCT
ijassa-759	227	1	mathematical	mathematical	ADJ
ijassa-759	227	2	modeling	modeling	NOUN
ijassa-759	227	3	of	of	ADP
ijassa-759	227	4	antitumor	antitumor	PROPN
ijassa-759	227	5	viral	viral	ADJ
ijassa-759	227	6	vaccine	vaccine	NOUN
ijassa-759	227	7	therapy	therapy	NOUN
ijassa-759	227	8	…	…	PUNCT
ijassa-759	227	9	copyright	copyright	NOUN
ijassa-759	227	10	©	©	PROPN
ijassa-759	227	11	2020	2020	NUM
ijassa-759	227	12	assa	assa	NOUN
ijassa-759	227	13	.	.	PUNCT
ijassa-759	228	1	adv	adv	PROPN
ijassa-759	228	2	.	.	PUNCT
ijassa-759	229	1	in	in	ADP
ijassa-759	229	2	systems	system	NOUN
ijassa-759	229	3	science	science	NOUN
ijassa-759	229	4	and	and	CCONJ
ijassa-759	229	5	appl	appl	NOUN
ijassa-759	229	6	.	.	PUNCT
ijassa-759	230	1	(	(	PUNCT
ijassa-759	230	2	2020	2020	NUM
ijassa-759	230	3	)	)	PUNCT
ijassa-759	230	4	13	13	NUM
ijassa-759	230	5	5.2	5.2	NUM
ijassa-759	230	6	.	.	PUNCT
ijassa-759	231	1	strategy	strategy	NOUN
ijassa-759	231	2	of	of	ADP
ijassa-759	231	3	tumor	tumor	NOUN
ijassa-759	231	4	growth	growth	NOUN
ijassa-759	231	5	suppression	suppression	NOUN
ijassa-759	231	6	with	with	ADP
ijassa-759	231	7	multiple	multiple	ADJ
ijassa-759	231	8	injection	injection	NOUN
ijassa-759	231	9	of	of	ADP
ijassa-759	231	10	the	the	DET
ijassa-759	231	11	viral	viral	ADJ
ijassa-759	231	12	vaccine	vaccine	NOUN
ijassa-759	231	13	to	to	PART
ijassa-759	231	14	solve	solve	VERB
ijassa-759	231	15	the	the	DET
ijassa-759	231	16	problem	problem	NOUN
ijassa-759	231	17	of	of	ADP
ijassa-759	231	18	reducing	reduce	VERB
ijassa-759	231	19	the	the	DET
ijassa-759	231	20	number	number	NOUN
ijassa-759	231	21	of	of	ADP
ijassa-759	231	22	tumor	tumor	NOUN
ijassa-759	231	23	cells	cell	NOUN
ijassa-759	231	24	below	below	ADP
ijassa-759	231	25	the	the	DET
ijassa-759	231	26	lethality	lethality	NOUN
ijassa-759	231	27	threshold	threshold	NOUN
ijassa-759	231	28	with	with	ADP
ijassa-759	231	29	repeated	repeat	VERB
ijassa-759	231	30	injection	injection	NOUN
ijassa-759	231	31	of	of	ADP
ijassa-759	231	32	the	the	DET
ijassa-759	231	33	vaccine	vaccine	NOUN
ijassa-759	231	34	for	for	ADP
ijassa-759	231	35	all	all	DET
ijassa-759	231	36	tumor	tumor	NOUN
ijassa-759	231	37	sizes	size	NOUN
ijassa-759	231	38	,	,	PUNCT
ijassa-759	231	39	agorhythm	agorhythm	PROPN
ijassa-759	231	40	was	be	AUX
ijassa-759	231	41	developed	develop	VERB
ijassa-759	231	42	,	,	PUNCT
ijassa-759	231	43	based	base	VERB
ijassa-759	231	44	on	on	ADP
ijassa-759	231	45	the	the	DET
ijassa-759	231	46	strategy	strategy	NOUN
ijassa-759	231	47	of	of	ADP
ijassa-759	231	48	stabilizing	stabilize	VERB
ijassa-759	231	49	tumor	tumor	NOUN
ijassa-759	231	50	growth	growth	NOUN
ijassa-759	231	51	,	,	PUNCT
ijassa-759	231	52	in	in	ADP
ijassa-759	231	53	which	which	PRON
ijassa-759	231	54	the	the	DET
ijassa-759	231	55	duration	duration	NOUN
ijassa-759	231	56	of	of	ADP
ijassa-759	231	57	intervals	interval	NOUN
ijassa-759	231	58	between	between	ADP
ijassa-759	231	59	repeated	repeat	VERB
ijassa-759	231	60	injections	injection	NOUN
ijassa-759	231	61	of	of	ADP
ijassa-759	231	62	the	the	DET
ijassa-759	231	63	viral	viral	ADJ
ijassa-759	231	64	vaccine	vaccine	NOUN
ijassa-759	231	65	was	be	AUX
ijassa-759	231	66	reduced	reduce	VERB
ijassa-759	231	67	step	step	NOUN
ijassa-759	231	68	by	by	ADP
ijassa-759	231	69	step	step	NOUN
ijassa-759	231	70	.	.	PUNCT
ijassa-759	232	1	figures	figure	NOUN
ijassa-759	233	1	9,а	9,а	NOUN
ijassa-759	233	2	and	and	CCONJ
ijassa-759	233	3	10,а	10,а	PRON
ijassa-759	233	4	show	show	VERB
ijassa-759	233	5	the	the	DET
ijassa-759	233	6	trajectories	trajectory	NOUN
ijassa-759	233	7	of	of	ADP
ijassa-759	233	8	tumor	tumor	NOUN
ijassa-759	233	9	growth	growth	NOUN
ijassa-759	233	10	when	when	SCONJ
ijassa-759	233	11	the	the	DET
ijassa-759	233	12	vaccine	vaccine	NOUN
ijassa-759	233	13	is	be	AUX
ijassa-759	233	14	injected	inject	VERB
ijassa-759	233	15	3	3	NUM
ijassa-759	233	16	and	and	CCONJ
ijassa-759	233	17	4	4	NUM
ijassa-759	233	18	times	time	NOUN
ijassa-759	233	19	,	,	PUNCT
ijassa-759	233	20	and	and	CCONJ
ijassa-759	233	21	the	the	DET
ijassa-759	233	22	time	time	NOUN
ijassa-759	233	23	intervals	interval	NOUN
ijassa-759	233	24	between	between	ADP
ijassa-759	233	25	consecutive	consecutive	ADJ
ijassa-759	233	26	injections	injection	NOUN
ijassa-759	233	27	are	be	AUX
ijassa-759	233	28	reduced	reduce	VERB
ijassa-759	233	29	.	.	PUNCT
ijassa-759	234	1	this	this	PRON
ijassa-759	234	2	allows	allow	VERB
ijassa-759	234	3	to	to	PART
ijassa-759	234	4	drive	drive	VERB
ijassa-759	234	5	the	the	DET
ijassa-759	234	6	number	number	NOUN
ijassa-759	234	7	of	of	ADP
ijassa-759	234	8	tumor	tumor	NOUN
ijassa-759	234	9	cells	cell	NOUN
ijassa-759	234	10	below	below	ADP
ijassa-759	234	11	the	the	DET
ijassa-759	234	12	lethality	lethality	NOUN
ijassa-759	234	13	threshold	threshold	NOUN
ijassa-759	234	14	.	.	PUNCT
ijassa-759	235	1	a	a	DET
ijassa-759	235	2	b	b	NOUN
ijassa-759	235	3	fig	fig	NOUN
ijassa-759	235	4	.	.	PUNCT
ijassa-759	236	1	9	9	X
ijassa-759	236	2	.	.	X
ijassa-759	236	3	the	the	DET
ijassa-759	236	4	strategy	strategy	NOUN
ijassa-759	236	5	for	for	ADP
ijassa-759	236	6	multiple	multiple	ADJ
ijassa-759	236	7	injection	injection	NOUN
ijassa-759	236	8	of	of	ADP
ijassa-759	236	9	the	the	DET
ijassa-759	236	10	vaccine	vaccine	NOUN
ijassa-759	236	11	by	by	ADP
ijassa-759	236	12	reducing	reduce	VERB
ijassa-759	236	13	the	the	DET
ijassa-759	236	14	interval	interval	NOUN
ijassa-759	236	15	between	between	ADP
ijassa-759	236	16	the	the	DET
ijassa-759	236	17	doses	dose	NOUN
ijassa-759	236	18	0v	0v	NOUN
ijassa-759	236	19	=	=	PUNCT
ijassa-759	236	20	0,056	0,056	NUM
ijassa-759	236	21	at	at	ADP
ijassa-759	236	22	the	the	DET
ijassa-759	236	23	beginning	beginning	NOUN
ijassa-759	236	24	of	of	ADP
ijassa-759	236	25	the	the	DET
ijassa-759	236	26	treatment	treatment	NOUN
ijassa-759	236	27	on	on	ADP
ijassa-759	236	28	τ1	τ1	NOUN
ijassa-759	236	29	=	=	SYM
ijassa-759	236	30	10	10	NUM
ijassa-759	236	31	day	day	NOUN
ijassa-759	236	32	with	with	ADP
ijassa-759	236	33	the	the	DET
ijassa-759	236	34	initial	initial	ADJ
ijassa-759	236	35	interval	interval	NOUN
ijassa-759	236	36	between	between	ADP
ijassa-759	236	37	injections	injection	NOUN
ijassa-759	236	38	∆tstab	∆tstab	ADP
ijassa-759	236	39	=	=	SYM
ijassa-759	236	40	20.1	20.1	NUM
ijassa-759	236	41	days	day	NOUN
ijassa-759	236	42	:	:	PUNCT
ijassa-759	236	43	а	а	PROPN
ijassa-759	236	44	shows	show	VERB
ijassa-759	236	45	the	the	DET
ijassa-759	236	46	trajectories	trajectory	NOUN
ijassa-759	236	47	of	of	ADP
ijassa-759	236	48	growth	growth	NOUN
ijassa-759	236	49	and	and	CCONJ
ijassa-759	236	50	death	death	NOUN
ijassa-759	236	51	of	of	ADP
ijassa-759	236	52	tumor	tumor	NOUN
ijassa-759	236	53	cells	cell	NOUN
ijassa-759	236	54	;	;	PUNCT
ijassa-759	236	55	b	b	X
ijassa-759	236	56	shows	show	VERB
ijassa-759	236	57	the	the	DET
ijassa-759	236	58	dynamics	dynamic	NOUN
ijassa-759	236	59	of	of	ADP
ijassa-759	236	60	formation	formation	NOUN
ijassa-759	236	61	of	of	ADP
ijassa-759	236	62	antibodies	antibody	NOUN
ijassa-759	236	63	0	0	NUM
ijassa-759	236	64	1	1	NUM
ijassa-759	236	65	(	(	PUNCT
ijassa-759	236	66	,	,	PUNCT
ijassa-759	236	67	)	)	PUNCT
ijassa-759	236	68	va	va	NOUN
ijassa-759	236	69	v	v	X
ijassa-759	236	70			NOUN
ijassa-759	236	71	at	at	ADP
ijassa-759	236	72	the	the	DET
ijassa-759	236	73	1st	1st	NOUN
ijassa-759	236	74	and	and	CCONJ
ijassa-759	236	75	0	0	NUM
ijassa-759	236	76	1	1	NUM
ijassa-759	236	77	(	(	PUNCT
ijassa-759	236	78	,	,	PUNCT
ijassa-759	236	79	)	)	PUNCT
ijassa-759	236	80	na	na	PART
ijassa-759	236	81	v	v	ADP
ijassa-759	236	82			NOUN
ijassa-759	236	83	at	at	ADP
ijassa-759	236	84	the	the	DET
ijassa-759	236	85	2nd	2nd	ADJ
ijassa-759	236	86	stage	stage	NOUN
ijassa-759	236	87	of	of	ADP
ijassa-759	236	88	the	the	DET
ijassa-759	236	89	immune	immune	ADJ
ijassa-759	236	90	response	response	NOUN
ijassa-759	236	91	(	(	PUNCT
ijassa-759	236	92	solid	solid	ADJ
ijassa-759	236	93	curve	curve	NOUN
ijassa-759	236	94	denotes	denote	NOUN
ijassa-759	236	95	av(t	av(t	NOUN
ijassa-759	236	96	)	)	PUNCT
ijassa-759	236	97	,	,	PUNCT
ijassa-759	236	98	dashed	dash	VERB
ijassa-759	236	99	curve	curve	NOUN
ijassa-759	236	100	denotes	denote	NOUN
ijassa-759	236	101	an(t	an(t	NOUN
ijassa-759	236	102	)	)	PUNCT
ijassa-759	236	103	)	)	PUNCT
ijassa-759	237	1	а	а	PROPN
ijassa-759	237	2	b	b	NOUN
ijassa-759	237	3	fig	fig	NOUN
ijassa-759	237	4	.	.	PUNCT
ijassa-759	238	1	10	10	NUM
ijassa-759	238	2	.	.	PUNCT
ijassa-759	239	1	the	the	DET
ijassa-759	239	2	strategy	strategy	NOUN
ijassa-759	239	3	for	for	ADP
ijassa-759	239	4	multiple	multiple	ADJ
ijassa-759	239	5	injection	injection	NOUN
ijassa-759	239	6	of	of	ADP
ijassa-759	239	7	the	the	DET
ijassa-759	239	8	vaccine	vaccine	NOUN
ijassa-759	239	9	by	by	ADP
ijassa-759	239	10	reducing	reduce	VERB
ijassa-759	239	11	the	the	DET
ijassa-759	239	12	interval	interval	NOUN
ijassa-759	239	13	between	between	ADP
ijassa-759	239	14	the	the	DET
ijassa-759	239	15	doses	dose	NOUN
ijassa-759	239	16	0v	0v	NOUN
ijassa-759	239	17	=	=	SYM
ijassa-759	239	18	0,06	0,06	PROPN
ijassa-759	239	19	at	at	ADP
ijassa-759	239	20	the	the	DET
ijassa-759	239	21	beginning	beginning	NOUN
ijassa-759	239	22	of	of	ADP
ijassa-759	239	23	the	the	DET
ijassa-759	239	24	treatment	treatment	NOUN
ijassa-759	239	25	on	on	ADP
ijassa-759	239	26	τ1	τ1	NOUN
ijassa-759	239	27	=	=	SYM
ijassa-759	239	28	20	20	NUM
ijassa-759	239	29	day	day	NOUN
ijassa-759	239	30	with	with	ADP
ijassa-759	239	31	the	the	DET
ijassa-759	239	32	initial	initial	ADJ
ijassa-759	239	33	interval	interval	NOUN
ijassa-759	239	34	between	between	ADP
ijassa-759	239	35	injections	injection	NOUN
ijassa-759	239	36	∆tstab	∆tstab	ADP
ijassa-759	239	37	=	=	SYM
ijassa-759	239	38	25.7	25.7	NUM
ijassa-759	239	39	days	day	NOUN
ijassa-759	239	40	:	:	PUNCT
ijassa-759	239	41	а	а	PROPN
ijassa-759	239	42	shows	show	VERB
ijassa-759	239	43	the	the	DET
ijassa-759	239	44	trajectories	trajectory	NOUN
ijassa-759	239	45	of	of	ADP
ijassa-759	239	46	growth	growth	NOUN
ijassa-759	239	47	and	and	CCONJ
ijassa-759	239	48	death	death	NOUN
ijassa-759	239	49	of	of	ADP
ijassa-759	239	50	tumor	tumor	NOUN
ijassa-759	239	51	cells	cell	NOUN
ijassa-759	239	52	;	;	PUNCT
ijassa-759	239	53	b	b	X
ijassa-759	239	54	shows	show	VERB
ijassa-759	239	55	the	the	DET
ijassa-759	239	56	dynamics	dynamic	NOUN
ijassa-759	239	57	of	of	ADP
ijassa-759	239	58	formation	formation	NOUN
ijassa-759	239	59	of	of	ADP
ijassa-759	239	60	antibodies	antibody	NOUN
ijassa-759	239	61	0	0	NUM
ijassa-759	239	62	1	1	NUM
ijassa-759	239	63	(	(	PUNCT
ijassa-759	239	64	,	,	PUNCT
ijassa-759	239	65	)	)	PUNCT
ijassa-759	239	66	va	va	NOUN
ijassa-759	239	67	v	v	X
ijassa-759	239	68			NOUN
ijassa-759	239	69	at	at	ADP
ijassa-759	239	70	the	the	DET
ijassa-759	239	71	1st	1st	NOUN
ijassa-759	239	72	and	and	CCONJ
ijassa-759	239	73	0	0	NUM
ijassa-759	239	74	1	1	NUM
ijassa-759	239	75	(	(	PUNCT
ijassa-759	239	76	,	,	PUNCT
ijassa-759	239	77	)	)	PUNCT
ijassa-759	239	78	na	na	PART
ijassa-759	239	79	v	v	ADP
ijassa-759	239	80			NOUN
ijassa-759	239	81	at	at	ADP
ijassa-759	239	82	the	the	DET
ijassa-759	239	83	2nd	2nd	ADJ
ijassa-759	239	84	stage	stage	NOUN
ijassa-759	239	85	of	of	ADP
ijassa-759	239	86	the	the	DET
ijassa-759	239	87	immune	immune	ADJ
ijassa-759	239	88	response	response	NOUN
ijassa-759	239	89	(	(	PUNCT
ijassa-759	239	90	solid	solid	ADJ
ijassa-759	239	91	curve	curve	NOUN
ijassa-759	239	92	denotes	denote	NOUN
ijassa-759	239	93	av(t	av(t	NOUN
ijassa-759	239	94	)	)	PUNCT
ijassa-759	239	95	,	,	PUNCT
ijassa-759	239	96	dashed	dash	VERB
ijassa-759	239	97	curve	curve	NOUN
ijassa-759	239	98	denotes	denote	NOUN
ijassa-759	239	99	an(t	an(t	NOUN
ijassa-759	239	100	)	)	PUNCT
ijassa-759	239	101	)	)	PUNCT
ijassa-759	240	1	the	the	DET
ijassa-759	240	2	dose	dose	NOUN
ijassa-759	240	3	of	of	ADP
ijassa-759	240	4	the	the	DET
ijassa-759	240	5	viral	viral	ADJ
ijassa-759	240	6	vaccine	vaccine	NOUN
ijassa-759	240	7	was	be	AUX
ijassa-759	240	8	determined	determine	VERB
ijassa-759	240	9	depending	depend	VERB
ijassa-759	240	10	on	on	ADP
ijassa-759	240	11	the	the	DET
ijassa-759	240	12	size	size	NOUN
ijassa-759	240	13	of	of	ADP
ijassa-759	240	14	the	the	DET
ijassa-759	240	15	tumor	tumor	NOUN
ijassa-759	240	16	to	to	PART
ijassa-759	240	17	implement	implement	VERB
ijassa-759	240	18	the	the	DET
ijassa-759	240	19	strategy	strategy	NOUN
ijassa-759	240	20	of	of	ADP
ijassa-759	240	21	stabilizing	stabilize	VERB
ijassa-759	240	22	the	the	DET
ijassa-759	240	23	tumor	tumor	NOUN
ijassa-759	240	24	size	size	NOUN
ijassa-759	240	25	at	at	ADP
ijassa-759	240	26	the	the	DET
ijassa-759	240	27	beginning	beginning	NOUN
ijassa-759	240	28	of	of	ADP
ijassa-759	240	29	treatment	treatment	NOUN
ijassa-759	240	30	v0	v0	NOUN
ijassa-759	240	31	stab	stab	NOUN
ijassa-759	240	32	(	(	PUNCT
ijassa-759	240	33	τ1	τ1	NOUN
ijassa-759	240	34	)	)	PUNCT
ijassa-759	240	35	(	(	PUNCT
ijassa-759	240	36	fig.8	fig.8	PROPN
ijassa-759	240	37	b	b	NOUN
ijassa-759	240	38	)	)	PUNCT
ijassa-759	240	39	.	.	PUNCT
ijassa-759	241	1	the	the	DET
ijassa-759	241	2	interval	interval	NOUN
ijassa-759	241	3	between	between	ADP
ijassa-759	241	4	the	the	DET
ijassa-759	241	5	first	first	ADJ
ijassa-759	241	6	and	and	CCONJ
ijassa-759	241	7	second	second	ADJ
ijassa-759	241	8	introduction	introduction	NOUN
ijassa-759	241	9	of	of	ADP
ijassa-759	241	10	the	the	DET
ijassa-759	241	11	vaccine	vaccine	NOUN
ijassa-759	241	12	∆t1	∆t1	PROPN
ijassa-759	241	13	stab	stab	PROPN
ijassa-759	241	14	(	(	PUNCT
ijassa-759	241	15	τ1	τ1	NOUN
ijassa-759	241	16	)	)	PUNCT
ijassa-759	241	17	was	be	AUX
ijassa-759	241	18	also	also	ADV
ijassa-759	241	19	determined	determine	VERB
ijassa-759	241	20	depending	depend	VERB
ijassa-759	241	21	on	on	ADP
ijassa-759	241	22	the	the	DET
ijassa-759	241	23	size	size	NOUN
ijassa-759	241	24	of	of	ADP
ijassa-759	241	25	the	the	DET
ijassa-759	241	26	tumor	tumor	NOUN
ijassa-759	241	27	at	at	ADP
ijassa-759	241	28	the	the	DET
ijassa-759	241	29	beginning	beginning	NOUN
ijassa-759	241	30	of	of	ADP
ijassa-759	241	31	treatment	treatment	NOUN
ijassa-759	241	32	based	base	VERB
ijassa-759	241	33	n.a	n.a	PROPN
ijassa-759	241	34	.	.	PROPN
ijassa-759	241	35	babushkina	babushkina	PROPN
ijassa-759	241	36	,	,	PUNCT
ijassa-759	242	1	e.a	e.a	PROPN
ijassa-759	242	2	.	.	PROPN
ijassa-759	242	3	kuzina	kuzina	PROPN
ijassa-759	242	4	copyright	copyright	PROPN
ijassa-759	242	5	©	©	PROPN
ijassa-759	242	6	2020	2020	NUM
ijassa-759	242	7	assa	assa	NOUN
ijassa-759	242	8	.	.	PUNCT
ijassa-759	243	1	adv	adv	PROPN
ijassa-759	243	2	.	.	PUNCT
ijassa-759	244	1	in	in	ADP
ijassa-759	244	2	systems	system	NOUN
ijassa-759	244	3	science	science	NOUN
ijassa-759	244	4	and	and	CCONJ
ijassa-759	244	5	appl	appl	NOUN
ijassa-759	244	6	.	.	PUNCT
ijassa-759	245	1	(	(	PUNCT
ijassa-759	245	2	2020	2020	NUM
ijassa-759	245	3	)	)	PUNCT
ijassa-759	245	4	14	14	NUM
ijassa-759	245	5	on	on	ADP
ijassa-759	245	6	the	the	DET
ijassa-759	245	7	condition	condition	NOUN
ijassa-759	245	8	of	of	ADP
ijassa-759	245	9	stabilization	stabilization	NOUN
ijassa-759	245	10	of	of	ADP
ijassa-759	245	11	the	the	DET
ijassa-759	245	12	tumor	tumor	NOUN
ijassa-759	245	13	size	size	NOUN
ijassa-759	245	14	(	(	PUNCT
ijassa-759	245	15	fig	fig	NOUN
ijassa-759	245	16	.	.	PUNCT
ijassa-759	246	1	8,а	8,а	PROPN
ijassa-759	246	2	)	)	PUNCT
ijassa-759	246	3	.	.	PUNCT
ijassa-759	247	1	the	the	DET
ijassa-759	247	2	moment	moment	NOUN
ijassa-759	247	3	of	of	ADP
ijassa-759	247	4	the	the	DET
ijassa-759	247	5	second	second	ADJ
ijassa-759	247	6	injection	injection	NOUN
ijassa-759	247	7	of	of	ADP
ijassa-759	247	8	the	the	DET
ijassa-759	247	9	vaccine	vaccine	NOUN
ijassa-759	247	10	was	be	AUX
ijassa-759	247	11	defined	define	VERB
ijassa-759	247	12	as	as	ADP
ijassa-759	247	13	τ2	τ2	NOUN
ijassa-759	247	14	=	=	SYM
ijassa-759	247	15	τ1	τ1	NOUN
ijassa-759	247	16	+	+	CCONJ
ijassa-759	247	17	∆t1	∆t1	NOUN
ijassa-759	247	18	stab	stab	NOUN
ijassa-759	247	19	.	.	PUNCT
ijassa-759	248	1	beginning	begin	VERB
ijassa-759	248	2	from	from	ADP
ijassa-759	248	3	the	the	DET
ijassa-759	248	4	third	third	ADJ
ijassa-759	248	5	moment	moment	NOUN
ijassa-759	248	6	of	of	ADP
ijassa-759	248	7	the	the	DET
ijassa-759	248	8	vaccine	vaccine	NOUN
ijassa-759	248	9	injection	injection	NOUN
ijassa-759	248	10	τ3	τ3	NOUN
ijassa-759	248	11	and	and	CCONJ
ijassa-759	248	12	further	furth	ADJ
ijassa-759	248	13	τi	τi	NOUN
ijassa-759	248	14	,	,	PUNCT
ijassa-759	248	15	the	the	DET
ijassa-759	248	16	moment	moment	NOUN
ijassa-759	248	17	of	of	ADP
ijassa-759	248	18	the	the	DET
ijassa-759	248	19	subsequent	subsequent	ADJ
ijassa-759	248	20	injection	injection	NOUN
ijassa-759	248	21	of	of	ADP
ijassa-759	248	22	the	the	DET
ijassa-759	248	23	vaccine	vaccine	NOUN
ijassa-759	248	24	was	be	AUX
ijassa-759	248	25	defined	define	VERB
ijassa-759	248	26	as	as	ADP
ijassa-759	248	27	τi	τi	ADV
ijassa-759	248	28	=	=	PUNCT
ijassa-759	248	29	τi-1	τi-1	PUNCT
ijassa-759	248	30	+	+	CCONJ
ijassa-759	248	31	∆ti-1	∆ti-1	PROPN
ijassa-759	248	32	.	.	PUNCT
ijassa-759	249	1	the	the	DET
ijassa-759	249	2	duration	duration	NOUN
ijassa-759	249	3	of	of	ADP
ijassa-759	249	4	the	the	DET
ijassa-759	249	5	interval	interval	NOUN
ijassa-759	249	6	between	between	ADP
ijassa-759	249	7	injections	injection	NOUN
ijassa-759	249	8	was	be	AUX
ijassa-759	249	9	reduced	reduce	VERB
ijassa-759	249	10	by	by	ADP
ijassa-759	249	11	the	the	DET
ijassa-759	249	12	step	step	NOUN
ijassa-759	249	13	value	value	NOUN
ijassa-759	249	14	and	and	CCONJ
ijassa-759	249	15	was	be	AUX
ijassa-759	249	16	calculated	calculate	VERB
ijassa-759	249	17	as	as	ADP
ijassa-759	249	18	∆ti-1	∆ti-1	NOUN
ijassa-759	249	19	=	=	SYM
ijassa-759	249	20	∆ti-2	∆ti-2	NOUN
ijassa-759	249	21	–	–	PUNCT
ijassa-759	249	22	step	step	NOUN
ijassa-759	249	23	.	.	PUNCT
ijassa-759	250	1	in	in	ADP
ijassa-759	250	2	fact	fact	NOUN
ijassa-759	250	3	,	,	PUNCT
ijassa-759	250	4	the	the	DET
ijassa-759	250	5	step	step	NOUN
ijassa-759	250	6	value	value	NOUN
ijassa-759	250	7	is	be	AUX
ijassa-759	250	8	the	the	DET
ijassa-759	250	9	control	control	NOUN
ijassa-759	250	10	parameter	parameter	NOUN
ijassa-759	250	11	for	for	ADP
ijassa-759	250	12	the	the	DET
ijassa-759	250	13	implementation	implementation	NOUN
ijassa-759	250	14	of	of	ADP
ijassa-759	250	15	the	the	DET
ijassa-759	250	16	strategy	strategy	NOUN
ijassa-759	250	17	of	of	ADP
ijassa-759	250	18	gradual	gradual	ADJ
ijassa-759	250	19	reduction	reduction	NOUN
ijassa-759	250	20	of	of	ADP
ijassa-759	250	21	tumor	tumor	NOUN
ijassa-759	250	22	size	size	NOUN
ijassa-759	250	23	with	with	ADP
ijassa-759	250	24	each	each	DET
ijassa-759	250	25	subsequent	subsequent	ADJ
ijassa-759	250	26	injections	injection	NOUN
ijassa-759	250	27	of	of	ADP
ijassa-759	250	28	a	a	DET
ijassa-759	250	29	viral	viral	ADJ
ijassa-759	250	30	vaccine	vaccine	NOUN
ijassa-759	250	31	.	.	PUNCT
ijassa-759	251	1	the	the	DET
ijassa-759	251	2	number	number	NOUN
ijassa-759	251	3	of	of	ADP
ijassa-759	251	4	repeated	repeat	VERB
ijassa-759	251	5	injections	injection	NOUN
ijassa-759	251	6	of	of	ADP
ijassa-759	251	7	the	the	DET
ijassa-759	251	8	vaccine	vaccine	NOUN
ijassa-759	251	9	to	to	PART
ijassa-759	251	10	achieve	achieve	VERB
ijassa-759	251	11	regression	regression	NOUN
ijassa-759	251	12	of	of	ADP
ijassa-759	251	13	tumor	tumor	NOUN
ijassa-759	251	14	growth	growth	NOUN
ijassa-759	251	15	depends	depend	VERB
ijassa-759	251	16	on	on	ADP
ijassa-759	251	17	the	the	DET
ijassa-759	251	18	step	step	NOUN
ijassa-759	251	19	value	value	NOUN
ijassa-759	251	20	.	.	PUNCT
ijassa-759	252	1	in	in	ADP
ijassa-759	252	2	the	the	DET
ijassa-759	252	3	framework	framework	NOUN
ijassa-759	252	4	of	of	ADP
ijassa-759	252	5	the	the	DET
ijassa-759	252	6	constructed	construct	VERB
ijassa-759	252	7	model	model	NOUN
ijassa-759	252	8	,	,	PUNCT
ijassa-759	252	9	this	this	PRON
ijassa-759	252	10	occurs	occur	VERB
ijassa-759	252	11	when	when	SCONJ
ijassa-759	252	12	the	the	DET
ijassa-759	252	13	number	number	NOUN
ijassa-759	252	14	of	of	ADP
ijassa-759	252	15	tumor	tumor	NOUN
ijassa-759	252	16	cells	cell	NOUN
ijassa-759	252	17	decreases	decrease	VERB
ijassa-759	252	18	below	below	ADP
ijassa-759	252	19	the	the	DET
ijassa-759	252	20	lethality	lethality	NOUN
ijassa-759	252	21	threshold	threshold	NOUN
ijassa-759	252	22	(	(	PUNCT
ijassa-759	252	23	fig	fig	NOUN
ijassa-759	252	24	.	.	PUNCT
ijassa-759	253	1	9,a-10,а	9,a-10,а	NUM
ijassa-759	253	2	)	)	PUNCT
ijassa-759	253	3	.	.	PUNCT
ijassa-759	254	1	this	this	DET
ijassa-759	254	2	strategy	strategy	NOUN
ijassa-759	254	3	allows	allow	VERB
ijassa-759	254	4	to	to	PART
ijassa-759	254	5	achieve	achieve	VERB
ijassa-759	254	6	a	a	DET
ijassa-759	254	7	reduction	reduction	NOUN
ijassa-759	254	8	in	in	ADP
ijassa-759	254	9	the	the	DET
ijassa-759	254	10	number	number	NOUN
ijassa-759	254	11	of	of	ADP
ijassa-759	254	12	tumor	tumor	NOUN
ijassa-759	254	13	cells	cell	NOUN
ijassa-759	254	14	below	below	ADP
ijassa-759	254	15	the	the	DET
ijassa-759	254	16	lethality	lethality	NOUN
ijassa-759	254	17	threshold	threshold	NOUN
ijassa-759	254	18	only	only	ADV
ijassa-759	254	19	if	if	SCONJ
ijassa-759	254	20	the	the	DET
ijassa-759	254	21	duration	duration	NOUN
ijassa-759	254	22	of	of	ADP
ijassa-759	254	23	tumor	tumor	NOUN
ijassa-759	254	24	growth	growth	NOUN
ijassa-759	254	25	does	do	AUX
ijassa-759	254	26	not	not	PART
ijassa-759	254	27	exceed	exceed	VERB
ijassa-759	254	28	20	20	NUM
ijassa-759	254	29	days	day	NOUN
ijassa-759	254	30	(	(	PUNCT
ijassa-759	254	31	fig	fig	NOUN
ijassa-759	254	32	.	.	PUNCT
ijassa-759	255	1	10,a	10,a	NUM
ijassa-759	255	2	)	)	PUNCT
ijassa-759	255	3	.	.	PUNCT
ijassa-759	256	1	for	for	ADP
ijassa-759	256	2	large	large	ADJ
ijassa-759	256	3	tumors	tumor	NOUN
ijassa-759	256	4	it	it	PRON
ijassa-759	256	5	is	be	AUX
ijassa-759	256	6	necessary	necessary	ADJ
ijassa-759	256	7	to	to	PART
ijassa-759	256	8	carry	carry	VERB
ijassa-759	256	9	out	out	ADP
ijassa-759	256	10	surgery	surgery	NOUN
ijassa-759	256	11	,	,	PUNCT
ijassa-759	256	12	or	or	CCONJ
ijassa-759	256	13	use	use	VERB
ijassa-759	256	14	a	a	DET
ijassa-759	256	15	strategy	strategy	NOUN
ijassa-759	256	16	to	to	PART
ijassa-759	256	17	stabilize	stabilize	VERB
ijassa-759	256	18	the	the	DET
ijassa-759	256	19	growth	growth	NOUN
ijassa-759	256	20	of	of	ADP
ijassa-759	256	21	the	the	DET
ijassa-759	256	22	tumor	tumor	NOUN
ijassa-759	256	23	(	(	PUNCT
ijassa-759	256	24	fig	fig	NOUN
ijassa-759	256	25	.	.	PUNCT
ijassa-759	257	1	11,a	11,a	NUM
ijassa-759	257	2	)	)	PUNCT
ijassa-759	257	3	.	.	PUNCT
ijassa-759	258	1	а	а	PROPN
ijassa-759	258	2	b	b	NOUN
ijassa-759	258	3	fig	fig	NOUN
ijassa-759	258	4	.	.	PUNCT
ijassa-759	259	1	11	11	NUM
ijassa-759	259	2	.	.	PUNCT
ijassa-759	260	1	the	the	DET
ijassa-759	260	2	strategy	strategy	NOUN
ijassa-759	260	3	for	for	ADP
ijassa-759	260	4	multiple	multiple	ADJ
ijassa-759	260	5	injection	injection	NOUN
ijassa-759	260	6	of	of	ADP
ijassa-759	260	7	the	the	DET
ijassa-759	260	8	vaccine	vaccine	NOUN
ijassa-759	260	9	by	by	ADP
ijassa-759	260	10	reducing	reduce	VERB
ijassa-759	260	11	the	the	DET
ijassa-759	260	12	interval	interval	NOUN
ijassa-759	260	13	between	between	ADP
ijassa-759	260	14	the	the	DET
ijassa-759	260	15	doses	dose	NOUN
ijassa-759	260	16	0v	0v	NOUN
ijassa-759	260	17	=	=	SYM
ijassa-759	260	18	0,06	0,06	PROPN
ijassa-759	260	19	at	at	ADP
ijassa-759	260	20	the	the	DET
ijassa-759	260	21	beginning	beginning	NOUN
ijassa-759	260	22	of	of	ADP
ijassa-759	260	23	the	the	DET
ijassa-759	260	24	treatment	treatment	NOUN
ijassa-759	260	25	on	on	ADP
ijassa-759	260	26	τ1	τ1	NOUN
ijassa-759	260	27	=	=	SYM
ijassa-759	260	28	25	25	NUM
ijassa-759	260	29	day	day	NOUN
ijassa-759	260	30	with	with	ADP
ijassa-759	260	31	the	the	DET
ijassa-759	260	32	initial	initial	ADJ
ijassa-759	260	33	interval	interval	NOUN
ijassa-759	260	34	between	between	ADP
ijassa-759	260	35	injections	injection	NOUN
ijassa-759	260	36	∆tstab	∆tstab	ADP
ijassa-759	260	37	=	=	SYM
ijassa-759	260	38	28.9	28.9	NUM
ijassa-759	260	39	days	day	NOUN
ijassa-759	260	40	:	:	PUNCT
ijassa-759	260	41	а	а	PROPN
ijassa-759	260	42	shows	show	VERB
ijassa-759	260	43	the	the	DET
ijassa-759	260	44	trajectories	trajectory	NOUN
ijassa-759	260	45	of	of	ADP
ijassa-759	260	46	growth	growth	NOUN
ijassa-759	260	47	and	and	CCONJ
ijassa-759	260	48	death	death	NOUN
ijassa-759	260	49	of	of	ADP
ijassa-759	260	50	tumor	tumor	NOUN
ijassa-759	260	51	cells	cell	NOUN
ijassa-759	260	52	;	;	PUNCT
ijassa-759	260	53	b	b	X
ijassa-759	260	54	shows	show	VERB
ijassa-759	260	55	the	the	DET
ijassa-759	260	56	dynamics	dynamic	NOUN
ijassa-759	260	57	of	of	ADP
ijassa-759	260	58	formation	formation	NOUN
ijassa-759	260	59	of	of	ADP
ijassa-759	260	60	antibodies	antibody	NOUN
ijassa-759	260	61	0	0	NUM
ijassa-759	260	62	1	1	NUM
ijassa-759	260	63	(	(	PUNCT
ijassa-759	260	64	,	,	PUNCT
ijassa-759	260	65	)	)	PUNCT
ijassa-759	260	66	va	va	NOUN
ijassa-759	260	67	v	v	X
ijassa-759	260	68			NOUN
ijassa-759	260	69	at	at	ADP
ijassa-759	260	70	the	the	DET
ijassa-759	260	71	1st	1st	NOUN
ijassa-759	260	72	and	and	CCONJ
ijassa-759	260	73	0	0	NUM
ijassa-759	260	74	1	1	NUM
ijassa-759	260	75	(	(	PUNCT
ijassa-759	260	76	,	,	PUNCT
ijassa-759	260	77	)	)	PUNCT
ijassa-759	260	78	na	na	PART
ijassa-759	260	79	v	v	ADP
ijassa-759	260	80			NOUN
ijassa-759	260	81	at	at	ADP
ijassa-759	260	82	the	the	DET
ijassa-759	260	83	2nd	2nd	ADJ
ijassa-759	260	84	stage	stage	NOUN
ijassa-759	260	85	of	of	ADP
ijassa-759	260	86	the	the	DET
ijassa-759	260	87	immune	immune	ADJ
ijassa-759	260	88	response	response	NOUN
ijassa-759	260	89	(	(	PUNCT
ijassa-759	260	90	solid	solid	ADJ
ijassa-759	260	91	curve	curve	NOUN
ijassa-759	260	92	denotes	denote	NOUN
ijassa-759	260	93	av(t	av(t	NOUN
ijassa-759	260	94	)	)	PUNCT
ijassa-759	260	95	,	,	PUNCT
ijassa-759	260	96	dashed	dash	VERB
ijassa-759	260	97	curve	curve	NOUN
ijassa-759	260	98	denotes	denote	NOUN
ijassa-759	260	99	an(t	an(t	NOUN
ijassa-759	260	100	)	)	PUNCT
ijassa-759	260	101	)	)	PUNCT
ijassa-759	261	1	5.3	5.3	NUM
ijassa-759	261	2	.	.	PUNCT
ijassa-759	261	3	strategy	strategy	NOUN
ijassa-759	261	4	of	of	ADP
ijassa-759	261	5	single	single	ADJ
ijassa-759	261	6	injection	injection	NOUN
ijassa-759	261	7	of	of	ADP
ijassa-759	261	8	the	the	DET
ijassa-759	261	9	viral	viral	ADJ
ijassa-759	261	10	vaccines	vaccine	NOUN
ijassa-759	261	11	testing	test	VERB
ijassa-759	261	12	the	the	DET
ijassa-759	261	13	effectiveness	effectiveness	NOUN
ijassa-759	261	14	of	of	ADP
ijassa-759	261	15	various	various	ADJ
ijassa-759	261	16	doses	dose	NOUN
ijassa-759	261	17	of	of	ADP
ijassa-759	261	18	viral	viral	ADJ
ijassa-759	261	19	vaccine	vaccine	NOUN
ijassa-759	261	20	in	in	ADP
ijassa-759	261	21	a	a	DET
ijassa-759	261	22	single	single	ADJ
ijassa-759	261	23	injection	injection	NOUN
ijassa-759	261	24	at	at	ADP
ijassa-759	261	25	different	different	ADJ
ijassa-759	261	26	points	point	NOUN
ijassa-759	261	27	in	in	ADP
ijassa-759	261	28	tumor	tumor	NOUN
ijassa-759	261	29	growth	growth	NOUN
ijassa-759	261	30	was	be	AUX
ijassa-759	261	31	carried	carry	VERB
ijassa-759	261	32	out	out	ADP
ijassa-759	261	33	on	on	ADP
ijassa-759	261	34	the	the	DET
ijassa-759	261	35	developed	develop	VERB
ijassa-759	261	36	program	program	NOUN
ijassa-759	261	37	module	module	NOUN
ijassa-759	261	38	.	.	PUNCT
ijassa-759	262	1	it	it	PRON
ijassa-759	262	2	was	be	AUX
ijassa-759	262	3	determined	determine	VERB
ijassa-759	262	4	that	that	SCONJ
ijassa-759	262	5	even	even	ADV
ijassa-759	262	6	with	with	ADP
ijassa-759	262	7	a	a	DET
ijassa-759	262	8	single	single	ADJ
ijassa-759	262	9	injection	injection	NOUN
ijassa-759	262	10	of	of	ADP
ijassa-759	262	11	a	a	DET
ijassa-759	262	12	viral	viral	ADJ
ijassa-759	262	13	vaccine	vaccine	NOUN
ijassa-759	262	14	in	in	ADP
ijassa-759	262	15	certain	certain	ADJ
ijassa-759	262	16	doses	dose	NOUN
ijassa-759	262	17	,	,	PUNCT
ijassa-759	262	18	it	it	PRON
ijassa-759	262	19	is	be	AUX
ijassa-759	262	20	possible	possible	ADJ
ijassa-759	262	21	to	to	PART
ijassa-759	262	22	obtain	obtain	VERB
ijassa-759	262	23	a	a	DET
ijassa-759	262	24	reduction	reduction	NOUN
ijassa-759	262	25	in	in	ADP
ijassa-759	262	26	the	the	DET
ijassa-759	262	27	number	number	NOUN
ijassa-759	262	28	of	of	ADP
ijassa-759	262	29	tumor	tumor	NOUN
ijassa-759	262	30	cells	cell	NOUN
ijassa-759	262	31	below	below	ADP
ijassa-759	262	32	the	the	DET
ijassa-759	262	33	v0let	v0let	NOUN
ijassa-759	262	34	threshold	threshold	NOUN
ijassa-759	262	35	,	,	PUNCT
ijassa-759	262	36	i.e.	i.e.	X
ijassa-759	262	37	achieve	achieve	VERB
ijassa-759	262	38	complete	complete	ADJ
ijassa-759	262	39	destruction	destruction	NOUN
ijassa-759	262	40	(	(	PUNCT
ijassa-759	262	41	fig.12a	fig.12a	ADJ
ijassa-759	262	42	,	,	PUNCT
ijassa-759	262	43	13a	13a	NUM
ijassa-759	262	44	)	)	PUNCT
ijassa-759	262	45	.	.	PUNCT
ijassa-759	263	1	at	at	ADP
ijassa-759	263	2	the	the	DET
ijassa-759	263	3	same	same	ADJ
ijassa-759	263	4	time	time	NOUN
ijassa-759	263	5	,	,	PUNCT
ijassa-759	263	6	the	the	DET
ijassa-759	263	7	number	number	NOUN
ijassa-759	263	8	of	of	ADP
ijassa-759	263	9	antibodies	antibody	NOUN
ijassa-759	263	10	produced	produce	VERB
ijassa-759	263	11	at	at	ADP
ijassa-759	263	12	the	the	DET
ijassa-759	263	13	first	first	ADJ
ijassa-759	263	14	stage	stage	NOUN
ijassa-759	263	15	of	of	ADP
ijassa-759	263	16	the	the	DET
ijassa-759	263	17	immune	immune	ADJ
ijassa-759	263	18	response	response	NOUN
ijassa-759	263	19	exceeds	exceed	VERB
ijassa-759	263	20	their	their	PRON
ijassa-759	263	21	number	number	NOUN
ijassa-759	263	22	at	at	ADP
ijassa-759	263	23	the	the	DET
ijassa-759	263	24	second	second	ADJ
ijassa-759	263	25	stage	stage	NOUN
ijassa-759	263	26	(	(	PUNCT
ijassa-759	263	27	fig	fig	NOUN
ijassa-759	263	28	.	.	PUNCT
ijassa-759	263	29	12b	12b	NOUN
ijassa-759	263	30	,	,	PUNCT
ijassa-759	263	31	13b	13b	NOUN
ijassa-759	263	32	)	)	PUNCT
ijassa-759	263	33	.	.	PUNCT
ijassa-759	264	1	mathematical	mathematical	ADJ
ijassa-759	264	2	modeling	modeling	NOUN
ijassa-759	264	3	of	of	ADP
ijassa-759	264	4	antitumor	antitumor	PROPN
ijassa-759	264	5	viral	viral	ADJ
ijassa-759	264	6	vaccine	vaccine	NOUN
ijassa-759	264	7	therapy	therapy	NOUN
ijassa-759	264	8	…	…	PUNCT
ijassa-759	264	9	copyright	copyright	NOUN
ijassa-759	264	10	©	©	PROPN
ijassa-759	264	11	2020	2020	NUM
ijassa-759	264	12	assa	assa	NOUN
ijassa-759	264	13	.	.	PUNCT
ijassa-759	265	1	adv	adv	PROPN
ijassa-759	265	2	.	.	PUNCT
ijassa-759	266	1	in	in	ADP
ijassa-759	266	2	systems	system	NOUN
ijassa-759	266	3	science	science	NOUN
ijassa-759	266	4	and	and	CCONJ
ijassa-759	266	5	appl	appl	NOUN
ijassa-759	266	6	.	.	PUNCT
ijassa-759	267	1	(	(	PUNCT
ijassa-759	267	2	2020	2020	NUM
ijassa-759	267	3	)	)	PUNCT
ijassa-759	267	4	15	15	NUM
ijassa-759	267	5	а	а	PROPN
ijassa-759	267	6	b	b	PROPN
ijassa-759	267	7	fig	fig	NOUN
ijassa-759	267	8	.	.	PUNCT
ijassa-759	268	1	12	12	NUM
ijassa-759	268	2	.	.	PUNCT
ijassa-759	269	1	the	the	DET
ijassa-759	269	2	strategy	strategy	NOUN
ijassa-759	269	3	of	of	ADP
ijassa-759	269	4	a	a	DET
ijassa-759	269	5	single	single	ADJ
ijassa-759	269	6	lethal	lethal	ADJ
ijassa-759	269	7	dose	dose	NOUN
ijassa-759	269	8	injection	injection	NOUN
ijassa-759	269	9	on	on	ADP
ijassa-759	269	10	let	let	VERB
ijassa-759	269	11	0v	0v	NOUN
ijassa-759	269	12	=	=	PUNCT
ijassa-759	269	13	0.048	0.048	NUM
ijassa-759	269	14	on	on	ADP
ijassa-759	269	15	τ1	τ1	NOUN
ijassa-759	269	16	=	=	SYM
ijassa-759	269	17	3	3	NUM
ijassa-759	269	18	day	day	NOUN
ijassa-759	269	19	;	;	PUNCT
ijassa-759	269	20	а	а	PROPN
ijassa-759	269	21	shows	show	VERB
ijassa-759	269	22	the	the	DET
ijassa-759	269	23	trajectories	trajectory	NOUN
ijassa-759	269	24	of	of	ADP
ijassa-759	269	25	growth	growth	NOUN
ijassa-759	269	26	and	and	CCONJ
ijassa-759	269	27	death	death	NOUN
ijassa-759	269	28	of	of	ADP
ijassa-759	269	29	tumor	tumor	NOUN
ijassa-759	269	30	cells	cell	NOUN
ijassa-759	269	31	;	;	PUNCT
ijassa-759	269	32	b	b	X
ijassa-759	269	33	shows	show	VERB
ijassa-759	269	34	the	the	DET
ijassa-759	269	35	dynamics	dynamic	NOUN
ijassa-759	269	36	of	of	ADP
ijassa-759	269	37	formation	formation	NOUN
ijassa-759	269	38	of	of	ADP
ijassa-759	269	39	antibodies	antibody	NOUN
ijassa-759	269	40	0	0	NUM
ijassa-759	269	41	1	1	NUM
ijassa-759	269	42	(	(	PUNCT
ijassa-759	269	43	,	,	PUNCT
ijassa-759	269	44	)	)	PUNCT
ijassa-759	269	45	va	va	NOUN
ijassa-759	269	46	v	v	X
ijassa-759	269	47			NOUN
ijassa-759	269	48	at	at	ADP
ijassa-759	269	49	the	the	DET
ijassa-759	269	50	1st	1st	NOUN
ijassa-759	269	51	and	and	CCONJ
ijassa-759	269	52	0	0	NUM
ijassa-759	269	53	1	1	NUM
ijassa-759	269	54	(	(	PUNCT
ijassa-759	269	55	,	,	PUNCT
ijassa-759	269	56	)	)	PUNCT
ijassa-759	269	57	na	na	PART
ijassa-759	269	58	v	v	ADP
ijassa-759	269	59			NOUN
ijassa-759	269	60	at	at	ADP
ijassa-759	269	61	the	the	DET
ijassa-759	269	62	2nd	2nd	ADJ
ijassa-759	269	63	stage	stage	NOUN
ijassa-759	269	64	of	of	ADP
ijassa-759	269	65	the	the	DET
ijassa-759	269	66	immune	immune	ADJ
ijassa-759	269	67	response	response	NOUN
ijassa-759	269	68	[	[	X
ijassa-759	269	69	19	19	NUM
ijassa-759	269	70	,	,	PUNCT
ijassa-759	269	71	p.	p.	NOUN
ijassa-759	269	72	48	48	NUM
ijassa-759	269	73	,	,	PUNCT
ijassa-759	269	74	fig	fig	NOUN
ijassa-759	269	75	.	.	PUNCT
ijassa-759	270	1	9	9	NUM
ijassa-759	270	2	]	]	PUNCT
ijassa-759	270	3	а	а	PROPN
ijassa-759	270	4	b	b	PROPN
ijassa-759	270	5	fig	fig	NOUN
ijassa-759	270	6	.	.	PUNCT
ijassa-759	271	1	13	13	NUM
ijassa-759	271	2	.	.	PUNCT
ijassa-759	272	1	the	the	DET
ijassa-759	272	2	strategy	strategy	NOUN
ijassa-759	272	3	of	of	ADP
ijassa-759	272	4	a	a	DET
ijassa-759	272	5	single	single	ADJ
ijassa-759	272	6	lethal	lethal	ADJ
ijassa-759	272	7	dose	dose	NOUN
ijassa-759	272	8	injection	injection	NOUN
ijassa-759	272	9	on	on	ADP
ijassa-759	272	10	let	let	VERB
ijassa-759	272	11	0v	0v	NOUN
ijassa-759	272	12	=	=	PUNCT
ijassa-759	272	13	0.075	0.075	NUM
ijassa-759	272	14	on	on	ADP
ijassa-759	272	15	τ1	τ1	NOUN
ijassa-759	272	16	=	=	SYM
ijassa-759	272	17	8	8	NUM
ijassa-759	272	18	day	day	NOUN
ijassa-759	272	19	;	;	PUNCT
ijassa-759	272	20	а	а	PROPN
ijassa-759	272	21	shows	show	VERB
ijassa-759	272	22	the	the	DET
ijassa-759	272	23	trajectories	trajectory	NOUN
ijassa-759	272	24	of	of	ADP
ijassa-759	272	25	growth	growth	NOUN
ijassa-759	272	26	and	and	CCONJ
ijassa-759	272	27	death	death	NOUN
ijassa-759	272	28	of	of	ADP
ijassa-759	272	29	tumor	tumor	NOUN
ijassa-759	272	30	cells	cell	NOUN
ijassa-759	272	31	;	;	PUNCT
ijassa-759	272	32	b	b	X
ijassa-759	272	33	shows	show	VERB
ijassa-759	272	34	the	the	DET
ijassa-759	272	35	dynamics	dynamic	NOUN
ijassa-759	272	36	of	of	ADP
ijassa-759	272	37	formation	formation	NOUN
ijassa-759	272	38	of	of	ADP
ijassa-759	272	39	antibodies	antibody	NOUN
ijassa-759	272	40	0	0	NUM
ijassa-759	272	41	1	1	NUM
ijassa-759	272	42	(	(	PUNCT
ijassa-759	272	43	,	,	PUNCT
ijassa-759	272	44	)	)	PUNCT
ijassa-759	272	45	va	va	NOUN
ijassa-759	272	46	v	v	X
ijassa-759	272	47			NOUN
ijassa-759	272	48	at	at	ADP
ijassa-759	272	49	the	the	DET
ijassa-759	272	50	1st	1st	NOUN
ijassa-759	272	51	and	and	CCONJ
ijassa-759	272	52	0	0	NUM
ijassa-759	272	53	1	1	NUM
ijassa-759	272	54	(	(	PUNCT
ijassa-759	272	55	,	,	PUNCT
ijassa-759	272	56	)	)	PUNCT
ijassa-759	272	57	na	na	PART
ijassa-759	272	58	v	v	ADP
ijassa-759	272	59			NOUN
ijassa-759	272	60	at	at	ADP
ijassa-759	272	61	the	the	DET
ijassa-759	272	62	2nd	2nd	ADJ
ijassa-759	272	63	stage	stage	NOUN
ijassa-759	272	64	of	of	ADP
ijassa-759	272	65	the	the	DET
ijassa-759	272	66	immune	immune	ADJ
ijassa-759	272	67	response	response	NOUN
ijassa-759	272	68	thus	thus	ADV
ijassa-759	272	69	,	,	PUNCT
ijassa-759	272	70	the	the	DET
ijassa-759	272	71	death	death	NOUN
ijassa-759	272	72	of	of	ADP
ijassa-759	272	73	tumor	tumor	NOUN
ijassa-759	272	74	cells	cell	NOUN
ijassa-759	272	75	with	with	ADP
ijassa-759	272	76	a	a	DET
ijassa-759	272	77	single	single	ADJ
ijassa-759	272	78	injection	injection	NOUN
ijassa-759	272	79	of	of	ADP
ijassa-759	272	80	lethal	lethal	ADJ
ijassa-759	272	81	doses	dose	NOUN
ijassa-759	272	82	occurs	occur	VERB
ijassa-759	272	83	immediately	immediately	ADV
ijassa-759	272	84	in	in	ADP
ijassa-759	272	85	the	the	DET
ijassa-759	272	86	first	first	ADJ
ijassa-759	272	87	stage	stage	NOUN
ijassa-759	272	88	of	of	ADP
ijassa-759	272	89	the	the	DET
ijassa-759	272	90	immune	immune	ADJ
ijassa-759	272	91	response	response	NOUN
ijassa-759	272	92	as	as	ADP
ijassa-759	272	93	a	a	DET
ijassa-759	272	94	result	result	NOUN
ijassa-759	272	95	of	of	ADP
ijassa-759	272	96	the	the	DET
ijassa-759	272	97	formation	formation	NOUN
ijassa-759	272	98	of	of	ADP
ijassa-759	272	99	large	large	ADJ
ijassa-759	272	100	amounts	amount	NOUN
ijassa-759	272	101	of	of	ADP
ijassa-759	272	102	antibodies	antibody	NOUN
ijassa-759	272	103	against	against	ADP
ijassa-759	272	104	the	the	DET
ijassa-759	272	105	virus	virus	NOUN
ijassa-759	272	106	0	0	NUM
ijassa-759	272	107	(	(	PUNCT
ijassa-759	272	108	)	)	PUNCT
ijassa-759	272	109	va	va	PROPN
ijassa-759	272	110	v	v	NOUN
ijassa-759	272	111	and	and	CCONJ
ijassa-759	272	112	a	a	DET
ijassa-759	272	113	slight	slight	ADJ
ijassa-759	272	114	formation	formation	NOUN
ijassa-759	272	115	of	of	ADP
ijassa-759	272	116	antibodies	antibody	NOUN
ijassa-759	272	117	against	against	ADP
ijassa-759	272	118	infected	infected	ADJ
ijassa-759	272	119	tumor	tumor	NOUN
ijassa-759	272	120	cells	cell	NOUN
ijassa-759	272	121	0	0	NUM
ijassa-759	272	122	(	(	PUNCT
ijassa-759	272	123	)	)	PUNCT
ijassa-759	272	124	na	na	NOUN
ijassa-759	272	125	v	v	NOUN
ijassa-759	272	126	.	.	PUNCT
ijassa-759	273	1	as	as	ADP
ijassa-759	273	2	a	a	DET
ijassa-759	273	3	result	result	NOUN
ijassa-759	273	4	of	of	ADP
ijassa-759	273	5	the	the	DET
ijassa-759	273	6	analysis	analysis	NOUN
ijassa-759	273	7	of	of	ADP
ijassa-759	273	8	the	the	DET
ijassa-759	273	9	obtained	obtain	VERB
ijassa-759	273	10	results	result	NOUN
ijassa-759	273	11	,	,	PUNCT
ijassa-759	273	12	a	a	DET
ijassa-759	273	13	dependence	dependence	NOUN
ijassa-759	273	14	was	be	AUX
ijassa-759	273	15	constructed	construct	VERB
ijassa-759	273	16	,	,	PUNCT
ijassa-759	273	17	indicating	indicate	VERB
ijassa-759	273	18	that	that	SCONJ
ijassa-759	273	19	the	the	DET
ijassa-759	273	20	magnitude	magnitude	NOUN
ijassa-759	273	21	of	of	ADP
ijassa-759	273	22	lethal	lethal	ADJ
ijassa-759	273	23	doses	dose	NOUN
ijassa-759	273	24	leading	lead	VERB
ijassa-759	273	25	to	to	ADP
ijassa-759	273	26	the	the	DET
ijassa-759	273	27	destruction	destruction	NOUN
ijassa-759	273	28	of	of	ADP
ijassa-759	273	29	all	all	DET
ijassa-759	273	30	tumor	tumor	NOUN
ijassa-759	273	31	cells	cell	NOUN
ijassa-759	273	32	at	at	ADP
ijassa-759	273	33	the	the	DET
ijassa-759	273	34	first	first	ADJ
ijassa-759	273	35	stage	stage	NOUN
ijassa-759	273	36	of	of	ADP
ijassa-759	273	37	the	the	DET
ijassa-759	273	38	immune	immune	ADJ
ijassa-759	273	39	response	response	NOUN
ijassa-759	273	40	depends	depend	VERB
ijassa-759	273	41	on	on	ADP
ijassa-759	273	42	the	the	DET
ijassa-759	273	43	size	size	NOUN
ijassa-759	273	44	of	of	ADP
ijassa-759	273	45	the	the	DET
ijassa-759	273	46	tumor	tumor	NOUN
ijassa-759	273	47	at	at	ADP
ijassa-759	273	48	the	the	DET
ijassa-759	273	49	time	time	NOUN
ijassa-759	273	50	of	of	ADP
ijassa-759	273	51	its	its	PRON
ijassa-759	273	52	introduction	introduction	NOUN
ijassa-759	273	53	(	(	PUNCT
ijassa-759	273	54	fig	fig	NOUN
ijassa-759	273	55	.	.	PUNCT
ijassa-759	274	1	14	14	NUM
ijassa-759	274	2	)	)	PUNCT
ijassa-759	274	3	.	.	PUNCT
ijassa-759	275	1	however	however	ADV
ijassa-759	275	2	,	,	PUNCT
ijassa-759	275	3	to	to	PART
ijassa-759	275	4	achieve	achieve	VERB
ijassa-759	275	5	the	the	DET
ijassa-759	275	6	complete	complete	ADJ
ijassa-759	275	7	destruction	destruction	NOUN
ijassa-759	275	8	of	of	ADP
ijassa-759	275	9	tumor	tumor	NOUN
ijassa-759	275	10	cells	cell	NOUN
ijassa-759	275	11	is	be	AUX
ijassa-759	275	12	possible	possible	ADJ
ijassa-759	275	13	only	only	ADV
ijassa-759	275	14	for	for	ADP
ijassa-759	275	15	small	small	ADJ
ijassa-759	275	16	tumors	tumor	NOUN
ijassa-759	275	17	,	,	PUNCT
ijassa-759	275	18	the	the	DET
ijassa-759	275	19	growth	growth	NOUN
ijassa-759	275	20	of	of	ADP
ijassa-759	275	21	which	which	PRON
ijassa-759	275	22	does	do	AUX
ijassa-759	275	23	not	not	PART
ijassa-759	275	24	exceed	exceed	VERB
ijassa-759	275	25	8	8	NUM
ijassa-759	275	26	days	day	NOUN
ijassa-759	275	27	.	.	PUNCT
ijassa-759	276	1	n.a	n.a	PROPN
ijassa-759	276	2	.	.	PROPN
ijassa-759	276	3	babushkina	babushkina	PROPN
ijassa-759	276	4	,	,	PUNCT
ijassa-759	276	5	e.a	e.a	PROPN
ijassa-759	276	6	.	.	PROPN
ijassa-759	276	7	kuzina	kuzina	PROPN
ijassa-759	276	8	copyright	copyright	PROPN
ijassa-759	277	1	©	©	PROPN
ijassa-759	277	2	2020	2020	NUM
ijassa-759	277	3	assa	assa	NOUN
ijassa-759	277	4	.	.	PUNCT
ijassa-759	278	1	adv	adv	PROPN
ijassa-759	278	2	.	.	PUNCT
ijassa-759	279	1	in	in	ADP
ijassa-759	279	2	systems	system	NOUN
ijassa-759	279	3	science	science	NOUN
ijassa-759	279	4	and	and	CCONJ
ijassa-759	279	5	appl	appl	NOUN
ijassa-759	279	6	.	.	PUNCT
ijassa-759	280	1	(	(	PUNCT
ijassa-759	280	2	2020	2020	NUM
ijassa-759	280	3	)	)	PUNCT
ijassa-759	280	4	16	16	NUM
ijassa-759	280	5	fig	fig	NOUN
ijassa-759	280	6	.	.	PUNCT
ijassa-759	281	1	14	14	NUM
ijassa-759	281	2	.	.	PUNCT
ijassa-759	282	1	the	the	DET
ijassa-759	282	2	graph	graph	NOUN
ijassa-759	282	3	of	of	ADP
ijassa-759	282	4	lethal	lethal	ADJ
ijassa-759	282	5	doses	dose	NOUN
ijassa-759	282	6	from	from	ADP
ijassa-759	282	7	the	the	DET
ijassa-759	282	8	beginning	beginning	NOUN
ijassa-759	282	9	of	of	ADP
ijassa-759	282	10	treatment	treatment	NOUN
ijassa-759	282	11	(	(	PUNCT
ijassa-759	282	12	)	)	PUNCT
ijassa-759	282	13	let	let	VERB
ijassa-759	282	14	0	0	NUM
ijassa-759	282	15	1v	1v	NUM
ijassa-759	282	16			NOUN
ijassa-759	282	17	with	with	ADP
ijassa-759	282	18	a	a	DET
ijassa-759	282	19	single	single	ADJ
ijassa-759	282	20	injection	injection	NOUN
ijassa-759	282	21	of	of	ADP
ijassa-759	282	22	a	a	DET
ijassa-759	282	23	viral	viral	ADJ
ijassa-759	282	24	vaccine	vaccine	NOUN
ijassa-759	282	25	[	[	X
ijassa-759	282	26	19	19	NUM
ijassa-759	282	27	,	,	PUNCT
ijassa-759	282	28	p.	p.	NOUN
ijassa-759	282	29	49	49	NUM
ijassa-759	282	30	,	,	PUNCT
ijassa-759	282	31	fig.11	fig.11	X
ijassa-759	282	32	]	]	X
ijassa-759	282	33	6	6	NUM
ijassa-759	282	34	.	.	PUNCT
ijassa-759	282	35	predicting	predict	VERB
ijassa-759	282	36	the	the	DET
ijassa-759	282	37	duration	duration	NOUN
ijassa-759	282	38	of	of	ADP
ijassa-759	282	39	the	the	DET
ijassa-759	282	40	periods	period	NOUN
ijassa-759	282	41	between	between	ADP
ijassa-759	282	42	the	the	DET
ijassa-759	282	43	repeated	repeat	VERB
ijassa-759	282	44	injections	injection	NOUN
ijassa-759	282	45	of	of	ADP
ijassa-759	282	46	virus	virus	NOUN
ijassa-759	282	47	vaccine	vaccine	NOUN
ijassa-759	282	48	for	for	ADP
ijassa-759	282	49	the	the	DET
ijassa-759	282	50	clinic	clinic	NOUN
ijassa-759	282	51	to	to	PART
ijassa-759	282	52	predict	predict	VERB
ijassa-759	282	53	the	the	DET
ijassa-759	282	54	duration	duration	NOUN
ijassa-759	282	55	of	of	ADP
ijassa-759	282	56	the	the	DET
ijassa-759	282	57	periods	period	NOUN
ijassa-759	282	58	between	between	ADP
ijassa-759	282	59	repeated	repeat	VERB
ijassa-759	282	60	injections	injection	NOUN
ijassa-759	282	61	of	of	ADP
ijassa-759	282	62	the	the	DET
ijassa-759	282	63	viral	viral	ADJ
ijassa-759	282	64	vaccine	vaccine	NOUN
ijassa-759	282	65	for	for	ADP
ijassa-759	282	66	the	the	DET
ijassa-759	282	67	clinic	clinic	NOUN
ijassa-759	282	68	according	accord	VERB
ijassa-759	282	69	to	to	ADP
ijassa-759	282	70	the	the	DET
ijassa-759	282	71	results	result	NOUN
ijassa-759	282	72	obtained	obtain	VERB
ijassa-759	282	73	in	in	ADP
ijassa-759	282	74	the	the	DET
ijassa-759	282	75	experiment	experiment	NOUN
ijassa-759	282	76	on	on	ADP
ijassa-759	282	77	mice	mouse	NOUN
ijassa-759	282	78	,	,	PUNCT
ijassa-759	282	79	it	it	PRON
ijassa-759	282	80	is	be	AUX
ijassa-759	282	81	proposed	propose	VERB
ijassa-759	282	82	to	to	PART
ijassa-759	282	83	use	use	VERB
ijassa-759	282	84	the	the	DET
ijassa-759	282	85	well	well	ADV
ijassa-759	282	86	-	-	PUNCT
ijassa-759	282	87	known	know	VERB
ijassa-759	282	88	in	in	ADP
ijassa-759	282	89	biodynamics	biodynamics	PROPN
ijassa-759	282	90	allometric	allometric	ADJ
ijassa-759	282	91	ratio	ratio	NOUN
ijassa-759	282	92	,	,	PUNCT
ijassa-759	282	93	which	which	PRON
ijassa-759	282	94	connects	connect	VERB
ijassa-759	282	95	the	the	DET
ijassa-759	282	96	rate	rate	NOUN
ijassa-759	282	97	of	of	ADP
ijassa-759	282	98	metabolic	metabolic	NOUN
ijassa-759	282	99	processes	process	NOUN
ijassa-759	282	100	in	in	ADP
ijassa-759	282	101	the	the	DET
ijassa-759	282	102	body	body	NOUN
ijassa-759	282	103	with	with	ADP
ijassa-759	282	104	the	the	DET
ijassa-759	282	105	body	body	NOUN
ijassa-759	282	106	weight	weight	NOUN
ijassa-759	282	107	in	in	ADP
ijassa-759	282	108	mammals	mammal	NOUN
ijassa-759	282	109	[	[	PUNCT
ijassa-759	282	110	24	24	NUM
ijassa-759	282	111	-	-	SYM
ijassa-759	282	112	26	26	NUM
ijassa-759	282	113	]	]	PUNCT
ijassa-759	282	114	:	:	PUNCT
ijassa-759	282	115	bm	bm	PROPN
ijassa-759	282	116	a	a	DET
ijassa-759	282	117	s=	s=	NOUN
ijassa-759	282	118			PROPN
ijassa-759	282	119	,	,	PUNCT
ijassa-759	282	120	(	(	PUNCT
ijassa-759	282	121	25	25	NUM
ijassa-759	282	122	)	)	PUNCT
ijassa-759	282	123	where	where	SCONJ
ijassa-759	282	124	m	m	NOUN
ijassa-759	282	125	is	be	AUX
ijassa-759	282	126	the	the	DET
ijassa-759	282	127	body	body	NOUN
ijassa-759	282	128	weight	weight	NOUN
ijassa-759	282	129	of	of	ADP
ijassa-759	282	130	the	the	DET
ijassa-759	282	131	mammal	mammal	NOUN
ijassa-759	282	132	,	,	PUNCT
ijassa-759	282	133	s	s	PART
ijassa-759	282	134	is	be	AUX
ijassa-759	282	135	the	the	DET
ijassa-759	282	136	rate	rate	NOUN
ijassa-759	282	137	of	of	ADP
ijassa-759	282	138	metabolic	metabolic	NOUN
ijassa-759	282	139	processes	process	NOUN
ijassa-759	282	140	in	in	ADP
ijassa-759	282	141	mammals	mammal	NOUN
ijassa-759	282	142	,	,	PUNCT
ijassa-759	282	143	a	a	PRON
ijassa-759	282	144	and	and	CCONJ
ijassa-759	282	145	b	b	NOUN
ijassa-759	282	146	are	be	AUX
ijassa-759	282	147	constant	constant	ADJ
ijassa-759	282	148	parameters	parameter	NOUN
ijassa-759	282	149	.	.	PUNCT
ijassa-759	283	1	allometric	allometric	ADJ
ijassa-759	283	2	relations	relation	NOUN
ijassa-759	283	3	connect	connect	VERB
ijassa-759	283	4	the	the	DET
ijassa-759	283	5	body	body	NOUN
ijassa-759	283	6	weight	weight	NOUN
ijassa-759	283	7	of	of	ADP
ijassa-759	283	8	animals	animal	NOUN
ijassa-759	283	9	and	and	CCONJ
ijassa-759	283	10	humans	human	NOUN
ijassa-759	283	11	with	with	ADP
ijassa-759	283	12	a	a	DET
ijassa-759	283	13	variety	variety	NOUN
ijassa-759	283	14	of	of	ADP
ijassa-759	283	15	other	other	ADJ
ijassa-759	283	16	biological	biological	ADJ
ijassa-759	283	17	parameters	parameter	NOUN
ijassa-759	283	18	that	that	PRON
ijassa-759	283	19	reflect	reflect	VERB
ijassa-759	283	20	the	the	DET
ijassa-759	283	21	temporal	temporal	ADJ
ijassa-759	283	22	characteristics	characteristic	NOUN
ijassa-759	283	23	of	of	ADP
ijassa-759	283	24	the	the	DET
ijassa-759	283	25	processes	process	NOUN
ijassa-759	283	26	of	of	ADP
ijassa-759	283	27	vital	vital	ADJ
ijassa-759	283	28	activity	activity	NOUN
ijassa-759	283	29	of	of	ADP
ijassa-759	283	30	the	the	DET
ijassa-759	283	31	organism	organism	NOUN
ijassa-759	283	32	,	,	PUNCT
ijassa-759	283	33	including	include	VERB
ijassa-759	283	34	the	the	DET
ijassa-759	283	35	duration	duration	NOUN
ijassa-759	283	36	of	of	ADP
ijassa-759	283	37	its	its	PRON
ijassa-759	283	38	life	life	NOUN
ijassa-759	283	39	[	[	X
ijassa-759	283	40	24	24	NUM
ijassa-759	283	41	-	-	SYM
ijassa-759	283	42	26	26	NUM
ijassa-759	283	43	]	]	PUNCT
ijassa-759	283	44	.	.	PUNCT
ijassa-759	284	1	then	then	ADV
ijassa-759	284	2	the	the	DET
ijassa-759	284	3	ratio	ratio	NOUN
ijassa-759	284	4	(	(	PUNCT
ijassa-759	284	5	25	25	NUM
ijassa-759	284	6	)	)	PUNCT
ijassa-759	284	7	can	can	AUX
ijassa-759	284	8	connect	connect	VERB
ijassa-759	284	9	the	the	DET
ijassa-759	284	10	body	body	NOUN
ijassa-759	284	11	weight	weight	NOUN
ijassa-759	284	12	of	of	ADP
ijassa-759	284	13	the	the	DET
ijassa-759	284	14	animal	animal	NOUN
ijassa-759	284	15	with	with	ADP
ijassa-759	284	16	any	any	DET
ijassa-759	284	17	other	other	ADJ
ijassa-759	284	18	time	time	NOUN
ijassa-759	284	19	parameter	parameter	NOUN
ijassa-759	284	20	.	.	PUNCT
ijassa-759	285	1	in	in	ADP
ijassa-759	285	2	this	this	DET
ijassa-759	285	3	case	case	NOUN
ijassa-759	285	4	,	,	PUNCT
ijassa-759	285	5	such	such	DET
ijassa-759	285	6	a	a	DET
ijassa-759	285	7	time	time	NOUN
ijassa-759	285	8	parameter	parameter	NOUN
ijassa-759	285	9	is	be	AUX
ijassa-759	285	10	considered	consider	VERB
ijassa-759	285	11	the	the	DET
ijassa-759	285	12	duration	duration	NOUN
ijassa-759	285	13	of	of	ADP
ijassa-759	285	14	the	the	DET
ijassa-759	285	15	periods	period	NOUN
ijassa-759	285	16	between	between	ADP
ijassa-759	285	17	successive	successive	ADJ
ijassa-759	285	18	injections	injection	NOUN
ijassa-759	285	19	of	of	ADP
ijassa-759	285	20	the	the	DET
ijassa-759	285	21	viral	viral	ADJ
ijassa-759	285	22	vaccine	vaccine	NOUN
ijassa-759	285	23	in	in	ADP
ijassa-759	285	24	the	the	DET
ijassa-759	285	25	implementation	implementation	NOUN
ijassa-759	285	26	of	of	ADP
ijassa-759	285	27	the	the	DET
ijassa-759	285	28	strategy	strategy	NOUN
ijassa-759	285	29	of	of	ADP
ijassa-759	285	30	stabilizing	stabilize	VERB
ijassa-759	285	31	the	the	DET
ijassa-759	285	32	tumor	tumor	NOUN
ijassa-759	285	33	size	size	NOUN
ijassa-759	285	34	∆t	∆t	PROPN
ijassa-759	285	35	:	:	PUNCT
ijassa-759	285	36	(	(	PUNCT
ijassa-759	285	37	)	)	PUNCT
ijassa-759	285	38	bm	bm	PROPN
ijassa-759	285	39	a	a	DET
ijassa-759	285	40	t=	t=	ADJ
ijassa-759	285	41			PROPN
ijassa-759	285	42			NOUN
ijassa-759	285	43	.	.	PUNCT
ijassa-759	286	1	(	(	PUNCT
ijassa-759	286	2	26	26	NUM
ijassa-759	286	3	)	)	PUNCT
ijassa-759	286	4	for	for	ADP
ijassa-759	286	5	two	two	NUM
ijassa-759	286	6	species	specie	NOUN
ijassa-759	286	7	of	of	ADP
ijassa-759	286	8	mammals	mammal	NOUN
ijassa-759	286	9	,	,	PUNCT
ijassa-759	286	10	which	which	PRON
ijassa-759	286	11	are	be	AUX
ijassa-759	286	12	human	human	ADJ
ijassa-759	286	13	and	and	CCONJ
ijassa-759	286	14	experimental	experimental	ADJ
ijassa-759	286	15	mouse	mouse	NOUN
ijassa-759	286	16	,	,	PUNCT
ijassa-759	286	17	we	we	PRON
ijassa-759	286	18	can	can	AUX
ijassa-759	286	19	write	write	VERB
ijassa-759	286	20	the	the	DET
ijassa-759	286	21	allometric	allometric	ADJ
ijassa-759	286	22	ratio	ratio	NOUN
ijassa-759	286	23	of	of	ADP
ijassa-759	286	24	the	the	DET
ijassa-759	286	25	form	form	NOUN
ijassa-759	286	26	:	:	PUNCT
ijassa-759	286	27	(	(	PUNCT
ijassa-759	286	28	)	)	PUNCT
ijassa-759	286	29	human	human	PROPN
ijassa-759	286	30	human	human	PROPN
ijassa-759	286	31	bm	bm	PROPN
ijassa-759	286	32	a	a	DET
ijassa-759	286	33	t=	t=	ADJ
ijassa-759	286	34			NUM
ijassa-759	286	35			NOUN
ijassa-759	286	36	and	and	CCONJ
ijassa-759	286	37	(	(	PUNCT
ijassa-759	286	38	)	)	PUNCT
ijassa-759	286	39	mouse	mouse	NOUN
ijassa-759	286	40	mouse	mouse	NOUN
ijassa-759	286	41	bm	bm	PROPN
ijassa-759	286	42	a	a	DET
ijassa-759	286	43	t=	t=	ADJ
ijassa-759	286	44			NUM
ijassa-759	286	45			NOUN
ijassa-759	286	46	,	,	PUNCT
ijassa-759	286	47	(	(	PUNCT
ijassa-759	286	48	27	27	NUM
ijassa-759	286	49	)	)	PUNCT
ijassa-759	286	50	where	where	SCONJ
ijassa-759	286	51	humant	humant	NUM
ijassa-759	286	52	and	and	CCONJ
ijassa-759	286	53	mouset	mouset	NUM
ijassa-759	286	54	denote	denote	VERB
ijassa-759	286	55	the	the	DET
ijassa-759	286	56	duration	duration	NOUN
ijassa-759	286	57	of	of	ADP
ijassa-759	286	58	the	the	DET
ijassa-759	286	59	periods	period	NOUN
ijassa-759	286	60	between	between	ADP
ijassa-759	286	61	the	the	DET
ijassa-759	286	62	injections	injection	NOUN
ijassa-759	286	63	of	of	ADP
ijassa-759	286	64	viral	viral	ADJ
ijassa-759	286	65	vaccines	vaccine	NOUN
ijassa-759	286	66	for	for	ADP
ijassa-759	286	67	human	human	ADJ
ijassa-759	286	68	being	being	NOUN
ijassa-759	286	69	and	and	CCONJ
ijassa-759	286	70	for	for	ADP
ijassa-759	286	71	mouse	mouse	NOUN
ijassa-759	286	72	.	.	PUNCT
ijassa-759	287	1	to	to	PART
ijassa-759	287	2	define	define	VERB
ijassa-759	287	3	the	the	DET
ijassa-759	287	4	duration	duration	NOUN
ijassa-759	287	5	of	of	ADP
ijassa-759	287	6	the	the	DET
ijassa-759	287	7	period	period	NOUN
ijassa-759	287	8	between	between	ADP
ijassa-759	287	9	injections	injection	NOUN
ijassa-759	287	10	for	for	ADP
ijassa-759	287	11	the	the	DET
ijassa-759	287	12	human	human	NOUN
ijassa-759	287	13	being	being	NOUN
ijassa-759	287	14	we	we	PRON
ijassa-759	287	15	can	can	AUX
ijassa-759	287	16	use	use	VERB
ijassa-759	287	17	the	the	DET
ijassa-759	287	18	ratio	ratio	NOUN
ijassa-759	287	19	:	:	PUNCT
ijassa-759	287	20	(	(	PUNCT
ijassa-759	287	21	)	)	PUNCT
ijassa-759	287	22	human	human	PROPN
ijassa-759	287	23	human	human	PROPN
ijassa-759	287	24	b	b	PROPN
ijassa-759	287	25	mouse	mouse	PROPN
ijassa-759	287	26	mouse	mouse	PROPN
ijassa-759	287	27	m	m	VERB
ijassa-759	287	28	t	t	PROPN
ijassa-759	287	29	m	m	PROPN
ijassa-759	287	30	t	t	NOUN
ijassa-759	287	31			NOUN
ijassa-759	287	32	=	=	PUNCT
ijassa-759	288	1			X
ijassa-759	288	2	based	base	VERB
ijassa-759	288	3	on	on	ADP
ijassa-759	288	4	the	the	DET
ijassa-759	288	5	fact	fact	NOUN
ijassa-759	288	6	that	that	SCONJ
ijassa-759	288	7	the	the	DET
ijassa-759	288	8	average	average	ADJ
ijassa-759	288	9	body	body	NOUN
ijassa-759	288	10	weight	weight	NOUN
ijassa-759	288	11	values	value	NOUN
ijassa-759	288	12	are	be	AUX
ijassa-759	288	13	known	know	VERB
ijassa-759	288	14	for	for	ADP
ijassa-759	288	15	a	a	DET
ijassa-759	288	16	human	human	ADJ
ijassa-759	288	17	being	being	NOUN
ijassa-759	288	18	and	and	CCONJ
ijassa-759	288	19	a	a	DET
ijassa-759	288	20	mouse	mouse	NOUN
ijassa-759	288	21	,	,	PUNCT
ijassa-759	288	22	and	and	CCONJ
ijassa-759	288	23	the	the	DET
ijassa-759	288	24	interval	interval	NOUN
ijassa-759	288	25	between	between	ADP
ijassa-759	288	26	successive	successive	ADJ
ijassa-759	288	27	injections	injection	NOUN
ijassa-759	288	28	of	of	ADP
ijassa-759	288	29	the	the	DET
ijassa-759	288	30	vaccine	vaccine	NOUN
ijassa-759	288	31	is	be	AUX
ijassa-759	288	32	determined	determine	VERB
ijassa-759	288	33	,	,	PUNCT
ijassa-759	288	34	the	the	DET
ijassa-759	288	35	mathematical	mathematical	ADJ
ijassa-759	288	36	modeling	modeling	NOUN
ijassa-759	288	37	of	of	ADP
ijassa-759	288	38	antitumor	antitumor	PROPN
ijassa-759	288	39	viral	viral	ADJ
ijassa-759	288	40	vaccine	vaccine	NOUN
ijassa-759	288	41	therapy	therapy	NOUN
ijassa-759	288	42	…	…	PUNCT
ijassa-759	288	43	copyright	copyright	NOUN
ijassa-759	288	44	©	©	PROPN
ijassa-759	288	45	2020	2020	NUM
ijassa-759	288	46	assa	assa	NOUN
ijassa-759	288	47	.	.	PUNCT
ijassa-759	289	1	adv	adv	PROPN
ijassa-759	289	2	.	.	PUNCT
ijassa-759	290	1	in	in	ADP
ijassa-759	290	2	systems	system	NOUN
ijassa-759	290	3	science	science	NOUN
ijassa-759	290	4	and	and	CCONJ
ijassa-759	290	5	appl	appl	NOUN
ijassa-759	290	6	.	.	PUNCT
ijassa-759	291	1	(	(	PUNCT
ijassa-759	291	2	2020	2020	NUM
ijassa-759	291	3	)	)	PUNCT
ijassa-759	291	4	17	17	NUM
ijassa-759	291	5	duration	duration	NOUN
ijassa-759	291	6	of	of	ADP
ijassa-759	291	7	the	the	DET
ijassa-759	291	8	period	period	NOUN
ijassa-759	291	9	between	between	ADP
ijassa-759	291	10	injections	injection	NOUN
ijassa-759	291	11	of	of	ADP
ijassa-759	291	12	the	the	DET
ijassa-759	291	13	vaccine	vaccine	NOUN
ijassa-759	291	14	for	for	ADP
ijassa-759	291	15	a	a	DET
ijassa-759	291	16	person	person	NOUN
ijassa-759	291	17	can	can	AUX
ijassa-759	291	18	be	be	AUX
ijassa-759	291	19	calculated	calculate	VERB
ijassa-759	291	20	from	from	ADP
ijassa-759	291	21	the	the	DET
ijassa-759	291	22	equation	equation	NOUN
ijassa-759	291	23	:	:	PUNCT
ijassa-759	291	24	1/	1/	NUM
ijassa-759	291	25	(	(	PUNCT
ijassa-759	291	26	)	)	PUNCT
ijassa-759	291	27	human	human	PROPN
ijassa-759	291	28	human	human	PROPN
ijassa-759	291	29	mouse	mouse	PROPN
ijassa-759	291	30	b	b	PROPN
ijassa-759	291	31	mouse	mouse	PROPN
ijassa-759	291	32	m	m	PROPN
ijassa-759	291	33	t	t	PROPN
ijassa-759	291	34	t	t	PROPN
ijassa-759	291	35	m	m	NOUN
ijassa-759	291	36			PUNCT
ijassa-759	291	37	=	=	PRON
ijassa-759	291	38			X
ijassa-759	291	39	(	(	PUNCT
ijassa-759	291	40	28	28	NUM
ijassa-759	291	41	)	)	PUNCT
ijassa-759	291	42	the	the	DET
ijassa-759	291	43	value	value	NOUN
ijassa-759	291	44	of	of	ADP
ijassa-759	291	45	the	the	DET
ijassa-759	291	46	parameter	parameter	PROPN
ijassa-759	291	47	b	b	PROPN
ijassa-759	291	48	was	be	AUX
ijassa-759	291	49	calculated	calculate	VERB
ijassa-759	291	50	as	as	ADP
ijassa-759	291	51	the	the	DET
ijassa-759	291	52	slope	slope	NOUN
ijassa-759	291	53	of	of	ADP
ijassa-759	291	54	the	the	DET
ijassa-759	291	55	straight	straight	ADJ
ijassa-759	291	56	line	line	NOUN
ijassa-759	291	57	formed	form	VERB
ijassa-759	291	58	by	by	ADP
ijassa-759	291	59	the	the	DET
ijassa-759	291	60	logarithmation	logarithmation	NOUN
ijassa-759	291	61	of	of	ADP
ijassa-759	291	62	the	the	DET
ijassa-759	291	63	allometric	allometric	ADJ
ijassa-759	291	64	ratio	ratio	NOUN
ijassa-759	291	65	,	,	PUNCT
ijassa-759	291	66	which	which	PRON
ijassa-759	291	67	relates	relate	VERB
ijassa-759	291	68	the	the	DET
ijassa-759	291	69	average	average	ADJ
ijassa-759	291	70	body	body	NOUN
ijassa-759	291	71	weight	weight	NOUN
ijassa-759	291	72	of	of	ADP
ijassa-759	291	73	different	different	ADJ
ijassa-759	291	74	mammals	mammal	NOUN
ijassa-759	291	75	and	and	CCONJ
ijassa-759	291	76	humans	human	NOUN
ijassa-759	291	77	with	with	ADP
ijassa-759	291	78	the	the	DET
ijassa-759	291	79	average	average	ADJ
ijassa-759	291	80	life	life	NOUN
ijassa-759	291	81	expectancy	expectancy	NOUN
ijassa-759	291	82	lifet	lifet	NOUN
ijassa-759	291	83	(	(	PUNCT
ijassa-759	291	84	fig	fig	NOUN
ijassa-759	291	85	.	.	PUNCT
ijassa-759	292	1	15	15	NUM
ijassa-759	292	2	)	)	PUNCT
ijassa-759	293	1	[	[	X
ijassa-759	293	2	10	10	NUM
ijassa-759	293	3	]	]	X
ijassa-759	293	4	:	:	PUNCT
ijassa-759	293	5	ln	ln	PROPN
ijassa-759	293	6	ln	ln	PROPN
ijassa-759	293	7	ln	ln	ADJ
ijassa-759	293	8	lnlife	lnlife	NOUN
ijassa-759	293	9	lifem	lifem	PROPN
ijassa-759	293	10	b	b	PROPN
ijassa-759	293	11	t	t	PROPN
ijassa-759	293	12	a	a	DET
ijassa-759	293	13	b	b	PROPN
ijassa-759	293	14	t	t	PROPN
ijassa-759	293	15	c=	c=	NOUN
ijassa-759	293	16			ADJ
ijassa-759	293	17	+	+	CCONJ
ijassa-759	293	18	=	=	PUNCT
ijassa-759	293	19			VERB
ijassa-759	293	20	+	+	CCONJ
ijassa-759	293	21	(	(	PUNCT
ijassa-759	293	22	29	29	NUM
ijassa-759	293	23	)	)	PUNCT
ijassa-759	293	24	as	as	ADP
ijassa-759	293	25	a	a	DET
ijassa-759	293	26	result	result	NOUN
ijassa-759	293	27	of	of	ADP
ijassa-759	293	28	the	the	DET
ijassa-759	293	29	regression	regression	NOUN
ijassa-759	293	30	analysis	analysis	NOUN
ijassa-759	293	31	,	,	PUNCT
ijassa-759	293	32	the	the	DET
ijassa-759	293	33	calculated	calculated	ADJ
ijassa-759	293	34	value	value	NOUN
ijassa-759	293	35	of	of	ADP
ijassa-759	293	36	the	the	DET
ijassa-759	293	37	parameter	parameter	PROPN
ijassa-759	293	38	b	b	PROPN
ijassa-759	293	39	was	be	AUX
ijassa-759	293	40	obtained	obtain	VERB
ijassa-759	293	41	as	as	ADP
ijassa-759	293	42	b	b	PROPN
ijassa-759	293	43	=	=	SYM
ijassa-759	293	44	2,4981	2,4981	PROPN
ijassa-759	293	45	,	,	PUNCT
ijassa-759	293	46	which	which	PRON
ijassa-759	293	47	characterizes	characterize	VERB
ijassa-759	293	48	the	the	DET
ijassa-759	293	49	slope	slope	NOUN
ijassa-759	293	50	of	of	ADP
ijassa-759	293	51	the	the	DET
ijassa-759	293	52	regression	regression	NOUN
ijassa-759	293	53	line	line	NOUN
ijassa-759	293	54	.	.	PUNCT
ijassa-759	294	1	fig	fig	NOUN
ijassa-759	294	2	.	.	PUNCT
ijassa-759	295	1	15	15	NUM
ijassa-759	295	2	.	.	PUNCT
ijassa-759	296	1	dependence	dependence	NOUN
ijassa-759	296	2	of	of	ADP
ijassa-759	296	3	the	the	DET
ijassa-759	296	4	life	life	NOUN
ijassa-759	296	5	expectancy	expectancy	NOUN
ijassa-759	296	6	of	of	ADP
ijassa-759	296	7	animals	animal	NOUN
ijassa-759	296	8	on	on	ADP
ijassa-759	296	9	their	their	PRON
ijassa-759	296	10	body	body	NOUN
ijassa-759	296	11	weight	weight	NOUN
ijassa-759	296	12	for	for	ADP
ijassa-759	296	13	○	○	PROPN
ijassa-759	296	14	mouse	mouse	PROPN
ijassa-759	296	15	,	,	PUNCT
ijassa-759	296	16	□	□	PUNCT
ijassa-759	296	17	rats	rat	NOUN
ijassa-759	296	18	,	,	PUNCT
ijassa-759	296	19	+	+	CCONJ
ijassa-759	296	20	guinea	guinea	NOUN
ijassa-759	296	21	pigs	pig	NOUN
ijassa-759	296	22	,	,	PUNCT
ijassa-759	296	23	х	х	PROPN
ijassa-759	296	24	rabbits	rabbit	NOUN
ijassa-759	296	25	,	,	PUNCT
ijassa-759	296	26	◊	◊	ADJ
ijassa-759	296	27	dogs	dog	NOUN
ijassa-759	296	28	,	,	PUNCT
ijassa-759	296	29	and	and	CCONJ
ijassa-759	296	30	*	*	PUNCT
ijassa-759	296	31	humans	human	NOUN
ijassa-759	296	32	[	[	X
ijassa-759	296	33	10	10	NUM
ijassa-759	296	34	]	]	X
ijassa-759	296	35	taking	take	VERB
ijassa-759	296	36	in	in	ADP
ijassa-759	296	37	equation	equation	NOUN
ijassa-759	296	38	(	(	PUNCT
ijassa-759	296	39	28	28	NUM
ijassa-759	296	40	)	)	PUNCT
ijassa-759	296	41	the	the	DET
ijassa-759	296	42	mass	mass	NOUN
ijassa-759	296	43	of	of	ADP
ijassa-759	296	44	the	the	DET
ijassa-759	296	45	mouse	mouse	NOUN
ijassa-759	296	46	equal	equal	ADJ
ijassa-759	296	47	to	to	ADP
ijassa-759	296	48	mousem	mousem	NOUN
ijassa-759	296	49	=	=	PUNCT
ijassa-759	296	50	0,025	0,025	NUM
ijassa-759	296	51	kg	kg	NOUN
ijassa-759	296	52	and	and	CCONJ
ijassa-759	296	53	the	the	DET
ijassa-759	296	54	weight	weight	NOUN
ijassa-759	296	55	of	of	ADP
ijassa-759	296	56	a	a	DET
ijassa-759	296	57	human	human	ADJ
ijassa-759	296	58	being	being	NOUN
ijassa-759	296	59	is	be	AUX
ijassa-759	296	60	equal	equal	ADJ
ijassa-759	296	61	to	to	ADP
ijassa-759	296	62	humanm	humanm	ADJ
ijassa-759	296	63	=	=	SYM
ijassa-759	296	64	70	70	NUM
ijassa-759	296	65	kg	kg	NOUN
ijassa-759	296	66	,	,	PUNCT
ijassa-759	296	67	with	with	ADP
ijassa-759	296	68	b	b	X
ijassa-759	296	69	=	=	SYM
ijassa-759	296	70	2,4981	2,4981	NUM
ijassa-759	296	71	=	=	SYM
ijassa-759	296	72	2,5	2,5	NUM
ijassa-759	296	73	and	and	CCONJ
ijassa-759	296	74	1	1	NUM
ijassa-759	296	75	/	/	SYM
ijassa-759	296	76	b	b	NOUN
ijassa-759	296	77	=	=	NOUN
ijassa-759	296	78	0,39	0,39	NOUN
ijassa-759	296	79	we	we	PRON
ijassa-759	296	80	can	can	AUX
ijassa-759	296	81	calculate	calculate	VERB
ijassa-759	296	82	the	the	DET
ijassa-759	296	83	time	time	NOUN
ijassa-759	296	84	conversion	conversion	NOUN
ijassa-759	296	85	factor	factor	NOUN
ijassa-759	296	86	from	from	ADP
ijassa-759	296	87	mouse	mouse	PROPN
ijassa-759	296	88	to	to	ADP
ijassa-759	296	89	human	human	NOUN
ijassa-759	296	90	.	.	PUNCT
ijassa-759	297	1	0.470	0.470	NUM
ijassa-759	297	2	(	(	PUNCT
ijassa-759	297	3	)	)	PUNCT
ijassa-759	297	4	23.9	23.9	NUM
ijassa-759	297	5	0.025	0.025	NUM
ijassa-759	297	6	k	k	NOUN
ijassa-759	297	7	=	=	PUNCT
ijassa-759	298	1	=	=	PUNCT
ijassa-759	298	2	then	then	ADV
ijassa-759	298	3	the	the	DET
ijassa-759	298	4	duration	duration	NOUN
ijassa-759	298	5	of	of	ADP
ijassa-759	298	6	the	the	DET
ijassa-759	298	7	period	period	NOUN
ijassa-759	298	8	between	between	ADP
ijassa-759	298	9	injections	injection	NOUN
ijassa-759	298	10	of	of	ADP
ijassa-759	298	11	the	the	DET
ijassa-759	298	12	vaccine	vaccine	NOUN
ijassa-759	298	13	for	for	ADP
ijassa-759	298	14	a	a	DET
ijassa-759	298	15	human	human	ADJ
ijassa-759	298	16	being	being	NOUN
ijassa-759	298	17	can	can	AUX
ijassa-759	298	18	be	be	AUX
ijassa-759	298	19	calculated	calculate	VERB
ijassa-759	298	20	from	from	ADP
ijassa-759	298	21	the	the	DET
ijassa-759	298	22	expression	expression	NOUN
ijassa-759	298	23	:	:	PUNCT
ijassa-759	298	24	1/	1/	NUM
ijassa-759	298	25	(	(	PUNCT
ijassa-759	298	26	)	)	PUNCT
ijassa-759	298	27	human	human	PROPN
ijassa-759	298	28	human	human	PROPN
ijassa-759	298	29	mouse	mouse	PROPN
ijassa-759	298	30	b	b	PROPN
ijassa-759	298	31	mouse	mouse	PROPN
ijassa-759	298	32	mouse	mouse	PROPN
ijassa-759	298	33	m	m	PROPN
ijassa-759	298	34	t	t	PROPN
ijassa-759	298	35	t	t	PROPN
ijassa-759	298	36	t	t	PROPN
ijassa-759	299	1	k	k	X
ijassa-759	299	2	m	m	VERB
ijassa-759	299	3			NOUN
ijassa-759	299	4	=	=	X
ijassa-759	299	5			X
ijassa-759	299	6	=	=	X
ijassa-759	299	7			PUNCT
ijassa-759	299	8			NUM
ijassa-759	299	9	(	(	PUNCT
ijassa-759	299	10	30	30	NUM
ijassa-759	299	11	)	)	PUNCT
ijassa-759	299	12	the	the	DET
ijassa-759	299	13	results	result	NOUN
ijassa-759	299	14	of	of	ADP
ijassa-759	299	15	the	the	DET
ijassa-759	299	16	evaluation	evaluation	NOUN
ijassa-759	299	17	of	of	ADP
ijassa-759	299	18	the	the	DET
ijassa-759	299	19	duration	duration	NOUN
ijassa-759	299	20	of	of	ADP
ijassa-759	299	21	the	the	DET
ijassa-759	299	22	periods	period	NOUN
ijassa-759	299	23	between	between	ADP
ijassa-759	299	24	repeated	repeat	VERB
ijassa-759	299	25	injections	injection	NOUN
ijassa-759	299	26	of	of	ADP
ijassa-759	299	27	viral	viral	ADJ
ijassa-759	299	28	vaccines	vaccine	NOUN
ijassa-759	299	29	in	in	ADP
ijassa-759	299	30	the	the	DET
ijassa-759	299	31	implementation	implementation	NOUN
ijassa-759	299	32	of	of	ADP
ijassa-759	299	33	the	the	DET
ijassa-759	299	34	strategy	strategy	NOUN
ijassa-759	299	35	of	of	ADP
ijassa-759	299	36	tumor	tumor	NOUN
ijassa-759	299	37	size	size	NOUN
ijassa-759	299	38	stabilization	stabilization	NOUN
ijassa-759	299	39	for	for	ADP
ijassa-759	299	40	humans	human	NOUN
ijassa-759	299	41	and	and	CCONJ
ijassa-759	299	42	mouse	mouse	NOUN
ijassa-759	299	43	are	be	AUX
ijassa-759	299	44	shown	show	VERB
ijassa-759	299	45	in	in	ADP
ijassa-759	299	46	the	the	DET
ijassa-759	299	47	table	table	NOUN
ijassa-759	299	48	1	1	NUM
ijassa-759	299	49	.	.	PUNCT
ijassa-759	299	50	table	table	NOUN
ijassa-759	299	51	1	1	NUM
ijassa-759	299	52	.	.	PUNCT
ijassa-759	299	53	intervals	interval	NOUN
ijassa-759	299	54	between	between	ADP
ijassa-759	299	55	repeated	repeat	VERB
ijassa-759	299	56	injections	injection	NOUN
ijassa-759	299	57	of	of	ADP
ijassa-759	299	58	viral	viral	ADJ
ijassa-759	299	59	vaccines	vaccine	NOUN
ijassa-759	299	60	for	for	ADP
ijassa-759	299	61	humans	human	NOUN
ijassa-759	299	62	and	and	CCONJ
ijassa-759	299	63	mouse	mouse	NOUN
ijassa-759	299	64	obtained	obtain	VERB
ijassa-759	299	65	on	on	ADP
ijassa-759	299	66	the	the	DET
ijassa-759	299	67	basis	basis	NOUN
ijassa-759	299	68	of	of	ADP
ijassa-759	299	69	allometric	allometric	ADJ
ijassa-759	299	70	ratios	ratio	NOUN
ijassa-759	299	71	dose	dose	VERB
ijassa-759	299	72	of	of	ADP
ijassa-759	299	73	viral	viral	ADJ
ijassa-759	299	74	vaccine	vaccine	NOUN
ijassa-759	299	75	0v	0v	NOUN
ijassa-759	299	76	and	and	CCONJ
ijassa-759	299	77	when	when	SCONJ
ijassa-759	299	78	the	the	DET
ijassa-759	299	79	vaccine	vaccine	NOUN
ijassa-759	299	80	was	be	AUX
ijassa-759	299	81	first	first	ADJ
ijassa-759	299	82	interval	interval	NOUN
ijassa-759	299	83	between	between	ADP
ijassa-759	299	84	injections	injection	NOUN
ijassa-759	299	85	to	to	PART
ijassa-759	299	86	stabilize	stabilize	VERB
ijassa-759	299	87	tumor	tumor	NOUN
ijassa-759	299	88	size	size	NOUN
ijassa-759	299	89	in	in	ADP
ijassa-759	299	90	the	the	DET
ijassa-759	299	91	experiment	experiment	NOUN
ijassa-759	299	92	on	on	ADP
ijassa-759	299	93	mouse	mouse	NOUN
ijassa-759	299	94	0	0	NUM
ijassa-759	299	95	1	1	NUM
ijassa-759	299	96	(	(	PUNCT
ijassa-759	299	97	,	,	PUNCT
ijassa-759	299	98	)	)	PUNCT
ijassa-759	299	99	mouset	mouset	NOUN
ijassa-759	299	100	v	v	ADJ
ijassa-759	299	101			NOUN
ijassa-759	299	102	interval	interval	NOUN
ijassa-759	299	103	between	between	ADP
ijassa-759	299	104	injections	injection	NOUN
ijassa-759	299	105	to	to	PART
ijassa-759	299	106	stabilize	stabilize	VERB
ijassa-759	299	107	the	the	DET
ijassa-759	299	108	size	size	NOUN
ijassa-759	299	109	of	of	ADP
ijassa-759	299	110	the	the	DET
ijassa-759	299	111	tumor	tumor	NOUN
ijassa-759	299	112	in	in	ADP
ijassa-759	299	113	the	the	DET
ijassa-759	299	114	clinic	clinic	NOUN
ijassa-759	299	115	for	for	ADP
ijassa-759	299	116	humans	human	NOUN
ijassa-759	299	117	0	0	NUM
ijassa-759	299	118	1	1	NUM
ijassa-759	299	119	(	(	PUNCT
ijassa-759	299	120	,	,	PUNCT
ijassa-759	299	121	)	)	PUNCT
ijassa-759	299	122	humant	humant	NOUN
ijassa-759	299	123	v	v	PROPN
ijassa-759	299	124			PROPN
ijassa-759	299	125	n.a	n.a	PROPN
ijassa-759	299	126	.	.	PROPN
ijassa-759	299	127	babushkina	babushkina	PROPN
ijassa-759	299	128	,	,	PUNCT
ijassa-759	300	1	e.a	e.a	PROPN
ijassa-759	300	2	.	.	PROPN
ijassa-759	300	3	kuzina	kuzina	PROPN
ijassa-759	300	4	copyright	copyright	PROPN
ijassa-759	300	5	©	©	PROPN
ijassa-759	300	6	2020	2020	NUM
ijassa-759	300	7	assa	assa	NOUN
ijassa-759	300	8	.	.	PUNCT
ijassa-759	301	1	adv	adv	PROPN
ijassa-759	301	2	.	.	PUNCT
ijassa-759	302	1	in	in	ADP
ijassa-759	302	2	systems	system	NOUN
ijassa-759	302	3	science	science	NOUN
ijassa-759	302	4	and	and	CCONJ
ijassa-759	302	5	appl	appl	NOUN
ijassa-759	302	6	.	.	PUNCT
ijassa-759	303	1	(	(	PUNCT
ijassa-759	303	2	2020	2020	NUM
ijassa-759	303	3	)	)	PUNCT
ijassa-759	303	4	18	18	NUM
ijassa-759	303	5	introduced	introduce	VERB
ijassa-759	303	6	1	1	NUM
ijassa-759	303	7	0v	0v	NOUN
ijassa-759	303	8	=	=	NOUN
ijassa-759	303	9	0.04	0.04	NUM
ijassa-759	303	10	on	on	ADP
ijassa-759	303	11	1	1	NUM
ijassa-759	303	12	=	=	SYM
ijassa-759	303	13	1	1	NUM
ijassa-759	303	14	day	day	NOUN
ijassa-759	303	15	0	0	NUM
ijassa-759	303	16	1	1	NUM
ijassa-759	303	17	(	(	PUNCT
ijassa-759	303	18	,	,	PUNCT
ijassa-759	303	19	)	)	PUNCT
ijassa-759	303	20	mouset	mouset	NOUN
ijassa-759	303	21	v	v	NOUN
ijassa-759	303	22			NOUN
ijassa-759	303	23	=	=	PROPN
ijassa-759	303	24	17.2	17.2	NUM
ijassa-759	303	25	day	day	NOUN
ijassa-759	303	26	0	0	NUM
ijassa-759	303	27	1	1	NUM
ijassa-759	303	28	(	(	PUNCT
ijassa-759	303	29	,	,	PUNCT
ijassa-759	303	30	)	)	PUNCT
ijassa-759	303	31	humant	humant	NOUN
ijassa-759	303	32	v	v	NOUN
ijassa-759	303	33			PROPN
ijassa-759	303	34	=	=	SYM
ijassa-759	303	35	1,14	1,14	NUM
ijassa-759	303	36	year	year	NOUN
ijassa-759	303	37	0v	0v	NOUN
ijassa-759	303	38	=	=	PUNCT
ijassa-759	303	39	0.047	0.047	NUM
ijassa-759	303	40	on	on	ADP
ijassa-759	303	41	1	1	NUM
ijassa-759	303	42	=3	=3	ADJ
ijassa-759	303	43	days	day	NOUN
ijassa-759	303	44	0	0	NUM
ijassa-759	303	45	1	1	NUM
ijassa-759	303	46	(	(	PUNCT
ijassa-759	303	47	,	,	PUNCT
ijassa-759	303	48	)	)	PUNCT
ijassa-759	303	49	mouset	mouset	NOUN
ijassa-759	303	50	v	v	NOUN
ijassa-759	303	51			NOUN
ijassa-759	303	52	=	=	PROPN
ijassa-759	303	53	18.4	18.4	NUM
ijassa-759	303	54	day	day	NOUN
ijassa-759	303	55	0	0	NUM
ijassa-759	303	56	1	1	NUM
ijassa-759	303	57	(	(	PUNCT
ijassa-759	303	58	,	,	PUNCT
ijassa-759	303	59	)	)	PUNCT
ijassa-759	303	60	humant	humant	NOUN
ijassa-759	303	61	v	v	NOUN
ijassa-759	303	62			PROPN
ijassa-759	303	63	=	=	PROPN
ijassa-759	303	64	1,22	1,22	NUM
ijassa-759	303	65	year	year	NOUN
ijassa-759	303	66	0v	0v	NOUN
ijassa-759	303	67	=	=	NOUN
ijassa-759	303	68	0.05	0.05	NUM
ijassa-759	303	69	on	on	ADP
ijassa-759	303	70	1	1	NUM
ijassa-759	303	71	=	=	SYM
ijassa-759	303	72	5	5	NUM
ijassa-759	303	73	days	day	NOUN
ijassa-759	303	74	0	0	NUM
ijassa-759	303	75	1	1	NUM
ijassa-759	303	76	(	(	PUNCT
ijassa-759	303	77	,	,	PUNCT
ijassa-759	303	78	)	)	PUNCT
ijassa-759	303	79	mouset	mouset	NOUN
ijassa-759	303	80	v	v	NOUN
ijassa-759	303	81			NOUN
ijassa-759	303	82	=	=	NOUN
ijassa-759	303	83	19.0	19.0	NUM
ijassa-759	303	84	day	day	NOUN
ijassa-759	303	85	0	0	NUM
ijassa-759	303	86	1	1	NUM
ijassa-759	303	87	(	(	PUNCT
ijassa-759	303	88	,	,	PUNCT
ijassa-759	303	89	)	)	PUNCT
ijassa-759	303	90	humant	humant	NOUN
ijassa-759	303	91	v	v	NOUN
ijassa-759	303	92			NOUN
ijassa-759	303	93	=	=	NOUN
ijassa-759	303	94	1,26	1,26	NUM
ijassa-759	303	95	year	year	NOUN
ijassa-759	303	96	0v	0v	NOUN
ijassa-759	303	97	=	=	PUNCT
ijassa-759	303	98	0.056	0.056	NUM
ijassa-759	303	99	on	on	ADP
ijassa-759	303	100	1	1	NUM
ijassa-759	303	101	=	=	SYM
ijassa-759	303	102	10	10	NUM
ijassa-759	303	103	days	day	NOUN
ijassa-759	303	104	0	0	NUM
ijassa-759	303	105	1	1	NUM
ijassa-759	303	106	(	(	PUNCT
ijassa-759	303	107	,	,	PUNCT
ijassa-759	303	108	)	)	PUNCT
ijassa-759	303	109	mouset	mouset	NOUN
ijassa-759	303	110	v	v	NOUN
ijassa-759	303	111			NOUN
ijassa-759	303	112	=	=	PROPN
ijassa-759	303	113	20.1	20.1	NUM
ijassa-759	303	114	day	day	NOUN
ijassa-759	303	115	0	0	NUM
ijassa-759	303	116	1	1	NUM
ijassa-759	303	117	(	(	PUNCT
ijassa-759	303	118	,	,	PUNCT
ijassa-759	303	119	)	)	PUNCT
ijassa-759	303	120	humant	humant	NOUN
ijassa-759	303	121	v	v	NOUN
ijassa-759	303	122			PROPN
ijassa-759	304	1	=	=	NOUN
ijassa-759	304	2	1,33	1,33	NUM
ijassa-759	304	3	year	year	NOUN
ijassa-759	304	4	0v	0v	NOUN
ijassa-759	304	5	=	=	PUNCT
ijassa-759	304	6	0.06	0.06	NUM
ijassa-759	304	7	on	on	ADP
ijassa-759	304	8	1	1	NUM
ijassa-759	304	9	=	=	SYM
ijassa-759	304	10	15	15	NUM
ijassa-759	304	11	days	day	NOUN
ijassa-759	304	12	0	0	NUM
ijassa-759	304	13	1	1	NUM
ijassa-759	304	14	(	(	PUNCT
ijassa-759	304	15	,	,	PUNCT
ijassa-759	304	16	)	)	PUNCT
ijassa-759	304	17	mouset	mouset	NOUN
ijassa-759	304	18	v	v	ADJ
ijassa-759	304	19			NOUN
ijassa-759	304	20	=	=	NOUN
ijassa-759	304	21	22.8	22.8	NUM
ijassa-759	304	22	day	day	NOUN
ijassa-759	304	23	0	0	NUM
ijassa-759	304	24	1	1	NUM
ijassa-759	304	25	(	(	PUNCT
ijassa-759	304	26	,	,	PUNCT
ijassa-759	304	27	)	)	PUNCT
ijassa-759	304	28	humant	humant	NOUN
ijassa-759	304	29	v	v	NOUN
ijassa-759	304	30			PROPN
ijassa-759	304	31	=	=	PROPN
ijassa-759	304	32	1,5	1,5	NUM
ijassa-759	304	33	year	year	NOUN
ijassa-759	304	34	0v	0v	NOUN
ijassa-759	304	35	=	=	PUNCT
ijassa-759	304	36	0.06	0.06	NUM
ijassa-759	304	37	on	on	ADP
ijassa-759	304	38	1	1	NUM
ijassa-759	304	39	=	=	SYM
ijassa-759	304	40	20	20	NUM
ijassa-759	304	41	days	day	NOUN
ijassa-759	304	42	0	0	NUM
ijassa-759	304	43	1	1	NUM
ijassa-759	304	44	(	(	PUNCT
ijassa-759	304	45	,	,	PUNCT
ijassa-759	304	46	)	)	PUNCT
ijassa-759	304	47	mouset	mouset	NOUN
ijassa-759	304	48	v	v	NOUN
ijassa-759	304	49			NOUN
ijassa-759	304	50	=	=	NOUN
ijassa-759	304	51	25.7	25.7	NUM
ijassa-759	304	52	day	day	NOUN
ijassa-759	304	53	0	0	NUM
ijassa-759	304	54	1	1	NUM
ijassa-759	304	55	(	(	PUNCT
ijassa-759	304	56	,	,	PUNCT
ijassa-759	304	57	)	)	PUNCT
ijassa-759	304	58	humant	humant	NOUN
ijassa-759	304	59	v	v	NOUN
ijassa-759	304	60			PROPN
ijassa-759	304	61	=	=	NOUN
ijassa-759	304	62	1,7	1,7	NUM
ijassa-759	304	63	year	year	NOUN
ijassa-759	304	64	0v	0v	NOUN
ijassa-759	304	65	=	=	SYM
ijassa-759	304	66	0.06	0.06	NUM
ijassa-759	304	67	on	on	ADP
ijassa-759	304	68	1	1	NUM
ijassa-759	304	69	=	=	SYM
ijassa-759	304	70	25	25	NUM
ijassa-759	304	71	days	day	NOUN
ijassa-759	304	72	0	0	NUM
ijassa-759	304	73	1	1	NUM
ijassa-759	304	74	(	(	PUNCT
ijassa-759	304	75	,	,	PUNCT
ijassa-759	304	76	)	)	PUNCT
ijassa-759	304	77	mouset	mouset	NOUN
ijassa-759	304	78	v	v	NOUN
ijassa-759	304	79			NOUN
ijassa-759	304	80	=	=	PROPN
ijassa-759	304	81	28.9	28.9	NUM
ijassa-759	304	82	day	day	NOUN
ijassa-759	304	83	0	0	NUM
ijassa-759	304	84	1	1	NUM
ijassa-759	304	85	(	(	PUNCT
ijassa-759	304	86	,	,	PUNCT
ijassa-759	304	87	)	)	PUNCT
ijassa-759	304	88	humant	humant	NOUN
ijassa-759	304	89	v	v	NOUN
ijassa-759	304	90			NOUN
ijassa-759	304	91	=	=	SYM
ijassa-759	304	92	2	2	NUM
ijassa-759	304	93	year	year	NOUN
ijassa-759	304	94	the	the	DET
ijassa-759	304	95	method	method	NOUN
ijassa-759	304	96	of	of	ADP
ijassa-759	304	97	allometric	allometric	ADJ
ijassa-759	304	98	ratios	ratio	NOUN
ijassa-759	304	99	is	be	AUX
ijassa-759	304	100	indirect	indirect	ADJ
ijassa-759	304	101	and	and	CCONJ
ijassa-759	304	102	can	can	AUX
ijassa-759	304	103	not	not	PART
ijassa-759	304	104	guarantee	guarantee	VERB
ijassa-759	304	105	100	100	NUM
ijassa-759	304	106	%	%	NOUN
ijassa-759	304	107	accuracy	accuracy	NOUN
ijassa-759	304	108	and	and	CCONJ
ijassa-759	304	109	reliability	reliability	NOUN
ijassa-759	304	110	of	of	ADP
ijassa-759	304	111	the	the	DET
ijassa-759	304	112	assessment	assessment	NOUN
ijassa-759	304	113	of	of	ADP
ijassa-759	304	114	the	the	DET
ijassa-759	304	115	duration	duration	NOUN
ijassa-759	304	116	of	of	ADP
ijassa-759	304	117	the	the	DET
ijassa-759	304	118	periods	period	NOUN
ijassa-759	304	119	between	between	ADP
ijassa-759	304	120	repeated	repeat	VERB
ijassa-759	304	121	injections	injection	NOUN
ijassa-759	304	122	of	of	ADP
ijassa-759	304	123	viral	viral	ADJ
ijassa-759	304	124	vaccines	vaccine	NOUN
ijassa-759	304	125	for	for	ADP
ijassa-759	304	126	their	their	PRON
ijassa-759	304	127	use	use	NOUN
ijassa-759	304	128	in	in	ADP
ijassa-759	304	129	the	the	DET
ijassa-759	304	130	clinic	clinic	NOUN
ijassa-759	304	131	.	.	PUNCT
ijassa-759	305	1	however	however	ADV
ijassa-759	305	2	,	,	PUNCT
ijassa-759	305	3	this	this	DET
ijassa-759	305	4	period	period	NOUN
ijassa-759	305	5	of	of	ADP
ijassa-759	305	6	repeated	repeat	VERB
ijassa-759	305	7	injections	injection	NOUN
ijassa-759	305	8	of	of	ADP
ijassa-759	305	9	the	the	DET
ijassa-759	305	10	viral	viral	ADJ
ijassa-759	305	11	vaccine	vaccine	NOUN
ijassa-759	305	12	may	may	AUX
ijassa-759	305	13	be	be	AUX
ijassa-759	305	14	a	a	DET
ijassa-759	305	15	recommendation	recommendation	NOUN
ijassa-759	305	16	for	for	ADP
ijassa-759	305	17	the	the	DET
ijassa-759	305	18	patient	patient	NOUN
ijassa-759	305	19	and	and	CCONJ
ijassa-759	305	20	for	for	ADP
ijassa-759	305	21	the	the	DET
ijassa-759	305	22	doctor	doctor	NOUN
ijassa-759	305	23	about	about	ADP
ijassa-759	305	24	the	the	DET
ijassa-759	305	25	timing	timing	NOUN
ijassa-759	305	26	of	of	ADP
ijassa-759	305	27	the	the	DET
ijassa-759	305	28	control	control	NOUN
ijassa-759	305	29	examination	examination	NOUN
ijassa-759	305	30	.	.	PUNCT
ijassa-759	306	1	according	accord	VERB
ijassa-759	306	2	to	to	ADP
ijassa-759	306	3	the	the	DET
ijassa-759	306	4	results	result	NOUN
ijassa-759	306	5	of	of	ADP
ijassa-759	306	6	the	the	DET
ijassa-759	306	7	examination	examination	NOUN
ijassa-759	306	8	,	,	PUNCT
ijassa-759	306	9	it	it	PRON
ijassa-759	306	10	is	be	AUX
ijassa-759	306	11	necessary	necessary	ADJ
ijassa-759	306	12	to	to	PART
ijassa-759	306	13	decide	decide	VERB
ijassa-759	306	14	on	on	ADP
ijassa-759	306	15	the	the	DET
ijassa-759	306	16	condition	condition	NOUN
ijassa-759	306	17	of	of	ADP
ijassa-759	306	18	stabilization	stabilization	NOUN
ijassa-759	306	19	of	of	ADP
ijassa-759	306	20	the	the	DET
ijassa-759	306	21	tumor	tumor	NOUN
ijassa-759	306	22	size	size	NOUN
ijassa-759	306	23	,	,	PUNCT
ijassa-759	306	24	which	which	PRON
ijassa-759	306	25	should	should	AUX
ijassa-759	306	26	not	not	PART
ijassa-759	306	27	exceed	exceed	VERB
ijassa-759	306	28	the	the	DET
ijassa-759	306	29	size	size	NOUN
ijassa-759	306	30	of	of	ADP
ijassa-759	306	31	the	the	DET
ijassa-759	306	32	tumor	tumor	NOUN
ijassa-759	306	33	at	at	ADP
ijassa-759	306	34	the	the	DET
ijassa-759	306	35	time	time	NOUN
ijassa-759	306	36	of	of	ADP
ijassa-759	306	37	treatment	treatment	NOUN
ijassa-759	306	38	.	.	PUNCT
ijassa-759	307	1	the	the	DET
ijassa-759	307	2	results	result	NOUN
ijassa-759	307	3	of	of	ADP
ijassa-759	307	4	the	the	DET
ijassa-759	307	5	medical	medical	ADJ
ijassa-759	307	6	inspection	inspection	NOUN
ijassa-759	307	7	should	should	AUX
ijassa-759	307	8	clarify	clarify	VERB
ijassa-759	307	9	the	the	DET
ijassa-759	307	10	dose	dose	NOUN
ijassa-759	307	11	and	and	CCONJ
ijassa-759	307	12	adjust	adjust	VERB
ijassa-759	307	13	the	the	DET
ijassa-759	307	14	strategy	strategy	NOUN
ijassa-759	307	15	of	of	ADP
ijassa-759	307	16	repeated	repeat	VERB
ijassa-759	307	17	injections	injection	NOUN
ijassa-759	307	18	of	of	ADP
ijassa-759	307	19	the	the	DET
ijassa-759	307	20	viral	viral	ADJ
ijassa-759	307	21	vaccine	vaccine	NOUN
ijassa-759	307	22	.	.	PUNCT
ijassa-759	308	1	7	7	X
ijassa-759	308	2	.	.	X
ijassa-759	308	3	conclusion	conclusion	NOUN
ijassa-759	308	4	the	the	DET
ijassa-759	308	5	results	result	NOUN
ijassa-759	308	6	of	of	ADP
ijassa-759	308	7	the	the	DET
ijassa-759	308	8	computational	computational	ADJ
ijassa-759	308	9	experiment	experiment	NOUN
ijassa-759	308	10	conducted	conduct	VERB
ijassa-759	308	11	within	within	ADP
ijassa-759	308	12	this	this	DET
ijassa-759	308	13	study	study	NOUN
ijassa-759	308	14	indicate	indicate	VERB
ijassa-759	308	15	that	that	SCONJ
ijassa-759	308	16	the	the	DET
ijassa-759	308	17	choice	choice	NOUN
ijassa-759	308	18	of	of	ADP
ijassa-759	308	19	cancer	cancer	NOUN
ijassa-759	308	20	treatment	treatment	NOUN
ijassa-759	308	21	strategy	strategy	NOUN
ijassa-759	308	22	depends	depend	VERB
ijassa-759	308	23	on	on	ADP
ijassa-759	308	24	the	the	DET
ijassa-759	308	25	tumor	tumor	NOUN
ijassa-759	308	26	size	size	NOUN
ijassa-759	308	27	at	at	ADP
ijassa-759	308	28	the	the	DET
ijassa-759	308	29	start	start	NOUN
ijassa-759	308	30	of	of	ADP
ijassa-759	308	31	the	the	DET
ijassa-759	308	32	treatment	treatment	NOUN
ijassa-759	308	33	.	.	PUNCT
ijassa-759	309	1	the	the	DET
ijassa-759	309	2	model	model	NOUN
ijassa-759	309	3	also	also	ADV
ijassa-759	309	4	indicates	indicate	VERB
ijassa-759	309	5	that	that	SCONJ
ijassa-759	309	6	it	it	PRON
ijassa-759	309	7	is	be	AUX
ijassa-759	309	8	possible	possible	ADJ
ijassa-759	309	9	to	to	PART
ijassa-759	309	10	reduce	reduce	VERB
ijassa-759	309	11	the	the	DET
ijassa-759	309	12	number	number	NOUN
ijassa-759	309	13	of	of	ADP
ijassa-759	309	14	tumor	tumor	NOUN
ijassa-759	309	15	cells	cell	NOUN
ijassa-759	309	16	beyond	beyond	ADP
ijassa-759	309	17	the	the	DET
ijassa-759	309	18	lethality	lethality	NOUN
ijassa-759	309	19	threshold	threshold	NOUN
ijassa-759	309	20	which	which	PRON
ijassa-759	309	21	guarantees	guarantee	VERB
ijassa-759	309	22	that	that	SCONJ
ijassa-759	309	23	the	the	DET
ijassa-759	309	24	tumor	tumor	NOUN
ijassa-759	309	25	does	do	AUX
ijassa-759	309	26	not	not	PART
ijassa-759	309	27	resume	resume	VERB
ijassa-759	309	28	its	its	PRON
ijassa-759	309	29	growth	growth	NOUN
ijassa-759	309	30	.	.	PUNCT
ijassa-759	310	1	for	for	ADP
ijassa-759	310	2	the	the	DET
ijassa-759	310	3	small	small	ADJ
ijassa-759	310	4	tumors	tumor	NOUN
ijassa-759	310	5	(	(	PUNCT
ijassa-759	310	6	less	less	ADJ
ijassa-759	310	7	than	than	ADP
ijassa-759	310	8	8	8	NUM
ijassa-759	310	9	days	day	NOUN
ijassa-759	310	10	’	'	PUNCT
ijassa-759	310	11	growth	growth	NOUN
ijassa-759	310	12	as	as	ADP
ijassa-759	310	13	per	per	ADP
ijassa-759	310	14	our	our	PRON
ijassa-759	310	15	model	model	NOUN
ijassa-759	310	16	)	)	PUNCT
ijassa-759	310	17	,	,	PUNCT
ijassa-759	310	18	elimination	elimination	NOUN
ijassa-759	310	19	of	of	ADP
ijassa-759	310	20	tumor	tumor	NOUN
ijassa-759	310	21	cells	cell	NOUN
ijassa-759	310	22	can	can	AUX
ijassa-759	310	23	be	be	AUX
ijassa-759	310	24	achieved	achieve	VERB
ijassa-759	310	25	through	through	ADP
ijassa-759	310	26	single	single	ADJ
ijassa-759	310	27	-	-	PUNCT
ijassa-759	310	28	shot	shot	NOUN
ijassa-759	310	29	virus	virus	NOUN
ijassa-759	310	30	-	-	PUNCT
ijassa-759	310	31	based	base	VERB
ijassa-759	310	32	vaccine	vaccine	NOUN
ijassa-759	310	33	administration	administration	NOUN
ijassa-759	310	34	.	.	PUNCT
ijassa-759	311	1	in	in	ADP
ijassa-759	311	2	this	this	DET
ijassa-759	311	3	case	case	NOUN
ijassa-759	311	4	,	,	PUNCT
ijassa-759	311	5	the	the	DET
ijassa-759	311	6	death	death	NOUN
ijassa-759	311	7	of	of	ADP
ijassa-759	311	8	tumor	tumor	NOUN
ijassa-759	311	9	cells	cell	NOUN
ijassa-759	311	10	is	be	AUX
ijassa-759	311	11	caused	cause	VERB
ijassa-759	311	12	by	by	ADP
ijassa-759	311	13	their	their	PRON
ijassa-759	311	14	destruction	destruction	NOUN
ijassa-759	311	15	by	by	ADP
ijassa-759	311	16	the	the	DET
ijassa-759	311	17	virus	virus	NOUN
ijassa-759	311	18	.	.	PUNCT
ijassa-759	312	1	however	however	ADV
ijassa-759	312	2	,	,	PUNCT
ijassa-759	312	3	in	in	ADP
ijassa-759	312	4	these	these	DET
ijassa-759	312	5	conditions	condition	NOUN
ijassa-759	312	6	the	the	DET
ijassa-759	312	7	number	number	NOUN
ijassa-759	312	8	of	of	ADP
ijassa-759	312	9	antibodies	antibody	NOUN
ijassa-759	312	10	produced	produce	VERB
ijassa-759	312	11	against	against	ADP
ijassa-759	312	12	tumor	tumor	NOUN
ijassa-759	312	13	cells	cell	NOUN
ijassa-759	312	14	is	be	AUX
ijassa-759	312	15	limited	limit	VERB
ijassa-759	312	16	,	,	PUNCT
ijassa-759	312	17	which	which	PRON
ijassa-759	312	18	can	can	AUX
ijassa-759	312	19	result	result	VERB
ijassa-759	312	20	in	in	ADP
ijassa-759	312	21	recurrence	recurrence	NOUN
ijassa-759	312	22	of	of	ADP
ijassa-759	312	23	the	the	DET
ijassa-759	312	24	tumor	tumor	NOUN
ijassa-759	312	25	growth	growth	NOUN
ijassa-759	312	26	in	in	ADP
ijassa-759	312	27	future	future	NOUN
ijassa-759	312	28	.	.	PUNCT
ijassa-759	313	1	for	for	ADP
ijassa-759	313	2	bigger	big	ADJ
ijassa-759	313	3	tumors	tumor	NOUN
ijassa-759	313	4	(	(	PUNCT
ijassa-759	313	5	within	within	ADP
ijassa-759	313	6	20	20	NUM
ijassa-759	313	7	days	day	NOUN
ijassa-759	313	8	’	'	PUNCT
ijassa-759	313	9	growth	growth	NOUN
ijassa-759	313	10	as	as	ADP
ijassa-759	313	11	per	per	ADP
ijassa-759	313	12	our	our	PRON
ijassa-759	313	13	model	model	NOUN
ijassa-759	313	14	)	)	PUNCT
ijassa-759	313	15	elimination	elimination	NOUN
ijassa-759	313	16	of	of	ADP
ijassa-759	313	17	tumor	tumor	NOUN
ijassa-759	313	18	cells	cell	NOUN
ijassa-759	313	19	is	be	AUX
ijassa-759	313	20	possible	possible	ADJ
ijassa-759	313	21	if	if	SCONJ
ijassa-759	313	22	the	the	DET
ijassa-759	313	23	vaccine	vaccine	NOUN
ijassa-759	313	24	is	be	AUX
ijassa-759	313	25	administered	administer	VERB
ijassa-759	313	26	repeatedly	repeatedly	ADV
ijassa-759	313	27	with	with	ADP
ijassa-759	313	28	stepwise	stepwise	ADJ
ijassa-759	313	29	reduction	reduction	NOUN
ijassa-759	313	30	of	of	ADP
ijassa-759	313	31	time	time	NOUN
ijassa-759	313	32	periods	period	NOUN
ijassa-759	313	33	between	between	ADP
ijassa-759	313	34	administrations	administration	NOUN
ijassa-759	313	35	.	.	PUNCT
ijassa-759	314	1	the	the	DET
ijassa-759	314	2	model	model	NOUN
ijassa-759	314	3	developed	develop	VERB
ijassa-759	314	4	within	within	ADP
ijassa-759	314	5	this	this	DET
ijassa-759	314	6	study	study	NOUN
ijassa-759	314	7	also	also	ADV
ijassa-759	314	8	makes	make	VERB
ijassa-759	314	9	it	it	PRON
ijassa-759	314	10	possible	possible	ADJ
ijassa-759	314	11	to	to	PART
ijassa-759	314	12	define	define	VERB
ijassa-759	314	13	treatment	treatment	NOUN
ijassa-759	314	14	strategy	strategy	NOUN
ijassa-759	314	15	that	that	PRON
ijassa-759	314	16	may	may	AUX
ijassa-759	314	17	restrain	restrain	VERB
ijassa-759	314	18	the	the	DET
ijassa-759	314	19	tumor	tumor	NOUN
ijassa-759	314	20	development	development	NOUN
ijassa-759	314	21	,	,	PUNCT
ijassa-759	314	22	i.e.	i.e.	X
ijassa-759	314	23	lead	lead	VERB
ijassa-759	314	24	to	to	ADP
ijassa-759	314	25	cancer	cancer	NOUN
ijassa-759	314	26	chronification	chronification	NOUN
ijassa-759	314	27	.	.	PUNCT
ijassa-759	315	1	dosages	dosage	NOUN
ijassa-759	315	2	and	and	CCONJ
ijassa-759	315	3	time	time	NOUN
ijassa-759	315	4	intervals	interval	NOUN
ijassa-759	315	5	between	between	ADP
ijassa-759	315	6	vaccine	vaccine	NOUN
ijassa-759	315	7	administrations	administration	NOUN
ijassa-759	315	8	for	for	ADP
ijassa-759	315	9	this	this	DET
ijassa-759	315	10	stabilization	stabilization	NOUN
ijassa-759	315	11	strategy	strategy	NOUN
ijassa-759	315	12	were	be	AUX
ijassa-759	315	13	defined	define	VERB
ijassa-759	315	14	in	in	ADP
ijassa-759	315	15	the	the	DET
ijassa-759	315	16	present	present	ADJ
ijassa-759	315	17	study	study	NOUN
ijassa-759	315	18	.	.	PUNCT
ijassa-759	316	1	an	an	DET
ijassa-759	316	2	advantage	advantage	NOUN
ijassa-759	316	3	of	of	ADP
ijassa-759	316	4	this	this	DET
ijassa-759	316	5	strategy	strategy	NOUN
ijassa-759	316	6	is	be	AUX
ijassa-759	316	7	that	that	SCONJ
ijassa-759	316	8	it	it	PRON
ijassa-759	316	9	can	can	AUX
ijassa-759	316	10	be	be	AUX
ijassa-759	316	11	used	use	VERB
ijassa-759	316	12	for	for	ADP
ijassa-759	316	13	the	the	DET
ijassa-759	316	14	tumors	tumor	NOUN
ijassa-759	316	15	of	of	ADP
ijassa-759	316	16	any	any	DET
ijassa-759	316	17	size	size	NOUN
ijassa-759	316	18	.	.	PUNCT
ijassa-759	317	1	thus	thus	ADV
ijassa-759	317	2	it	it	PRON
ijassa-759	317	3	can	can	AUX
ijassa-759	317	4	be	be	AUX
ijassa-759	317	5	beneficial	beneficial	ADJ
ijassa-759	317	6	for	for	ADP
ijassa-759	317	7	the	the	DET
ijassa-759	317	8	patients	patient	NOUN
ijassa-759	317	9	who	who	PRON
ijassa-759	317	10	can	can	AUX
ijassa-759	317	11	not	not	PART
ijassa-759	317	12	be	be	AUX
ijassa-759	317	13	subjected	subject	VERB
ijassa-759	317	14	to	to	ADP
ijassa-759	317	15	surgical	surgical	ADJ
ijassa-759	317	16	treatment	treatment	NOUN
ijassa-759	317	17	,	,	PUNCT
ijassa-759	317	18	and	and	CCONJ
ijassa-759	317	19	creates	create	VERB
ijassa-759	317	20	new	new	ADJ
ijassa-759	317	21	treatment	treatment	NOUN
ijassa-759	317	22	possibilities	possibility	NOUN
ijassa-759	317	23	for	for	ADP
ijassa-759	317	24	far	far	ADV
ijassa-759	317	25	-	-	PUNCT
ijassa-759	317	26	advanced	advanced	ADJ
ijassa-759	317	27	cancer	cancer	NOUN
ijassa-759	317	28	.	.	PUNCT
ijassa-759	318	1	this	this	DET
ijassa-759	318	2	study	study	NOUN
ijassa-759	318	3	also	also	ADV
ijassa-759	318	4	proposes	propose	VERB
ijassa-759	318	5	a	a	DET
ijassa-759	318	6	method	method	NOUN
ijassa-759	318	7	of	of	ADP
ijassa-759	318	8	transferring	transfer	VERB
ijassa-759	318	9	the	the	DET
ijassa-759	318	10	results	result	NOUN
ijassa-759	318	11	of	of	ADP
ijassa-759	318	12	the	the	DET
ijassa-759	318	13	computational	computational	ADJ
ijassa-759	318	14	experiment	experiment	NOUN
ijassa-759	318	15	to	to	ADP
ijassa-759	318	16	the	the	DET
ijassa-759	318	17	treatment	treatment	NOUN
ijassa-759	318	18	of	of	ADP
ijassa-759	318	19	humans	human	NOUN
ijassa-759	318	20	,	,	PUNCT
ijassa-759	318	21	based	base	VERB
ijassa-759	318	22	on	on	ADP
ijassa-759	318	23	allometric	allometric	ADJ
ijassa-759	318	24	relationships	relationship	NOUN
ijassa-759	318	25	between	between	ADP
ijassa-759	318	26	human	human	ADJ
ijassa-759	318	27	and	and	CCONJ
ijassa-759	318	28	animal	animal	NOUN
ijassa-759	318	29	body	body	NOUN
ijassa-759	318	30	weights	weight	NOUN
ijassa-759	318	31	,	,	PUNCT
ijassa-759	318	32	enabling	enable	VERB
ijassa-759	318	33	clinicians	clinician	NOUN
ijassa-759	318	34	to	to	PART
ijassa-759	318	35	calculate	calculate	VERB
ijassa-759	318	36	the	the	DET
ijassa-759	318	37	appropriate	appropriate	ADJ
ijassa-759	318	38	intervals	interval	NOUN
ijassa-759	318	39	between	between	ADP
ijassa-759	318	40	repeated	repeat	VERB
ijassa-759	318	41	vaccine	vaccine	NOUN
ijassa-759	318	42	administrations	administration	NOUN
ijassa-759	318	43	.	.	PUNCT
ijassa-759	319	1	this	this	DET
ijassa-759	319	2	method	method	NOUN
ijassa-759	319	3	makes	make	VERB
ijassa-759	319	4	it	it	PRON
ijassa-759	319	5	possible	possible	ADJ
ijassa-759	319	6	to	to	PART
ijassa-759	319	7	plan	plan	VERB
ijassa-759	319	8	the	the	DET
ijassa-759	319	9	return	return	NOUN
ijassa-759	319	10	visit	visit	NOUN
ijassa-759	319	11	to	to	ADP
ijassa-759	319	12	the	the	DET
ijassa-759	319	13	therapist	therapist	NOUN
ijassa-759	319	14	to	to	PART
ijassa-759	319	15	make	make	VERB
ijassa-759	319	16	a	a	DET
ijassa-759	319	17	decision	decision	NOUN
ijassa-759	319	18	on	on	ADP
ijassa-759	319	19	subsequent	subsequent	ADJ
ijassa-759	319	20	vaccine	vaccine	NOUN
ijassa-759	319	21	administration	administration	NOUN
ijassa-759	319	22	.	.	PUNCT
ijassa-759	320	1	mathematical	mathematical	ADJ
ijassa-759	320	2	modeling	modeling	NOUN
ijassa-759	320	3	of	of	ADP
ijassa-759	320	4	antitumor	antitumor	PROPN
ijassa-759	320	5	viral	viral	ADJ
ijassa-759	320	6	vaccine	vaccine	NOUN
ijassa-759	320	7	therapy	therapy	NOUN
ijassa-759	320	8	…	…	PUNCT
ijassa-759	320	9	copyright	copyright	NOUN
ijassa-759	320	10	©	©	PROPN
ijassa-759	320	11	2020	2020	NUM
ijassa-759	320	12	assa	assa	NOUN
ijassa-759	320	13	.	.	PUNCT
ijassa-759	321	1	adv	adv	PROPN
ijassa-759	321	2	.	.	PUNCT
ijassa-759	322	1	in	in	ADP
ijassa-759	322	2	systems	system	NOUN
ijassa-759	322	3	science	science	NOUN
ijassa-759	322	4	and	and	CCONJ
ijassa-759	322	5	appl	appl	NOUN
ijassa-759	322	6	.	.	PUNCT
ijassa-759	323	1	(	(	PUNCT
ijassa-759	323	2	2020	2020	NUM
ijassa-759	323	3	)	)	PUNCT
ijassa-759	323	4	19	19	NUM
ijassa-759	323	5	finally	finally	ADV
ijassa-759	323	6	,	,	PUNCT
ijassa-759	323	7	results	result	NOUN
ijassa-759	323	8	of	of	ADP
ijassa-759	323	9	the	the	DET
ijassa-759	323	10	computational	computational	ADJ
ijassa-759	323	11	experiment	experiment	NOUN
ijassa-759	323	12	based	base	VERB
ijassa-759	323	13	on	on	ADP
ijassa-759	323	14	mathematical	mathematical	ADJ
ijassa-759	323	15	modelling	modelling	NOUN
ijassa-759	323	16	may	may	AUX
ijassa-759	323	17	substantially	substantially	ADV
ijassa-759	323	18	and	and	CCONJ
ijassa-759	323	19	meaningfully	meaningfully	ADV
ijassa-759	323	20	complement	complement	VERB
ijassa-759	323	21	in	in	ADP
ijassa-759	323	22	vivo	vivo	ADJ
ijassa-759	323	23	experiments	experiment	NOUN
ijassa-759	323	24	for	for	ADP
ijassa-759	323	25	defining	define	VERB
ijassa-759	323	26	efficient	efficient	ADJ
ijassa-759	323	27	cancer	cancer	NOUN
ijassa-759	323	28	treatment	treatment	NOUN
ijassa-759	323	29	strategies	strategy	NOUN
ijassa-759	323	30	.	.	PUNCT
ijassa-759	324	1	development	development	NOUN
ijassa-759	324	2	of	of	ADP
ijassa-759	324	3	advanced	advanced	ADJ
ijassa-759	324	4	methods	method	NOUN
ijassa-759	324	5	of	of	ADP
ijassa-759	324	6	cancer	cancer	NOUN
ijassa-759	324	7	treatment	treatment	NOUN
ijassa-759	324	8	is	be	AUX
ijassa-759	324	9	highly	highly	ADV
ijassa-759	324	10	dependent	dependent	ADJ
ijassa-759	324	11	on	on	ADP
ijassa-759	324	12	the	the	DET
ijassa-759	324	13	costs	cost	NOUN
ijassa-759	324	14	of	of	ADP
ijassa-759	324	15	conducting	conduct	VERB
ijassa-759	324	16	experiments	experiment	NOUN
ijassa-759	324	17	.	.	PUNCT
ijassa-759	325	1	active	active	ADJ
ijassa-759	325	2	implementation	implementation	NOUN
ijassa-759	325	3	of	of	ADP
ijassa-759	325	4	mathematical	mathematical	ADJ
ijassa-759	325	5	modelling	modelling	NOUN
ijassa-759	325	6	approach	approach	NOUN
ijassa-759	325	7	on	on	ADP
ijassa-759	325	8	different	different	ADJ
ijassa-759	325	9	stages	stage	NOUN
ijassa-759	325	10	of	of	ADP
ijassa-759	325	11	experimental	experimental	ADJ
ijassa-759	325	12	research	research	NOUN
ijassa-759	325	13	and	and	CCONJ
ijassa-759	325	14	clinical	clinical	ADJ
ijassa-759	325	15	studies	study	NOUN
ijassa-759	325	16	may	may	AUX
ijassa-759	325	17	contribute	contribute	VERB
ijassa-759	325	18	to	to	ADP
ijassa-759	325	19	the	the	DET
ijassa-759	325	20	reduction	reduction	NOUN
ijassa-759	325	21	of	of	ADP
ijassa-759	325	22	these	these	DET
ijassa-759	325	23	costs	cost	NOUN
ijassa-759	325	24	as	as	ADV
ijassa-759	325	25	well	well	ADV
ijassa-759	325	26	.	.	PUNCT
ijassa-759	326	1	references	reference	NOUN
ijassa-759	326	2	1	1	NUM
ijassa-759	326	3	.	.	PUNCT
ijassa-759	327	1	baryshnikov	baryshnikov	PROPN
ijassa-759	327	2	,	,	PUNCT
ijassa-759	327	3	a.	a.	PROPN
ijassa-759	327	4	yu	yu	PROPN
ijassa-759	327	5	.	.	PUNCT
ijassa-759	328	1	(	(	PUNCT
ijassa-759	328	2	2003	2003	NUM
ijassa-759	328	3	)	)	PUNCT
ijassa-759	328	4	.	.	PUNCT
ijassa-759	329	1	vzaimootnoshenie	vzaimootnoshenie	NOUN
ijassa-759	329	2	opukholi	opukholi	VERB
ijassa-759	330	1	i	i	PRON
ijassa-759	330	2	immunnoy	immunnoy	VERB
ijassa-759	330	3	sistemy	sistemy	PROPN
ijassa-759	330	4	organizma	organizma	PROPN
ijassa-759	331	1	[	[	X
ijassa-759	331	2	interaction	interaction	NOUN
ijassa-759	331	3	between	between	ADP
ijassa-759	331	4	tumor	tumor	NOUN
ijassa-759	331	5	and	and	CCONJ
ijassa-759	331	6	immune	immune	ADJ
ijassa-759	331	7	system	system	NOUN
ijassa-759	331	8	]	]	PUNCT
ijassa-759	331	9	.	.	PUNCT
ijassa-759	332	1	prakticheskaya	prakticheskaya	PROPN
ijassa-759	332	2	onkologiya	onkologiya	PROPN
ijassa-759	332	3	,	,	PUNCT
ijassa-759	332	4	4(3	4(3	NUM
ijassa-759	332	5	)	)	PUNCT
ijassa-759	332	6	,	,	PUNCT
ijassa-759	333	1	128–130	128–130	NUM
ijassa-759	333	2	[	[	PUNCT
ijassa-759	333	3	in	in	ADP
ijassa-759	333	4	russian	russian	PROPN
ijassa-759	333	5	]	]	PUNCT
ijassa-759	333	6	.	.	PUNCT
ijassa-759	334	1	2	2	X
ijassa-759	334	2	.	.	X
ijassa-759	334	3	grinevich	grinevich	PROPN
ijassa-759	334	4	,	,	PUNCT
ijassa-759	334	5	yu	yu	PROPN
ijassa-759	334	6	.	.	PUNCT
ijassa-759	334	7	a.	a.	PROPN
ijassa-759	334	8	,	,	PUNCT
ijassa-759	334	9	khranovskaya	khranovskaya	PROPN
ijassa-759	334	10	,	,	PUNCT
ijassa-759	334	11	n.	n.	PROPN
ijassa-759	334	12	n.	n.	PROPN
ijassa-759	334	13	(	(	PUNCT
ijassa-759	334	14	2007	2007	NUM
ijassa-759	334	15	)	)	PUNCT
ijassa-759	334	16	.	.	PUNCT
ijassa-759	335	1	vaktsiny	vaktsiny	VERB
ijassa-759	335	2	na	na	PRON
ijassa-759	335	3	osnove	osnove	ADJ
ijassa-759	335	4	antigenprezentiruyushchikh	antigenprezentiruyushchikh	NOUN
ijassa-759	335	5	dendridnykh	dendridnykh	PROPN
ijassa-759	335	6	kletok	kletok	PROPN
ijassa-759	335	7	v	v	PROPN
ijassa-759	335	8	immunoterapii	immunoterapii	NOUN
ijassa-759	335	9	bol'nykh	bol'nykh	VERB
ijassa-759	336	1	so	so	ADV
ijassa-759	336	2	zlokachestvennymi	zlokachestvennymi	VERB
ijassa-759	336	3	opukholyami	opukholyami	NOUN
ijassa-759	337	1	[	[	X
ijassa-759	337	2	vaccines	vaccine	NOUN
ijassa-759	337	3	on	on	ADP
ijassa-759	337	4	the	the	DET
ijassa-759	337	5	base	base	NOUN
ijassa-759	337	6	of	of	ADP
ijassa-759	337	7	antigen	antigen	NOUN
ijassa-759	337	8	presenting	present	VERB
ijassa-759	337	9	dendritic	dendritic	ADJ
ijassa-759	337	10	cells	cell	NOUN
ijassa-759	337	11	for	for	ADP
ijassa-759	337	12	immunotherapy	immunotherapy	NOUN
ijassa-759	337	13	of	of	ADP
ijassa-759	337	14	cancer	cancer	NOUN
ijassa-759	337	15	patients	patient	NOUN
ijassa-759	337	16	]	]	PUNCT
ijassa-759	337	17	.	.	PUNCT
ijassa-759	338	1	prakticheskaya	prakticheskaya	PROPN
ijassa-759	338	2	onkologiya	onkologiya	PROPN
ijassa-759	338	3	,	,	PUNCT
ijassa-759	338	4	9(4	9(4	NUM
ijassa-759	338	5	)	)	PUNCT
ijassa-759	338	6	,	,	PUNCT
ijassa-759	339	1	365–370	365–370	NUM
ijassa-759	339	2	[	[	X
ijassa-759	339	3	in	in	ADP
ijassa-759	339	4	russian	russian	PROPN
ijassa-759	339	5	]	]	PUNCT
ijassa-759	339	6	.	.	PUNCT
ijassa-759	340	1	3	3	X
ijassa-759	340	2	.	.	X
ijassa-759	340	3	kose	kose	PROPN
ijassa-759	340	4	,	,	PUNCT
ijassa-759	340	5	e.	e.	PROPN
ijassa-759	340	6	,	,	PUNCT
ijassa-759	340	7	moore	moore	PROPN
ijassa-759	340	8	,	,	PUNCT
ijassa-759	340	9	s.	s.	PROPN
ijassa-759	340	10	,	,	PUNCT
ijassa-759	340	11	ofodile	ofodile	NOUN
ijassa-759	340	12	,	,	PUNCT
ijassa-759	340	13	c.	c.	NOUN
ijassa-759	340	14	,	,	PUNCT
ijassa-759	340	15	radunskaya	radunskaya	PROPN
ijassa-759	340	16	,	,	PUNCT
ijassa-759	340	17	a.	a.	NOUN
ijassa-759	340	18	,	,	PUNCT
ijassa-759	340	19	ellen	ellen	PROPN
ijassa-759	340	20	,	,	PUNCT
ijassa-759	340	21	r.	r.	PROPN
ijassa-759	340	22	(	(	PUNCT
ijassa-759	340	23	2017	2017	NUM
ijassa-759	340	24	)	)	PUNCT
ijassa-759	340	25	.	.	PUNCT
ijassa-759	341	1	immuno	immuno	PROPN
ijassa-759	341	2	-	-	PUNCT
ijassa-759	341	3	kinetics	kinetic	NOUN
ijassa-759	341	4	of	of	ADP
ijassa-759	341	5	immunotherapy	immunotherapy	NOUN
ijassa-759	341	6	:	:	PUNCT
ijassa-759	341	7	dosing	dose	VERB
ijassa-759	341	8	with	with	ADP
ijassa-759	341	9	dcs	dcs	PROPN
ijassa-759	341	10	.	.	PUNCT
ijassa-759	341	11	letters	letter	NOUN
ijassa-759	341	12	in	in	ADP
ijassa-759	341	13	biomathematics	biomathematic	NOUN
ijassa-759	341	14	,	,	PUNCT
ijassa-759	341	15	4(1	4(1	NOUN
ijassa-759	341	16	)	)	PUNCT
ijassa-759	341	17	,	,	PUNCT
ijassa-759	341	18	39–58	39–58	NUM
ijassa-759	341	19	.	.	PUNCT
ijassa-759	342	1	4	4	NUM
ijassa-759	342	2	.	.	X
ijassa-759	342	3	loktev	loktev	PROPN
ijassa-759	342	4	,	,	PUNCT
ijassa-759	342	5	v.	v.	PROPN
ijassa-759	342	6	b.	b.	PROPN
ijassa-759	342	7	,	,	PUNCT
ijassa-759	342	8	ivankina	ivankina	PROPN
ijassa-759	342	9	,	,	PUNCT
ijassa-759	342	10	t.	t.	PROPN
ijassa-759	342	11	yu	yu	PROPN
ijassa-759	342	12	.	.	PROPN
ijassa-759	342	13	,	,	PUNCT
ijassa-759	342	14	netesov	netesov	PROPN
ijassa-759	342	15	,	,	PUNCT
ijassa-759	342	16	s.	s.	PROPN
ijassa-759	342	17	v.	v.	PROPN
ijassa-759	342	18	,	,	PUNCT
ijassa-759	342	19	chumakov	chumakov	PROPN
ijassa-759	342	20	,	,	PUNCT
ijassa-759	342	21	p.	p.	NOUN
ijassa-759	342	22	m.	m.	NOUN
ijassa-759	342	23	(	(	PUNCT
ijassa-759	342	24	2012	2012	NUM
ijassa-759	342	25	)	)	PUNCT
ijassa-759	342	26	.	.	PUNCT
ijassa-759	343	1	onkoliticheskie	onkoliticheskie	PROPN
ijassa-759	343	2	parvovirusy	parvovirusy	PROPN
ijassa-759	343	3	.	.	PUNCT
ijassa-759	344	1	novye	novye	PROPN
ijassa-759	344	2	podhody	podhody	NOUN
ijassa-759	344	3	k	k	PROPN
ijassa-759	344	4	lecheniju	lecheniju	PROPN
ijassa-759	344	5	rakovyh	rakovyh	PROPN
ijassa-759	344	6	zabolevanij	zabolevanij	NOUN
ijassa-759	345	1	[	[	X
ijassa-759	345	2	oncolytic	oncolytic	ADJ
ijassa-759	345	3	parvoviruses	parvovirus	NOUN
ijassa-759	345	4	.	.	PUNCT
ijassa-759	346	1	new	new	ADJ
ijassa-759	346	2	approaches	approach	NOUN
ijassa-759	346	3	to	to	ADP
ijassa-759	346	4	the	the	DET
ijassa-759	346	5	treatment	treatment	NOUN
ijassa-759	346	6	of	of	ADP
ijassa-759	346	7	cancer	cancer	NOUN
ijassa-759	346	8	diseases	disease	NOUN
ijassa-759	346	9	]	]	PUNCT
ijassa-759	346	10	.	.	PUNCT
ijassa-759	347	1	vestnik	vestnik	PROPN
ijassa-759	347	2	rossijskoj	rossijskoj	PROPN
ijassa-759	347	3	akademii	akademii	PROPN
ijassa-759	347	4	medicinskih	medicinskih	NOUN
ijassa-759	347	5	nauk	nauk	NOUN
ijassa-759	348	1	[	[	X
ijassa-759	348	2	bulletin	bulletin	NOUN
ijassa-759	348	3	of	of	ADP
ijassa-759	348	4	the	the	DET
ijassa-759	348	5	russian	russian	ADJ
ijassa-759	348	6	academy	academy	PROPN
ijassa-759	348	7	of	of	ADP
ijassa-759	348	8	medical	medical	ADJ
ijassa-759	348	9	sciences	science	NOUN
ijassa-759	348	10	]	]	PUNCT
ijassa-759	348	11	,	,	PUNCT
ijassa-759	348	12	67(2	67(2	NUM
ijassa-759	348	13	)	)	PUNCT
ijassa-759	348	14	,	,	PUNCT
ijassa-759	348	15	42–47	42–47	NUM
ijassa-759	349	1	[	[	X
ijassa-759	349	2	in	in	ADP
ijassa-759	349	3	russian	russian	PROPN
ijassa-759	349	4	]	]	PUNCT
ijassa-759	349	5	.	.	PUNCT
ijassa-759	350	1	5	5	X
ijassa-759	350	2	.	.	X
ijassa-759	351	1	lezhnin	lezhnin	PROPN
ijassa-759	351	2	,	,	PUNCT
ijassa-759	351	3	yu	yu	PROPN
ijassa-759	351	4	.	.	PUNCT
ijassa-759	351	5	n.	n.	PROPN
ijassa-759	351	6	,	,	PUNCT
ijassa-759	351	7	kravchenko	kravchenko	PROPN
ijassa-759	351	8	,	,	PUNCT
ijassa-759	351	9	yu	yu	PROPN
ijassa-759	351	10	.	.	PROPN
ijassa-759	351	11	e.	e.	PROPN
ijassa-759	351	12	,	,	PUNCT
ijassa-759	351	13	frolova	frolova	PROPN
ijassa-759	351	14	,	,	PUNCT
ijassa-759	351	15	e.	e.	PROPN
ijassa-759	351	16	i.	i.	PROPN
ijassa-759	351	17	,	,	PUNCT
ijassa-759	351	18	chumakov	chumakov	PROPN
ijassa-759	351	19	,	,	PUNCT
ijassa-759	351	20	p.	p.	NOUN
ijassa-759	351	21	m.	m.	NOUN
ijassa-759	351	22	,	,	PUNCT
ijassa-759	351	23	chumakov	chumakov	PROPN
ijassa-759	351	24	,	,	PUNCT
ijassa-759	351	25	s.	s.	PROPN
ijassa-759	351	26	p.	p.	PROPN
ijassa-759	351	27	(	(	PUNCT
ijassa-759	351	28	2015	2015	NUM
ijassa-759	351	29	)	)	PUNCT
ijassa-759	351	30	.	.	PUNCT
ijassa-759	352	1	onkotoksicheskie	onkotoksicheskie	PROPN
ijassa-759	352	2	belki	belki	VERB
ijassa-759	352	3	v	v	PROPN
ijassa-759	352	4	protivorakovoj	protivorakovoj	PROPN
ijassa-759	352	5	terapii	terapii	NOUN
ijassa-759	352	6	:	:	PUNCT
ijassa-759	352	7	mehanizmy	mehanizmy	PROPN
ijassa-759	352	8	dejstvija	dejstvija	NOUN
ijassa-759	353	1	[	[	X
ijassa-759	353	2	oncotoxic	oncotoxic	ADJ
ijassa-759	353	3	proteins	protein	NOUN
ijassa-759	353	4	in	in	ADP
ijassa-759	353	5	anticancer	anticancer	NOUN
ijassa-759	353	6	therapy	therapy	NOUN
ijassa-759	353	7	:	:	PUNCT
ijassa-759	353	8	mechanisms	mechanism	NOUN
ijassa-759	353	9	of	of	ADP
ijassa-759	353	10	action	action	NOUN
ijassa-759	353	11	]	]	PUNCT
ijassa-759	353	12	.	.	PUNCT
ijassa-759	354	1	molekuljarnaja	molekuljarnaja	PROPN
ijassa-759	354	2	biologija	biologija	NOUN
ijassa-759	354	3	[	[	X
ijassa-759	354	4	molecular	molecular	ADJ
ijassa-759	354	5	biology	biology	NOUN
ijassa-759	354	6	]	]	X
ijassa-759	354	7	,	,	PUNCT
ijassa-759	354	8	49(2	49(2	NUM
ijassa-759	354	9	)	)	PUNCT
ijassa-759	354	10	,	,	PUNCT
ijassa-759	354	11	264–278	264–278	NUM
ijassa-759	354	12	[	[	PUNCT
ijassa-759	354	13	in	in	ADP
ijassa-759	354	14	russian	russian	PROPN
ijassa-759	354	15	]	]	PUNCT
ijassa-759	354	16	.	.	PUNCT
ijassa-759	355	1	6	6	NUM
ijassa-759	355	2	.	.	X
ijassa-759	355	3	rommelaere	rommelaere	NOUN
ijassa-759	355	4	,	,	PUNCT
ijassa-759	355	5	j.	j.	PROPN
ijassa-759	355	6	,	,	PUNCT
ijassa-759	355	7	geletneky	geletneky	PROPN
ijassa-759	355	8	,	,	PUNCT
ijassa-759	355	9	k.	k.	PROPN
ijassa-759	355	10	,	,	PUNCT
ijassa-759	355	11	angelova	angelova	PROPN
ijassa-759	355	12	,	,	PUNCT
ijassa-759	355	13	a.l	a.l	PROPN
ijassa-759	355	14	.	.	PROPN
ijassa-759	355	15	,	,	PUNCT
ijassa-759	355	16	daeffler	daeffler	PROPN
ijassa-759	355	17	,	,	PUNCT
ijassa-759	355	18	l.	l.	PROPN
ijassa-759	355	19	,	,	PUNCT
ijassa-759	355	20	dinsart	dinsart	NOUN
ijassa-759	355	21	,	,	PUNCT
ijassa-759	355	22	c.	c.	PROPN
ijassa-759	355	23	,	,	PUNCT
ijassa-759	355	24	kiprianova	kiprianova	PROPN
ijassa-759	355	25	,	,	PUNCT
ijassa-759	355	26	i.	i.	PROPN
ijassa-759	355	27	,	,	PUNCT
ijassa-759	355	28	schlehofer	schlehofer	VERB
ijassa-759	355	29	,	,	PUNCT
ijassa-759	355	30	j.	j.	PROPN
ijassa-759	355	31	r.	r.	PROPN
ijassa-759	355	32	,	,	PUNCT
ijassa-759	355	33	raykov	raykov	PROPN
ijassa-759	355	34	,	,	PUNCT
ijassa-759	355	35	z.	z.	PROPN
ijassa-759	355	36	(	(	PUNCT
ijassa-759	355	37	2010	2010	NUM
ijassa-759	355	38	)	)	PUNCT
ijassa-759	355	39	.	.	PUNCT
ijassa-759	356	1	oncolytic	oncolytic	ADJ
ijassa-759	356	2	parvoviruses	parvovirus	NOUN
ijassa-759	356	3	as	as	ADP
ijassa-759	356	4	cancer	cancer	NOUN
ijassa-759	356	5	therapeutics	therapeutic	NOUN
ijassa-759	356	6	.	.	PUNCT
ijassa-759	357	1	cytokine	cytokine	VERB
ijassa-759	357	2	&	&	CCONJ
ijassa-759	357	3	growth	growth	NOUN
ijassa-759	357	4	factor	factor	NOUN
ijassa-759	357	5	reviews	review	NOUN
ijassa-759	357	6	,	,	PUNCT
ijassa-759	357	7	21(2	21(2	NUM
ijassa-759	357	8	)	)	PUNCT
ijassa-759	357	9	,	,	PUNCT
ijassa-759	357	10	185–195	185–195	NUM
ijassa-759	357	11	.	.	NOUN
ijassa-759	358	1	7	7	NUM
ijassa-759	358	2	.	.	X
ijassa-759	358	3	raykov	raykov	PROPN
ijassa-759	358	4	,	,	PUNCT
ijassa-759	358	5	z.	z.	PROPN
ijassa-759	358	6	,	,	PUNCT
ijassa-759	358	7	grekova	grekova	PROPN
ijassa-759	358	8	,	,	PUNCT
ijassa-759	358	9	s.	s.	PROPN
ijassa-759	358	10	,	,	PUNCT
ijassa-759	358	11	galabov	galabov	PROPN
ijassa-759	358	12	,	,	PUNCT
ijassa-759	358	13	a.	a.	PROPN
ijassa-759	358	14	s.	s.	PROPN
ijassa-759	358	15	,	,	PUNCT
ijassa-759	358	16	balboni	balboni	PROPN
ijassa-759	358	17	,	,	PUNCT
ijassa-759	358	18	g.	g.	PROPN
ijassa-759	358	19	,	,	PUNCT
ijassa-759	358	20	koch	koch	PROPN
ijassa-759	358	21	,	,	PUNCT
ijassa-759	358	22	u.	u.	PROPN
ijassa-759	358	23	,	,	PUNCT
ijassa-759	358	24	aprahamian	aprahamian	ADJ
ijassa-759	358	25	,	,	PUNCT
ijassa-759	358	26	m.	m.	NOUN
ijassa-759	358	27	,	,	PUNCT
ijassa-759	358	28	rommelaere	rommelaere	NOUN
ijassa-759	358	29	,	,	PUNCT
ijassa-759	358	30	j.	j.	PROPN
ijassa-759	358	31	(	(	PUNCT
ijassa-759	358	32	2007	2007	NUM
ijassa-759	358	33	)	)	PUNCT
ijassa-759	358	34	.	.	PUNCT
ijassa-759	359	1	combined	combine	VERB
ijassa-759	359	2	oncolytic	oncolytic	NOUN
ijassa-759	359	3	and	and	CCONJ
ijassa-759	359	4	vaccination	vaccination	NOUN
ijassa-759	359	5	activities	activity	NOUN
ijassa-759	359	6	of	of	ADP
ijassa-759	359	7	parvovirus	parvovirus	NOUN
ijassa-759	359	8	h-1	h-1	NOUN
ijassa-759	359	9	in	in	ADP
ijassa-759	359	10	a	a	DET
ijassa-759	359	11	metastatic	metastatic	ADJ
ijassa-759	359	12	tumor	tumor	NOUN
ijassa-759	359	13	model	model	NOUN
ijassa-759	359	14	.	.	PUNCT
ijassa-759	360	1	oncology	oncology	NOUN
ijassa-759	360	2	reports	report	NOUN
ijassa-759	360	3	,	,	PUNCT
ijassa-759	360	4	17(6	17(6	NUM
ijassa-759	360	5	)	)	PUNCT
ijassa-759	360	6	,	,	PUNCT
ijassa-759	360	7	1493–1500	1493–1500	NUM
ijassa-759	360	8	.	.	NOUN
ijassa-759	360	9	8	8	NUM
ijassa-759	360	10	.	.	X
ijassa-759	360	11	de	de	PROPN
ijassa-759	360	12	pillis	pillis	PROPN
ijassa-759	360	13	,	,	PUNCT
ijassa-759	360	14	l.	l.	PROPN
ijassa-759	360	15	,	,	PUNCT
ijassa-759	360	16	gallegos	gallegos	PROPN
ijassa-759	360	17	,	,	PUNCT
ijassa-759	360	18	a.	a.	PROPN
ijassa-759	360	19	,	,	PUNCT
ijassa-759	360	20	radunskaya	radunskaya	PROPN
ijassa-759	360	21	,	,	PUNCT
ijassa-759	360	22	a.	a.	NOUN
ijassa-759	360	23	(	(	PUNCT
ijassa-759	360	24	2013	2013	NUM
ijassa-759	360	25	)	)	PUNCT
ijassa-759	360	26	.	.	PUNCT
ijassa-759	361	1	a	a	DET
ijassa-759	361	2	model	model	NOUN
ijassa-759	361	3	of	of	ADP
ijassa-759	361	4	dendritic	dendritic	ADJ
ijassa-759	361	5	cell	cell	NOUN
ijassa-759	361	6	therapy	therapy	NOUN
ijassa-759	361	7	for	for	ADP
ijassa-759	361	8	melanoma	melanoma	NOUN
ijassa-759	361	9	.	.	PUNCT
ijassa-759	362	1	front	front	ADJ
ijassa-759	362	2	.	.	PUNCT
ijassa-759	363	1	oncol	oncol	ADJ
ijassa-759	363	2	.	.	PROPN
ijassa-759	363	3	,	,	PUNCT
ijassa-759	363	4	3(56	3(56	NUM
ijassa-759	363	5	)	)	PUNCT
ijassa-759	363	6	,	,	PUNCT
ijassa-759	363	7	1	1	NUM
ijassa-759	363	8	-	-	SYM
ijassa-759	363	9	14	14	NUM
ijassa-759	363	10	.	.	PUNCT
ijassa-759	364	1	9	9	NUM
ijassa-759	364	2	.	.	X
ijassa-759	365	1	kim	kim	PROPN
ijassa-759	365	2	,	,	PUNCT
ijassa-759	365	3	r.	r.	PROPN
ijassa-759	365	4	,	,	PUNCT
ijassa-759	365	5	woods	wood	NOUN
ijassa-759	365	6	,	,	PUNCT
ijassa-759	365	7	t.	t.	PROPN
ijassa-759	365	8	,	,	PUNCT
ijassa-759	365	9	radunskaya	radunskaya	PROPN
ijassa-759	365	10	,	,	PUNCT
ijassa-759	365	11	a.	a.	NOUN
ijassa-759	365	12	(	(	PUNCT
ijassa-759	365	13	2018	2018	NUM
ijassa-759	365	14	)	)	PUNCT
ijassa-759	365	15	.	.	PUNCT
ijassa-759	366	1	mathematical	mathematical	ADJ
ijassa-759	366	2	modeling	modeling	NOUN
ijassa-759	366	3	of	of	ADP
ijassa-759	366	4	tumor	tumor	NOUN
ijassa-759	366	5	immune	immune	ADJ
ijassa-759	366	6	interactions	interaction	NOUN
ijassa-759	366	7	:	:	PUNCT
ijassa-759	366	8	a	a	DET
ijassa-759	366	9	closer	close	ADJ
ijassa-759	366	10	look	look	NOUN
ijassa-759	366	11	at	at	ADP
ijassa-759	366	12	a	a	DET
ijassa-759	366	13	pd	pd	PROPN
ijassa-759	366	14	-	-	PUNCT
ijassa-759	366	15	l1	l1	PROPN
ijassa-759	366	16	inhibitor	inhibitor	NOUN
ijassa-759	366	17	in	in	ADP
ijassa-759	366	18	cancer	cancer	NOUN
ijassa-759	366	19	immunotherapy	immunotherapy	NOUN
ijassa-759	366	20	.	.	PUNCT
ijassa-759	367	1	spora	spora	PROPN
ijassa-759	367	2	:	:	PUNCT
ijassa-759	367	3	a	a	DET
ijassa-759	367	4	journal	journal	NOUN
ijassa-759	367	5	of	of	ADP
ijassa-759	367	6	biomathematics	biomathematic	NOUN
ijassa-759	367	7	,	,	PUNCT
ijassa-759	367	8	4(1	4(1	NOUN
ijassa-759	367	9	)	)	PUNCT
ijassa-759	367	10	,	,	PUNCT
ijassa-759	367	11	25–41	25–41	NUM
ijassa-759	367	12	.	.	PUNCT
ijassa-759	368	1	10	10	NUM
ijassa-759	368	2	.	.	PUNCT
ijassa-759	369	1	babushkina	babushkina	PROPN
ijassa-759	369	2	,	,	PUNCT
ijassa-759	369	3	n.	n.	PROPN
ijassa-759	369	4	,	,	PUNCT
ijassa-759	369	5	kuzina	kuzina	PROPN
ijassa-759	369	6	,	,	PUNCT
ijassa-759	369	7	e.	e.	PROPN
ijassa-759	369	8	(	(	PUNCT
ijassa-759	369	9	2018	2018	NUM
ijassa-759	369	10	)	)	PUNCT
ijassa-759	369	11	.	.	PUNCT
ijassa-759	370	1	analytical	analytical	ADJ
ijassa-759	370	2	study	study	NOUN
ijassa-759	370	3	of	of	ADP
ijassa-759	370	4	the	the	DET
ijassa-759	370	5	antitumor	antitumor	PROPN
ijassa-759	370	6	viral	viral	ADJ
ijassa-759	370	7	vaccine	vaccine	NOUN
ijassa-759	370	8	introduction	introduction	NOUN
ijassa-759	370	9	regimens	regimen	NOUN
ijassa-759	370	10	based	base	VERB
ijassa-759	370	11	on	on	ADP
ijassa-759	370	12	mathematical	mathematical	ADJ
ijassa-759	370	13	modeling	modeling	NOUN
ijassa-759	370	14	.	.	PUNCT
ijassa-759	371	1	advances	advance	NOUN
ijassa-759	371	2	in	in	ADP
ijassa-759	371	3	systems	system	NOUN
ijassa-759	371	4	science	science	NOUN
ijassa-759	371	5	and	and	CCONJ
ijassa-759	371	6	applications	application	NOUN
ijassa-759	371	7	,	,	PUNCT
ijassa-759	371	8	18(1	18(1	NUM
ijassa-759	371	9	)	)	PUNCT
ijassa-759	371	10	,	,	PUNCT
ijassa-759	371	11	59–84	59–84	NUM
ijassa-759	371	12	.	.	PUNCT
ijassa-759	372	1	doi	doi	NOUN
ijassa-759	372	2	:	:	PUNCT
ijassa-759	372	3	10.25728	10.25728	NUM
ijassa-759	372	4	/	/	SYM
ijassa-759	372	5	assa.2018.18.1.493	assa.2018.18.1.493	VERB
ijassa-759	372	6	11	11	NUM
ijassa-759	372	7	.	.	PUNCT
ijassa-759	373	1	kogan	kogan	PROPN
ijassa-759	373	2	,	,	PUNCT
ijassa-759	373	3	y.	y.	PROPN
ijassa-759	373	4	,	,	PUNCT
ijassa-759	373	5	halevi	halevi	PROPN
ijassa-759	373	6	–	–	PUNCT
ijassa-759	373	7	tobias	tobias	PROPN
ijassa-759	373	8	,	,	PUNCT
ijassa-759	373	9	k.	k.	PROPN
ijassa-759	373	10	,	,	PUNCT
ijassa-759	373	11	elishmereni	elishmereni	NOUN
ijassa-759	373	12	,	,	PUNCT
ijassa-759	373	13	m.	m.	NOUN
ijassa-759	373	14	,	,	PUNCT
ijassa-759	373	15	vuk	vuk	NOUN
ijassa-759	373	16	-	-	PUNCT
ijassa-759	373	17	pavlovic	pavlovic	ADJ
ijassa-759	373	18	,	,	PUNCT
ijassa-759	373	19	s.	s.	PROPN
ijassa-759	373	20	,	,	PUNCT
ijassa-759	373	21	agur	agur	PROPN
ijassa-759	373	22	,	,	PUNCT
ijassa-759	373	23	z.	z.	PROPN
ijassa-759	373	24	(	(	PUNCT
ijassa-759	373	25	2012	2012	NUM
ijassa-759	373	26	)	)	PUNCT
ijassa-759	373	27	.	.	PUNCT
ijassa-759	374	1	reconsidering	reconsider	VERB
ijassa-759	374	2	the	the	DET
ijassa-759	374	3	paradigm	paradigm	NOUN
ijassa-759	374	4	of	of	ADP
ijassa-759	374	5	cancer	cancer	NOUN
ijassa-759	374	6	immunotherapy	immunotherapy	NOUN
ijassa-759	374	7	by	by	ADP
ijassa-759	374	8	computationally	computationally	ADV
ijassa-759	374	9	aided	aid	VERB
ijassa-759	374	10	real	real	ADJ
ijassa-759	374	11	-	-	PUNCT
ijassa-759	374	12	time	time	NOUN
ijassa-759	374	13	personalization	personalization	NOUN
ijassa-759	374	14	.	.	PUNCT
ijassa-759	375	1	cancer	cancer	NOUN
ijassa-759	375	2	res	re	NOUN
ijassa-759	375	3	.	.	PUNCT
ijassa-759	375	4	,72(9	,72(9	PROPN
ijassa-759	375	5	)	)	PUNCT
ijassa-759	375	6	,	,	PUNCT
ijassa-759	375	7	2218–2227	2218–2227	NUM
ijassa-759	375	8	.	.	PUNCT
ijassa-759	376	1	https://doi.org/10.25728/assa.2018.18.1.493	https://doi.org/10.25728/assa.2018.18.1.493	PROPN
ijassa-759	376	2	n.a	n.a	PROPN
ijassa-759	376	3	.	.	PROPN
ijassa-759	376	4	babushkina	babushkina	PROPN
ijassa-759	376	5	,	,	PUNCT
ijassa-759	376	6	e.a	e.a	PROPN
ijassa-759	376	7	.	.	PROPN
ijassa-759	376	8	kuzina	kuzina	PROPN
ijassa-759	376	9	copyright	copyright	PROPN
ijassa-759	377	1	©	©	PROPN
ijassa-759	377	2	2020	2020	NUM
ijassa-759	377	3	assa	assa	NOUN
ijassa-759	377	4	.	.	PUNCT
ijassa-759	378	1	adv	adv	PROPN
ijassa-759	378	2	.	.	PUNCT
ijassa-759	379	1	in	in	ADP
ijassa-759	379	2	systems	system	NOUN
ijassa-759	379	3	science	science	NOUN
ijassa-759	379	4	and	and	CCONJ
ijassa-759	379	5	appl	appl	NOUN
ijassa-759	379	6	.	.	PUNCT
ijassa-759	380	1	(	(	PUNCT
ijassa-759	380	2	2020	2020	NUM
ijassa-759	380	3	)	)	PUNCT
ijassa-759	380	4	20	20	NUM
ijassa-759	380	5	12	12	NUM
ijassa-759	380	6	.	.	PUNCT
ijassa-759	381	1	lai	lai	PROPN
ijassa-759	381	2	,	,	PUNCT
ijassa-759	381	3	x.	x.	PROPN
ijassa-759	381	4	,	,	PUNCT
ijassa-759	381	5	friedman	friedman	PROPN
ijassa-759	381	6	,	,	PUNCT
ijassa-759	381	7	a.	a.	NOUN
ijassa-759	381	8	(	(	PUNCT
ijassa-759	381	9	2017	2017	NUM
ijassa-759	381	10	)	)	PUNCT
ijassa-759	381	11	.	.	PUNCT
ijassa-759	382	1	combination	combination	NOUN
ijassa-759	382	2	therapy	therapy	NOUN
ijassa-759	382	3	of	of	ADP
ijassa-759	382	4	cancer	cancer	NOUN
ijassa-759	382	5	vaccine	vaccine	NOUN
ijassa-759	382	6	and	and	CCONJ
ijassa-759	382	7	immune	immune	ADJ
ijassa-759	382	8	checkpoint	checkpoint	NOUN
ijassa-759	382	9	inhibitors	inhibitor	NOUN
ijassa-759	382	10	:	:	PUNCT
ijassa-759	382	11	a	a	DET
ijassa-759	382	12	mathematical	mathematical	ADJ
ijassa-759	382	13	model	model	NOUN
ijassa-759	382	14	.	.	PUNCT
ijassa-759	383	1	plos	plos	PROPN
ijassa-759	383	2	one	one	NUM
ijassa-759	383	3	,	,	PUNCT
ijassa-759	383	4	12(5	12(5	NUM
ijassa-759	383	5	):	):	PUNCT
ijassa-759	384	1	e0178479	e0178479	PROPN
ijassa-759	384	2	.	.	PUNCT
ijassa-759	384	3	doi	doi	PROPN
ijassa-759	384	4	:	:	PUNCT
ijassa-759	384	5	https://dx.doi.org/10.1371%2fjournal.pone.0178479	https://dx.doi.org/10.1371%2fjournal.pone.0178479	PROPN
ijassa-759	384	6	13	13	NUM
ijassa-759	384	7	.	.	PUNCT
ijassa-759	385	1	enderling	enderle	VERB
ijassa-759	385	2	,	,	PUNCT
ijassa-759	385	3	h.	h.	PROPN
ijassa-759	385	4	,	,	PUNCT
ijassa-759	385	5	chaplain	chaplain	PROPN
ijassa-759	385	6	,	,	PUNCT
ijassa-759	385	7	m.	m.	NOUN
ijassa-759	385	8	a.	a.	PROPN
ijassa-759	385	9	j.	j.	PROPN
ijassa-759	385	10	(	(	PUNCT
ijassa-759	385	11	2014	2014	NUM
ijassa-759	385	12	)	)	PUNCT
ijassa-759	385	13	.	.	PUNCT
ijassa-759	386	1	mathematical	mathematical	ADJ
ijassa-759	386	2	modeling	modeling	NOUN
ijassa-759	386	3	of	of	ADP
ijassa-759	386	4	tumor	tumor	NOUN
ijassa-759	386	5	growth	growth	NOUN
ijassa-759	386	6	end	end	VERB
ijassa-759	386	7	treatment	treatment	NOUN
ijassa-759	386	8	.	.	PUNCT
ijassa-759	387	1	current	current	ADJ
ijassa-759	387	2	pharmaceutical	pharmaceutical	ADJ
ijassa-759	387	3	design	design	NOUN
ijassa-759	387	4	,	,	PUNCT
ijassa-759	387	5	20(30	20(30	NUM
ijassa-759	387	6	)	)	PUNCT
ijassa-759	387	7	,	,	PUNCT
ijassa-759	387	8	4934–4940	4934–4940	NUM
ijassa-759	387	9	.	.	NOUN
ijassa-759	387	10	14	14	NUM
ijassa-759	387	11	.	.	PUNCT
ijassa-759	388	1	mutsenietse	mutsenietse	PROPN
ijassa-759	388	2	,	,	PUNCT
ijassa-759	388	3	a.	a.	PROPN
ijassa-759	388	4	ya	ya	PROPN
ijassa-759	388	5	.	.	PUNCT
ijassa-759	389	1	(	(	PUNCT
ijassa-759	389	2	1972	1972	NUM
ijassa-759	389	3	)	)	PUNCT
ijassa-759	389	4	onkotropizm	onkotropizm	PROPN
ijassa-759	389	5	virusov	virusov	NOUN
ijassa-759	389	6	i	i	PRON
ijassa-759	389	7	problema	problema	VERB
ijassa-759	389	8	viroterapii	viroterapii	NOUN
ijassa-759	389	9	zlokachestvennyh	zlokachestvennyh	NOUN
ijassa-759	389	10	opuholej	opuholej	NOUN
ijassa-759	389	11	[	[	PUNCT
ijassa-759	389	12	oncotropism	oncotropism	NOUN
ijassa-759	389	13	of	of	ADP
ijassa-759	389	14	viruses	virus	NOUN
ijassa-759	389	15	and	and	CCONJ
ijassa-759	389	16	the	the	DET
ijassa-759	389	17	problem	problem	NOUN
ijassa-759	389	18	of	of	ADP
ijassa-759	389	19	viral	viral	ADJ
ijassa-759	389	20	therapy	therapy	NOUN
ijassa-759	389	21	of	of	ADP
ijassa-759	389	22	malignant	malignant	ADJ
ijassa-759	389	23	tumors	tumor	NOUN
ijassa-759	389	24	]	]	PUNCT
ijassa-759	389	25	.	.	PUNCT
ijassa-759	390	1	riga	riga	ADJ
ijassa-759	390	2	:	:	PUNCT
ijassa-759	390	3	zinatne	zinatne	NOUN
ijassa-759	390	4	,	,	PUNCT
ijassa-759	390	5	[	[	X
ijassa-759	390	6	in	in	ADP
ijassa-759	390	7	russian	russian	PROPN
ijassa-759	390	8	]	]	PUNCT
ijassa-759	390	9	.	.	PUNCT
ijassa-759	390	10	15	15	NUM
ijassa-759	390	11	.	.	PUNCT
ijassa-759	390	12	gromova	gromova	PROPN
ijassa-759	390	13	,	,	PUNCT
ijassa-759	390	14	a.	a.	PROPN
ijassa-759	390	15	yu	yu	PROPN
ijassa-759	390	16	.	.	PUNCT
ijassa-759	390	17	(	(	PUNCT
ijassa-759	390	18	1999	1999	NUM
ijassa-759	390	19	)	)	PUNCT
ijassa-759	390	20	protivoopuholevye	protivoopuholevye	PROPN
ijassa-759	390	21	svojstva	svojstva	VERB
ijassa-759	390	22	vakcinnogo	vakcinnogo	ADJ
ijassa-759	390	23	shtamma	shtamma	PROPN
ijassa-759	390	24	virusa	virusa	NOUN
ijassa-759	390	25	venesujel'skogo	venesujel'skogo	ADJ
ijassa-759	390	26	jencefalomielita	jencefalomielita	NOUN
ijassa-759	391	1	i	i	PRON
ijassa-759	391	2	ego	ego	ADJ
ijassa-759	391	3	onkolizata	onkolizata	NOUN
ijassa-759	391	4	[	[	X
ijassa-759	391	5	antitumor	antitumor	NOUN
ijassa-759	391	6	properties	property	NOUN
ijassa-759	391	7	of	of	ADP
ijassa-759	391	8	the	the	DET
ijassa-759	391	9	vaccine	vaccine	NOUN
ijassa-759	391	10	strain	strain	VERB
ijassa-759	391	11	of	of	ADP
ijassa-759	391	12	the	the	DET
ijassa-759	391	13	venezuelan	venezuelan	ADJ
ijassa-759	391	14	encephalomyelitis	encephalomyelitis	NOUN
ijassa-759	391	15	virus	virus	NOUN
ijassa-759	391	16	and	and	CCONJ
ijassa-759	391	17	its	its	PRON
ijassa-759	391	18	oncolyte	oncolyte	NOUN
ijassa-759	391	19	]	]	PUNCT
ijassa-759	391	20	.	.	PUNCT
ijassa-759	392	1	thesis	thesis	NOUN
ijassa-759	392	2	of	of	ADP
ijassa-759	392	3	candidate	candidate	NOUN
ijassa-759	392	4	of	of	ADP
ijassa-759	392	5	science	science	NOUN
ijassa-759	392	6	(	(	PUNCT
ijassa-759	392	7	biology	biology	NOUN
ijassa-759	392	8	)	)	PUNCT
ijassa-759	392	9	.	.	PUNCT
ijassa-759	393	1	st	st	PROPN
ijassa-759	393	2	.	.	PROPN
ijassa-759	393	3	petersburg	petersburg	PROPN
ijassa-759	393	4	,	,	PUNCT
ijassa-759	394	1	[	[	X
ijassa-759	394	2	in	in	ADP
ijassa-759	394	3	russian	russian	PROPN
ijassa-759	394	4	]	]	PUNCT
ijassa-759	394	5	.	.	PUNCT
ijassa-759	395	1	16	16	NUM
ijassa-759	395	2	.	.	PUNCT
ijassa-759	396	1	urazova	urazova	PROPN
ijassa-759	396	2	,	,	PUNCT
ijassa-759	396	3	l.	l.	PROPN
ijassa-759	396	4	n.	n.	PROPN
ijassa-759	396	5	(	(	PUNCT
ijassa-759	396	6	2003	2003	NUM
ijassa-759	396	7	)	)	PUNCT
ijassa-759	396	8	jeffektivnost	jeffektivnost	NOUN
ijassa-759	396	9	'	'	PUNCT
ijassa-759	397	1	i	i	PRON
ijassa-759	397	2	mehanizmy	mehanizmy	VERB
ijassa-759	397	3	protivoopuholevogo	protivoopuholevogo	PROPN
ijassa-759	397	4	dejstvija	dejstvija	PROPN
ijassa-759	397	5	virusnyh	virusnyh	PROPN
ijassa-759	397	6	vakcin	vakcin	VERB
ijassa-759	397	7	pri	pri	PROPN
ijassa-759	397	8	jeksperimental'nom	jeksperimental'nom	PROPN
ijassa-759	397	9	onkogeneze	onkogeneze	VERB
ijassa-759	397	10	[	[	X
ijassa-759	397	11	efficiency	efficiency	NOUN
ijassa-759	397	12	and	and	CCONJ
ijassa-759	397	13	mechanisms	mechanism	NOUN
ijassa-759	397	14	of	of	ADP
ijassa-759	397	15	the	the	DET
ijassa-759	397	16	antitumor	antitumor	PROPN
ijassa-759	397	17	action	action	NOUN
ijassa-759	397	18	of	of	ADP
ijassa-759	397	19	viral	viral	ADJ
ijassa-759	397	20	vaccines	vaccine	NOUN
ijassa-759	397	21	in	in	ADP
ijassa-759	397	22	experimental	experimental	ADJ
ijassa-759	397	23	oncogenesis	oncogenesis	NOUN
ijassa-759	397	24	]	]	PUNCT
ijassa-759	397	25	.	.	PUNCT
ijassa-759	398	1	thesis	thesis	NOUN
ijassa-759	398	2	of	of	ADP
ijassa-759	398	3	candidate	candidate	NOUN
ijassa-759	398	4	of	of	ADP
ijassa-759	398	5	science	science	NOUN
ijassa-759	398	6	(	(	PUNCT
ijassa-759	398	7	biology	biology	NOUN
ijassa-759	398	8	)	)	PUNCT
ijassa-759	398	9	.	.	PUNCT
ijassa-759	399	1	st	st	PROPN
ijassa-759	399	2	.	.	PROPN
ijassa-759	399	3	petersburg	petersburg	PROPN
ijassa-759	399	4	,	,	PUNCT
ijassa-759	400	1	[	[	X
ijassa-759	400	2	in	in	ADP
ijassa-759	400	3	russian	russian	PROPN
ijassa-759	400	4	]	]	PUNCT
ijassa-759	400	5	.	.	PUNCT
ijassa-759	401	1	17	17	NUM
ijassa-759	401	2	.	.	PUNCT
ijassa-759	402	1	vidyaeva	vidyaeva	PROPN
ijassa-759	402	2	,	,	PUNCT
ijassa-759	402	3	i.	i.	PROPN
ijassa-759	402	4	g.	g.	PROPN
ijassa-759	402	5	(	(	PUNCT
ijassa-759	402	6	2005	2005	NUM
ijassa-759	402	7	)	)	PUNCT
ijassa-759	402	8	virusnye	virusnye	NOUN
ijassa-759	402	9	vakciny	vakciny	VERB
ijassa-759	402	10	i	i	PRON
ijassa-759	402	11	ih	ih	VERB
ijassa-759	402	12	onkolizaty	onkolizaty	NOUN
ijassa-759	402	13	v	v	ADP
ijassa-759	402	14	terapii	terapii	NOUN
ijassa-759	402	15	jeksperimental'nyh	jeksperimental'nyh	NOUN
ijassa-759	402	16	opuholej	opuholej	NOUN
ijassa-759	402	17	[	[	PUNCT
ijassa-759	402	18	viral	viral	ADJ
ijassa-759	402	19	vaccines	vaccine	NOUN
ijassa-759	402	20	and	and	CCONJ
ijassa-759	402	21	their	their	PRON
ijassa-759	402	22	oncolytes	oncolyte	NOUN
ijassa-759	402	23	in	in	ADP
ijassa-759	402	24	the	the	DET
ijassa-759	402	25	therapy	therapy	NOUN
ijassa-759	402	26	of	of	ADP
ijassa-759	402	27	experimental	experimental	ADJ
ijassa-759	402	28	tumors	tumor	NOUN
ijassa-759	402	29	]	]	PUNCT
ijassa-759	402	30	.	.	PUNCT
ijassa-759	403	1	thesis	thesis	NOUN
ijassa-759	403	2	of	of	ADP
ijassa-759	403	3	candidate	candidate	NOUN
ijassa-759	403	4	of	of	ADP
ijassa-759	403	5	science	science	NOUN
ijassa-759	403	6	(	(	PUNCT
ijassa-759	403	7	medicine	medicine	NOUN
ijassa-759	403	8	)	)	PUNCT
ijassa-759	403	9	.	.	PUNCT
ijassa-759	404	1	tomsk	tomsk	PROPN
ijassa-759	404	2	,	,	PUNCT
ijassa-759	405	1	[	[	X
ijassa-759	405	2	in	in	ADP
ijassa-759	405	3	russian	russian	PROPN
ijassa-759	405	4	]	]	PUNCT
ijassa-759	405	5	.	.	PUNCT
ijassa-759	405	6	18	18	NUM
ijassa-759	405	7	.	.	PUNCT
ijassa-759	405	8	babushkina	babushkina	PROPN
ijassa-759	405	9	,	,	PUNCT
ijassa-759	405	10	n.	n.	PROPN
ijassa-759	405	11	a.	a.	PROPN
ijassa-759	405	12	,	,	PUNCT
ijassa-759	405	13	kuzina	kuzina	PROPN
ijassa-759	405	14	,	,	PUNCT
ijassa-759	405	15	e.	e.	PROPN
ijassa-759	405	16	a.	a.	PROPN
ijassa-759	405	17	,	,	PUNCT
ijassa-759	405	18	loos	loos	PROPN
ijassa-759	405	19	,	,	PUNCT
ijassa-759	405	20	а	а	PROPN
ijassa-759	405	21	.	.	PUNCT
ijassa-759	406	1	а	а	PROPN
ijassa-759	406	2	.	.	PROPN
ijassa-759	406	3	,	,	PUNCT
ijassa-759	406	4	belyaeva	belyaeva	PROPN
ijassa-759	406	5	,	,	PUNCT
ijassa-759	406	6	е	е	X
ijassa-759	406	7	.	.	PUNCT
ijassa-759	407	1	v.	v.	PROPN
ijassa-759	407	2	(	(	PUNCT
ijassa-759	407	3	2018	2018	NUM
ijassa-759	407	4	)	)	PUNCT
ijassa-759	407	5	rezul'taty	rezul'taty	PROPN
ijassa-759	407	6	issledovaniya	issledovaniya	PROPN
ijassa-759	407	7	rezhimov	rezhimov	PROPN
ijassa-759	407	8	primeneniya	primeneniya	PROPN
ijassa-759	407	9	protivoopuholevyh	protivoopuholevyh	PROPN
ijassa-759	407	10	virusnyh	virusnyh	PROPN
ijassa-759	407	11	vakcin	vakcin	VERB
ijassa-759	407	12	na	na	ADP
ijassa-759	407	13	osnove	osnove	NOUN
ijassa-759	407	14	matematicheskogo	matematicheskogo	ADJ
ijassa-759	407	15	modelirovaniya	modelirovaniya	NOUN
ijassa-759	408	1	[	[	X
ijassa-759	408	2	the	the	DET
ijassa-759	408	3	results	result	NOUN
ijassa-759	408	4	of	of	ADP
ijassa-759	408	5	the	the	DET
ijassa-759	408	6	study	study	NOUN
ijassa-759	408	7	of	of	ADP
ijassa-759	408	8	the	the	DET
ijassa-759	408	9	modes	mode	NOUN
ijassa-759	408	10	of	of	ADP
ijassa-759	408	11	application	application	NOUN
ijassa-759	408	12	of	of	ADP
ijassa-759	408	13	anticancer	anticancer	NOUN
ijassa-759	408	14	virus	virus	NOUN
ijassa-759	408	15	vaccines	vaccine	NOUN
ijassa-759	408	16	based	base	VERB
ijassa-759	408	17	on	on	ADP
ijassa-759	408	18	mathematical	mathematical	ADJ
ijassa-759	408	19	modeling	modeling	NOUN
ijassa-759	408	20	]	]	PUNCT
ijassa-759	408	21	//	//	SYM
ijassa-759	408	22	problemy	problemy	PROPN
ijassa-759	408	23	upravlenija	upravlenija	ADJ
ijassa-759	408	24	[	[	X
ijassa-759	408	25	control	control	NOUN
ijassa-759	408	26	sciences	science	NOUN
ijassa-759	408	27	]	]	PUNCT
ijassa-759	408	28	,	,	PUNCT
ijassa-759	408	29	4	4	NUM
ijassa-759	408	30	,	,	PUNCT
ijassa-759	408	31	61–70	61–70	NOUN
ijassa-759	408	32	,	,	PUNCT
ijassa-759	408	33	[	[	X
ijassa-759	408	34	in	in	ADP
ijassa-759	408	35	russian	russian	PROPN
ijassa-759	408	36	]	]	PUNCT
ijassa-759	408	37	.	.	PUNCT
ijassa-759	409	1	19	19	NUM
ijassa-759	409	2	.	.	PUNCT
ijassa-759	409	3	babushkina	babushkina	PROPN
ijassa-759	409	4	,	,	PUNCT
ijassa-759	409	5	n.	n.	PROPN
ijassa-759	409	6	a.	a.	PROPN
ijassa-759	409	7	,	,	PUNCT
ijassa-759	409	8	kuzina	kuzina	PROPN
ijassa-759	409	9	,	,	PUNCT
ijassa-759	409	10	e.	e.	PROPN
ijassa-759	409	11	a.	a.	PROPN
ijassa-759	409	12	,	,	PUNCT
ijassa-759	409	13	loos	loo	NOUN
ijassa-759	409	14	,	,	PUNCT
ijassa-759	409	15	a.	a.	NOUN
ijassa-759	409	16	a.	a.	PROPN
ijassa-759	409	17	,	,	PUNCT
ijassa-759	409	18	belyaeva	belyaeva	PROPN
ijassa-759	409	19	,	,	PUNCT
ijassa-759	409	20	e.v	e.v	PROPN
ijassa-759	409	21	.	.	PUNCT
ijassa-759	409	22	(	(	PUNCT
ijassa-759	409	23	2019	2019	NUM
ijassa-759	409	24	)	)	PUNCT
ijassa-759	409	25	.	.	PUNCT
ijassa-759	410	1	otsenka	otsenka	PROPN
ijassa-759	410	2	effektivnykh	effektivnykh	PROPN
ijassa-759	410	3	strategiy	strategiy	PROPN
ijassa-759	410	4	primeneniya	primeneniya	PROPN
ijassa-759	410	5	protivoopukholevoy	protivoopukholevoy	NOUN
ijassa-759	410	6	vaktsinoterapii	vaktsinoterapii	ADV
ijassa-759	410	7	na	na	PUNCT
ijassa-759	410	8	osnove	osnove	NOUN
ijassa-759	410	9	matematicheskogo	matematicheskogo	ADJ
ijassa-759	410	10	modelirovaniya	modelirovaniya	NOUN
ijassa-759	411	1	[	[	X
ijassa-759	411	2	assessment	assessment	NOUN
ijassa-759	411	3	of	of	ADP
ijassa-759	411	4	the	the	DET
ijassa-759	411	5	efficient	efficient	ADJ
ijassa-759	411	6	strategies	strategy	NOUN
ijassa-759	411	7	for	for	ADP
ijassa-759	411	8	applying	apply	VERB
ijassa-759	411	9	atitumor	atitumor	DET
ijassa-759	411	10	viral	viral	ADJ
ijassa-759	411	11	vaccine	vaccine	NOUN
ijassa-759	411	12	therapy	therapy	NOUN
ijassa-759	411	13	based	base	VERB
ijassa-759	411	14	on	on	ADP
ijassa-759	411	15	mathematical	mathematical	ADJ
ijassa-759	411	16	modeling	modeling	NOUN
ijassa-759	411	17	]	]	PUNCT
ijassa-759	411	18	.	.	PUNCT
ijassa-759	412	1	matematicheskaya	matematicheskaya	NOUN
ijassa-759	412	2	biologiya	biologiya	NOUN
ijassa-759	412	3	i	i	PRON
ijassa-759	412	4	bioinformatika	bioinformatika	VERB
ijassa-759	413	1	[	[	X
ijassa-759	413	2	mathematical	mathematical	ADJ
ijassa-759	413	3	biology	biology	NOUN
ijassa-759	413	4	and	and	CCONJ
ijassa-759	413	5	bioinformatics	bioinformatic	NOUN
ijassa-759	413	6	]	]	PUNCT
ijassa-759	413	7	,	,	PUNCT
ijassa-759	413	8	14(1	14(1	NUM
ijassa-759	413	9	)	)	PUNCT
ijassa-759	413	10	,	,	PUNCT
ijassa-759	413	11	34–54	34–54	NUM
ijassa-759	413	12	.	.	PUNCT
ijassa-759	413	13	doi	doi	NOUN
ijassa-759	413	14	:	:	PUNCT
ijassa-759	413	15	10.17537/2019.14.34	10.17537/2019.14.34	NUM
ijassa-759	414	1	[	[	X
ijassa-759	414	2	in	in	ADP
ijassa-759	414	3	russian	russian	PROPN
ijassa-759	414	4	]	]	PUNCT
ijassa-759	414	5	.	.	PUNCT
ijassa-759	415	1	20	20	NUM
ijassa-759	415	2	.	.	X
ijassa-759	415	3	marchuk	marchuk	PROPN
ijassa-759	415	4	,	,	PUNCT
ijassa-759	415	5	g.	g.	PROPN
ijassa-759	415	6	i.	i.	PROPN
ijassa-759	415	7	(	(	PUNCT
ijassa-759	415	8	1991	1991	NUM
ijassa-759	415	9	)	)	PUNCT
ijassa-759	415	10	matematicheskie	matematicheskie	NOUN
ijassa-759	415	11	modeli	modeli	PROPN
ijassa-759	415	12	v	v	ADP
ijassa-759	415	13	immunologii	immunologii	PROPN
ijassa-759	415	14	.	.	PUNCT
ijassa-759	416	1	vychislitel'nye	vychislitel'nye	ADV
ijassa-759	416	2	metody	metody	ADJ
ijassa-759	417	1	i	i	PRON
ijassa-759	417	2	jeksperimenty	jeksperimenty	VERB
ijassa-759	417	3	[	[	X
ijassa-759	417	4	mathematical	mathematical	ADJ
ijassa-759	417	5	models	model	NOUN
ijassa-759	417	6	in	in	ADP
ijassa-759	417	7	immunology	immunology	NOUN
ijassa-759	417	8	.	.	PUNCT
ijassa-759	418	1	computational	computational	ADJ
ijassa-759	418	2	methods	method	NOUN
ijassa-759	418	3	and	and	CCONJ
ijassa-759	418	4	experiments	experiment	NOUN
ijassa-759	418	5	]	]	PUNCT
ijassa-759	418	6	.	.	PUNCT
ijassa-759	419	1	moscow	moscow	PROPN
ijassa-759	419	2	:	:	PUNCT
ijassa-759	419	3	nauka	nauka	PROPN
ijassa-759	419	4	,	,	PUNCT
ijassa-759	420	1	[	[	X
ijassa-759	420	2	in	in	ADP
ijassa-759	420	3	russian	russian	PROPN
ijassa-759	420	4	]	]	PUNCT
ijassa-759	420	5	.	.	PUNCT
ijassa-759	421	1	21	21	NUM
ijassa-759	421	2	.	.	PUNCT
ijassa-759	421	3	pertsev	pertsev	PROPN
ijassa-759	421	4	,	,	PUNCT
ijassa-759	421	5	n.	n.	PROPN
ijassa-759	421	6	v.	v.	PROPN
ijassa-759	421	7	(	(	PUNCT
ijassa-759	421	8	2018	2018	NUM
ijassa-759	421	9	)	)	PUNCT
ijassa-759	421	10	.	.	PUNCT
ijassa-759	422	1	global'naya	global'naya	NOUN
ijassa-759	422	2	razreshimost	razreshimost	NOUN
ijassa-759	422	3	'	'	PUNCT
ijassa-759	422	4	i	i	PRON
ijassa-759	422	5	otsenki	otsenki	AUX
ijassa-759	422	6	resheniy	resheniy	VERB
ijassa-759	422	7	zadachi	zadachi	PROPN
ijassa-759	422	8	koshi	koshi	PROPN
ijassa-759	422	9	dlya	dlya	PROPN
ijassa-759	422	10	funktsional'no	funktsional'no	PROPN
ijassa-759	422	11	-	-	PUNCT
ijassa-759	422	12	differentsial'nykh	differentsial'nykh	PROPN
ijassa-759	422	13	uravneniy	uravneniy	ADJ
ijassa-759	422	14	s	s	PART
ijassa-759	422	15	zapazdyvaniem	zapazdyvaniem	NOUN
ijassa-759	422	16	,	,	PUNCT
ijassa-759	422	17	ispol'zuemykh	ispol'zuemykh	PROPN
ijassa-759	422	18	v	v	NUM
ijassa-759	422	19	modelyakh	modelyakh	NOUN
ijassa-759	422	20	zhivykh	zhivykh	NOUN
ijassa-759	422	21	system	system	NOUN
ijassa-759	423	1	[	[	X
ijassa-759	423	2	global	global	ADJ
ijassa-759	423	3	solvability	solvability	NOUN
ijassa-759	423	4	and	and	CCONJ
ijassa-759	423	5	estimates	estimate	NOUN
ijassa-759	423	6	for	for	ADP
ijassa-759	423	7	solutions	solution	NOUN
ijassa-759	423	8	to	to	ADP
ijassa-759	423	9	the	the	DET
ijassa-759	423	10	cauchy	cauchy	ADJ
ijassa-759	423	11	problem	problem	NOUN
ijassa-759	423	12	for	for	ADP
ijassa-759	423	13	the	the	DET
ijassa-759	423	14	retarded	retarded	ADJ
ijassa-759	423	15	functional	functional	ADJ
ijassa-759	423	16	differential	differential	ADJ
ijassa-759	423	17	equations	equation	NOUN
ijassa-759	423	18	that	that	PRON
ijassa-759	423	19	are	be	AUX
ijassa-759	423	20	used	use	VERB
ijassa-759	423	21	to	to	ADP
ijassa-759	423	22	the	the	DET
ijassa-759	423	23	model	model	NOUN
ijassa-759	423	24	living	living	NOUN
ijassa-759	423	25	systems	system	NOUN
ijassa-759	423	26	]	]	PUNCT
ijassa-759	423	27	.	.	PUNCT
ijassa-759	424	1	sibirskiy	sibirskiy	NOUN
ijassa-759	424	2	matematicheskiy	matematicheskiy	VERB
ijassa-759	424	3	zhurnal	zhurnal	NOUN
ijassa-759	425	1	[	[	X
ijassa-759	425	2	siberian	siberian	ADJ
ijassa-759	425	3	mathematical	mathematical	ADJ
ijassa-759	425	4	journal	journal	NOUN
ijassa-759	425	5	]	]	X
ijassa-759	425	6	,	,	PUNCT
ijassa-759	425	7	59(1	59(1	NUM
ijassa-759	425	8	)	)	PUNCT
ijassa-759	425	9	,	,	PUNCT
ijassa-759	425	10	143–157	143–157	NUM
ijassa-759	426	1	[	[	X
ijassa-759	426	2	in	in	ADP
ijassa-759	426	3	russian	russian	PROPN
ijassa-759	426	4	]	]	PUNCT
ijassa-759	426	5	.	.	PUNCT
ijassa-759	427	1	22	22	NUM
ijassa-759	427	2	.	.	PUNCT
ijassa-759	428	1	romanyukha	romanyukha	NOUN
ijassa-759	428	2	,	,	PUNCT
ijassa-759	428	3	a.	a.	NOUN
ijassa-759	428	4	a.	a.	NOUN
ijassa-759	428	5	(	(	PUNCT
ijassa-759	428	6	2011	2011	NUM
ijassa-759	428	7	)	)	PUNCT
ijassa-759	428	8	matematicheskie	matematicheskie	NOUN
ijassa-759	428	9	modeli	modeli	PROPN
ijassa-759	429	1	v	v	NUM
ijassa-759	429	2	immunologii	immunologii	PROPN
ijassa-759	430	1	i	i	PRON
ijassa-759	430	2	jepidemiologii	jepidemiologii	PROPN
ijassa-759	430	3	infekcionnyh	infekcionnyh	PROPN
ijassa-759	430	4	zabolevanij	zabolevanij	PROPN
ijassa-759	431	1	[	[	X
ijassa-759	431	2	mathematical	mathematical	ADJ
ijassa-759	431	3	models	model	NOUN
ijassa-759	431	4	in	in	ADP
ijassa-759	431	5	immunology	immunology	NOUN
ijassa-759	431	6	and	and	CCONJ
ijassa-759	431	7	epidemiology	epidemiology	NOUN
ijassa-759	431	8	of	of	ADP
ijassa-759	431	9	infectious	infectious	ADJ
ijassa-759	431	10	diseases	disease	NOUN
ijassa-759	431	11	]	]	PUNCT
ijassa-759	431	12	.	.	PUNCT
ijassa-759	432	1	moscow	moscow	PROPN
ijassa-759	432	2	:	:	PUNCT
ijassa-759	433	1	binom	binom	PROPN
ijassa-759	433	2	.	.	PUNCT
ijassa-759	433	3	laboratory	laboratory	NOUN
ijassa-759	433	4	of	of	ADP
ijassa-759	433	5	knowledge	knowledge	NOUN
ijassa-759	433	6	[	[	X
ijassa-759	433	7	laboratorija	laboratorija	NOUN
ijassa-759	433	8	znanij	znanij	NOUN
ijassa-759	433	9	]	]	X
ijassa-759	433	10	,	,	PUNCT
ijassa-759	434	1	[	[	X
ijassa-759	434	2	in	in	ADP
ijassa-759	434	3	russian	russian	PROPN
ijassa-759	434	4	]	]	X
ijassa-759	434	5	.	.	PUNCT
ijassa-759	435	1	23	23	NUM
ijassa-759	435	2	.	.	PUNCT
ijassa-759	436	1	skipper	skipper	PROPN
ijassa-759	436	2	,	,	PUNCT
ijassa-759	436	3	h.	h.	PROPN
ijassa-759	436	4	f.	f.	PROPN
ijassa-759	436	5	(	(	PUNCT
ijassa-759	436	6	1971	1971	NUM
ijassa-759	436	7	)	)	PUNCT
ijassa-759	436	8	.	.	PUNCT
ijassa-759	437	1	kinetics	kinetic	NOUN
ijassa-759	437	2	of	of	ADP
ijassa-759	437	3	mammary	mammary	ADJ
ijassa-759	437	4	tumor	tumor	NOUN
ijassa-759	437	5	cell	cell	NOUN
ijassa-759	437	6	-	-	PUNCT
ijassa-759	437	7	growth	growth	NOUN
ijassa-759	437	8	and	and	CCONJ
ijassa-759	437	9	implications	implication	NOUN
ijassa-759	437	10	for	for	ADP
ijassa-759	437	11	therapy	therapy	NOUN
ijassa-759	437	12	.	.	PUNCT
ijassa-759	438	1	cancer	cancer	NOUN
ijassa-759	438	2	,	,	PUNCT
ijassa-759	438	3	28(6	28(6	NOUN
ijassa-759	438	4	)	)	PUNCT
ijassa-759	438	5	,	,	PUNCT
ijassa-759	438	6	1479–1499	1479–1499	NUM
ijassa-759	438	7	.	.	PUNCT
ijassa-759	439	1	24	24	NUM
ijassa-759	439	2	.	.	PUNCT
ijassa-759	439	3	monichev	monichev	PROPN
ijassa-759	439	4	,	,	PUNCT
ijassa-759	439	5	a.	a.	PROPN
ijassa-759	439	6	yu	yu	PROPN
ijassa-759	439	7	.	.	PUNCT
ijassa-759	440	1	(	(	PUNCT
ijassa-759	440	2	1984	1984	NUM
ijassa-759	440	3	)	)	PUNCT
ijassa-759	440	4	dinamika	dinamika	PROPN
ijassa-759	440	5	krovetvorenija	krovetvorenija	NOUN
ijassa-759	440	6	.	.	PUNCT
ijassa-759	441	1	[	[	X
ijassa-759	441	2	dynamics	dynamic	NOUN
ijassa-759	441	3	of	of	ADP
ijassa-759	441	4	hematopoiesis	hematopoiesis	NOUN
ijassa-759	441	5	]	]	PUNCT
ijassa-759	441	6	.	.	PUNCT
ijassa-759	442	1	moscow	moscow	PROPN
ijassa-759	442	2	:	:	PUNCT
ijassa-759	442	3	medizina	medizina	NOUN
ijassa-759	443	1	[	[	X
ijassa-759	443	2	medicine	medicine	NOUN
ijassa-759	443	3	]	]	PUNCT
ijassa-759	443	4	,	,	PUNCT
ijassa-759	443	5	[	[	X
ijassa-759	443	6	in	in	ADP
ijassa-759	443	7	russian	russian	NOUN
ijassa-759	443	8	]	]	PUNCT
ijassa-759	443	9	.	.	PUNCT
ijassa-759	444	1	mathematical	mathematical	ADJ
ijassa-759	444	2	modeling	modeling	NOUN
ijassa-759	444	3	of	of	ADP
ijassa-759	444	4	antitumor	antitumor	PROPN
ijassa-759	444	5	viral	viral	ADJ
ijassa-759	444	6	vaccine	vaccine	NOUN
ijassa-759	444	7	therapy	therapy	NOUN
ijassa-759	444	8	…	…	PUNCT
ijassa-759	444	9	copyright	copyright	NOUN
ijassa-759	444	10	©	©	PROPN
ijassa-759	444	11	2020	2020	NUM
ijassa-759	444	12	assa	assa	NOUN
ijassa-759	444	13	.	.	PUNCT
ijassa-759	445	1	adv	adv	PROPN
ijassa-759	445	2	.	.	PUNCT
ijassa-759	446	1	in	in	ADP
ijassa-759	446	2	systems	system	NOUN
ijassa-759	446	3	science	science	NOUN
ijassa-759	446	4	and	and	CCONJ
ijassa-759	446	5	appl	appl	NOUN
ijassa-759	446	6	.	.	PUNCT
ijassa-759	447	1	(	(	PUNCT
ijassa-759	447	2	2020	2020	NUM
ijassa-759	447	3	)	)	PUNCT
ijassa-759	447	4	21	21	NUM
ijassa-759	447	5	25	25	NUM
ijassa-759	447	6	.	.	PUNCT
ijassa-759	448	1	monichev	monichev	PROPN
ijassa-759	448	2	,	,	PUNCT
ijassa-759	448	3	a.	a.	PROPN
ijassa-759	448	4	yu	yu	PROPN
ijassa-759	448	5	.	.	PUNCT
ijassa-759	448	6	(	(	PUNCT
ijassa-759	448	7	1987	1987	NUM
ijassa-759	448	8	)	)	PUNCT
ijassa-759	448	9	.	.	PUNCT
ijassa-759	449	1	a	a	DET
ijassa-759	449	2	mathematical	mathematical	ADJ
ijassa-759	449	3	model	model	NOUN
ijassa-759	449	4	of	of	ADP
ijassa-759	449	5	the	the	DET
ijassa-759	449	6	spatial	spatial	ADJ
ijassa-759	449	7	structure	structure	NOUN
ijassa-759	449	8	of	of	ADP
ijassa-759	449	9	bone	bone	NOUN
ijassa-759	449	10	marrow	marrow	NOUN
ijassa-759	449	11	in	in	ADP
ijassa-759	449	12	hemopoietic	hemopoietic	ADJ
ijassa-759	449	13	dynamics	dynamic	NOUN
ijassa-759	449	14	.	.	PUNCT
ijassa-759	450	1	cybernetics	cybernetic	NOUN
ijassa-759	450	2	and	and	CCONJ
ijassa-759	450	3	systems	system	NOUN
ijassa-759	450	4	analysis	analysis	NOUN
ijassa-759	450	5	,	,	PUNCT
ijassa-759	450	6	23(2	23(2	NOUN
ijassa-759	450	7	)	)	PUNCT
ijassa-759	450	8	,	,	PUNCT
ijassa-759	450	9	274–280	274–280	NUM
ijassa-759	450	10	.	.	PUNCT
ijassa-759	451	1	26	26	NUM
ijassa-759	451	2	.	.	PUNCT
ijassa-759	452	1	kuzina	kuzina	PROPN
ijassa-759	452	2	,	,	PUNCT
ijassa-759	452	3	e.a	e.a	PROPN
ijassa-759	452	4	.	.	PROPN
ijassa-759	452	5	,	,	PUNCT
ijassa-759	452	6	babushkina	babushkina	PROPN
ijassa-759	452	7	,	,	PUNCT
ijassa-759	452	8	n.a	n.a	PROPN
ijassa-759	452	9	.	.	PROPN
ijassa-759	452	10	(	(	PUNCT
ijassa-759	452	11	2016	2016	NUM
ijassa-759	452	12	)	)	PUNCT
ijassa-759	452	13	.	.	PUNCT
ijassa-759	453	1	programmnaja	programmnaja	PROPN
ijassa-759	453	2	realizacija	realizacija	PROPN
ijassa-759	453	3	metoda	metoda	PROPN
ijassa-759	453	4	prognozirovanija	prognozirovanija	PROPN
ijassa-759	453	5	jeffektivnosti	jeffektivnosti	PROPN
ijassa-759	453	6	vakcinoterapii	vakcinoterapii	PROPN
ijassa-759	453	7	ot	ot	PROPN
ijassa-759	453	8	jeksperimenta	jeksperimenta	PROPN
ijassa-759	453	9	v	v	PROPN
ijassa-759	453	10	kliniku	kliniku	PROPN
ijassa-759	454	1	[	[	X
ijassa-759	454	2	software	software	NOUN
ijassa-759	454	3	implementation	implementation	NOUN
ijassa-759	454	4	of	of	ADP
ijassa-759	454	5	the	the	DET
ijassa-759	454	6	method	method	NOUN
ijassa-759	454	7	for	for	ADP
ijassa-759	454	8	predicting	predict	VERB
ijassa-759	454	9	the	the	DET
ijassa-759	454	10	efficacy	efficacy	NOUN
ijassa-759	454	11	of	of	ADP
ijassa-759	454	12	vaccine	vaccine	NOUN
ijassa-759	454	13	therapy	therapy	NOUN
ijassa-759	454	14	from	from	ADP
ijassa-759	454	15	experiment	experiment	NOUN
ijassa-759	454	16	to	to	ADP
ijassa-759	454	17	the	the	DET
ijassa-759	454	18	clinic	clinic	NOUN
ijassa-759	454	19	]	]	PUNCT
ijassa-759	454	20	.	.	PUNCT
ijassa-759	455	1	proc	proc	PROPN
ijassa-759	455	2	.	.	PUNCT
ijassa-759	456	1	of	of	ADP
ijassa-759	456	2	the	the	DET
ijassa-759	456	3	12th	12th	ADJ
ijassa-759	456	4	int	int	NOUN
ijassa-759	456	5	.	.	PUNCT
ijassa-759	457	1	conf	conf	NOUN
ijassa-759	457	2	.	.	PUNCT
ijassa-759	458	1	“	"	PUNCT
ijassa-759	458	2	physics	physics	NOUN
ijassa-759	458	3	and	and	CCONJ
ijassa-759	458	4	radioelectronics	radioelectronic	NOUN
ijassa-759	458	5	in	in	ADP
ijassa-759	458	6	medicine	medicine	NOUN
ijassa-759	458	7	and	and	CCONJ
ijassa-759	458	8	ecology	ecology	NOUN
ijassa-759	458	9	”	"	PUNCT
ijassa-759	458	10	phreme-2016	phreme-2016	NOUN
ijassa-759	458	11	.	.	PUNCT
ijassa-759	459	1	vladimir	vladimir	NOUN
ijassa-759	459	2	:	:	PUNCT
ijassa-759	459	3	vgu	vgu	PROPN
ijassa-759	459	4	,	,	PUNCT
ijassa-759	459	5	125–130	125–130	NUM
ijassa-759	459	6	,	,	PUNCT
ijassa-759	459	7	[	[	X
ijassa-759	459	8	in	in	ADP
ijassa-759	459	9	russian	russian	PROPN
ijassa-759	459	10	]	]	PUNCT
ijassa-759	459	11	.	.	PUNCT
ijassa-759	460	1	n.a	n.a	PROPN
ijassa-759	460	2	.	.	PROPN
ijassa-759	460	3	babushkina	babushkina	PROPN
ijassa-759	460	4	,	,	PUNCT
ijassa-759	460	5	e.a	e.a	PROPN
ijassa-759	460	6	.	.	PROPN
ijassa-759	460	7	kuzina	kuzina	PROPN
ijassa-759	460	8	copyright	copyright	PROPN
ijassa-759	461	1	©	©	PROPN
ijassa-759	461	2	2020	2020	NUM
ijassa-759	461	3	assa	assa	NOUN
ijassa-759	461	4	.	.	PUNCT
ijassa-759	462	1	adv	adv	PROPN
ijassa-759	462	2	.	.	PUNCT
ijassa-759	463	1	in	in	ADP
ijassa-759	463	2	systems	system	NOUN
ijassa-759	463	3	science	science	NOUN
ijassa-759	463	4	and	and	CCONJ
ijassa-759	463	5	appl	appl	NOUN
ijassa-759	463	6	.	.	PUNCT
ijassa-759	464	1	(	(	PUNCT
ijassa-759	464	2	2020	2020	NUM
ijassa-759	464	3	)	)	PUNCT
ijassa-759	464	4	22	22	NUM
ijassa-759	464	5	appendix	appendix	NOUN
ijassa-759	464	6	1	1	NUM
ijassa-759	464	7	.	.	PUNCT
ijassa-759	464	8	values	value	NOUN
ijassa-759	464	9	of	of	ADP
ijassa-759	464	10	model	model	NOUN
ijassa-759	464	11	parameters	parameter	NOUN
ijassa-759	464	12	equation	equation	NOUN
ijassa-759	464	13	parameter	parameter	NOUN
ijassa-759	464	14	description	description	NOUN
ijassa-759	464	15	(	(	PUNCT
ijassa-759	464	16	)	)	PUNCT
ijassa-759	464	17	dn	dn	PROPN
ijassa-759	464	18	t	t	PROPN
ijassa-759	464	19	dt	dt	PROPN
ijassa-759	464	20	–	–	PUNCT
ijassa-759	464	21	(	(	PUNCT
ijassa-759	464	22	1	1	NUM
ijassa-759	464	23	-	-	SYM
ijassa-759	464	24	2	2	NUM
ijassa-759	464	25	)	)	PUNCT
ijassa-759	464	26	n	n	ADV
ijassa-759	464	27	=	=	SYM
ijassa-759	464	28	3.3613	3.3613	NUM
ijassa-759	464	29	,	,	PUNCT
ijassa-759	464	30	n	n	PROPN
ijassa-759	464	31	=	=	SYM
ijassa-759	464	32	0.0332	0.0332	NUM
ijassa-759	464	33	n	n	NOUN
ijassa-759	464	34	=	=	NUM
ijassa-759	464	35	23	23	NUM
ijassa-759	464	36	0n	0n	NUM
ijassa-759	464	37	=	=	SYM
ijassa-759	464	38	0.75	0.75	NUM
ijassa-759	464	39	the	the	DET
ijassa-759	464	40	parameters	parameter	NOUN
ijassa-759	464	41	of	of	ADP
ijassa-759	464	42	the	the	DET
ijassa-759	464	43	function	function	NOUN
ijassa-759	464	44	of	of	ADP
ijassa-759	464	45	gompertz	gompertz	NOUN
ijassa-759	464	46	approximating	approximate	VERB
ijassa-759	464	47	the	the	DET
ijassa-759	464	48	experimental	experimental	ADJ
ijassa-759	464	49	curves	curve	NOUN
ijassa-759	464	50	of	of	ADP
ijassa-759	464	51	growth	growth	NOUN
ijassa-759	464	52	of	of	ADP
ijassa-759	464	53	population	population	NOUN
ijassa-759	464	54	of	of	ADP
ijassa-759	464	55	tumor	tumor	NOUN
ijassa-759	464	56	cells	cell	NOUN
ijassa-759	464	57	without	without	ADP
ijassa-759	464	58	vaccination	vaccination	NOUN
ijassa-759	464	59	(	(	PUNCT
ijassa-759	464	60	control	control	NOUN
ijassa-759	464	61	)	)	PUNCT
ijassa-759	464	62	(	(	PUNCT
ijassa-759	464	63	)	)	PUNCT
ijassa-759	464	64	dn	dn	PROPN
ijassa-759	464	65	t	t	PROPN
ijassa-759	464	66	dt	dt	PROPN
ijassa-759	464	67	–	–	PUNCT
ijassa-759	464	68	(	(	PUNCT
ijassa-759	464	69	3	3	X
ijassa-759	464	70	)	)	PUNCT
ijassa-759	464	71	1	1	NUM
ijassa-759	464	72	=	=	SYM
ijassa-759	464	73	1	1	NUM
ijassa-759	464	74	1v	1v	NUM
ijassa-759	464	75	cvt	cvt	PROPN
ijassa-759	464	76	z=	z=	PUNCT
ijassa-759	464	77			PROPN
ijassa-759	464	78	+	+	CCONJ
ijassa-759	464	79	cvz	cvz	X
ijassa-759	464	80	=	=	VERB
ijassa-759	464	81	4.5	4.5	NUM
ijassa-759	464	82	the	the	DET
ijassa-759	464	83	moment	moment	NOUN
ijassa-759	464	84	of	of	ADP
ijassa-759	464	85	the	the	DET
ijassa-759	464	86	first	first	ADJ
ijassa-759	464	87	injection	injection	NOUN
ijassa-759	464	88	of	of	ADP
ijassa-759	464	89	a	a	DET
ijassa-759	464	90	viral	viral	ADJ
ijassa-759	464	91	vaccine	vaccine	NOUN
ijassa-759	464	92	the	the	DET
ijassa-759	464	93	moment	moment	NOUN
ijassa-759	464	94	the	the	DET
ijassa-759	464	95	beginning	beginning	NOUN
ijassa-759	464	96	of	of	ADP
ijassa-759	464	97	the	the	DET
ijassa-759	464	98	immune	immune	ADJ
ijassa-759	464	99	response	response	NOUN
ijassa-759	464	100	against	against	ADP
ijassa-759	464	101	the	the	DET
ijassa-759	464	102	virus	virus	NOUN
ijassa-759	464	103	delay	delay	VERB
ijassa-759	464	104	time	time	NOUN
ijassa-759	464	105	of	of	ADP
ijassa-759	464	106	the	the	DET
ijassa-759	464	107	immune	immune	ADJ
ijassa-759	464	108	response	response	NOUN
ijassa-759	464	109	against	against	ADP
ijassa-759	464	110	the	the	DET
ijassa-759	464	111	virus	virus	NOUN
ijassa-759	464	112	(	(	PUNCT
ijassa-759	464	113	)	)	PUNCT
ijassa-759	464	114	vdn	vdn	PROPN
ijassa-759	464	115	t	t	X
ijassa-759	464	116	dt	dt	PROPN
ijassa-759	464	117	–	–	PUNCT
ijassa-759	464	118	(	(	PUNCT
ijassa-759	464	119	4	4	NUM
ijassa-759	464	120	-	-	SYM
ijassa-759	464	121	5	5	NUM
ijassa-759	464	122	)	)	PUNCT
ijassa-759	464	123	1n	1n	NOUN
ijassa-759	464	124	cnt	cnt	PROPN
ijassa-759	464	125	z=	z=	VERB
ijassa-759	464	126			PROPN
ijassa-759	465	1	+	+	CCONJ
ijassa-759	465	2	the	the	DET
ijassa-759	465	3	moment	moment	NOUN
ijassa-759	465	4	the	the	DET
ijassa-759	465	5	beginning	beginning	NOUN
ijassa-759	465	6	of	of	ADP
ijassa-759	465	7	the	the	DET
ijassa-759	465	8	immune	immune	ADJ
ijassa-759	465	9	response	response	NOUN
ijassa-759	465	10	against	against	ADP
ijassa-759	465	11	infected	infected	ADJ
ijassa-759	465	12	tumor	tumor	NOUN
ijassa-759	465	13	cells	cell	NOUN
ijassa-759	465	14	сnz	сnz	X
ijassa-759	465	15	=	=	SYM
ijassa-759	465	16	10.5	10.5	NUM
ijassa-759	465	17	delay	delay	NOUN
ijassa-759	465	18	time	time	NOUN
ijassa-759	465	19	of	of	ADP
ijassa-759	465	20	immune	immune	ADJ
ijassa-759	465	21	response	response	NOUN
ijassa-759	465	22	against	against	ADP
ijassa-759	465	23	infected	infected	ADJ
ijassa-759	465	24	tumor	tumor	NOUN
ijassa-759	465	25	cells	cell	NOUN
ijassa-759	465	26	vk	vk	VERB
ijassa-759	466	1	=	=	SYM
ijassa-759	466	2	0.25	0.25	NUM
ijassa-759	466	3	avk	avk	NOUN
ijassa-759	466	4	=	=	PUNCT
ijassa-759	466	5	0.8	0.8	NUM
ijassa-759	466	6	ank	ank	PROPN
ijassa-759	466	7	=	=	PROPN
ijassa-759	466	8	0.8	0.8	NUM
ijassa-759	466	9	the	the	DET
ijassa-759	466	10	constant	constant	ADJ
ijassa-759	466	11	coefficients	coefficient	NOUN
ijassa-759	466	12	of	of	ADP
ijassa-759	466	13	the	the	DET
ijassa-759	466	14	equation	equation	NOUN
ijassa-759	466	15	of	of	ADP
ijassa-759	466	16	dynamics	dynamic	NOUN
ijassa-759	466	17	of	of	ADP
ijassa-759	466	18	the	the	DET
ijassa-759	466	19	number	number	NOUN
ijassa-759	466	20	of	of	ADP
ijassa-759	466	21	cells	cell	NOUN
ijassa-759	466	22	after	after	ADP
ijassa-759	466	23	a	a	DET
ijassa-759	466	24	single	single	ADJ
ijassa-759	466	25	injection	injection	NOUN
ijassa-759	466	26	of	of	ADP
ijassa-759	466	27	the	the	DET
ijassa-759	466	28	vaccine	vaccine	NOUN
ijassa-759	466	29	(	(	PUNCT
ijassa-759	466	30	)	)	PUNCT
ijassa-759	466	31	dv	dv	PROPN
ijassa-759	466	32	t	t	PROPN
ijassa-759	466	33	dt	dt	PROPN
ijassa-759	466	34	–	–	PUNCT
ijassa-759	466	35	(	(	PUNCT
ijassa-759	466	36	6	6	NUM
ijassa-759	466	37	)	)	PUNCT
ijassa-759	466	38	v	v	NOUN
ijassa-759	466	39	=	=	NOUN
ijassa-759	466	40	0.1	0.1	NUM
ijassa-759	466	41	the	the	DET
ijassa-759	466	42	reproductive	reproductive	ADJ
ijassa-759	466	43	rate	rate	NOUN
ijassa-759	466	44	of	of	ADP
ijassa-759	466	45	the	the	DET
ijassa-759	466	46	virus	virus	NOUN
ijassa-759	466	47	v	v	X
ijassa-759	466	48	=	=	PUNCT
ijassa-759	466	49	15	15	NUM
ijassa-759	466	50	the	the	DET
ijassa-759	466	51	rate	rate	NOUN
ijassa-759	466	52	of	of	ADP
ijassa-759	466	53	death	death	NOUN
ijassa-759	466	54	of	of	ADP
ijassa-759	466	55	viruses	virus	NOUN
ijassa-759	466	56	in	in	ADP
ijassa-759	466	57	their	their	PRON
ijassa-759	466	58	interaction	interaction	NOUN
ijassa-759	466	59	with	with	ADP
ijassa-759	466	60	antibodies	antibody	NOUN
ijassa-759	466	61	0v	0v	NOUN
ijassa-759	466	62	=	=	PUNCT
ijassa-759	466	63	0.015	0.015	NUM
ijassa-759	466	64	the	the	DET
ijassa-759	466	65	initial	initial	ADJ
ijassa-759	466	66	condition	condition	NOUN
ijassa-759	466	67	of	of	ADP
ijassa-759	466	68	equation	equation	NOUN
ijassa-759	466	69	(	(	PUNCT
ijassa-759	466	70	2	2	NUM
ijassa-759	466	71	)	)	PUNCT
ijassa-759	466	72	,	,	PUNCT
ijassa-759	466	73	which	which	PRON
ijassa-759	466	74	reflects	reflect	VERB
ijassa-759	466	75	the	the	DET
ijassa-759	466	76	dose	dose	NOUN
ijassa-759	466	77	of	of	ADP
ijassa-759	466	78	the	the	DET
ijassa-759	466	79	viral	viral	ADJ
ijassa-759	466	80	vaccine	vaccine	NOUN
ijassa-759	466	81	(	(	PUNCT
ijassa-759	466	82	)	)	PUNCT
ijassa-759	466	83	vda	vda	PROPN
ijassa-759	466	84	t	t	NOUN
ijassa-759	466	85	dt	dt	PROPN
ijassa-759	466	86	–	–	PUNCT
ijassa-759	466	87	(	(	PUNCT
ijassa-759	466	88	7	7	X
ijassa-759	466	89	)	)	PUNCT
ijassa-759	467	1	a	a	ADV
ijassa-759	467	2	=	=	SYM
ijassa-759	467	3	100	100	NUM
ijassa-759	467	4	the	the	DET
ijassa-759	467	5	rate	rate	NOUN
ijassa-759	467	6	of	of	ADP
ijassa-759	467	7	formation	formation	NOUN
ijassa-759	467	8	of	of	ADP
ijassa-759	467	9	antibodies	antibody	NOUN
ijassa-759	467	10	from	from	ADP
ijassa-759	467	11	the	the	DET
ijassa-759	467	12	single	single	ADJ
ijassa-759	467	13	plasma	plasma	NOUN
ijassa-759	467	14	cells	cell	NOUN
ijassa-759	467	15	av	av	VERB
ijassa-759	467	16	=	=	SYM
ijassa-759	467	17	70	70	NUM
ijassa-759	467	18	the	the	DET
ijassa-759	467	19	rate	rate	NOUN
ijassa-759	467	20	of	of	ADP
ijassa-759	467	21	loss	loss	NOUN
ijassa-759	467	22	of	of	ADP
ijassa-759	467	23	antibody	antibody	NOUN
ijassa-759	467	24	due	due	ADP
ijassa-759	467	25	to	to	ADP
ijassa-759	467	26	the	the	DET
ijassa-759	467	27	interaction	interaction	NOUN
ijassa-759	467	28	with	with	ADP
ijassa-759	467	29	viruses	virus	NOUN
ijassa-759	467	30	v	v	X
ijassa-759	467	31	=	=	SYM
ijassa-759	467	32	5	5	NUM
ijassa-759	467	33	the	the	DET
ijassa-759	467	34	rate	rate	NOUN
ijassa-759	467	35	of	of	ADP
ijassa-759	467	36	reduction	reduction	NOUN
ijassa-759	467	37	of	of	ADP
ijassa-759	467	38	the	the	DET
ijassa-759	467	39	number	number	NOUN
ijassa-759	467	40	of	of	ADP
ijassa-759	467	41	antibodies	antibody	NOUN
ijassa-759	467	42	due	due	ADP
ijassa-759	467	43	to	to	ADP
ijassa-759	467	44	natural	natural	ADJ
ijassa-759	467	45	destruction	destruction	NOUN
ijassa-759	467	46	max	max	PROPN
ijassa-759	467	47	va	va	PROPN
ijassa-759	467	48	=	=	PROPN
ijassa-759	467	49	1.05	1.05	NUM
ijassa-759	467	50	the	the	DET
ijassa-759	467	51	maximum	maximum	ADJ
ijassa-759	467	52	calculated	calculate	VERB
ijassa-759	467	53	number	number	NOUN
ijassa-759	467	54	of	of	ADP
ijassa-759	467	55	the	the	DET
ijassa-759	467	56	antibodies	antibody	NOUN
ijassa-759	467	57	(	(	PUNCT
ijassa-759	467	58	)	)	PUNCT
ijassa-759	467	59	vdc	vdc	PROPN
ijassa-759	467	60	t	t	PROPN
ijassa-759	467	61	dt	dt	PROPN
ijassa-759	467	62	–	–	PUNCT
ijassa-759	467	63	(	(	PUNCT
ijassa-759	467	64	8)	8)	NUM
ijassa-759	467	65	с	с	X
ijassa-759	467	66	=	=	PUNCT
ijassa-759	467	67	100	100	NUM
ijassa-759	467	68	the	the	DET
ijassa-759	467	69	rate	rate	NOUN
ijassa-759	467	70	of	of	ADP
ijassa-759	467	71	formation	formation	NOUN
ijassa-759	467	72	of	of	ADP
ijassa-759	467	73	plasma	plasma	NOUN
ijassa-759	467	74	cells	cell	NOUN
ijassa-759	467	75	cv	cv	ADV
ijassa-759	467	76	=	=	PUNCT
ijassa-759	467	77	4.5	4.5	NUM
ijassa-759	467	78	the	the	DET
ijassa-759	467	79	size	size	NOUN
ijassa-759	467	80	factor	factor	NOUN
ijassa-759	467	81	vnc	vnc	NOUN
ijassa-759	467	82	=	=	PROPN
ijassa-759	467	83	0.001	0.001	NUM
ijassa-759	467	84	the	the	DET
ijassa-759	467	85	initial	initial	ADJ
ijassa-759	467	86	number	number	NOUN
ijassa-759	467	87	of	of	ADP
ijassa-759	467	88	plasma	plasma	NOUN
ijassa-759	467	89	cells	cell	NOUN
ijassa-759	467	90	(	(	PUNCT
ijassa-759	467	91	)	)	PUNCT
ijassa-759	467	92	nda	nda	PROPN
ijassa-759	467	93	t	t	PROPN
ijassa-759	467	94	dt	dt	PROPN
ijassa-759	467	95	–	–	PUNCT
ijassa-759	467	96	(	(	PUNCT
ijassa-759	467	97	9	9	X
ijassa-759	467	98	)	)	PUNCT
ijassa-759	467	99	an	an	NOUN
ijassa-759	467	100	=	=	PUNCT
ijassa-759	467	101	30	30	NUM
ijassa-759	467	102	the	the	DET
ijassa-759	467	103	rate	rate	NOUN
ijassa-759	467	104	of	of	ADP
ijassa-759	467	105	formation	formation	NOUN
ijassa-759	467	106	of	of	ADP
ijassa-759	467	107	antibodies	antibody	NOUN
ijassa-759	467	108	from	from	ADP
ijassa-759	467	109	the	the	DET
ijassa-759	467	110	single	single	ADJ
ijassa-759	467	111	plasma	plasma	NOUN
ijassa-759	467	112	cells	cell	NOUN
ijassa-759	467	113	an	an	VERB
ijassa-759	468	1	=	=	PUNCT
ijassa-759	468	2	6.2	6.2	NUM
ijassa-759	468	3	the	the	DET
ijassa-759	468	4	rate	rate	NOUN
ijassa-759	468	5	of	of	ADP
ijassa-759	468	6	decline	decline	NOUN
ijassa-759	468	7	of	of	ADP
ijassa-759	468	8	antibodies	antibody	NOUN
ijassa-759	468	9	due	due	ADP
ijassa-759	468	10	to	to	ADP
ijassa-759	468	11	the	the	DET
ijassa-759	468	12	interaction	interaction	NOUN
ijassa-759	468	13	with	with	ADP
ijassa-759	468	14	the	the	DET
ijassa-759	468	15	tumor	tumor	NOUN
ijassa-759	468	16	cells	cell	NOUN
ijassa-759	468	17	nn	nn	NOUN
ijassa-759	469	1	=	=	PUNCT
ijassa-759	469	2	6.3	6.3	NUM
ijassa-759	469	3	the	the	DET
ijassa-759	469	4	rate	rate	NOUN
ijassa-759	469	5	of	of	ADP
ijassa-759	469	6	the	the	DET
ijassa-759	469	7	reduction	reduction	NOUN
ijassa-759	469	8	of	of	ADP
ijassa-759	469	9	the	the	DET
ijassa-759	469	10	number	number	NOUN
ijassa-759	469	11	of	of	ADP
ijassa-759	469	12	antibodies	antibody	NOUN
ijassa-759	469	13	due	due	ADP
ijassa-759	469	14	to	to	ADP
ijassa-759	469	15	the	the	DET
ijassa-759	469	16	natural	natural	ADJ
ijassa-759	469	17	destruction	destruction	NOUN
ijassa-759	469	18	max	max	NOUN
ijassa-759	469	19	na	na	ADP
ijassa-759	469	20	=	=	SYM
ijassa-759	469	21	4.64	4.64	NUM
ijassa-759	469	22	the	the	DET
ijassa-759	469	23	maximum	maximum	ADJ
ijassa-759	469	24	calculated	calculate	VERB
ijassa-759	469	25	number	number	NOUN
ijassa-759	469	26	of	of	ADP
ijassa-759	469	27	antibodies	antibody	NOUN
ijassa-759	469	28	(	(	PUNCT
ijassa-759	469	29	)	)	PUNCT
ijassa-759	469	30	ndc	ndc	PROPN
ijassa-759	469	31	t	t	PROPN
ijassa-759	469	32	dt	dt	PROPN
ijassa-759	469	33	–	–	PUNCT
ijassa-759	469	34	(	(	PUNCT
ijassa-759	469	35	10	10	NUM
ijassa-759	469	36	)	)	PUNCT
ijassa-759	469	37	cn	cn	NOUN
ijassa-759	469	38	=	=	PUNCT
ijassa-759	470	1	76.677	76.677	NUM
ijassa-759	470	2	the	the	DET
ijassa-759	470	3	rate	rate	NOUN
ijassa-759	470	4	of	of	ADP
ijassa-759	470	5	formation	formation	NOUN
ijassa-759	470	6	of	of	ADP
ijassa-759	470	7	plasma	plasma	NOUN
ijassa-759	470	8	cells	cell	NOUN
ijassa-759	470	9	cn	cn	VERB
ijassa-759	470	10	=	=	PUNCT
ijassa-759	471	1	38	38	NUM
ijassa-759	471	2	the	the	DET
ijassa-759	471	3	size	size	NOUN
ijassa-759	471	4	factor	factor	NOUN
ijassa-759	471	5	nnc	nnc	PROPN
ijassa-759	471	6	=	=	PROPN
ijassa-759	471	7	0.0001	0.0001	NUM
ijassa-759	471	8	the	the	DET
ijassa-759	471	9	initial	initial	ADJ
ijassa-759	471	10	number	number	NOUN
ijassa-759	471	11	of	of	ADP
ijassa-759	471	12	plasma	plasma	NOUN
ijassa-759	471	13	cells	cell	NOUN
ijassa-759	471	14	(	(	PUNCT
ijassa-759	471	15	)	)	PUNCT
ijassa-759	471	16	p	p	PROPN
ijassa-759	471	17	t	t	PROPN
ijassa-759	471	18	–	–	PUNCT
ijassa-759	471	19	(	(	PUNCT
ijassa-759	471	20	11	11	NUM
ijassa-759	471	21	)	)	PUNCT
ijassa-759	471	22	p	p	NOUN
ijassa-759	471	23	=	=	NOUN
ijassa-759	471	24	0.3	0.3	NUM
ijassa-759	471	25	pk	pk	NOUN
ijassa-759	471	26	=	=	NOUN
ijassa-759	471	27	0.95	0.95	NUM
ijassa-759	471	28	*	*	NUM
ijassa-759	471	29	1	1	NUM
ijassa-759	471	30	/	/	SYM
ijassa-759	471	31	p	p	NOUN
ijassa-759	471	32	t	t	X
ijassa-759	471	33	=	=	PUNCT
ijassa-759	471	34	the	the	DET
ijassa-759	471	35	parameters	parameter	NOUN
ijassa-759	471	36	of	of	ADP
ijassa-759	471	37	the	the	DET
ijassa-759	471	38	p(t	p(t	NOUN
ijassa-759	471	39	)	)	PUNCT
ijassa-759	471	40	function	function	NOUN
ijassa-759	471	41	describing	describe	VERB
ijassa-759	471	42	the	the	DET
ijassa-759	471	43	dynamics	dynamic	NOUN
ijassa-759	471	44	of	of	ADP
ijassa-759	471	45	the	the	DET
ijassa-759	471	46	decrease	decrease	NOUN
ijassa-759	471	47	in	in	ADP
ijassa-759	471	48	the	the	DET
ijassa-759	471	49	proportion	proportion	NOUN
ijassa-759	471	50	of	of	ADP
ijassa-759	471	51	rapidly	rapidly	ADV
ijassa-759	471	52	proliferating	proliferate	VERB
ijassa-759	471	53	cells	cell	NOUN
ijassa-759	471	54	as	as	SCONJ
ijassa-759	471	55	the	the	DET
ijassa-759	471	56	tumor	tumor	NOUN
ijassa-759	471	57	size	size	NOUN
ijassa-759	471	58	increases	increase	VERB
ijassa-759	471	59	the	the	DET
ijassa-759	471	60	moment	moment	NOUN
ijassa-759	471	61	at	at	ADP
ijassa-759	471	62	which	which	PRON
ijassa-759	471	63	the	the	DET
ijassa-759	471	64	number	number	NOUN
ijassa-759	471	65	of	of	ADP
ijassa-759	471	66	fractions	fraction	NOUN
ijassa-759	471	67	of	of	ADP
ijassa-759	471	68	rapidly	rapidly	ADV
ijassa-759	471	69	and	and	CCONJ
ijassa-759	471	70	mathematical	mathematical	ADJ
ijassa-759	471	71	modeling	modeling	NOUN
ijassa-759	471	72	of	of	ADP
ijassa-759	471	73	antitumor	antitumor	PROPN
ijassa-759	471	74	viral	viral	ADJ
ijassa-759	471	75	vaccine	vaccine	NOUN
ijassa-759	471	76	therapy	therapy	NOUN
ijassa-759	471	77	…	…	PUNCT
ijassa-759	471	78	copyright	copyright	NOUN
ijassa-759	471	79	©	©	PROPN
ijassa-759	471	80	2020	2020	NUM
ijassa-759	471	81	assa	assa	NOUN
ijassa-759	471	82	.	.	PUNCT
ijassa-759	472	1	adv	adv	PROPN
ijassa-759	472	2	.	.	PUNCT
ijassa-759	473	1	in	in	ADP
ijassa-759	473	2	systems	system	NOUN
ijassa-759	473	3	science	science	NOUN
ijassa-759	473	4	and	and	CCONJ
ijassa-759	473	5	appl	appl	NOUN
ijassa-759	473	6	.	.	PUNCT
ijassa-759	474	1	(	(	PUNCT
ijassa-759	474	2	2020	2020	NUM
ijassa-759	474	3	)	)	PUNCT
ijassa-759	475	1	23	23	NUM
ijassa-759	476	1	*	*	PUNCT
ijassa-759	476	2	t	t	NOUN
ijassa-759	476	3	=	=	SYM
ijassa-759	476	4	35	35	NUM
ijassa-759	476	5	суток	суток	NOUN
ijassa-759	476	6	slowly	slowly	ADV
ijassa-759	476	7	proliferating	proliferate	VERB
ijassa-759	476	8	cells	cell	NOUN
ijassa-759	476	9	are	be	AUX
ijassa-759	476	10	equal	equal	ADJ
ijassa-759	476	11	(	(	PUNCT
ijassa-759	476	12	)	)	PUNCT
ijassa-759	476	13	dn	dn	PROPN
ijassa-759	476	14	t	t	PROPN
ijassa-759	476	15	dt	dt	PROPN
ijassa-759	476	16	–	–	PUNCT
ijassa-759	476	17	(	(	PUNCT
ijassa-759	476	18	13	13	NUM
ijassa-759	476	19	)	)	PUNCT
ijassa-759	476	20	v	v	PROPN
ijassa-759	476	21	=	=	NOUN
ijassa-759	476	22	4.5	4.5	NUM
ijassa-759	476	23	сут	сут	NOUN
ijassa-759	476	24	.	.	PUNCT
ijassa-759	477	1	the	the	DET
ijassa-759	477	2	delay	delay	NOUN
ijassa-759	477	3	in	in	ADP
ijassa-759	477	4	the	the	DET
ijassa-759	477	5	growth	growth	NOUN
ijassa-759	477	6	of	of	ADP
ijassa-759	477	7	tumor	tumor	NOUN
ijassa-759	477	8	cells	cell	NOUN
ijassa-759	477	9	as	as	ADP
ijassa-759	477	10	a	a	DET
ijassa-759	477	11	result	result	NOUN
ijassa-759	477	12	of	of	ADP
ijassa-759	477	13	their	their	PRON
ijassa-759	477	14	death	death	NOUN
ijassa-759	477	15	under	under	ADP
ijassa-759	477	16	the	the	DET
ijassa-759	477	17	action	action	NOUN
ijassa-759	477	18	of	of	ADP
ijassa-759	477	19	the	the	DET
ijassa-759	477	20	virus	virus	NOUN
ijassa-759	477	21	v	v	X
ijassa-759	477	22	=	=	PROPN
ijassa-759	477	23	9.8	9.8	NUM
ijassa-759	477	24	сут	сут	NOUN
ijassa-759	477	25	.	.	PUNCT
ijassa-759	478	1	the	the	DET
ijassa-759	478	2	delay	delay	NOUN
ijassa-759	478	3	in	in	ADP
ijassa-759	478	4	the	the	DET
ijassa-759	478	5	growth	growth	NOUN
ijassa-759	478	6	of	of	ADP
ijassa-759	478	7	tumor	tumor	NOUN
ijassa-759	478	8	cells	cell	NOUN
ijassa-759	478	9	as	as	ADP
ijassa-759	478	10	a	a	DET
ijassa-759	478	11	result	result	NOUN
ijassa-759	478	12	of	of	ADP
ijassa-759	478	13	their	their	PRON
ijassa-759	478	14	death	death	NOUN
ijassa-759	478	15	under	under	ADP
ijassa-759	478	16	the	the	DET
ijassa-759	478	17	action	action	NOUN
ijassa-759	478	18	of	of	ADP
ijassa-759	478	19	antibodies	antibody	NOUN
ijassa-759	478	20	against	against	ADP
ijassa-759	478	21	infected	infected	ADJ
ijassa-759	478	22	tumor	tumor	NOUN
ijassa-759	478	23	cells	cell	NOUN
ijassa-759	478	24	1	1	NUM
ijassa-759	478	25	vt	vt	NOUN
ijassa-759	478	26	=	=	NOUN
ijassa-759	478	27	5.82	5.82	NUM
ijassa-759	478	28	1	1	NUM
ijassa-759	478	29	nt	not	PART
ijassa-759	478	30	=	=	NOUN
ijassa-759	478	31	12.32	12.32	NUM
ijassa-759	478	32	the	the	DET
ijassa-759	478	33	moments	moment	NOUN
ijassa-759	478	34	of	of	ADP
ijassa-759	478	35	reaching	reach	VERB
ijassa-759	478	36	the	the	DET
ijassa-759	478	37	maximum	maximum	ADJ
ijassa-759	478	38	number	number	NOUN
ijassa-759	478	39	of	of	ADP
ijassa-759	478	40	infected	infected	ADJ
ijassa-759	478	41	tumor	tumor	NOUN
ijassa-759	478	42	cells	cell	NOUN
ijassa-759	478	43	by	by	ADP
ijassa-759	478	44	the	the	DET
ijassa-759	478	45	beginning	beginning	NOUN
ijassa-759	478	46	of	of	ADP
ijassa-759	478	47	the	the	DET
ijassa-759	478	48	immune	immune	ADJ
ijassa-759	478	49	response	response	NOUN
ijassa-759	478	50	2	2	NUM
ijassa-759	478	51	vt	vt	NOUN
ijassa-759	478	52	=	=	NOUN
ijassa-759	478	53	7.13	7.13	NUM
ijassa-759	478	54	2	2	NUM
ijassa-759	478	55	nt	not	PART
ijassa-759	478	56	=	=	NOUN
ijassa-759	478	57	14.29	14.29	NUM
ijassa-759	478	58	the	the	DET
ijassa-759	478	59	moments	moment	NOUN
ijassa-759	478	60	of	of	ADP
ijassa-759	478	61	reaching	reach	VERB
ijassa-759	478	62	the	the	DET
ijassa-759	478	63	minimum	minimum	ADJ
ijassa-759	478	64	number	number	NOUN
ijassa-759	478	65	of	of	ADP
ijassa-759	478	66	infected	infected	ADJ
ijassa-759	478	67	tumor	tumor	NOUN
ijassa-759	478	68	cells	cell	NOUN
ijassa-759	478	69	by	by	ADP
ijassa-759	478	70	the	the	DET
ijassa-759	478	71	end	end	NOUN
ijassa-759	478	72	of	of	ADP
ijassa-759	478	73	the	the	DET
ijassa-759	478	74	immune	immune	ADJ
ijassa-759	478	75	response	response	NOUN
ijassa-759	478	76	(	(	PUNCT
ijassa-759	478	77	)	)	PUNCT
ijassa-759	478	78	1	1	NUM
ijassa-759	478	79	v	v	NOUN
ijassa-759	478	80	v	v	INTJ
ijassa-759	478	81	vn	vn	PROPN
ijassa-759	478	82	t	t	PROPN
ijassa-759	478	83	=	=	PROPN
ijassa-759	478	84	1.31	1.31	NUM
ijassa-759	478	85	,	,	PUNCT
ijassa-759	478	86	(	(	PUNCT
ijassa-759	478	87	)	)	SYM
ijassa-759	478	88	1	1	NUM
ijassa-759	478	89	n	n	NUM
ijassa-759	478	90	n	n	NUM
ijassa-759	478	91	vn	vn	PROPN
ijassa-759	478	92	t	t	PROPN
ijassa-759	478	93	=	=	PUNCT
ijassa-759	478	94	1.15	1.15	NUM
ijassa-759	478	95	the	the	DET
ijassa-759	478	96	maximum	maximum	ADJ
ijassa-759	478	97	values	value	NOUN
ijassa-759	478	98	of	of	ADP
ijassa-759	478	99	the	the	DET
ijassa-759	478	100	number	number	NOUN
ijassa-759	478	101	of	of	ADP
ijassa-759	478	102	infected	infected	ADJ
ijassa-759	478	103	tumor	tumor	NOUN
ijassa-759	478	104	cells	cell	NOUN
ijassa-759	478	105	before	before	ADP
ijassa-759	478	106	the	the	DET
ijassa-759	478	107	immune	immune	ADJ
ijassa-759	478	108	response	response	NOUN
ijassa-759	478	109	at	at	ADP
ijassa-759	478	110	each	each	PRON
ijassa-759	478	111	of	of	ADP
ijassa-759	478	112	the	the	DET
ijassa-759	478	113	two	two	NUM
ijassa-759	478	114	stages	stage	NOUN
ijassa-759	478	115	of	of	ADP
ijassa-759	478	116	their	their	PRON
ijassa-759	478	117	death	death	NOUN
ijassa-759	478	118	(	(	PUNCT
ijassa-759	478	119	)	)	PUNCT
ijassa-759	478	120	2	2	NUM
ijassa-759	478	121	v	v	NOUN
ijassa-759	478	122	v	v	ADP
ijassa-759	478	123	vn	vn	PROPN
ijassa-759	478	124	t	t	PROPN
ijassa-759	478	125	=	=	PUNCT
ijassa-759	478	126	0.84	0.84	NUM
ijassa-759	478	127	,	,	PUNCT
ijassa-759	478	128	(	(	PUNCT
ijassa-759	478	129	)	)	PUNCT
ijassa-759	478	130	2	2	NUM
ijassa-759	478	131	n	n	NUM
ijassa-759	478	132	n	n	NOUN
ijassa-759	478	133	vn	vn	NOUN
ijassa-759	478	134	t	t	NOUN
ijassa-759	478	135	=	=	PUNCT
ijassa-759	478	136	0.1	0.1	NUM
ijassa-759	478	137	the	the	DET
ijassa-759	478	138	minimum	minimum	ADJ
ijassa-759	478	139	values	value	NOUN
ijassa-759	478	140	of	of	ADP
ijassa-759	478	141	the	the	DET
ijassa-759	478	142	number	number	NOUN
ijassa-759	478	143	of	of	ADP
ijassa-759	478	144	infected	infected	ADJ
ijassa-759	478	145	tumor	tumor	NOUN
ijassa-759	478	146	cells	cell	NOUN
ijassa-759	478	147	at	at	ADP
ijassa-759	478	148	the	the	DET
ijassa-759	478	149	end	end	NOUN
ijassa-759	478	150	of	of	ADP
ijassa-759	478	151	the	the	DET
ijassa-759	478	152	immune	immune	ADJ
ijassa-759	478	153	response	response	NOUN
ijassa-759	478	154	at	at	ADP
ijassa-759	478	155	each	each	PRON
ijassa-759	478	156	of	of	ADP
ijassa-759	478	157	the	the	DET
ijassa-759	478	158	two	two	NUM
ijassa-759	478	159	stages	stage	NOUN
ijassa-759	478	160	of	of	ADP
ijassa-759	478	161	their	their	PRON
ijassa-759	478	162	death	death	NOUN
ijassa-759	478	163	(	(	PUNCT
ijassa-759	478	164	)	)	PUNCT
ijassa-759	478	165	1	1	NUM
ijassa-759	478	166	v	v	NOUN
ijassa-759	478	167	v	v	ADP
ijassa-759	478	168	vn	vn	NOUN
ijassa-759	478	169	t	t	NOUN
ijassa-759	478	170	=	=	SYM
ijassa-759	478	171	0.47	0.47	NUM
ijassa-759	478	172	,	,	PUNCT
ijassa-759	478	173	(	(	PUNCT
ijassa-759	478	174	)	)	SYM
ijassa-759	478	175	1	1	NUM
ijassa-759	478	176	n	n	NUM
ijassa-759	478	177	n	n	NUM
ijassa-759	478	178	vn	vn	NOUN
ijassa-759	478	179	t	t	NOUN
ijassa-759	478	180	=	=	NOUN
ijassa-759	478	181	1.04	1.04	NUM
ijassa-759	478	182	the	the	DET
ijassa-759	478	183	number	number	NOUN
ijassa-759	478	184	of	of	ADP
ijassa-759	478	185	infected	infected	ADJ
ijassa-759	478	186	cells	cell	NOUN
ijassa-759	478	187	killed	kill	VERB
ijassa-759	478	188	in	in	ADP
ijassa-759	478	189	the	the	DET
ijassa-759	478	190	first	first	ADJ
ijassa-759	478	191	and	and	CCONJ
ijassa-759	478	192	second	second	ADJ
ijassa-759	478	193	stages	stage	NOUN
ijassa-759	478	194	of	of	ADP
ijassa-759	478	195	immune	immune	ADJ
ijassa-759	478	196	system	system	NOUN
ijassa-759	478	197	stimulation	stimulation	NOUN
ijassa-759	478	198	1	1	NUM
ijassa-759	478	199	.	.	PUNCT
ijassa-759	479	1	introduction	introduction	NOUN
ijassa-759	479	2	2	2	NUM
ijassa-759	479	3	.	.	PUNCT
ijassa-759	479	4	problem	problem	NOUN
ijassa-759	479	5	statement	statement	NOUN